<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Sci</journal-id><journal-id journal-id-type="iso-abbrev">Brain Sci</journal-id><journal-id journal-id-type="publisher-id">brainsci</journal-id><journal-title-group><journal-title>Brain Sciences</journal-title></journal-title-group><issn pub-type="epub">2076-3425</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4061890</article-id><article-id pub-id-type="doi">10.3390/brainsci3041483</article-id><article-id pub-id-type="publisher-id">brainsci-03-01483</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Henkin</surname><given-names>Robert I.</given-names></name><xref ref-type="aff" rid="af1-brainsci-03-01483">1</xref><xref rid="c1-brainsci-03-01483" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Potolicchio</surname><given-names>Samuel J.</given-names></name><xref ref-type="aff" rid="af2-brainsci-03-01483">2</xref><xref ref-type="author-notes" rid="fn1-brainsci-03-01483">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Levy</surname><given-names>Lucien M.</given-names></name><xref ref-type="aff" rid="af3-brainsci-03-01483">3</xref><xref ref-type="author-notes" rid="fn1-brainsci-03-01483">&#x02020;</xref></contrib></contrib-group><aff id="af1-brainsci-03-01483"><label>1</label>Center for Molecular Nutrition and Sensory Disorders, The Taste and Smell Clinic, 5125 MacArthur Blvd, NW, Suite 20, Washington, DC 20016, USA</aff><aff id="af2-brainsci-03-01483"><label>2</label>Department of Neurology, The George Washington University Medical Center, 2150 Pennsylvania Avenue, NW, 7th Floor, Washington, DC 20037, USA; E-Mail: <email>spotolicchio@mfa.gwu.edu</email></aff><aff id="af3-brainsci-03-01483"><label>3</label>Department of Radiology, The George Washington University Medical Center, 900 23rd Street, NW, Washington, DC 20037, USA; E-Mail: <email>llevy@mfa.gwu.edu</email></aff><author-notes><fn id="fn1-brainsci-03-01483"><label>&#x02020;</label><p>These authors contributed equally to this work. </p></fn><corresp id="c1-brainsci-03-01483"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>doc@tasteandsmell.com</email>; Tel.: +1-202-364-4180; Fax: +1-202-364-9727.</corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>11</month><year>2013</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2013</year></pub-date><volume>3</volume><issue>4</issue><fpage>1483</fpage><lpage>1553</lpage><history><date date-type="received"><day>26</day><month>6</month><year>2013</year></date><date date-type="rev-recd"><day>11</day><month>10</month><year>2013</year></date><date date-type="accepted"><day>12</day><month>10</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2013 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>).</license-p></license></permissions><abstract><p>Olfactory hallucinations without subsequent myoclonic activity have not been well characterized or understood. Herein we describe, in a retrospective study, two major forms of olfactory hallucinations labeled phantosmias: one, unirhinal, the other, birhinal. To describe these disorders we performed several procedures to elucidate similarities and differences between these processes. From 1272, patients evaluated for taste and smell dysfunction at The Taste and Smell Clinic, Washington, DC with clinical history, neurological and otolaryngological examinations, evaluations of taste and smell function, EEG and neuroradiological studies 40 exhibited cyclic unirhinal phantosmia (CUP) usually without hyposmia whereas 88 exhibited non-cyclic birhinal phantosmia with associated symptomology (BPAS) with hyposmia. Patients with CUP developed phantosmia spontaneously or after laughing, coughing or shouting initially with spontaneous inhibition and subsequently with Valsalva maneuvers, sleep or nasal water inhalation; they had frequent EEG changes usually ipsilateral sharp waves. Patients with BPAS developed phantosmia secondary to several clinical events usually after hyposmia onset with few EEG changes; their phantosmia could not be initiated or inhibited by any physiological maneuver. CUP is uncommonly encountered and represents a newly defined clinical syndrome. BPAS is commonly encountered, has been observed previously but has not been clearly defined. Mechanisms responsible for phantosmia in each group were related to decreased gamma-aminobutyric acid (GABA) activity in specific brain regions. Treatment which activated brain GABA inhibited phantosmia in both groups.</p></abstract><kwd-group><kwd>phantosmia</kwd><kwd>hallucination</kwd><kwd>aura</kwd><kwd>olfaction</kwd><kwd>taste</kwd><kwd>phantageusia</kwd><kwd>epilepsy</kwd><kwd>Valsalva</kwd><kwd>GABA</kwd><kwd>brain plasticity</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>Perception of visual and auditory hallucinations in the absence of any apparent stimulus has been recognized since antiquity but similar perceptions of olfactory hallucinations may not have been recorded until 131 A.D. when Aretaeus, the Cappodocian wrote &#x0201c;a heavy smell sometimes preceded the accession of a paroxysm&#x0201d; [<xref rid="B1-brainsci-03-01483" ref-type="bibr">1</xref>]. Association of an odor preceding a subsequent seizure-like event was emphasized with his statement &#x0201c;sometimes the smell of the gagate stone makes them fall down&#x0201d; [<xref rid="B1-brainsci-03-01483" ref-type="bibr">1</xref>]. The odor preceding the seizure was considered an aura, a term introduced by Pelop, the master of Galeni to describe literally &#x0201c;a breath of air&#x0201d; [<xref rid="B2-brainsci-03-01483" ref-type="bibr">2</xref>]. The term was then associated with the Latin translation as odor or breeze, which was subsequently applied to all sensations preceding a seizure, and recognized as a spontaneous sensation without a specific initiating stimulus. Auras clinically associated with a subsequent seizure were considered to represent manifestations of early stages of build up of abnormal, synchronous electrical activity [<xref rid="B3-brainsci-03-01483" ref-type="bibr">3</xref>].</p><p>Historically, all sensory phenomena preceding a seizure were classified under the general term hallucination although the modus operandi for each sensory modality might differ and the mechanism(s) which initiated the so-called hallucinatory activity related to a multiplicity of antecedent causes. The word hallucinate derives from the verb to dream and hallucination defined as a dream-like state with perception of objects with no reality [<xref rid="B4-brainsci-03-01483" ref-type="bibr">4</xref>] clinically described as a disorder of the nervous system; this term may have been first introduced clinically in 1837 in Esquirol&#x02019;s textbook [<xref rid="B5-brainsci-03-01483" ref-type="bibr">5</xref>] and, hence, it acquired a pathological implication usually related to an altered mental state. The term apparition, derived from the verb appearance [<xref rid="B4-brainsci-03-01483" ref-type="bibr">4</xref>], defined simply as an unusual appearance [<xref rid="B4-brainsci-03-01483" ref-type="bibr">4</xref>], is usually applied to visual perception of a non-existent ghostly figure without any clinical implication. The term phantom has been applied to these same phenomena defined as something apparent to the sense, e.g., a ghost or spectre, but without substantial existence or initiating stimulus [<xref rid="B4-brainsci-03-01483" ref-type="bibr">4</xref>]. These terms have been commonly used to describe transient visual or auditory phenomena, which are usually frightening or threatening although their physiology was not clearly specified. The terms aura, dreamy state and hallucination, describing the same fixed sensation have, on occasion, been used and considered interchangeable, as with Jackson&#x02019;s localization of a dreamy state prior to a seizure related to a temporal lobe lesion [<xref rid="B6-brainsci-03-01483" ref-type="bibr">6</xref>,<xref rid="B7-brainsci-03-01483" ref-type="bibr">7</xref>,<xref rid="B8-brainsci-03-01483" ref-type="bibr">8</xref>]. </p><p>There is considerable confusion related to diversity of auras [<xref rid="B9-brainsci-03-01483" ref-type="bibr">9</xref>,<xref rid="B10-brainsci-03-01483" ref-type="bibr">10</xref>,<xref rid="B11-brainsci-03-01483" ref-type="bibr">11</xref>,<xref rid="B12-brainsci-03-01483" ref-type="bibr">12</xref>,<xref rid="B13-brainsci-03-01483" ref-type="bibr">13</xref>] and to what an aura represents. On the one hand aura has been formally defined as &#x0201c;that portion of the seizure which occurs before consciousness is lost and for which memory is retained afterwards&#x0201d; [<xref rid="B14-brainsci-03-01483" ref-type="bibr">14</xref>,<xref rid="B15-brainsci-03-01483" ref-type="bibr">15</xref>,<xref rid="B16-brainsci-03-01483" ref-type="bibr">16</xref>]. This suggests aura is part of the seizure complex [<xref rid="B17-brainsci-03-01483" ref-type="bibr">17</xref>,<xref rid="B18-brainsci-03-01483" ref-type="bibr">18</xref>,<xref rid="B19-brainsci-03-01483" ref-type="bibr">19</xref>,<xref rid="B20-brainsci-03-01483" ref-type="bibr">20</xref>], is associated anatomically with the mechanism initiating the seizure (tumor, mesial temporal sclerosis, <italic>etc</italic>.) and has value in localizing [<xref rid="B13-brainsci-03-01483" ref-type="bibr">13</xref>,<xref rid="B21-brainsci-03-01483" ref-type="bibr">21</xref>,<xref rid="B22-brainsci-03-01483" ref-type="bibr">22</xref>,<xref rid="B23-brainsci-03-01483" ref-type="bibr">23</xref>,<xref rid="B24-brainsci-03-01483" ref-type="bibr">24</xref>,<xref rid="B25-brainsci-03-01483" ref-type="bibr">25</xref>,<xref rid="B26-brainsci-03-01483" ref-type="bibr">26</xref>] or lateralizing [<xref rid="B14-brainsci-03-01483" ref-type="bibr">14</xref>,<xref rid="B16-brainsci-03-01483" ref-type="bibr">16</xref>,<xref rid="B17-brainsci-03-01483" ref-type="bibr">17</xref>] seizure onset. Attempts have been made to classify aura on a systematic basis (e.g., simple and complex [<xref rid="B27-brainsci-03-01483" ref-type="bibr">27</xref>]). Some investigators suggested aura was the whole seizure [<xref rid="B16-brainsci-03-01483" ref-type="bibr">16</xref>] whereas others suggested that it only preceded the seizure [<xref rid="B10-brainsci-03-01483" ref-type="bibr">10</xref>]. On the other hand, several investigators questioned the localizing value of aura [<xref rid="B28-brainsci-03-01483" ref-type="bibr">28</xref>,<xref rid="B29-brainsci-03-01483" ref-type="bibr">29</xref>,<xref rid="B30-brainsci-03-01483" ref-type="bibr">30</xref>,<xref rid="B31-brainsci-03-01483" ref-type="bibr">31</xref>] and some considered it an unnecessary component of epilepsy, albeit auras of taste and smell were considered reliable indicators of temporal lobe lesions [<xref rid="B27-brainsci-03-01483" ref-type="bibr">27</xref>]. With stereoelectroencephalography, particularly in amygdala, temporal or olfactory bulb regions, olfactory hallucinations were reported with electrical brain stimulation [<xref rid="B21-brainsci-03-01483" ref-type="bibr">21</xref>,<xref rid="B24-brainsci-03-01483" ref-type="bibr">24</xref>,<xref rid="B32-brainsci-03-01483" ref-type="bibr">32</xref>] whereas gustatory hallucinations were reported with stimulation in hippocampus and amygdala regions [<xref rid="B32-brainsci-03-01483" ref-type="bibr">32</xref>,<xref rid="B33-brainsci-03-01483" ref-type="bibr">33</xref>,<xref rid="B34-brainsci-03-01483" ref-type="bibr">34</xref>]. We have extended these concepts by use of techniques of functional magnetic resonance imaging (fMRI) of brain [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>] and by use of metabolic studies using magnetic resonance spectroscopy (MRS) [<xref rid="B36-brainsci-03-01483" ref-type="bibr">36</xref>] to describe the hallucinatory activities of these patients. By use of these techniques we have been able to develop both neurological and metabolic concepts upon which this hallucinatory activity is based.</p><p>A pathophysiological dissociation of seizure and aura was first proposed by Jackson who suggested auras might arise connected to but not in the seizure focus [<xref rid="B37-brainsci-03-01483" ref-type="bibr">37</xref>,<xref rid="B38-brainsci-03-01483" ref-type="bibr">38</xref>,<xref rid="B39-brainsci-03-01483" ref-type="bibr">39</xref>]. Sperling <italic>et al</italic>. using intracranial electrodes found limbic EEG correlates of auras lacking in patients who had specific limbic seizure localization [<xref rid="B31-brainsci-03-01483" ref-type="bibr">31</xref>]. Penfield described &#x0201c;experiential auras&#x0201d; elicited by electrical stimulation of temporal neocortex, not limbic cortex [<xref rid="B21-brainsci-03-01483" ref-type="bibr">21</xref>]. Gloor <italic>et al</italic>. stated aura represented activation of a neuronal network [<xref rid="B24-brainsci-03-01483" ref-type="bibr">24</xref>,<xref rid="B40-brainsci-03-01483" ref-type="bibr">40</xref>,<xref rid="B41-brainsci-03-01483" ref-type="bibr">41</xref>]. Auras have been associated with simple [<xref rid="B42-brainsci-03-01483" ref-type="bibr">42</xref>] and complex [<xref rid="B30-brainsci-03-01483" ref-type="bibr">30</xref>] partial seizures and considered to arise from specific brain regions; resection of this region (defined by subdural EEG recordings) resulted in cessation or significant reduction of these seizures in 60% of patients in one study [<xref rid="B42-brainsci-03-01483" ref-type="bibr">42</xref>]. However, as noted, the region from which EEG discharges arose may not be the only region in which functional alteration produced clinical features of simple partial seizures [<xref rid="B11-brainsci-03-01483" ref-type="bibr">11</xref>,<xref rid="B32-brainsci-03-01483" ref-type="bibr">32</xref>,<xref rid="B42-brainsci-03-01483" ref-type="bibr">42</xref>,<xref rid="B43-brainsci-03-01483" ref-type="bibr">43</xref>,<xref rid="B44-brainsci-03-01483" ref-type="bibr">44</xref>,<xref rid="B45-brainsci-03-01483" ref-type="bibr">45</xref>,<xref rid="B46-brainsci-03-01483" ref-type="bibr">46</xref>]. Using brain fMRI we have shown localization of phantosmia (<italic>i.e.</italic>, an olfactory hallucination in the absence of any external odor stimulus [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>]) in frontal, orbitofrontal and cingulate cortex and for phantageusia (<italic>i.e.</italic>, a gustatory hallucination in the absence of any oral stimulus) in insular cortex [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>].</p><p>Auras have persisted even after removal of pathological substrate for seizure discharge [<xref rid="B24-brainsci-03-01483" ref-type="bibr">24</xref>,<xref rid="B40-brainsci-03-01483" ref-type="bibr">40</xref>,<xref rid="B41-brainsci-03-01483" ref-type="bibr">41</xref>]. Conversely, patients with simple partial seizures related to focal temporal lobe activation may not exhibit aura of any type but after successful surgical resection of a localized focus which eliminates seizures with or without a motor component, aura may appear; this aura may be of any sensory modality but an intermittent recurrent olfactory aura or phantosmia is common (S.J. Potolicchio, unpublished observations). While most patients considered elimination of seizures with or without a motor component as successful seizure treatment following surgical central nervous system (CNS) resection, aura onset was considered a negative post operative component. Aura believed to be the beginning of convulsive attack or seizure [<xref rid="B45-brainsci-03-01483" ref-type="bibr">45</xref>,<xref rid="B47-brainsci-03-01483" ref-type="bibr">47</xref>], following successful CNS surgery for intractable epilepsy, has been reported to persist albeit patients were seizure free (<italic>i.e.</italic>, with or without motor components [<xref rid="B47-brainsci-03-01483" ref-type="bibr">47</xref>]). These results relate to auras of many types including visual, auditory, somatosensory, viscerosensory, gustatory or olfactory [<xref rid="B47-brainsci-03-01483" ref-type="bibr">47</xref>]. </p><p>Patients with both temporal lobe epilepsy [<xref rid="B14-brainsci-03-01483" ref-type="bibr">14</xref>,<xref rid="B24-brainsci-03-01483" ref-type="bibr">24</xref>] and migraine headaches [<xref rid="B48-brainsci-03-01483" ref-type="bibr">48</xref>,<xref rid="B49-brainsci-03-01483" ref-type="bibr">49</xref>,<xref rid="B50-brainsci-03-01483" ref-type="bibr">50</xref>,<xref rid="B51-brainsci-03-01483" ref-type="bibr">51</xref>,<xref rid="B52-brainsci-03-01483" ref-type="bibr">52</xref>,<xref rid="B53-brainsci-03-01483" ref-type="bibr">53</xref>,<xref rid="B54-brainsci-03-01483" ref-type="bibr">54</xref>] also reported olfactory auras prior to seizure or headache pain onset, respectively. One group of authors related these phantosmias to trigeminal nerve activation [<xref rid="B55-brainsci-03-01483" ref-type="bibr">55</xref>]. These auras were related to suspected CNS pathology in temporal lobe in epilepsy (v.i.) and initially to medial temporal lobe ischemia in migraine [<xref rid="B48-brainsci-03-01483" ref-type="bibr">48</xref>]. However, more recent studies have considered the physiological substrate of migraine aura to relate to cortical spreading depression and blood flow changes more related to oligemic neuronal dysfunction rather than primary cerebrovascular ischemia. Odor character was usually reported as obnoxious or unpleasant. Phantosmia in patients with migraine on occasion was familial with both mother and daughter experiencing the same type of olfactory aura and headache [<xref rid="B50-brainsci-03-01483" ref-type="bibr">50</xref>]. This may not be unexpected since a positive family history of migraine has been reported in 20%&#x02013;70% of cases [<xref rid="B48-brainsci-03-01483" ref-type="bibr">48</xref>,<xref rid="B56-brainsci-03-01483" ref-type="bibr">56</xref>,<xref rid="B57-brainsci-03-01483" ref-type="bibr">57</xref>]. Patients with auras and temporal lobe epilepsy commonly exhibited EEG abnormalities [<xref rid="B16-brainsci-03-01483" ref-type="bibr">16</xref>,<xref rid="B32-brainsci-03-01483" ref-type="bibr">32</xref>] whereas those with aura and migraine usually exhibited both normal EEGs [<xref rid="B34-brainsci-03-01483" ref-type="bibr">34</xref>] and CT brain scans [<xref rid="B34-brainsci-03-01483" ref-type="bibr">34</xref>]; however, these latter patients can also exhibit paroxysmal EEG and other neuronal abnormalities [<xref rid="B58-brainsci-03-01483" ref-type="bibr">58</xref>,<xref rid="B59-brainsci-03-01483" ref-type="bibr">59</xref>,<xref rid="B60-brainsci-03-01483" ref-type="bibr">60</xref>,<xref rid="B61-brainsci-03-01483" ref-type="bibr">61</xref>,<xref rid="B62-brainsci-03-01483" ref-type="bibr">62</xref>] suggesting an underlying neuronal component in the generation of these symptoms [<xref rid="B63-brainsci-03-01483" ref-type="bibr">63</xref>,<xref rid="B64-brainsci-03-01483" ref-type="bibr">64</xref>]. The aura of migraine has been considered a separate phenomenon from the headache [<xref rid="B65-brainsci-03-01483" ref-type="bibr">65</xref>], considered by some investigators to be determined by aura suceptibility genes [<xref rid="B66-brainsci-03-01483" ref-type="bibr">66</xref>], the pain associated with other genes [<xref rid="B67-brainsci-03-01483" ref-type="bibr">67</xref>,<xref rid="B68-brainsci-03-01483" ref-type="bibr">68</xref>]. Some investigators considered migraine aura characterized by a wave of oligemia [<xref rid="B67-brainsci-03-01483" ref-type="bibr">67</xref>,<xref rid="B69-brainsci-03-01483" ref-type="bibr">69</xref>,<xref rid="B70-brainsci-03-01483" ref-type="bibr">70</xref>], considered the human counterpart of Le&#x000e3;o&#x02019;s spreading depression [<xref rid="B71-brainsci-03-01483" ref-type="bibr">71</xref>] that passes across the cortex.</p><p>Some investigators reported more than 50% of patients with temporal lobe epilepsy had an aura of some type [<xref rid="B14-brainsci-03-01483" ref-type="bibr">14</xref>,<xref rid="B17-brainsci-03-01483" ref-type="bibr">17</xref>,<xref rid="B18-brainsci-03-01483" ref-type="bibr">18</xref>]. Estimates of frequency of olfactory auras associated with seizure activity vary considerably ranging from 1% or less [<xref rid="B42-brainsci-03-01483" ref-type="bibr">42</xref>,<xref rid="B72-brainsci-03-01483" ref-type="bibr">72</xref>], to 8% [<xref rid="B23-brainsci-03-01483" ref-type="bibr">23</xref>,<xref rid="B73-brainsci-03-01483" ref-type="bibr">73</xref>], to 16%&#x02013;20% [<xref rid="B17-brainsci-03-01483" ref-type="bibr">17</xref>,<xref rid="B74-brainsci-03-01483" ref-type="bibr">74</xref>] to over 30% [<xref rid="B75-brainsci-03-01483" ref-type="bibr">75</xref>]. Reports of incidence of phantosmia in patients with temporal lobe foci vary from 6% to 12% [<xref rid="B32-brainsci-03-01483" ref-type="bibr">32</xref>,<xref rid="B51-brainsci-03-01483" ref-type="bibr">51</xref>] whereas with occipital or central foci incidence was 4% and 3%, respectively [<xref rid="B32-brainsci-03-01483" ref-type="bibr">32</xref>]. Gustatory hallucinations in patients with seizures have an incidence reportedly about one-half that of olfactory hallucinations [<xref rid="B16-brainsci-03-01483" ref-type="bibr">16</xref>,<xref rid="B33-brainsci-03-01483" ref-type="bibr">33</xref>] or as low as less than 1% [<xref rid="B73-brainsci-03-01483" ref-type="bibr">73</xref>]. Gustatory hallucinations have been reported in patients with temporal lobe epilepsy [<xref rid="B33-brainsci-03-01483" ref-type="bibr">33</xref>,<xref rid="B34-brainsci-03-01483" ref-type="bibr">34</xref>]. While reports of visual and auditory hallucinations are much more frequent than olfactory or gustatory hallucinations in patients with epilepsy, these latter sensations have been described as being the most prominent and consistent features of a seizure disorder [<xref rid="B14-brainsci-03-01483" ref-type="bibr">14</xref>,<xref rid="B27-brainsci-03-01483" ref-type="bibr">27</xref>,<xref rid="B34-brainsci-03-01483" ref-type="bibr">34</xref>].</p><p>Most frequent reports of olfactory hallucinations without subsequent clinical motor activity are in psychiatric literature [<xref rid="B76-brainsci-03-01483" ref-type="bibr">76</xref>,<xref rid="B77-brainsci-03-01483" ref-type="bibr">77</xref>,<xref rid="B78-brainsci-03-01483" ref-type="bibr">78</xref>,<xref rid="B79-brainsci-03-01483" ref-type="bibr">79</xref>] with estimates ranging from 11% to 83% among patients with schizophrenia [<xref rid="B80-brainsci-03-01483" ref-type="bibr">80</xref>,<xref rid="B81-brainsci-03-01483" ref-type="bibr">81</xref>,<xref rid="B82-brainsci-03-01483" ref-type="bibr">82</xref>,<xref rid="B83-brainsci-03-01483" ref-type="bibr">83</xref>,<xref rid="B84-brainsci-03-01483" ref-type="bibr">84</xref>] and from 19% to 33% among patients with major depressive illness [<xref rid="B85-brainsci-03-01483" ref-type="bibr">85</xref>]. Phantosmia has been reported in patients with severe depression [<xref rid="B86-brainsci-03-01483" ref-type="bibr">86</xref>]. Patients with schizophrenia commonly do not describe their phantosmia distinctly; they usually use vague descriptive terms such as strange or peculiar although phantosmia is generally considered unpleasant. About 25% of patients with what has been termed the olfactory reference syndrome [<xref rid="B87-brainsci-03-01483" ref-type="bibr">87</xref>,<xref rid="B88-brainsci-03-01483" ref-type="bibr">88</xref>,<xref rid="B89-brainsci-03-01483" ref-type="bibr">89</xref>,<xref rid="B90-brainsci-03-01483" ref-type="bibr">90</xref>] reported perception of a foul odor emanating from a body orifice other than nose or mouth or on occasion from the body as a whole (e.g., skin) unrelieved by any maneuver to remove the odor such as a cleaning procedure; this syndrome is characterized by this fixed, monosymptomatic odor. Successful treatment of this syndrome has been reported by use of aripiprazole presumably as its use as a partial agonist of dopamine D<sub>2</sub> receptors in the olfactory bulb [<xref rid="B91-brainsci-03-01483" ref-type="bibr">91</xref>]. On the other hand, psychiatric symptoms have been associated with several types of organic brain lesions [<xref rid="B92-brainsci-03-01483" ref-type="bibr">92</xref>,<xref rid="B93-brainsci-03-01483" ref-type="bibr">93</xref>,<xref rid="B94-brainsci-03-01483" ref-type="bibr">94</xref>].</p><p>More recently, olfactory hallucinations without subsequent clinical motor activity have been reported in as many as 29% of patients with several types of eating disorders [<xref rid="B95-brainsci-03-01483" ref-type="bibr">95</xref>], in patients with hypochondriasis [<xref rid="B96-brainsci-03-01483" ref-type="bibr">96</xref>] or associated with enuresis [<xref rid="B97-brainsci-03-01483" ref-type="bibr">97</xref>]. Olfactory hallucinations have occurred after use of intravenous caffeine infusion [<xref rid="B98-brainsci-03-01483" ref-type="bibr">98</xref>,<xref rid="B99-brainsci-03-01483" ref-type="bibr">99</xref>] but with these patients having associated seizure induction. Gustatory and olfactory hallucinations have occurred after treatment with bupropion [<xref rid="B100-brainsci-03-01483" ref-type="bibr">100</xref>]. Phantosmia without associated seizure induction has also been reported in over 60% of patients who reported hyposmia following head injury [<xref rid="B101-brainsci-03-01483" ref-type="bibr">101</xref>], following a variety of other clinical conditions [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>], following intake of therapeutic drugs [<xref rid="B103-brainsci-03-01483" ref-type="bibr">103</xref>] and for no clinically apparent cause [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>,<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>].</p><p>Incidence of phantosmia without seizure activity has been reported by other investigators to occur in as many as 10%&#x02013;31% in a randomly selected group of factory workers [<xref rid="B106-brainsci-03-01483" ref-type="bibr">106</xref>]; this subject has recently been reviewed [<xref rid="B107-brainsci-03-01483" ref-type="bibr">107</xref>]. However, among patients with partial seizures one group of investigators estimated that only 0.9% exhibited what they described as olfactory epileptic auras [<xref rid="B72-brainsci-03-01483" ref-type="bibr">72</xref>] whereas another group estimated that 5.5% of these patients exhibited these olfactory auras [<xref rid="B108-brainsci-03-01483" ref-type="bibr">108</xref>]. Our incidence estimates of phantosmia without associated epileptic activity among patients with self reported and measured loss of smell and/or taste acuity varied between 40% and 60% of the group of over 5000 patients studied at The Taste and Smell Clinic in Washington, DC, USA [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>].</p><p>Olfactory hallucinations have also occurred without seizure activity as a presenting symptom in patients with intracerebral hemorrhage [<xref rid="B109-brainsci-03-01483" ref-type="bibr">109</xref>,<xref rid="B110-brainsci-03-01483" ref-type="bibr">110</xref>], with glioblastoma multiforme [<xref rid="B111-brainsci-03-01483" ref-type="bibr">111</xref>] or with electrical stimulation of the olfactory bulb and tract [<xref rid="B112-brainsci-03-01483" ref-type="bibr">112</xref>]. Olfactory hallucinations have occurred in local nasal disease related to rhinosinusitis [<xref rid="B113-brainsci-03-01483" ref-type="bibr">113</xref>]. Patients with Parkinson disease have been reported to exhibit phantosmia without associated seizure activity [<xref rid="B114-brainsci-03-01483" ref-type="bibr">114</xref>,<xref rid="B115-brainsci-03-01483" ref-type="bibr">115</xref>,<xref rid="B116-brainsci-03-01483" ref-type="bibr">116</xref>] and after treatment with rasagiline [<xref rid="B117-brainsci-03-01483" ref-type="bibr">117</xref>]. Olfactory hallucinations without associated seizure activity have been reported following radiation therapy [<xref rid="B118-brainsci-03-01483" ref-type="bibr">118</xref>].</p><p>On the other hand phantosmia has been treated with surgical excision of the olfactory epithelium [<xref rid="B119-brainsci-03-01483" ref-type="bibr">119</xref>] following resection of the olfactory bulbs [<xref rid="B120-brainsci-03-01483" ref-type="bibr">120</xref>] by use of venlafaxine [<xref rid="B121-brainsci-03-01483" ref-type="bibr">121</xref>] or by use of topiramate [<xref rid="B122-brainsci-03-01483" ref-type="bibr">122</xref>]. One group of investigators reported that what they described as &#x0201c;idiopathic phantosmia&#x0201d; disappeared spontaneously after the symptoms were present for a period of more than five years [<xref rid="B123-brainsci-03-01483" ref-type="bibr">123</xref>].</p><p>However, symptoms associated with these phantosmias have been confusing and considered by some investigators to be psychogenic, nonepileptic seizures [<xref rid="B124-brainsci-03-01483" ref-type="bibr">124</xref>], with altered brain connectivity among some of these patients [<xref rid="B125-brainsci-03-01483" ref-type="bibr">125</xref>]; however, these workers appear to lack understanding of the biochemical parameters underlying these symptoms [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>,<xref rid="B36-brainsci-03-01483" ref-type="bibr">36</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>].</p><p>We recognized that patients with birhinal phantosmia without subsequent clinical motor activity occurred commonly after a clinical event which induced loss of smell [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>]; these patients are a much larger group than those with phantosmia associated with either epilepsy, brain tumors or migraine. In a survey of smell among over 5000 men and women in the US who attended a commercial fragrance establishment about 7% reported chronic smell loss or hyposmia [<xref rid="B126-brainsci-03-01483" ref-type="bibr">126</xref>]. Extrapolation of this number to the total US population suggests an estimated 21 million people in the US may have some form of hyposmia (vi). In another publication we estimated that 40% to 60% of patients with hyposmia, regardless of cause, reported birhinal phantosmia and/or global oral phantageusia without clinical motor activity [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>]. These estimates are supported, in part, by investigators who reported phantosmia without subsequent clinical motor activity in a small group of patients with what they called &#x0201c;simple partial status epilepticus&#x0201d; whom they considered greatly underdiagnosed [<xref rid="B3-brainsci-03-01483" ref-type="bibr">3</xref>]. In another study involving 1000 patients evaluated at a Japanese otolaryngological clinic for any symptom related to any pathology of the head and neck about 14% spontaneously reported presence of phantageusia without clinical motor activity [<xref rid="B127-brainsci-03-01483" ref-type="bibr">127</xref>].</p><p>With respect to terminology we defined phantosmia as an odor in the nose in the absence of any external initiating stimulus [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B128-brainsci-03-01483" ref-type="bibr">128</xref>]. Phantosmia may have been clinically first described systematically by Jackson as a transient, unpleasant odor preceding a seizure [<xref rid="B6-brainsci-03-01483" ref-type="bibr">6</xref>,<xref rid="B7-brainsci-03-01483" ref-type="bibr">7</xref>,<xref rid="B8-brainsci-03-01483" ref-type="bibr">8</xref>]. Descriptions were almost uniformly birhinal, unpleasant, usually a rotten, sickening, burning, bad or indescribable odor [<xref rid="B38-brainsci-03-01483" ref-type="bibr">38</xref>,<xref rid="B129-brainsci-03-01483" ref-type="bibr">129</xref>]. They were also described as tobacco-like, smoky or sulfur-gas-like. We classified phantosmias into three general types: (1) cacosmic (rotten, decayed or fecal [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B103-brainsci-03-01483" ref-type="bibr">103</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B130-brainsci-03-01483" ref-type="bibr">130</xref>], (2) torquosmic (burned, metallic, chemical-like [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B103-brainsci-03-01483" ref-type="bibr">103</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B130-brainsci-03-01483" ref-type="bibr">130</xref>]), or mixed, a combination of both cacosmia and torquosmia [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B103-brainsci-03-01483" ref-type="bibr">103</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B130-brainsci-03-01483" ref-type="bibr">130</xref>]. Phantosmias as such were previously recognized by others [<xref rid="B38-brainsci-03-01483" ref-type="bibr">38</xref>,<xref rid="B131-brainsci-03-01483" ref-type="bibr">131</xref>,<xref rid="B132-brainsci-03-01483" ref-type="bibr">132</xref>,<xref rid="B133-brainsci-03-01483" ref-type="bibr">133</xref>] with associated EEG abnormalities, changes in positron emission tomography (PET), computerized tomography (CT) and magnetic resonance imaging of brain (MRI) [<xref rid="B26-brainsci-03-01483" ref-type="bibr">26</xref>,<xref rid="B47-brainsci-03-01483" ref-type="bibr">47</xref>] and with typical subsequent seizure activity [<xref rid="B10-brainsci-03-01483" ref-type="bibr">10</xref>,<xref rid="B11-brainsci-03-01483" ref-type="bibr">11</xref>,<xref rid="B12-brainsci-03-01483" ref-type="bibr">12</xref>,<xref rid="B13-brainsci-03-01483" ref-type="bibr">13</xref>] related to temporal lobe [<xref rid="B38-brainsci-03-01483" ref-type="bibr">38</xref>,<xref rid="B131-brainsci-03-01483" ref-type="bibr">131</xref>,<xref rid="B132-brainsci-03-01483" ref-type="bibr">132</xref>,<xref rid="B133-brainsci-03-01483" ref-type="bibr">133</xref>] and other brain tumors [<xref rid="B21-brainsci-03-01483" ref-type="bibr">21</xref>,<xref rid="B22-brainsci-03-01483" ref-type="bibr">22</xref>,<xref rid="B26-brainsci-03-01483" ref-type="bibr">26</xref>]. Seizures associated with brain tumors were commonly reported to begin with abnormal sensations of global oral taste or birhinal smell (auras) along with masticatory movements and spitting [<xref rid="B75-brainsci-03-01483" ref-type="bibr">75</xref>] and were called uncinate fits by F&#x000e9;r&#x000e9; [<xref rid="B134-brainsci-03-01483" ref-type="bibr">134</xref>] who suggested that taste and smell sensations originated in the uncinate gyrus. </p><p>We defined phantageusia as a global taste in the entire mouth in the absence of any initiating oral stimulus [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B103-brainsci-03-01483" ref-type="bibr">103</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B135-brainsci-03-01483" ref-type="bibr">135</xref>]. Prior descriptions of phantageusias as such were also predominantly present in the entire oral cavity, were unpleasant and varied in character from rotten, bitter, salty, acidic or burned to pleasant or even sweet [<xref rid="B33-brainsci-03-01483" ref-type="bibr">33</xref>,<xref rid="B34-brainsci-03-01483" ref-type="bibr">34</xref>,<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B135-brainsci-03-01483" ref-type="bibr">135</xref>]. We classified phantageusias as either cacogeusic, torquegeusic or mixed [<xref rid="B128-brainsci-03-01483" ref-type="bibr">128</xref>], similar to phantosmias. Phantageusias [<xref rid="B136-brainsci-03-01483" ref-type="bibr">136</xref>,<xref rid="B137-brainsci-03-01483" ref-type="bibr">137</xref>] have also been reported preceding seizures, usually associated with brain tumors [<xref rid="B6-brainsci-03-01483" ref-type="bibr">6</xref>,<xref rid="B7-brainsci-03-01483" ref-type="bibr">7</xref>,<xref rid="B8-brainsci-03-01483" ref-type="bibr">8</xref>].</p><p>Association of both birhinal phantosmia and global oral phantageusia without subsequent clinical motor activity with loss of smell and taste acuity, respectively, [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>] is consistent with changes in CNS plasticity. Onset of similar hallucinatory behavior has been previously observed with sensory losses of visual and auditory systems; association of visual hallucinations with loss of visual acuity has been reported in patients with cataract [<xref rid="B138-brainsci-03-01483" ref-type="bibr">138</xref>], and with age, sometimes referred to as Bonnet syndrome [<xref rid="B139-brainsci-03-01483" ref-type="bibr">139</xref>,<xref rid="B140-brainsci-03-01483" ref-type="bibr">140</xref>,<xref rid="B141-brainsci-03-01483" ref-type="bibr">141</xref>,<xref rid="B142-brainsci-03-01483" ref-type="bibr">142</xref>,<xref rid="B143-brainsci-03-01483" ref-type="bibr">143</xref>]; auditory hallucinations without subsequent clinical motor activity have been reported in patients with loss of auditory acuity [<xref rid="B144-brainsci-03-01483" ref-type="bibr">144</xref>,<xref rid="B145-brainsci-03-01483" ref-type="bibr">145</xref>,<xref rid="B146-brainsci-03-01483" ref-type="bibr">146</xref>].</p><p>Most patients with sensory hallucinations reported these phenomena as involving an entire sensory system; most visual hallucinations involved both visual fields, auditory hallucinations both auditory fields, olfactory hallucinations, both nares and gustatory hallucinations in the entire oral cavity. However, unilateral sensory hallucinations have been reported in only one visual field [<xref rid="B147-brainsci-03-01483" ref-type="bibr">147</xref>,<xref rid="B148-brainsci-03-01483" ref-type="bibr">148</xref>] or one ear [<xref rid="B149-brainsci-03-01483" ref-type="bibr">149</xref>,<xref rid="B150-brainsci-03-01483" ref-type="bibr">150</xref>,<xref rid="B151-brainsci-03-01483" ref-type="bibr">151</xref>,<xref rid="B152-brainsci-03-01483" ref-type="bibr">152</xref>,<xref rid="B153-brainsci-03-01483" ref-type="bibr">153</xref>,<xref rid="B154-brainsci-03-01483" ref-type="bibr">154</xref>]. In a preliminary study we previously described a patient group with olfactory hallucinations in only one naris [<xref rid="B155-brainsci-03-01483" ref-type="bibr">155</xref>]. These patients independently related a strikingly similar history; insidious onset of an obnoxious, initially unirhinal odor without any initiating external stimulus which initially arose without any antecedent cause, initially occurring spontaneously, intermittently, but over time increasing in frequency, initiated by coughing, laughing, crying, shouting, vigorous nasal inhalation and/or exhalation or sneezing and initially inhibited spontaneously but over time only relieved by sleep or a Valsalva type maneuver [<xref rid="B155-brainsci-03-01483" ref-type="bibr">155</xref>]. These patients were usually young women who, because of associated EEG abnormalities, were commonly considered to have a form of partial seizure disorder despite absence of antecedent or subsequent clinical motor activity and were initially treated with various anticonvulsant agents which did not induce any symptomatic relief.</p><p>Whereas we have previously briefly reported these patients [<xref rid="B155-brainsci-03-01483" ref-type="bibr">155</xref>], as well as their fMRI and biochemical responses [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>,<xref rid="B156-brainsci-03-01483" ref-type="bibr">156</xref>], it is the purpose of this study to describe these patients in detail for the first time. To our knowledge, these patients reflect the only group in whom phantosmia (and/or phantageusia) without subsequent clinical motor activity is either spontaneously initiated or inhibited and subsequently inhibited by specific physiological maneuvers. We will contrast these patients with the much larger, more common but previously poorly defined patient group with birhinal phantosmia without subsequent clinical motor activity who initially experienced an illness or some event which impaired their smell (and/or taste) acuity and who subsequently developed birhinal phantosmia.</p></sec><sec><title>2. Material and Methods</title><sec><title>2.1. Subjects</title><p>Subjects were 128 consecutive patients with phantosmia [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>] without subsequent clinical motor activity from a total group of 1272 consecutive patients evaluated at The Taste and Smell Clinic, Washington, DC, USA from 1985 to 1995 for various abnormalities of taste and/or smell dysfunction and six consecutive normal volunteers recruited from the normal volunteer pool at the National Institutes of Health (NIH), Bethesda, MD, USA. </p><p>Normal volunteers were three men and three women, all right handed Caucasians, aged 21&#x02013;34 years, who were in good health and not taking any medication. Their taste and smell function were within normal limits. The subjects served as volunteers only for the functional magnetic resonance brain imaging and magnetic resonance spectroscopy studies performed at the National Institute of Neurological Diseases and Stoke, NIH, Bethesda, MD, USA.</p><p>The 128 patients, studied in a retrospective manner, were all those of the 1272 who had symptoms of phantosmia, either unirhinal or birhinal, and also had sleep-deprived EEGs with nasopharyngeal leads as part of their initial evaluation (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). Eighty-eight of these 128 presented with hyposmia but also other sensory abnormalities including hypogeusia, phantageusia, aliageusia (an obnoxious taste in the mouth initiated by presence of food or drink and related directly to the ambient tastant [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B103-brainsci-03-01483" ref-type="bibr">103</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B130-brainsci-03-01483" ref-type="bibr">130</xref>]) and/or aliosmia (presence of an obnoxious smell in the nose initiated by presence of an external vapor and related directly to the ambient odor [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B103-brainsci-03-01483" ref-type="bibr">103</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B130-brainsci-03-01483" ref-type="bibr">130</xref>]). These patients developed birhinal phantosmia which was either persistent or intermittent, neither cyclic nor episodic (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>) but related to a specific clinical condition which initiated their hyposmia including head injury [<xref rid="B101-brainsci-03-01483" ref-type="bibr">101</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>], post influenza-like illness [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B157-brainsci-03-01483" ref-type="bibr">157</xref>], post nasal surgery [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B128-brainsci-03-01483" ref-type="bibr">128</xref>] or several other medically related conditions [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B158-brainsci-03-01483" ref-type="bibr">158</xref>,<xref rid="B159-brainsci-03-01483" ref-type="bibr">159</xref>]. Seventy-six (86%) of these 88 patients initially presented with hyposmia [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>]; 12 presented with complaints of either phantageusia [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B135-brainsci-03-01483" ref-type="bibr">135</xref>], aliosmia [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B130-brainsci-03-01483" ref-type="bibr">130</xref>], aliageusia [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B130-brainsci-03-01483" ref-type="bibr">130</xref>] or some symptom combination. Although many other patients among the 1272 evaluated reported birhinal phantosmia [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>], the relatively small patient number who met these latter criteria in this report (88 of 1272) was due to the fact that only patients with birhinal phantosmia who had EEGs with nasopharyngeal leads as part of their initial evaluation were included in this study.</p><table-wrap id="brainsci-03-01483-t001" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t001_Table 1</object-id><label>Table 1</label><caption><p>Clinical characteristics of patients with phantosmia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Condition</th><th align="center" valign="middle" rowspan="1" colspan="1">Cyclic Unirhinal Phantosmia (CUP)</th><th align="center" valign="middle" rowspan="1" colspan="1">Birhinal Phantosmia with Associated Symptoms (BPAS)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Patient number</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">88</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Gender</td><td align="center" valign="middle" rowspan="1" colspan="1">30 women, 10 men <sup>z</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">47 women, 41 men</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Ratio women:men</td><td align="center" valign="middle" rowspan="1" colspan="1">3:1</td><td align="center" valign="middle" rowspan="1" colspan="1">1:1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Age (year)</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">31 &#x000b1; 1 *<sup>, a</sup> (19&#x02013;49 years)</td><td align="center" valign="middle" rowspan="1" colspan="1">46 &#x000b1; 2 (12&#x02013;82 years)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Men</td><td align="center" valign="middle" rowspan="1" colspan="1">31 &#x000b1; 1 <sup>a</sup> (19&#x02013;46 years)</td><td align="center" valign="middle" rowspan="1" colspan="1">41 &#x000b1; 3 (12&#x02013;81 years)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Women</td><td align="center" valign="middle" rowspan="1" colspan="1">30 &#x000b1; 1 <sup>a</sup> (19&#x02013;49 years)</td><td align="center" valign="middle" rowspan="1" colspan="1">49 &#x000b1; 2 (19&#x02013;82 years)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Symptom duration before evaluation (year)</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"> 7.2 &#x000b1; 1.0 <sup>a</sup> (0.5&#x02013;28 years)</td><td align="center" valign="middle" rowspan="1" colspan="1"> 1.8 &#x000b1; 0.2 (1 week&#x02013;10 years)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Initial phantosmia character</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Cacosmic</td><td align="center" valign="middle" rowspan="1" colspan="1">31 <sup>&#x02020;, w1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">20 <sup>&#x02020;</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Torquosmic</td><td align="center" valign="middle" rowspan="1" colspan="1">9 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">68 <sup>w2</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Onset of phantosmia</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Unirhinal</td><td align="center" valign="middle" rowspan="1" colspan="1">40 <sup>w, w1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Birhinal</td><td align="center" valign="middle" rowspan="1" colspan="1">0 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">88 <sup>w2</sup></td></tr></tbody></table><table-wrap-foot><fn><p>* Mean &#x000b1; SEM; <sup>&#x02020;</sup> Patient Number; ( ) Range; <italic>CUP vs. BPAS</italic>: <sup>a</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>t</italic> test; <sup>w</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (torquosmic, unirhinal, birhinal); <sup>z</sup>
<italic>p</italic> &#x0003c; 0.05, <italic>X</italic><sup>2</sup> (women <italic>vs</italic>. men); <italic>CUP</italic>: <sup>w1</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (cacosmic <italic>vs</italic>. torquosmic, unirhinal <italic>vs</italic>. birhinal); <italic>BPAS</italic>: <sup>w2</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (cacosmic <italic>vs</italic>. torquosmic, unirhinal <italic>vs</italic>. birhinal).</p></fn></table-wrap-foot></table-wrap><p>Forty of these 128 were all those who presented with a history of a cyclic, episodic, initially unirhinal phantosmia as their only complaint (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>).</p><p>To differentiate these two groups we labeled patients with cyclic, episodic, recurrent, initially unirhinal phantosmia as having cyclic unirhinal phantosmia (CUP); those who presented with non-cyclic, non-episodic birhinal phantosmia and hyposmia (and/or other symptoms of taste and/or smell dysfunction) and were labeled as having birhinal phantosmia with associated symptoms (BPAS). </p><p>The purpose of this study is to describe, in a retrospective manner, the symptoms which define these two types of olfactory hallucinations and then, based upon these descriptions, describe the procedures developed to understand the putative neurological and metabolic parameters responsible for these hallucinatory activities. The hypothesis underlying this study relates to an attempt to develop the neurological and metabolic parameters associated with and putatively responsible for the development of these hallucinations.</p><p>All studies were approved by the Institutional Review Boards of the Clinical Center of the National Institutes of Health, the Georgetown University Medical Center and the George Washington University Medical Center. All subjects who participated in these studies formally signified their agreement after specific explanation of any study protocol which they signed.</p></sec><sec><title>2.2. Clinical History</title><p>Each patient had a complete medical history with special emphasis on taste and smell dysfunction [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B160-brainsci-03-01483" ref-type="bibr">160</xref>,<xref rid="B161-brainsci-03-01483" ref-type="bibr">161</xref>]. Examination of head and neck was performed in each patient (including indirect nasopharyngoscopy with use of a topically applied vasoconstrictive agent (e.g., 0.25% neosynephrine)) to assist visualization of nasal airways [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B128-brainsci-03-01483" ref-type="bibr">128</xref>].</p><p>Taste function tests (gustometry) were performed using the entire oral cavity with a standard forced choice, three stimuli, staircase drop technique using NaCl (salty), sucrose (sweet), HCl (sour) and urea (bitter) as stimuli [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B161-brainsci-03-01483" ref-type="bibr">161</xref>] by which detection thresholds (DT), recognition thresholds (RT) and estimations of magnitude intensity (ME) for each tastant were obtained [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B135-brainsci-03-01483" ref-type="bibr">135</xref>,<xref rid="B161-brainsci-03-01483" ref-type="bibr">161</xref>]. Four types of taste loss were defined (ageusia, Type I, II, III) based upon loss severity with ageusia the most severe, Type I, II and III in decreasing severity as type increased [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B128-brainsci-03-01483" ref-type="bibr">128</xref>,<xref rid="B160-brainsci-03-01483" ref-type="bibr">160</xref>]. Ageusia was defined as inability to detect or recognize any tastant (DT = 0, RT = 0, ME = 0). Type I hypogeusia was defined as inability to recognize any tastant (DT &#x0003e; 0, RT = 0, ME = 0). Type II hypogeusia was defined as decreased ability to detect or recognize tastants but ability to do so at a level less than normal (DT &#x0003c; normal, RT &#x0003c; normal, ME &#x0003c; normal). Type III hypogeusia was defined as normal ability to detect and recognize tastants but decreased ability to quantitate tastant intensity (DT = normal, RT = normal, ME &#x0003c; normal). Taste distortions (dysgeusias) were quantified by questionnaire [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B135-brainsci-03-01483" ref-type="bibr">135</xref>] on a scale from 1 to 100 and labeled aliageusia or phantageusia with subcategories of aliageusia and phantageusia defined as noted above as cacogeusic, torquegeusic, or mixed [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B128-brainsci-03-01483" ref-type="bibr">128</xref>].</p><p>Smell function tests (olfactometry) were performed with a standard forced choice three-stimuli, staircase sniff technique using pyridine (pungent), nitrobenzene (bitter almond), thiophene (petroleum-like), amyl acetate (banana oil) and menthone (minty) as stimuli [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B160-brainsci-03-01483" ref-type="bibr">160</xref>] by which DT, RT and ME for each odorant was obtained [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B130-brainsci-03-01483" ref-type="bibr">130</xref>,<xref rid="B160-brainsci-03-01483" ref-type="bibr">160</xref>,<xref rid="B161-brainsci-03-01483" ref-type="bibr">161</xref>]. Four types of smell loss were defined (anosmia, Type I, II, III) based upon severity of loss with anosmia the most severe and Type I, II, III in decreasing severity as type increased. Definitions of smell loss type were similar to those described for taste loss [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B160-brainsci-03-01483" ref-type="bibr">160</xref>]. Both unirhinal and birhinal smell function tests were performed in each patient; results did not differ significantly in any patient. Smell distortions were defined similar to taste distortions and labeled aliosmia and phantosmia with subcategories defined as cacosmic, torquosmic or mixed [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B160-brainsci-03-01483" ref-type="bibr">160</xref>].</p><sec><title>2.2.1. Electroencephalographic (EEG) Studies</title><p>EEGs were performed in all patients after sleep deprivation for 12&#x02013;24 h; each refrained from taking caffeine-containing beverages during this period but ate a complete meal prior to study. Nasopharyngeal leads were employed in all studies. Studies were performed on an 8, 10, 16, or 21 channel electroencephalograph monitored by a registered EEG technician. All examinations included photostimulation and hyperventilation performed by International EEG Society standard techniques. All records were initially interpreted by a Clinical Neurophysiology Board certified physician (SP) without specific knowledge of patient clinical status and reviewed independently by an ANA board eligible neurophysiologist (EC, see acknowledgements). </p><p>CUP: Prolonged recordings (30 min&#x02013;24 h) were obtained in each patient. Twenty-four hour recordings were obtained in 11 patients with 30&#x02013;180 min recordings obtained in the remainder. Twenty-seven of the 40 records were interpreted similarly by both neurophysiologists. In 15 records clinical interpretations differed; each was reinterpreted by each neurophysiologist and a consensus report was issued. </p><p>BPAS: Twenty-four hour recordings were obtained in 12 patients with 30&#x02013;180 min recordings obtained in the remainder. Each of the 88 records was interpreted similarly by both neurophysiologists.</p></sec><sec><title>2.2.2. Neuroimaging Studies</title><p>Computer assisted tomographic (CT) scans of brain was performed on 29 patients with CUP and 55 patients with BPAS on either a GE (Syracuse, NY, USA) or Siemens Vision (Iselin, NJ, USA) unit. MRI of brain was performed using a quadrature headcoil on five patients with CUP and two patients with BPAS on a GE or a Siemens 1.5 Tesla scanner. One patient with CUP had both a CT scan and MRI study; one patient with CUP had two MRI studies. One patient with BPAS had two CT brain studies and one had four such studies. A venous angiogram of the orbit was performed in one patient with CUP and two had four vessel cerebral angiograms based upon initial abnormal findings on CT scans. Skull roentgenograms were performed in 20 patients with CUP and in six with BPAS. Sinus roentgenograms were performed in 12 patients with CUP and in 14 with BPAS. Tc99m brain scans were performed in six patients with BPAS. All results were interpreted by an ARA board certified neuroradiologist (LML) without any specific knowledge of the clinical status of the patient. Results were reviewed by at least one author (RH and/or SP) and no disputed readings were obtained.</p></sec><sec><title>2.2.3. Functional Magnetic Resonance Brain Imaging (fMRI)</title><p>Two patients with CUP (one man, one women) [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>,<xref rid="B156-brainsci-03-01483" ref-type="bibr">156</xref>] and two patients with BPAS (one man, one woman) [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>] were studied using fMRI. For these studies each patient was placed in the 1.5T Siemens MR scanner using a quadrature head coil. Under standard conditions as shown previously for odor memory [<xref rid="B162-brainsci-03-01483" ref-type="bibr">162</xref>] and taste memory [<xref rid="B163-brainsci-03-01483" ref-type="bibr">163</xref>], normal volunteers and patients with CUP and BPAS were requested to think of (remember) their phantosmia and in patients with CUP to attempt to initiate and inhibit it. Results were quantitated by calculation of significant activation of pixel number activated in specific anatomical regions by each condition [<xref rid="B162-brainsci-03-01483" ref-type="bibr">162</xref>,<xref rid="B163-brainsci-03-01483" ref-type="bibr">163</xref>].</p></sec><sec><title>2.2.4. Magnetic Resonance Spectroscopy (MRS)</title><p>Two patients (two women) with CUP, three patients (two women, one man) with BPAS and the six normal volunteers were studied using MRS as previously described [<xref rid="B36-brainsci-03-01483" ref-type="bibr">36</xref>,<xref rid="B164-brainsci-03-01483" ref-type="bibr">164</xref>]. Subjects were placed in a 1.5T General Electric (GE) MR scanner using a quadrature head coil. Under standard conditions specific brain regions (occipital, cingulate and insular cortex) were evaluated for levels of gamma-aminobutyric acid (GABA) and creatine. Patients with CUP had onset of their phantosmia and phantageusia induced either spontaneously or by hyperventilation at initiation of these studies. Patients with BPAS had persistent phantosmia during MRS. Data were analyzed using software previously developed and utilized by L.M. Levy <italic>et al</italic>. [<xref rid="B36-brainsci-03-01483" ref-type="bibr">36</xref>,<xref rid="B164-brainsci-03-01483" ref-type="bibr">164</xref>]. Results were calculated as ratio of GABA: creatine in each region studied and comparisons were made between each group studied.</p></sec><sec><title>2.2.5. CO<sub>2</sub> Inhalation</title><p>Ten patients (three men, seven women) with CUP were treated with inhalation of 50% CO<sub>2</sub> delivered through nasal prongs within a nasal mask for periods of 10&#x02013;60 s during presence of unirhinal phantosmia. Each patient was seated in a chair, prongs fitted snugly into the nose and CO<sub>2</sub> flow adjusted to a maximum of 50 lbs/in<sup>2</sup>.</p></sec><sec><title>2.2.6. Unirhinal Cocaine Administration</title><p>A solution of 10% cocaine was administered by nasal spray into the upper nasal cavity on the side of phantosmia on one occasion in two patients (two women) with CUP during the time they reported unirhinal phantosmia and birhinally into the upper nasal cavity in one patient (one woman) with BPAS during the time she reported birhinal phantosmia.</p></sec><sec><title>2.2.7. Repetitive Transcranial Magnetic Stimulation (rTMS)</title><p>Two right handed patients (two women) with CUP and four right handed patients (two men, two women) with BPAS were studied using rTMS, as previously described [<xref rid="B165-brainsci-03-01483" ref-type="bibr">165</xref>,<xref rid="B166-brainsci-03-01483" ref-type="bibr">166</xref>]. Signal was generated by use of a Cadwell electromagnetic stimulator (Seattle, WA, USA) monitored with a TECA TD20 (Pleasantville, NY, USA) wave form generator, as previously described [<xref rid="B165-brainsci-03-01483" ref-type="bibr">165</xref>,<xref rid="B166-brainsci-03-01483" ref-type="bibr">166</xref>]. Stimulation was applied with a single quadrangular coil in three phases; initially two sham phases and then one active phase. In the first sham phase stimulation was applied at 40% of maximal output (40% of 1.5 Tesla or about 0.8 T) to each shoulder at Erb&#x02019;s point and to the posterior neck. This stimulation resulted in significant movement of each shoulder and of head extension. In the second sham phase stimulation was applied at 10% of maximal output (20% of 1.5 Tesla or about 0.1 T). The stimulation was applied to each of four skull regions (left and right temporoparietal, occipital, frontal) and was considered a non-significant stimulation since no physical response occurred after this stimulation. A third set of stimuli at 60% maximal output (between 0.8 and 1.2 T since stimulus delivery was non-linear) was then delivered to each of these same four skull locations. This third set of stimuli was repeated at a specific response location (usually left temporoparietal) in patients in whom a change (usually lowering) in phantosmia intensity and/or change in phantosmia character occurred for three to six additional stimuli or until no further lowering or change in phantosmia character occurred. Stimulus frequency was 1 pulse per 1&#x02013;2 s for 30&#x02013;90 s. Stimulation was monitored in each phase by degree of flexion of muscle groups associated with stimulus application (e.g., right radial, median and/or ulnar nerve stimulation with left temporoparietal stimulation) and was graded on a six point scale with one, the least amount of muscle flexion and six, the greatest. Quantitative patient responses were elicited after each application in each skull location on a scale of 0&#x02013;100 with 100 reflecting the greatest phantosmia intensity encountered, zero the absence (inhibition with disappearance) of phantosmia and intermediate numbers indicating intermediate changes of inhibition. Any change in phantosmia character was also reported. Response to stimulation was recorded for periods up to 60 months following this procedure. Following rTMS increases in specific blood plasma, erythrocytes and salivary growth factors were measured in CUP and BPAS [<xref rid="B167-brainsci-03-01483" ref-type="bibr">167</xref>].</p></sec><sec><title>2.2.8. Statistics</title><p>Means of each parameter measured for each patient group were determined and differences evaluated by Student t test with <italic>p</italic> &#x0003c; 0.05 considered significant. Differences between sets of parameters were also evaluated by Chi square (<italic>X</italic><sup>2</sup>, <italic>F</italic> test) and ANOVA with <italic>p</italic> &#x0003c; 0.05 considered significant.</p></sec></sec></sec><sec><title>3. Results</title><sec><title>3.1. Patient Characteristics</title><p>CUP: Thirty women and 10 men had CUP (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). Patients&#x02019; age ranged from 18 to 49 years (31 &#x000b1; 1 years, mean &#x000b1; SEM, (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>)). The ratio of women to men was 3:1. All patients developed symptoms post puberty. All were Caucasian. Symptoms were experienced 3 months&#x02013;28 years (mean, 7.2 years) prior to presentation at The Clinic (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). Initial symptom was always onset of an unirhinal phantom odor usually of a cacosmic type (78%). Each patient related a similar history; none had any prior knowledge of this symptom or syndrome. This syndrome consisted of two phases, an initial one (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>) associated with symptom onset and a subsequent one associated with symptom persistence (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref>). No prior or subsequent clinical motor activity ever occurred in any patient.</p><table-wrap id="brainsci-03-01483-t002" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t002_Table 2</object-id><label>Table 2</label><caption><p>Odor character of patients with phantosmia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Condition</th><th align="center" valign="middle" rowspan="1" colspan="1">CUP <sup>&#x02020;</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">BPAS <sup>&#x02020;</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Final odor character</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Cacosmic</td><td align="center" valign="middle" rowspan="1" colspan="1">20 <sup>y1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Putrid/rotten</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Torquosmic</td><td align="center" valign="middle" rowspan="1" colspan="1">9 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">70</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Burned/smoky</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">22</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Stale</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Metallic</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Fetid</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Diesel-like exhaust fumes</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Chemical/bitter</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Sweaty</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Excessively sweet</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Body odor-like</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Indescribable</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">16</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Mixed</td><td align="center" valign="middle" rowspan="1" colspan="1">11 <sup>z</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Initial phantosmia location</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Unilateral</td><td align="center" valign="middle" rowspan="1" colspan="1">40 <sup>w, w1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Right naris</td><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Left naris</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Bilateral</td><td align="center" valign="middle" rowspan="1" colspan="1">0 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">88</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Final phantosmia location</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Unilateral</td><td align="center" valign="middle" rowspan="1" colspan="1">25 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Right naris</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Left naris</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Bilateral</td><td align="center" valign="middle" rowspan="1" colspan="1">15 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">88</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>&#x02020;</sup></bold> Patient Number; <italic>CUP vs. BPAS</italic>: <sup>w</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (torquosmic); <sup>z</sup>
<italic>p</italic> &#x0003c; 0.05, <italic>X</italic><sup>2</sup> (unilateral, initial and final; bilateral, initial and final); <italic>CUP</italic>: <sup>w1</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (initial unilateral <italic>vs</italic>. bilateral), <sup>y1</sup>
<italic>p</italic> &#x0003c; 0.02, <italic>X</italic><sup>2</sup> (cacosmic <italic>vs</italic>. torquosmic; unilateral (initial) <italic>vs</italic>. bilateral; cacosmic <italic>vs</italic>. mixed).</p></fn></table-wrap-foot></table-wrap><p>Initial Phase: Phantosmia usually occurred spontaneously, unirhinally, usually without any other symptom (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). It occurred usually without warning and was an extremely unpleasant odor (commonly described as rotten, decayed, fecal (cacosmic) but also less frequently as chemical, metallic or burned (torquosmic)). It initially appeared in only one naris in the absence of any external ambient odor/or external stimulus and lasted from 5 to 10 s to as long as 10 to 20 min and then spontaneously disappeared (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref> and <xref ref-type="table" rid="brainsci-03-01483-t003">Table 3</xref>). The odor would then reappear, in the same naris again usually without any external stimulus after d, wk or mo, again lasting a few sec or min and then disappeared. After this second appearance and disappearance the interval between phantosmia onset and offset shortened such that it occurred with increasing frequency, intensity and duration eventually occurring in some patients daily lasting sec-min-hr and recurring as frequently as 5&#x02013;20 times daily.</p><table-wrap id="brainsci-03-01483-t003" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t003_Table 3</object-id><label>Table 3</label><caption><p>Clinical history in patients with phantosmia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="top" rowspan="1" colspan="1">Condition</th><th align="center" valign="top" rowspan="1" colspan="1">CUP</th><th align="center" valign="top" rowspan="1" colspan="1">BPAS</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Initial symptom</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Phantosmia (100% (40/40))</td><td align="left" valign="top" rowspan="1" colspan="1">Hyposmia (80% (76/88))</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Symptom onset</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02004;Naris location</td><td align="left" valign="top" rowspan="1" colspan="1">Unirhinal (100% (40/40))</td><td align="left" valign="top" rowspan="1" colspan="1">Birhinal (100% (88/88))</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02004;Length</td><td align="left" valign="top" rowspan="1" colspan="1">Momentary (s&#x02013;min), Fleeting</td><td align="left" valign="top" rowspan="1" colspan="1">Intermittent (10 s&#x02013;24 h), Variable</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02004;Frequency</td><td align="left" valign="top" rowspan="1" colspan="1">1&#x02013;20&#x000d7;/day</td><td align="left" valign="top" rowspan="1" colspan="1">1&#x02013;10&#x000d7;/day or persistent</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Symptom progression</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02004;Naris location</td><td align="left" valign="top" rowspan="1" colspan="1">Mainly unirhinal, occasionally birhinal</td><td align="left" valign="top" rowspan="1" colspan="1">Birhinal only</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02004;Length</td><td align="left" valign="top" rowspan="1" colspan="1">Gradual longer episodes 2&#x02013;30 min; rarely persistent</td><td align="left" valign="top" rowspan="1" colspan="1">No change (intermittent, persistent) or gradual symptom shortening with disappearance</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02004;Intensity</td><td align="left" valign="top" rowspan="1" colspan="1">Increasing</td><td align="left" valign="top" rowspan="1" colspan="1">No change or decreased intensity</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02004;Character</td><td align="left" valign="top" rowspan="1" colspan="1">No change&#x02014;always unpleasant</td><td align="left" valign="top" rowspan="1" colspan="1">May vary, can change from one unpleasant odor to another (occasionally less unpleasant)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Triggers initiating phantosmia</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Sneeze</td><td align="left" valign="top" rowspan="1" colspan="1">None; onset is spontaneous</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Nasal Sniffing</td><td align="left" valign="top" rowspan="1" colspan="1">Strong external odor may occasionally</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Nasal Blowing Out</td><td align="left" valign="top" rowspan="1" colspan="1">trigger phantom (Allodynosmia)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Rhinorrhea</td><td align="left" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Cough</td><td align="left" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Laugh</td><td align="left" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Loud Speech</td><td align="left" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Vigorous Physical Activity</td><td align="left" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Strong External Odor, may occasionally trigger phantom (Allodynosmia)</td><td align="left" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Physiological phantom inhibitors</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Sleep (30&#x02013;180 min), usually in PM</td><td align="left" valign="top" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Total Nasal Blockage</td><td align="left" valign="top" rowspan="1" colspan="1">May decrease over time spontaneously</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
</td><td align="left" valign="top" rowspan="1" colspan="1">Valsalva</td><td align="left" valign="top" rowspan="1" colspan="1">
</td></tr></tbody></table></table-wrap><p>After initial and second insidious onset all patients noted phantosmia was initiated following coughing, laughing, crying, sneezing, blowing the nose, loud speech or shouting, any intense emotional outburst, physical exertion, strenuous exercise, forced nasal inhalation and/or exhalation or hyperventilation (<xref ref-type="table" rid="brainsci-03-01483-t003">Table 3</xref>). One patient elicited phantosmia when diving into a swimming pool. No movement disorder, change in behavioral state, loss of consciousness, change in awareness of surrounding or automatism of any type was associated with phantosmia onset or presence. Over time half the patients, only on occasion, noted phantosmia (and/or phantageusia (v.i.)) onset after contact with a common, ambient vapor at its usual concentration (e.g., smell of brewing coffee, cigarette smoke, perfume, garlic or cutting onion) or taste of a flavorful food (e.g., taste of coffee, garlic, onion, <italic>etc</italic>.) labeled allodynosmia (for smell) and allodyngeusia (for taste), respectively, similar to allodynia (a painful sensation related to an usually perceived non-painful touch stimulus) [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>]. In presence of these distortions they perceived these ambient vapors and oral tastes appropriately as the vapor or taste would be perceived normally (<italic>i.e.</italic>, no aliosmia or aliageusia, respectively). After removal of stimulating vapor or taste, phantosmia and/or phantageusia persisted as it did after any physiologically based initiating stimulus (e.g., sneezing, laughing) and continued until inhibited by one of the physiological maneuvers used by the patient to terminate phantosmia (and/or phantageusia) (v.i.). </p><p>After a few weeks all patients recognized that phantosmia was inhibited by sleep (<xref ref-type="table" rid="brainsci-03-01483-t003">Table 3</xref>). Naps as short as 20&#x02013;30 min, if deep enough sleep were obtained, alleviated phantosmia. This effect was most commonly noted if sleep were obtained in mid or late afternoon. Naps in younger patients were more effective in inhibiting phantosmia than in older patients. However, over time, naps became less effective in relieving phantosmia. During the initial phase of this syndrome no matter how intense or persistent the phantosmia, an overnight sleep was uniformly associated with phantom disappearance upon awakening in the morning. After an extended time period (&#x0003e;5 years) overnight sleep became somewhat less effective in relieving phantosmia (secondary phase). </p><p>Independently, most patients discovered that a Valsalva-type maneuver terminated phantosmia (<xref ref-type="table" rid="brainsci-03-01483-t003">Table 3</xref>). Variations of this procedure included hanging the body trunk over a sofa and either holding breath or crying, snorting tap water or NaCl into the affected naris, or forced induction of emesis. After initial discovery of this technique, termination of phantosmia was uniformly successful and inhibition usually persisted for h. During this refractory period events such as sneezing or shouting did not reinitiate phantosmia. However, over time, while Valsalva still terminated phantosmia, length of inhibitory period became progressively shorter and less likely to resist reinitiation by crying, shouting, blowing of nose, or sneezing. </p><p>Some patients discovered that plugging the naris in which phantosmia appeared reduced intensity or eliminated it; however, this was generally ineffective over relatively prolonged time periods since if a cotton plug were used it became soaked with nasal mucus and had to be replaced or removed which activated phantosmia, or if a rubber or plastic plug were used, it induced excess nasal mucus so that the patient had to remove the plug in order to retain normal nasal and oral mechanics which reactivated phantosmia. Some patients habitually breathed through their mouth with some phantosmia relief; however, return to nasal breathing with nose blowing, <italic>etc</italic>., reinitiated phantosmia. </p><p>Acute coryza had a dichotomous effect; associated with nasal congestion, phantosmia was temporarily diminished or terminated but associated with sneezing and/or rhinorrhea, with or without nasal congestion, phantosmia was exacerbated (<xref ref-type="table" rid="brainsci-03-01483-t003">Table 3</xref>). One patient reported phantosmia inhibition coupled with hyposmia onset during recreational snorting of cocaine; cessation of snorting was associated with a gradual return of normal smell function and phantosmia. This patient also reported recurrent smoking tetrahydrocannanibol (THC) inhibited phantosmia without change in olfactory acuity; with termination of smoking, phantosmia gradually returned. This patient used this latter technique on multiple daily occasions to inhibit phantosmia with complete success on each occasion. Inhibition usually occurred 20&#x02013;30 min after initiation of THC use and continued throughout the smoking process. Deffervescence occurred gradually, coincident with deffervescence of THC effects. </p><p>After phantosmia terminated either spontaneously, following sleep or a Valsalva maneuver, no physiological carry-over (<italic>i.e.</italic>, no post-ictal-type symptoms) was present. Patients continued their normal daily activities without any change from their usual practice no matter how frequently they performed a Valsalva or some similar maneuver to relieve their phantosmia. Patients were usually embarrassed to perform a Valsalva maneuver in public and usually closeted themselves in some private area to perform this act; on occasion a patient might perform a Valsalva-type maneuver 5&#x02013;20 times daily in order to obtain effective relief.</p><p>Patients were very disturbed by presence of this strong obnoxious odor. Phantosmia character was always constant, considered obnoxious and intolerable, causing the patient to focus on its presence because of its intensity and character. In 78% of patients the phantosmia was cacosmic, in the remainder it was torquosmic (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). Although a few patients had difficulty describing the odor, once parameters of cacosmia and torquosmia were discussed each was able to categorize the odor specifically (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref>). No patient reported ever previously experiencing such an intense, unpleasant, overwhelming sensation. In this sense, its presence interfered with patient activities although each could continue to and did perform usual work activities. At times, however, phantosmia intensity became so great that patients terminated normal daily activities, most to attempt to alleviate the symptom with a Valsalva-type maneuver (<xref ref-type="table" rid="brainsci-03-01483-t003">Table 3</xref>). Phantosmia presence was not associated with any behavioral, mental or consciousness change. No specific change in emotional state other than displeasure and discomfort with phantosmia presence was associated with its initiation or inhibition. No willful behavior of any type other than the specific physiological maneuvers described (v.s.) affected either phantosmia onset or termination.</p><p>In 21 of 40 (52.5%) patients once phantosmia became recurrent, some characteristic sensation alerted them prior to its appearance. These sensations varied from nasal appearance of an odor similar to phantosmia but of much less intensity (12 patients), a feeling of facial pressure (five patients), a metallic taste (one patient), an indescribable intranasal sensation (one patient) or depression (one patient). Time preceding phantosmia onset varied from sec to 3 h (two patients (1&#x02013;59 s), 16 patients (1&#x02013;59 min), three patients (1&#x02013;3 h)).</p><p>Phantosmia occurred in absence of any clinical disorder and was of an unknown cause in 85% of patients (34 of 40, <xref ref-type="table" rid="brainsci-03-01483-t004">Table 4</xref>). A viral illness was associated with phantosmia onset in three (7.5%). Phantosmia occurred either during first trimester of pregnancy or immediately post partum in two (5%) (<xref ref-type="table" rid="brainsci-03-01483-t004">Table 4</xref>). Phantosmia arose after head injury in one patient (2%) (<xref ref-type="table" rid="brainsci-03-01483-t004">Table 4</xref>). One patient with phantosmia of idiopathic onset had a prior diagnosis of progressive systemic sclerosis, which was in remission (without treatment) at time of phantosmia onset. </p><table-wrap id="brainsci-03-01483-t004" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t004_Table 4</object-id><label>Table 4</label><caption><p>Phantosmia etiology in patients with phantosmia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Primary etiology</th><th align="center" valign="middle" rowspan="1" colspan="1">CUP <sup>&#x02020;</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">BPAS <sup>&#x02020;</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Idiopathic</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">32 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Other</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">8 <sup>x1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">78 <sup>w2</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Head injury</td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">40</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;PIHH <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">24</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Infectious mononucleosis</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Pregnancy (during/post partum)</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Allergic rhinitis</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Post nasal surgery</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Post stroke</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Idiopathic hyposmia</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Idiopathic aliosmia <sup>&#x003c6;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>&#x02020;</sup></bold> Patient Number; <sup>&#x02021;</sup> Post influenza-like hyposmia and hypogeusia; <sup>&#x003c6;</sup> Distorted smell in presence of external vapor; <italic>CUP vs. BPAS</italic>: <sup>w</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (idiopathic <italic>vs</italic>. other); PIHH; Infectious mononucleosis; <italic>CUP</italic>: <sup>x1</sup>
<italic>p</italic> &#x0003c; 0.01, <italic>X</italic><sup>2</sup> (idiopathic <italic>vs</italic>. other); <italic>BPAS</italic>: <sup>w2</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (idiopathic <italic>vs</italic>. other).</p></fn></table-wrap-foot></table-wrap><p>Phantosmia was initially present only in right naris in 60% (24 of 40) (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref>). In 40% phantosmia was initially present only in left naris (16 of 40 patients). Of patients with right naris presentation 54% were right handed 46% were left handed (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref>). Of patients with left naris presentation, 61% were right handed, 39% were left handed (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref>). There were no differences in phantosmia naris location in left or right handed patients. There were no gender related differences with respect to handedness or initial side of phantosmia. Nineteen percent of patients were left handed, a greater number than the 10%&#x02013;15% usually considered to be left handed in the general population [<xref rid="B168-brainsci-03-01483" ref-type="bibr">168</xref>,<xref rid="B169-brainsci-03-01483" ref-type="bibr">169</xref>]. </p><p>Phantosmia occurred initially spontaneously without any stimulation in 36 patients (90%) (<xref ref-type="table" rid="brainsci-03-01483-t005">Table 5</xref>). Phantosmia occurred initially after an endogenous stimulatory event in four patients (9.5%); in two (5%) after they blew their nose, in one after she sneezed and in one after she took oral adrenal corticosteroids for treatment of a systemic reaction to a bee sting.</p><p>No patient spontaneously complained of or recognized any loss of taste or smell acuity either before or after phantosmia onset but each complained that their smell and taste function was changed (<italic>i.e.</italic>, distorted) in presence of phantosmia. However, using specific psychophysical tests (gustometry and olfactometry) in the absence of phantosmia 8 of 40 (20%) had a mild smell loss (Type II or III hyposmia) and 9 (22.5%), a mild taste loss (Type II or III hypogeusia [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>] (<xref ref-type="table" rid="brainsci-03-01483-t005">Table 5</xref>)). Each patient with hyposmia detected and recognized all odorants but seven of eight (those with Type II hyposmia [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B160-brainsci-03-01483" ref-type="bibr">160</xref>]) had DT and/or RT greater than those of normal subjects; one patient had Type III hyposmia. Any smell deficit was birhinal. Each patient with hypogeusia detected and recognized all tastants but eight of these nine had Type II hypogeusia [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B161-brainsci-03-01483" ref-type="bibr">161</xref>] (<xref ref-type="table" rid="brainsci-03-01483-t006">Table 6</xref>) and one patient had Type III hypogeusia [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B161-brainsci-03-01483" ref-type="bibr">161</xref>]. Any taste deficit was orally global.</p><p>While each patient developed phantosmia as an independent symptom which did not subjectively influence taste or smell acuity, eventually as phantosmia became more intense and occurred more frequently, each complained that the odor interfered with ability to eat and enjoy food with eating and drinking intolerable due to this overriding obnoxious sensation. Only in this sense did patients report that phantosmia affected smell or taste function.</p><table-wrap id="brainsci-03-01483-t005" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t005_Table 5</object-id><label>Table 5</label><caption><p>Taste and smell acuity in patients with phantosmia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">
</th><th align="center" valign="middle" rowspan="1" colspan="1">CUP <sup>&#x02020;</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">BPAS <sup>&#x02020;</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Taste acuity</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Normal</td><td align="center" valign="middle" rowspan="1" colspan="1">31 <sup>w1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Abnormal</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">71 <sup>w2</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Ageusia</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;I</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;II</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">61</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;III</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Smell acuity</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Normal</td><td align="center" valign="middle" rowspan="1" colspan="1">32 <sup>w1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Abnormal</td><td align="center" valign="middle" rowspan="1" colspan="1">8 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">76 <sup>w2</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Unilateral</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Bilateral</td><td align="center" valign="middle" rowspan="1" colspan="1">8 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">76 <sup>w2</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Anosmia</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;I</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;II</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">42</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;III</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>&#x02020;</sup></bold> Patient Number; <italic>CUP vs. BPAS</italic>: <sup>w</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (taste acuity, abnormal; smell acuity, bilateral, abnormal); <italic>CUP</italic>: <sup>w1</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (taste acuity, normal <italic>vs</italic>. abnormal; smell acuity, normal <italic>vs</italic>. abnormal); <italic>BPAS</italic>: <sup>w2</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (taste acuity, normal <italic>vs</italic>. abnormal; smell acuity, normal <italic>vs</italic>. abnormal; unilateral <italic>vs</italic>. bilateral).</p></fn></table-wrap-foot></table-wrap><table-wrap id="brainsci-03-01483-t006" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t006_Table 6</object-id><label>Table 6</label><caption><p>Final naris localization in patients with phantosmia with respect to odor character.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="top" rowspan="1" colspan="1">
</th><th colspan="3" align="center" valign="top" rowspan="1">CUP <sup>&#x02020;</sup><break/>Final naris odor localization</th><th colspan="3" align="center" valign="top" rowspan="1">BPAS <sup>&#x02020;</sup><break/>Final naris odor localization</th></tr><tr style="border-top: solid thin"><th align="center" valign="top" rowspan="1" colspan="1">Odor character</th><th align="center" valign="top" rowspan="1" colspan="1">Right</th><th align="center" valign="top" rowspan="1" colspan="1">Left</th><th align="center" valign="top" rowspan="1" colspan="1">Birhinal</th><th align="center" valign="top" rowspan="1" colspan="1">Right</th><th align="center" valign="top" rowspan="1" colspan="1">Left</th><th align="center" valign="top" rowspan="1" colspan="1">Birhinal</th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1">Cacosmic (putrid)</td><td align="center" valign="top" rowspan="1" colspan="1">7 <sup>4</sup></td><td align="center" valign="top" rowspan="1" colspan="1">9 <sup>1</sup></td><td align="center" valign="top" rowspan="1" colspan="1">4 <sup>3</sup></td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">20</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Mixed (cacosmic and torquosmic)</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Torquosmic (burned, metallic,
<italic>etc</italic>.)</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">67</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>&#x02020;</sup></bold> Patient Number; <sup>1</sup>
<italic>p</italic> &#x0003c; 0.01, ANOVA, left <italic>vs</italic>. bilateral, cacosmic <italic>vs</italic>. mixed (CUP), left <italic>vs</italic>. bilateral, cacosmic <italic>vs</italic>. torquosmic (CUP), right <italic>vs</italic>. bilateral, cacosmic <italic>vs</italic>. torquosmic (CUP); <sup>3</sup>
<italic>p</italic> &#x0003c; 0.02, ANOVA, bilateral, cacosmic <italic>vs</italic>. mixed (CUP, BPAS); <sup>4</sup>
<italic>p</italic> &#x0003c; 0.05, ANOVA, right <italic>vs</italic>. left, cacosmic <italic>vs</italic>. mixed (CUP).</p></fn></table-wrap-foot></table-wrap><p>An associated history of some prior clinical nasal pathology was reported by 15 patients (37.5%). Five had a history of chronic allergic rhinitis with hayfever and two of these had chronic sinusitis. Two of these five patients also had a history of nasal polyps in the naris of the phantosmia prior to phantosmia onset although polyps were not present at time of presentation at The Clinic. Ten patients, prior to their visit at The Clinic, but after phantosmia onset, had surgical procedures in the naris on the side of phantosmia in an apparent attempt to relieve phantosmia; this included submucous resection (7 patients) and unilateral Caldwell-Luc operation (three patients). No surgical procedure influenced phantosmia onset, offset or intensity.</p><p>Most patients (85% (34 of 40)) reported an associated recurrent, cyclic, episodic orally global phantom taste sensation (cyclic phantageusia) time-locked with phantosmia. Cacogeusic phantageusia was present initially in over 90% of patients and was similar to phantosmia character. Because most considered phantosmia to permeate their entire oronasopharyngeal cavity, albeit it began in one naris, phantageusia might be considered an extension of phantosmia so that it is difficult to insure that this symptom was independent and related only to taste, per se, rather than a phantosmia manifestation. In 10%, cyclic phantageusia was of a torquegeusic character, different from that of phantosmia (<italic>i.e.</italic>, cacogeusic) albeit still time-locked to appearance and disappearance of phantosmia. In these latter patients reports of this symptom may be considered an indicator of phantageusia <italic>per se</italic>. Just as phantosmia was initiated by cough, sneeze, blowing of nose, <italic>etc</italic>., or inhibited by sleep or Valsalva, so phantageusia was also initiated or inhibited.</p><p>In some patients intermittent cyclic nature of phantosmia, once it attained a specific level of intensity, frequency, and duration, persisted in this pattern for y, occurring as often as 5&#x02013;20 times daily on some d, being absent on others, but always recurring in an episodic manner in the same manner in which it initially occurred (<xref ref-type="table" rid="brainsci-03-01483-t003">Table 3</xref>). Its onset did not have any specific relationship to menses in women. The episodic pattern was interrupted following Valsalva performance or daytime nap for periods varying from minutes to hours but following this inhibition the cyclic, episodic pattern eventually resumed. In these patients after Valsalva or nap, inhibition of phantosmia lasted for minutes&#x02013;hours, but then it either returned spontaneously or was reinitiated by cough, sneeze, nasal discharge, blowing of nose, <italic>etc</italic>., as noted above. Because phantosmia could be initiated or triggered by these activities some patients attempted to suppress all activities that might initiate phantosmia causing them to limit self-expression, social and physical activity and was eventually associated with a degree of depression. Phantosmia intensity usually reached a specific level at which it remained albeit to some extent intensity waxed and waned.</p><p>No patient reported headache or facial fullness as part of the onset or offset of this initial phase of hallucinatory activity or during any part of the post symptom period.</p><p>Second Phase: In some patients, usually after a period of years, phantosmia did not spontaneously disappear after onset but became relatively persistent. Thus, once phantosmia appeared in the morning or afternoon it persisted until sleep or Valsalva relieved it. Among patients in whom phantosmia became more permanent most found it progressively more difficult to inhibit it with either sleep or Valsalva. </p><p>During this second phase there was some change in phantosmia character. In half the patients (20 of 40) phantosmia in this second phase persisted as cacosmic (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref> and <xref ref-type="table" rid="brainsci-03-01483-t006">Table 6</xref>), in 22% (9 of 40) it persisted as torquosmic but in the remainder (11 patients, 28%) it became mixed (both cacosmic and torquosmic). </p><p>Phantosmia persisted unirhinally in 62.5% (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref>, <xref ref-type="table" rid="brainsci-03-01483-t003">Table 3</xref> and <xref ref-type="table" rid="brainsci-03-01483-t006">Table 6</xref>). In 27.5% (11 of 40 patients) phantosmia was initially present only in left naris and it remained localized on that side (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref> and <xref ref-type="table" rid="brainsci-03-01483-t006">Table 6</xref>); in 40% (16 of 40 patients) phantosmia was present initially in right naris and it remained localized on that side. In 37.5%, phantosmia became birhinal. Among patients with unirhinal cacosmic phantosmia, four (10%) developed a birhinal component; among patients with unirhinal torquosmic phantosmia eight (20%) developed a birhinal component and among patients with a mixed unirhinal phantosmia three (7.5%) developed a birhinal component (<xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref> and <xref ref-type="table" rid="brainsci-03-01483-t006">Table 6</xref>). These results indicate that patients with unirhinal torquosmic phantosmia were significantly more likely to develop a birhinal component than were patients with either unirhinal mixed or unirhinal cacosmic phantosmia (<italic>p</italic> &#x0003c; 0.01, <italic>X</italic><sup>2</sup>). This difference may be of value in differentiating patients with these phantosmic characteristics.</p><p>All patients related a consistent history that the side of initial phantosmia retained its initial character, although frequency and intensity increased. However if phantosmia occurred in the opposite naris it rarely appeared alone but usually in both nares simultaneously. When this occurred phantosmia in the initial naris retained its initial character and intensity but the naris to which phantosmia extended was usually of less intensity and frequency and was usually of a different character than initial unirhinal phantosmia; this was commonly of a torquosmic type (v.s.). In these patients it was still most common to perceive phantosmia in one naris and only on occasion would phantosmia appear in both nares simultaneously. However, when phantosmia appeared birhinally patients reported that it was more overwhelmingly obnoxious and their ability to disregard it was even more impaired than it was when it appeared unirhinally due to odor character and intensity.</p><p>One patient developed unique sequelae. She developed painful optic neuritis in the left eye 10 years after phantosmia onset associated with optic atrophy, which was unresponsive to systemic adrenal corticosteroid therapy. Visual acuity progressively decreased in this eye to only light-dark perception with absence of finger counting and eventually decreased in right eye to only finger counting. This patient also had varicosities in venous plexi in both retinae, which became engorged during Valsalva used to relieve phantosmia. Neither oligoclonal immunoglobulin pattern in cerebral spinal fluid (CSF) nor periventricular white matter lesions on MRI were present. </p><p>No patient reported headache or facial fullness either as part of the onset or offset of this initial or second phase of this syndrome or during any part of the post symptom period.</p><p>BPAS: Forty-seven women and 41 men had BPAS (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). Patients&#x02019; age varied from 1 to 82 years (46 &#x000b1; 2 years, mean &#x000b1; SEM (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). Three patients developed symptoms prior to puberty. All were Caucasian. Symptoms were experienced one week to 10 years (mean 1.8 years) prior to presentation at The Clinic. Birhinal phantosmia followed hyposmia onset by 1 week&#x02013;6 months in 70 patients (80%); it occurred simultaneously with onset of either hyposmia or other symptoms in 18 (20%) (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). The most common initial symptom was hyposmia (in 86%). Phantosmia was always birhinal as opposed to the unirhinal character in CUP (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). It was usually torquosmic as opposed to the primarily cacosmic character in CUP (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). Mean age in BPAS was significantly older than in CUP (<italic>p</italic> &#x0003c; 0.01, <italic>t</italic> test) (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>). In BPAS there was a similar number of men and women whereas in CUP women outnumbered men by 3:1, a significant different gender ratio (<italic>p</italic> &#x0003c; 0.05, <italic>X</italic><sup>2</sup>). No prior or subsequent clinical motor activity occurred in any patient.</p><p>Birhinal hyposmia was the initial presenting clinical complaint in 86% (as opposed to initial presenting complaint of unirhinal phantosmia in 100% of patients with CUP (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>)); the remainder of BPAS patients had other associated smell and/or taste dysfunction including global hypogeusia and/or global aliageusia, aliosmia and phantageusia (<xref ref-type="table" rid="brainsci-03-01483-t005">Table 5</xref> (v.s.)). BPAS patients recognized their impaired smell acuity as opposed to CUP patients who generally did not have this symptom (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref> and <xref ref-type="table" rid="brainsci-03-01483-t006">Table 6</xref>); 28% of BPAS patients exhibited an inability to recognize any vapor at any concentration (<italic>i.e.</italic>, absent recognition thresholds for any odorant, Type I hyposmia [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B130-brainsci-03-01483" ref-type="bibr">130</xref>]), whereas no CUP patient exhibited Type I hyposmia (<xref ref-type="table" rid="brainsci-03-01483-t005">Table 5</xref>).</p><p>Phantosmia developed as a sequela of an illness, secondary to hyposmia in 86% of patients with BPAS (<xref ref-type="table" rid="brainsci-03-01483-t004">Table 4</xref> (v.s.)). The most common cause was head injury (post-concussive syndrome, 40 patients, 45% of total group [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>]), followed by an influenza-type viral infection (post influenza-like hyposmia and hypogeusia (PIHH), 24 patients, 27% of total group [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B157-brainsci-03-01483" ref-type="bibr">157</xref>] (<xref ref-type="table" rid="brainsci-03-01483-t004">Table 4</xref>)). As opposed to CUP in whom unirhinal phantosmia was the first and only symptom, phantosmia in BPAS usually appeared later, days, weeks or even months after appearance of hyposmia or other symptoms (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref>); infrequently it appeared with onset of their associated symptoms. No patient experienced a seizure with motor activity before or after phantosmia onset despite the fact that 45% experienced head injury as the cause of their hyposmia and several of these patients experienced prograde and retrograde amnesia, loss of consciousness and skull fracture with their injury. After phantosmia terminated no physiological carry-over (<italic>i.e.</italic>, no post-ictal type symptoms) were present similar to CUP.</p><p>Phantosmia was always birhinal (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref> and <xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref>) and it always retained this character. It was initially intermittent or persistent but neither cyclic nor episodic, usually lasting from seconds to minutes to hours (<xref ref-type="table" rid="brainsci-03-01483-t003">Table 3</xref>); in some patients phantosmia was persistent and was present for days to weeks. In contrast to CUP, phantosmia in BPAS usually remained intermittent or persistent and, rather than increase in frequency and intensity, as in CUP; overtime it either remained the same or, more commonly, decreased in both frequency and intensity and in some patients disappeared although hyposmia always persisted. Phantosmia onset and offset usually occurred in an irregular, unpatterned, unpredictable manner. Phantosmia was not elicited by any physiological maneuver, usually occurring spontaneously; however, in a few patients, a strong, common ambient odor triggered phantosmia (<italic>i.e.</italic>, allodynosmia) with no distortion associated with the ambient odor per se (<italic>i.e.</italic>, no aliosmia). If phantosmia occurred after exposure to an ambient odor, after external odor removal, phantosmia either disappeared immediately or pursued its usual course and then disappeared as opposed to phantosmia persistence in CUP. No physiological maneuver initiated, diminished or abolished phantosmia. Phantosmia usually retained its initial character, which did not vary over time (v.s.).</p><p>Only on occasion did BPAS patients experience phantageusia (in 22 patients or 25% of the total group). This symptom was usually independent of phantosmia, was of a different character than phantosmia and of much less severity than phantosmia. When it occurred, phantageusia was orally global but usually transient and unrelated to any physiological stimulus. Allodyngeusia rarely occurred in BPAS.</p><p>Phantosmia character was significantly more frequently torquosmic (70 patients, 80% of the total group) than cacosmic (in 17 patients or 21%) or mixed (1 patient, 1% of the total group) (<xref ref-type="table" rid="brainsci-03-01483-t001">Table 1</xref> and <xref ref-type="table" rid="brainsci-03-01483-t002">Table 2</xref>), in contrast to CUP patients in whom phantosmia were more frequently cacosmic (ANOVA, <italic>p</italic> &#x0003c; 0.01, <italic>t</italic> test).</p><p>Two patients had psychiatric diagnoses at their first visit to The Clinic; one had an obsessive-compulsive disorder and one had clinical depression. Both were under psychiatric care and taking anxiolytic drugs at that time; this treatment did not alter character or frequency of phantosmia or hyposmia.</p><p>No patient experienced any sensation in nose, taste in mouth or unusual feelings of any type prior to phantosmia onset; it occurred spontaneously after hyposmia onset.</p><p>No change in emotional state, willful behavior or physiological maneuver initiated or altered phantosmia.</p><p>No patient reported headache or facial fullness either as part of the onset or offset of the hallucinatory activity or during any part of the post symptom period.</p></sec><sec><title>3.2. Physical Examination of Head and Neck</title><p>CUP: No patient had any observable change from normal in nasopharyngeal cavity, mouth or neck. Uvular and palatal reflexes were normal. Each patient had both thick and thin nasal mucus in both nasal cavities. Nasal mucous membranes in both nares were of normal character and turgor. Nasal breathing was not altered in any patient.</p><p>BPAS: Twelve of 88 patients (14%) exhibited observable changes from normal in their nasal cavity; these were in 10 patients with PIHH and two patients with allergic rhinitis. In patients with PIHH there was observable thinning of nasal mucous membranes with absence of thick nasal mucus and increased nasal airways patency, as previously described [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B157-brainsci-03-01483" ref-type="bibr">157</xref>]. In patients with allergic rhinitis there was modest edema of nasal mucous membranes birhinally, increased nasal congestion and slightly decreased nasal airways patency [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>,<xref rid="B158-brainsci-03-01483" ref-type="bibr">158</xref>]. Changes did not subjectively restrict nasal air flow in any patient and each stated that nasal breathing was unchanged either after loss of olfactory acuity and/or onset of birhinal phantosmia. No patient exhibited nasal polyposis and none exhibited polypoid degeneration of nasal mucous membranes. No abnormalities were found in examination of mouth or neck in any patient.</p></sec><sec><title>3.3. Neurological Examination</title><p>CUP: Except for the presence of phantosmia the clinical neurological examination was within normal limits in each patient.</p><p>BPAS: Except for the presence of phantosmia and hyposmia the clinical neurological examination was within normal limits in each patient.</p></sec><sec><title>3.4. EEG Changes</title><p>CUP: EEG abnormalities were observed in 19 of 40 patients (47.5%) (<xref ref-type="table" rid="brainsci-03-01483-t007">Table 7</xref> and <xref ref-type="table" rid="brainsci-03-01483-t008">Table 8</xref>). Abnormalities were found in temporal lobe in 13 patients, in fronto-temporal region in two, in frontal region in three and location was indeterminate in one. EEG slowing was observed in two patients and was diffuse. Seventeen patients (89%) exhibited sharp waves, three exhibited spike discharges. Photostimulation elicited abnormalities in two patients but changes were only exacerbations of already existing EEG abnormalities, both left temporal sharp wave discharges. Hyperventilation elicited abnormalities in two records, one in which photostimulation also exacerbated previously observed sharp waves in left temporal lobe.</p><p>Of 15 right handed patients with EEG abnormalities, eight exhibited left sided changes, six, bilateral and one with right sided changes (<xref ref-type="table" rid="brainsci-03-01483-t008">Table 8</xref>). Of six patients with bilateral abnormalities, three exhibited changes greater on left than right. Of the five left handed patients with EEG abnormalities, two exhibited right sided changes, two exhibited left sided changes and one exhibited bilateral changes with changes greater on left side than right.</p><table-wrap id="brainsci-03-01483-t007" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t007_Table 7</object-id><label>Table 7</label><caption><p>EEG characteristics in patients with phantosmia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Condition</th><th align="center" valign="middle" rowspan="1" colspan="1">CUP <sup>&#x02020;</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">BPAS <sup>&#x02020;</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>EEG abnormality present</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;No</td><td align="center" valign="middle" rowspan="1" colspan="1">22 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">76</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Men</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Women</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Abnormality type</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Slowing</td><td align="center" valign="middle" rowspan="1" colspan="1">2 <sup>z1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Sharp waves</td><td align="center" valign="middle" rowspan="1" colspan="1">16 <sup>z</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Abnormality site</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Localized</td><td align="center" valign="middle" rowspan="1" colspan="1">17 <sup>z, w1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Generalized</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Similar side phantosmia/EEG abnormality</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">4 <sup>z1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;No</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>&#x0201c;Opposite side&#x0201d; phantosmia/EEG abnormality</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;No</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>&#x02020;</sup></bold> Patient Number; <italic>CUP vs. BPAS</italic>: <sup>w</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (EEG abnormality, no <italic>vs</italic>. yes); <sup>z</sup>
<italic>p</italic> &#x0003c; 0.05, <italic>X</italic><sup>2</sup>, (sharp waves present, localized EEG changes); <italic>CUP</italic>: <sup>w1</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (localized <italic>vs</italic>. generalized); <sup>z1</sup>
<italic>p</italic> &#x0003c; 0.05, <italic>X</italic><sup>2</sup> (slowing <italic>vs</italic>. sharp waves; EEG abnormality, not on similar side EEG abnormality).</p></fn></table-wrap-foot></table-wrap><table-wrap id="brainsci-03-01483-t008" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t008_Table 8</object-id><label>Table 8</label><caption><p>EEG characteristics in patients with phantosmia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Condition</th><th align="center" valign="middle" rowspan="1" colspan="1">CUP <sup>&#x02020;</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">BPAS <sup>&#x02020;</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Skilled Hand</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Right (R)</td><td align="center" valign="middle" rowspan="1" colspan="1">37 <sup>x</sup> (78)</td><td align="center" valign="middle" rowspan="1" colspan="1">85 (97)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Left (L)</td><td align="center" valign="middle" rowspan="1" colspan="1">9 <sup>x</sup> (22)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (3)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Final naris side of phantosmia</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Sided Phantom</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Sided Phantom</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Bilateral phantom</td><td align="center" valign="middle" rowspan="1" colspan="1">12 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">88</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Handedness vs. Final side of phantosmia</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Handed, L Sided Phantom</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (30)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Handed, R Sided Phantom</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (22)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (2)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Handed, Bilateral Phantom</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">85 <sup>w2</sup> (97)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Handed, R Sided Phantom</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (1)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Handed, L Sided Phantom</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (2)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Handed, Bilateral Phantom</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (10)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (3)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Handedness vs. Side of EEG abnormality</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Handed, L Sided EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (44)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (25)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Handed, R Sided EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (8)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Handed, Bilateral EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (22)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (67)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Handed, R Sided EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Handed, L Sided EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (11)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Handed, Bilateral EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (11)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Final side of phantosmia vs. Side of EEG abnormality</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Side, L EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (22)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Side, R EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;R Side, Bilateral EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (17)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Side, R EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (11)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Side, L EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (17)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;L Side, Bilateral EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (11)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Bilateral, L EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (17)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Bilateral, R EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Bilateral, Bilateral EEG</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>&#x02020;</sup></bold> Patient Number; ( ) Percent; <italic>CUP vs. BPAS</italic>: <sup>w</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (bilateral phantom, final side); <sup>x</sup>
<italic>p</italic> &#x0003c; 0.01, <italic>X</italic><sup>2</sup> (R skilled hand, L skilled hand); <italic>BPAS</italic>: <sup>w2</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2</sup> (bilateral phantom <italic>vs</italic>. L or R sided phantom).</p></fn></table-wrap-foot></table-wrap><p>Stage II sleep was obtained in 22 patients (55%) demonstrated by sleep spindles on EEG record; in only one patient were EEG changes not observed during the waking EEG observed during sleep. </p><p>Phantosmia was elicited and specifically noted during EEG recording in 24 patients (60%); no abnormality not previously observed was elicited with phantosmia. Mean duration of phantosmia was 21.4 min (range 1&#x02013;120 min). In some patients phantosmia was not present at beginning of EEG but was elicited during the record by deep, rapid, repeated nasal sniffs or hyperventilation; in other patients phantosmia was present at initiation of EEG record and was terminated by a Valsalva maneuver. No matter the sequence, no change in EEG over that observed before initiation or termination of phantosmia was observed.</p><p>Nasopharyngeal leads revealed no additional abnormalities over those observed without use of these leads.</p><p>BPAS: EEG abnormalities were observed in 12 of 88 patients (14%) a significantly smaller percentage than in CUP (<xref ref-type="table" rid="brainsci-03-01483-t007">Table 7</xref>) (<italic>p</italic> &#x0003c; 0.01, <italic>X</italic><sup>2</sup>, <italic>F</italic> test). Of EEG changes observed, six showed slowing and six showed sharp waves (all among the 40 who had head injury), also significantly less than in CUP (<xref ref-type="table" rid="brainsci-03-01483-t007">Table 7</xref>) (<italic>p</italic> &#x0003c; 0.05, <italic>X</italic><sup>2</sup>, <italic>F</italic> test). EEG changes were localized in eight patients and generalized in four, also significantly different from increased localization of EEG changes observed in CUP (<italic>p</italic> &#x0003c; 0.05, <italic>X</italic><sup>2</sup>, <italic>F</italic> test). Phantosmia was reported present during EEG in 15 patients lasting from sec to the entire EEG; this symptom was not and could not be elicited by any behavioral or physiological maneuver in any patient who did not have the symptom at initiation of EEG. Phantosmia presence was not associated with any specific abnormality observed in EEG record and did not distinguish EEG records of these patients from others with BPAS. </p><p>Stage II sleep was obtained in 47 patients (53%) demonstrated by sleep spindles on EEG record; no EEG changes not observed during wakefulness were observed during sleep. Nasopharyneal leads revealed no additional abnormalities over those observed without these leads.</p></sec><sec><title>3.5. Neuroimaging Studies</title><p>CUP: Some abnormality was observed in 11 patients (27.5% (<xref ref-type="table" rid="brainsci-03-01483-t009">Table 9</xref>); these were CT brain scan changes in six patients (bilateral parietal parasagital encephalomalacia (one patient), mild frontal atrophy (one patient), undefined soft tissue density (one patient), calcification within the sella turcica (one patient) mucoperiosteal thickening of ethmoid and maxillary sinuses, bilaterally (one patient) and a cystic formation in the left maxillary antrum (one patient)). In one patient a solitary plaque was found in central white matter on MRI. In the three women who underwent cerebral angiography one had bilateral orbital vein varicosities with right superior orbital vein thrombosis whereas no abnormalities were observed in the other two. Abnormalities on skull X-rays were sella turcica calcification and mucoperiosteal sinus thickening also observed on CT brain scan. Abnormalities on sinus x-rays were mucoperiosteal thickening of the maxillary sinuses, bilaterally, in two patients. </p><table-wrap id="brainsci-03-01483-t009" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t009_Table 9</object-id><label>Table 9</label><caption><p>Imaging studies in patients with phantosmia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Condition</th><th align="center" valign="middle" rowspan="1" colspan="1">CUP <sup>&#x02020;</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">BPAS <sup>&#x02020;</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>CAT scan&#x02014;brain</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">28 <sup>z</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">55</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Abnormal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">16</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Normal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">39</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>MRI brain</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Abnormal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Normal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Tc99<sup>m</sup> brain scan</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Abnormal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Normal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Skull X-ray</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Abnormal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Normal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Sinus X-ray</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Abnormal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Normal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Total patients with radiographic studies</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">83</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Abnormal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Normal studies</td><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">62</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>&#x02020;</sup></bold> Patient Number; <italic>CUP vs. BPAS</italic>: <sup>z</sup>
<italic>p</italic> &#x0003c; 0.05, <italic>X</italic><sup>2</sup> (abnormal CAT scan).</p></fn></table-wrap-foot></table-wrap><p>BPAS: Abnormalities were observed in 21 patients (24% (<xref ref-type="table" rid="brainsci-03-01483-t009">Table 9</xref>)), not significantly different from that observed in CUP. Abnormalities on brain CT scans included seven with encephalomalacia with or without atrophy, four with specific frontal or temporal atrophic changes, one with a subdural hematoma, one with a subarachnoid hemorrhage, one with an occipital skull fracture (all 14 abnormalities among the 40 patients with a prior history of head injury) and two with bilateral maxillary sinusitis (among the four patients with allergic rhinitis). The abnormality on skull X-ray was a basilar skull fracture in one patient at time of prior head trauma. Abnormalities on sinus-X rays were sinusitis of maxillary antra (unilateral or bilateral) in four patients (two among the four patients with allergic rhinitis and two among the three patients post nasal surgery). </p><p>In a recent study of brain MRI scans in 1000 asymptomatic nominally normal volunteers 18% showed abnormal results with 13.2% exhibiting what was interpreted radiographically as paranasal sinusitis [<xref rid="B170-brainsci-03-01483" ref-type="bibr">170</xref>]. In other studies of this type paranasal sinusitis was found in 42%&#x02013;49% of supposedly normal subjects [<xref rid="B170-brainsci-03-01483" ref-type="bibr">170</xref>,<xref rid="B171-brainsci-03-01483" ref-type="bibr">171</xref>,<xref rid="B172-brainsci-03-01483" ref-type="bibr">172</xref>,<xref rid="B173-brainsci-03-01483" ref-type="bibr">173</xref>].</p></sec><sec><title>3.6. fMRI Studies</title><p>CUP: Brain activation to phantosmia memory was extremely robust and quantitatively greater than to any other olfactory stimulus (e.g., smell of any vapor, including absolute pyridine, an extremely pungent, unpleasant odor [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>]). Although phantosmia was unirhinal, brain activation to phantosmia and phantosmia memory was bihemispheric. CNS activation was not related to patient handedness or side of phantosmia although a suggestion of preponderance of right as opposed to left hemispheric activation was apparent [<xref rid="B174-brainsci-03-01483" ref-type="bibr">174</xref>]. After forced nasal inhalation and exhalation initiated unirhinal phantosmia, increased bihemispheric CNS activation occurred [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>]. After Valsalva inhibited unirhinal phantosmia increased bihemispheric CNS activation also occurred [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>]. Regional CNS activation was sensory specific, greatest in anterior frontal and temporal cortex [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>], but prominent activation was measured in cingulate and in striatum.</p><p>BPAS: Brain activation to phantosmia memory was also robust and quantitatively greater than to any olfactory stimulus previously presented [<xref rid="B162-brainsci-03-01483" ref-type="bibr">162</xref>]. Regional CNS activation was sensory specific, greatest in the anterior frontal and temporal cortex with little or no activation in striatum [<xref rid="B162-brainsci-03-01483" ref-type="bibr">162</xref>]. No physiological maneuver increased and inhibited CNS activation in patients with BPAS.</p></sec><sec><title>3.7. MRS Studies</title><p>CUP: Results of preliminary studies indicated ratio of GABA: creatine in occipital cortex was not different between the two patients studied and the normal volunteers (patients, mean, 0.22, normals, 0.18 &#x000b1; 0.03 (Mean &#x000b1; SEM)). Ratio of GABA: creatine was lower in cingulate and right insula cortex in patients compared to normal volunteers (patients, mean, cingulate, 0.12, right insula, 0.10; normals, cingulate, 0.21 &#x000b1; 0.05, right insula, 0.22 &#x000b1; 0.06). Results indicate mean ratio of GABA: creatine in cingulate cortex in patients was 57% that in normal volunteers, mean ratio in right insula in patients was 45% that in normals. </p><p>BPAS: Similar regional changes in GABA: creatine to those found in CUP were also found in BPAS. In occipital cortex, ratio of GABA: creatine was similar in patients and normals (patients, 0.17 &#x000b1; 0.04, normals, 0.18 &#x000b1; 0.03). In patients, in cingulate and right insular cortex, ratio of GABA: creatine were significantly lower than in normals (cingulate, patients, 0.11 &#x000b1; 0.007, normals, 0.21 &#x000b1; 0.05, <italic>p</italic> &#x0003c; 0.01 <italic>t</italic> test; right insula, patients, 0.14 &#x000b1; 0.03, normals, 0.22 &#x000b1; 0.06, <italic>p</italic> &#x0003c; 0.01, <italic>t</italic> test).</p></sec><sec><title>3.8. CO<sub>2</sub> Inhalation Studies</title><p>CUP: Following CO<sub>2</sub> inhalation, inhibition of phantosmia was reported by seven of the 10 patients (six women, one man) to whom it was administered. CO<sub>2</sub> inhalation was difficult to maintain due to its abrasive character. After initial CO<sub>2</sub> inhalation phantosmia inhibition persisted from periods of one-48 h (five women, one man) to 7 days (one woman). The longer the patient tolerated CO<sub>2</sub> exposure the longer phantosmia inhibition. During this inhibition period no physiological maneuver which previously initiated phantosmia (e.g., sneezing, crying, blowing the nose, hyperventilation) initiated phantosmia despite repeated efforts to perform these maneuvers. At termination of this refractory period phantosmia either returned spontaneously or was initiated by a maneuver which commonly initiated it prior to CO<sub>2</sub> inhalation. In the woman in whom phantosmia was inhibited for 7 days, phantosmia returned after she blew her nose. CO<sub>2</sub> inhalation was then repeated on two additional occasions over a period of five weeks; after each inhalation her phantosmia was inhibited, albeit length of inhibition period decreased after each CO<sub>2</sub> inhalation. In four of the 10 patients (one woman, three men) no effect of CO<sub>2</sub> inhalation could be convincingly demonstrated. Administration of CO<sub>2</sub> by facial mask may play a role in delivery of this agent since, by analogy, delivery of oxygen through nasal prongs did not influence incidence of post-operative wound infections [<xref rid="B175-brainsci-03-01483" ref-type="bibr">175</xref>,<xref rid="B176-brainsci-03-01483" ref-type="bibr">176</xref>] whereas delivery through facial mask decreased wound infection incidence [<xref rid="B177-brainsci-03-01483" ref-type="bibr">177</xref>] presumably through increased arterial oxygen tension and subcuteneous tissue oxygen tension [<xref rid="B178-brainsci-03-01483" ref-type="bibr">178</xref>]. No change in smell acuity occurred following this procedure. </p><p>BPAS: CO<sub>2</sub> inhalation was not used in any patient.</p></sec><sec><title>3.9. Intranasal Cocaine Administration</title><p>CUP: Unirhinal intranasal cocainization initiated immediate cessation of phantosmia in each patient in whom it was used. This effect persisted for 2 h in one patient and for 8 h in the other. During this inhibitory period no physiological maneuver, which previously initiated phantosmia, did so despite repeated attempts to initiate it. Whereas prior to this intervention both exhibited normal smell function Type I hyposmia was induced in the cocainized naris subsequent to this procedure (determined by absent RT and diminished DT for all odorants using unirhinal testing) and its time course roughly followed onset and offset of phantosmia. Phantosmia returned either spontaneously (one patient) or after blowing the nose (one patient), which terminated this inhibitory period. Subsequent to this intervention with phantosmia return smell function also returned to normal in each patient.</p><p>BPAS: Birhinal intranasal cocainization initiated immediate cessation of phantosmia in the patient in whom it was used. This effect persisted for approximately 10 days after which time it returned in a pattern similar to that noted prior to this procedure. This patient exhibited Type I hyposmia prior to nasal cocainization and it did not change after intranasal cocainization. </p></sec><sec><title>3.10. rTMS Studies</title><p>CUP: No patient reported any change in phantosmia intensity or character after shoulder or neck stimulation at 40% intensity or after stimulation to any skull region at 20% intensity. Each patient reported a significant initial decrease (10%&#x02013;30%) in phantosmia after stimulation at 60% maximal intensity in left temporoparietal region with no further change after stimulation in any other region. Repeat stimulation (one to six applications) in this region induced a continued decrease to a stable inhibition level about 50% of pre stimulation phantosmia which persisted for 3 h in one patient and 20 days in the other. During this inhibitory period no physiological maneuver (e.g., nose blowing, hyperventilation) induced phantosmia. In the patient in whom inhibition persisted for three hours phantosmia intensity increased to prestimulation levels after this period following hyperventilation. In the patient in whom phantosmia inhibition persisted for 20 days phantosmia intensity increased after this period but only to about 60% of pre stimulation intensity after nose blowing and did not increase further in intensity with any physiological maneuver. Significant increases in carbonic anhydrase I, II and VI occurred in blood plasma, erythrocytes and saliva, respectively, and in plasma, erythrocytes and saliva zinc and copper measured after rTMS consistent with the phantosmia decrease in each patient [<xref rid="B167-brainsci-03-01483" ref-type="bibr">167</xref>]. Repeat stimulation was not performed in either patient.</p><p>BPAS: No patient reported any change in phantosmia intensity or character after stimulation to shoulder or neck or after stimulation in any skull region at 20% intensity. Each patient reported a significant initial decrease in phantosmia after stimulation at 60% maximal intensity [<xref rid="B165-brainsci-03-01483" ref-type="bibr">165</xref>,<xref rid="B166-brainsci-03-01483" ref-type="bibr">166</xref>]. Three reported an initial decrease in phantosmia intensity after stimulation in left temperoparietal region with no further change after stimulation in any other region. Initial response was usually a decrease of 20%&#x02013;50%. Repeat stimulation (one to six applications) in this region induced a report of total absence of phantosmia (an intensity decrease of 50%&#x02013;100%). Associated with this decrease changes in carbonic anhydrase I, II and VI and in zinc and copper similar to those measured in CUP were also reported [<xref rid="B167-brainsci-03-01483" ref-type="bibr">167</xref>].</p><p>The decrease in phantosmia was as long lasting as reports were obtained in two patients (both women (<italic>i.e.</italic>, after 24 months)) and lasted two mo (one man) in the other patient; repeat stimulation in this latter patient induced a four month phantosmia remission after a spontaneous return to about 50% of its prior intensity. After another spontaneous return to about 40% of prior phantosmia intensity a further stimulation resulted in phantosmia inhibition that has lasted for over one year. One patient (one man) reported an initial decrease (~40%) in phantosmia after initial stimulation in right temporoparietal region without further change in stimulation in any other region. Repeat right temporoparietal stimulation resulted in complete inhibition of phantosmia (100% decrease), which has lasted as long as records were obtained (&#x0003e;48 months).</p></sec><sec><title>3.11. Evaluation and Treatment Prior to This Study</title><p>CUP: After phantosmia onset each patient sought assistance from some medical caregiver to attempt to evaluate and alleviate the symptom [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>]. Each treated patient was evaluated by an average of four practitioners prior to evaluation and treatment at The Taste and Smell Clinic in Washington, DC, USA. Initially patients received little or no encouragement or treatment from their local medical consultants. Subsequently, 28 of the 40 (70%) received at least one form of treatment for periods of one wk to four mo prior to their visit to The Clinic (<xref ref-type="table" rid="brainsci-03-01483-t010">Table 10</xref>). Thirteen (32.5%) were told their phantosmia was psychosomatic and were referred for psychiatric evaluation and treatment. Each of these patients underwent psychiatric treatment and were given anxiolytic agents which did not alter phantosmia (<xref ref-type="table" rid="brainsci-03-01483-t010">Table 10</xref>). Twelve (30%) received antidepressants, (including dibenzocycloheptadines (eight patients), benzodiazepines (two patients), phenothiazines (one patient) and other tricyclic antidepressants (one patient)) which improved mood in four patients but did not significantly alter phantosmia in any patient. Thirty patients (75%) were referred to a neurologist. After obtaining an EEG, the results of which are not available, each was considered to have some type of seizure disorder and 24 (60%) were given an anticonvulsant either singly (usually phenytoin) or in combination with another anticonvulsant agent (<xref ref-type="table" rid="brainsci-03-01483-t010">Table 10</xref>); phantosmia was not permanently altered by any of these drugs although one patient reported temporary relief from phenobarbital treatment. Some patients went to otolaryngologists. Thirteen (32.5%) were given antibiotics; five of these were also given antihistamines and eight were also given either systemic adrenocorticosteroids or intranasal steroid sprays; no phantosmia change resulted from these therapies. Three were treated with allergic immunotherapy without benefit. Three received intranasal installation of 10% cocaine; in two patients phantosmia was inhibited for 24 h and then returned; in one patient phantosmia was inhibited for four mo before returning. Ten patients underwent surgical procedures involving the affected naris in an attempt to relieve phantosmia; seven underwent nasal submucous resections and three underwent Caldwell-Luc procedures. No procedure inhibited phantosmia. Eleven were given exogenous oral zinc ion and two were treated with massive doses of vitamins (vitamin A, 50,000 units daily (one patient), B complex vitamins (one patient)) without change in phantosmia. Other attempts to evaluate and control phantosmia included various forms of alternative medical practice including medicinal herbs, nutritional supplements, hypnosis and acupuncture. One patient reported phantosmia inhibition with daily smoking of THC (v.s.). Two patients received thioridazine with one noting diminution in phantosmia intensity after the drug was administered for one mo whereas the other noted no benefit after one mo of treatment.</p><p>BPAS: Each patient repeatedly sought medical assistance primarily for treatment of loss of smell and flavor acuity, their major complaints [<xref rid="B102-brainsci-03-01483" ref-type="bibr">102</xref>,<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>], although not all patients received treatment (<xref ref-type="table" rid="brainsci-03-01483-t010">Table 10</xref>). While not unconcerned with their phantosmia most physicians considered this a lesser problem than loss of ability to smell and taste (obtain flavor) from food. Patients were evaluated and treated by an average of four practitioners prior to their first visit to The Clinic. Seventy-one patients (81%) received at least one form of treatment for two weeks to six months prior to their visit to The Clinic (<xref ref-type="table" rid="brainsci-03-01483-t010">Table 10</xref>). Most patients, after receiving little assistance from their local medical consultant, were referred to an otolaryngologist who usually considered their symptoms a local nasal disease. Fifty-five (62.5%) were treated with antibiotics, 23 (26%) with antihistamines and 22 (25%) with adrenocorticosteroids (systemic therapy (19 patients), intranasal sprays or injections (12 patients)); none of these treatments changed phantosmia. Oxymetazoline nasal spray was used in six patients without alteration of phantosmia. Eleven were treated with allergic immunotherapy without benefit. Surgical procedures were attempted to correct what was considered clinically to be either nasal anatomical problems (e.g., deviated nasal septum) or as treatment for hyposmia and/or phantosmia. Eight patients underwent submucous nasal resection and three underwent birhinal Caldwell-Luc procedures. None of these procedures was effective in relieving the patients&#x02019; symptoms. When this approach failed to restore smell and flavor acuity patients went to a variety of other physicians for assistance. Nine went to neurologists (significantly fewer than those with CUP (<italic>p</italic> &#x0003c; 0.01, <italic>X</italic><sup>2</sup>)) who treated them with anticonvulsant medication either singly or in some drug combination (<xref ref-type="table" rid="brainsci-03-01483-t010">Table 10</xref>); this therapy was ineffective in relieving phantosmia. Five patients were referred to psychiatrists; each was treated with antidepressants (dibenzocycloheptadines (two patients), benzodiazepines (one patient) and other tricyclic antidepressants (two patients)), significantly fewer than those with CUP. As in CUP no patient noted any change in phantosmia with this therapy. Thirty (34%) were treated with exogenous oral zinc ion and 10 were treated with massive doses of vitamins (vitamin A, 50,000 units daily (five patients) B complex vitamins (five patients)) without any change in phantosmia. Some patients were evaluated and treated by alternative healthcare practitioners including nutritionists, acupuncturists and hypnotists without change in phantosmia. Neurologists and neurosurgeons who initially evaluated most patients with head injury commonly considered the associated loss of smell and flavor perception related to irreversible anatomical damage to the olfactory nerves and/or CNS and usually told patients that there was no possible treatment for their loss of acuity [<xref rid="B179-brainsci-03-01483" ref-type="bibr">179</xref>] albeit some instituted therapy for phantosmia and/or phantageusia with antiepileptic agents if these symptoms were prominent enough that they considered them consistent with a seizure disorder. If phantosmia and/or phantageusia still persisted many patients returned to otolaryngologists who again treated their loss of acuity as a local nasal disease with agents noted above, again without success. </p><table-wrap id="brainsci-03-01483-t010" position="float"><object-id pub-id-type="pii">brainsci-03-01483-t010_Table 10</object-id><label>Table 10</label><caption><p>Treatment prior to evaluation at The Taste and Smell Clinic in patients with phantosmia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Condition</th><th align="center" valign="middle" rowspan="1" colspan="1">CUP <sup>&#x02020;</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">BPAS <sup>&#x02020;</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Prior treatment</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;No</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">71 <sup>w</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic>Treatment type</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Anti-convulsants</td><td align="center" valign="middle" rowspan="1" colspan="1">23 <sup>w</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Phenytoin</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Primidone</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Carbamazepine</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Mebaral</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Phenobarbitol</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Alone</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;With another ac</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Anti-depressants</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Anti-histamines</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">23</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Adrenocorticosteroids</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">22</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Systemic</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">19 <sup>x</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Intranasal</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Spray</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Local injection</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Other nasal sprays</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Oxymetazoline</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Allergy immunotherapy</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Surgical intervention</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Submucous resection</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Other</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Vitamins/minerals</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">30</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">22</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Vitamin A</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Other</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Intranasal cocaine</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02004;Thioridazine</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>&#x02020;</sup></bold> Patient Number; <italic>CUP vs. BPAS</italic>: <sup>w</sup>
<italic>p</italic> &#x0003c; 0.001, <italic>X</italic><sup>2 </sup>(yes, prior treatment; anti-convulsant treatment); <sup>x</sup>
<italic>p</italic> &#x0003c; 0.01, <italic>X</italic><sup>2</sup> (systemic adrenocorticosteroids).</p></fn></table-wrap-foot></table-wrap></sec></sec><sec><title>4. Discussion</title><sec><title>4.1. Pathophysiological, Peripheral and CNS Components of CUP</title><p>A significant peripheral component initiated phantosmia in CUP consistent with peripheral hypersensitivity leading to CNS reorganization and plasticity. Phantosmia was initiated after unirhinal stimulation with normal physiological activities that would not cause any symptom in normal subjects; e.g., blowing the nose, repetitive or excessively intense breathing or exposure to ambient odors initiated phantosmia. These results indicate increased local excitation manifested by peripheral hypersensitivity played a significant role in initiating phantosmia and these effects were localized to olfactory epithelium in one naris. We suggest an endogenous loss of GABAergic function occurred in these patients thereby sensitizing the olfactory system to normal sensory input which initiated inappropriate peripheral responses, extending to CNS as well, as we previously reported [<xref rid="B36-brainsci-03-01483" ref-type="bibr">36</xref>].</p><p>While explanation for this observed peripheral hypersensitivity in CUP may appear to be simplistic it may be similar to task related plasticity [<xref rid="B180-brainsci-03-01483" ref-type="bibr">180</xref>,<xref rid="B181-brainsci-03-01483" ref-type="bibr">181</xref>,<xref rid="B182-brainsci-03-01483" ref-type="bibr">182</xref>,<xref rid="B183-brainsci-03-01483" ref-type="bibr">183</xref>,<xref rid="B184-brainsci-03-01483" ref-type="bibr">184</xref>,<xref rid="B185-brainsci-03-01483" ref-type="bibr">185</xref>] and peripheral hypersensitivity previously observed in dystonia [<xref rid="B180-brainsci-03-01483" ref-type="bibr">180</xref>,<xref rid="B183-brainsci-03-01483" ref-type="bibr">183</xref>]. It is well known that repetitive hand or arm movements or extremity overuse initiated and/or increased dystonia [<xref rid="B180-brainsci-03-01483" ref-type="bibr">180</xref>,<xref rid="B181-brainsci-03-01483" ref-type="bibr">181</xref>] associated with CNS somatosensory degradation [<xref rid="B180-brainsci-03-01483" ref-type="bibr">180</xref>], abnormal recruitment of cortical areas involved with control of voluntary movement [<xref rid="B186-brainsci-03-01483" ref-type="bibr">186</xref>] with impaired and inefficient CNS sensory integration [<xref rid="B183-brainsci-03-01483" ref-type="bibr">183</xref>]. These phenomena were reproduced in animal models of dystonia in which CNS GABA levels in specific regions were decreased compared to controls [<xref rid="B186-brainsci-03-01483" ref-type="bibr">186</xref>,<xref rid="B187-brainsci-03-01483" ref-type="bibr">187</xref>]. Reduction of intracortical GABAergic inhibition in animals by local CNS application of GABA antagonists to motor cortex (e.g., bicuculline, muscimol, lamotrigene) led to hypersensitivity exacerbating dystonic-like movements [<xref rid="B186-brainsci-03-01483" ref-type="bibr">186</xref>,<xref rid="B188-brainsci-03-01483" ref-type="bibr">188</xref>,<xref rid="B189-brainsci-03-01483" ref-type="bibr">189</xref>]. Reduction in putamen and globus pallidus GABA levels were also found in a patient with symptomatic dystonia [<xref rid="B190-brainsci-03-01483" ref-type="bibr">190</xref>].</p><p>Blocking this peripheral component in CUP by a variety of maneuvers always inhibited phantosmia. Unirhinal nasal blockage, unirhinal installation of cocaine, smoking of THC or excision of olfactory epithelium [<xref rid="B191-brainsci-03-01483" ref-type="bibr">191</xref>] inhibited phantosmia. We suggest peripheral blocking activities in CUP inhibited peripheral hypersensitivity in the unirhinal olfactory epithelium either by inhibiting local stimulus delivery or by increasing local and/or CNS GABAergic activity. These results are similar in several ways to those in task specific focal dystonia [<xref rid="B180-brainsci-03-01483" ref-type="bibr">180</xref>] in which decreased peripheral input [<xref rid="B184-brainsci-03-01483" ref-type="bibr">184</xref>] or decreased repetitive activity [<xref rid="B192-brainsci-03-01483" ref-type="bibr">192</xref>] decreased dystonic movements. For example, limb immobilization [<xref rid="B184-brainsci-03-01483" ref-type="bibr">184</xref>] inhibited sensory input that might otherwise initiate dystonia [<xref rid="B183-brainsci-03-01483" ref-type="bibr">183</xref>]. These results support the concept of a balance between peripheral excitation and inhibition in these patients. </p><p>However, these blocking maneuvers (e.g., intranasal cocaine) induced two effects in CUP; <italic>i.e.</italic>, both phantosmia inhibition and hyposmia induction, and it may be difficult to separate these effects functionally or anatomically. Thus, each of these maneuvers that inhibited phantosmia induced loss of smell by directly blocking delivery of vapor to olfactory receptors (nasal plugging) or by inhibiting olfactory activation at the olfactory epithelium (cocaine inhalation). Although changes in olfactory acuity with THC have not been systematically investigated these effects indicate that it is possible to inhibit phantosmia locally by a peripheral effect in one naris. This effect may be due to changes in peripheral GABAergic function or GABA concentration, which putatively increases, since GABA effects, including <sc>l</sc>-glutamic acid decarboxylase (GAD) metabolism, may relate to its effects in peripheral tissues [<xref rid="B193-brainsci-03-01483" ref-type="bibr">193</xref>] as well as in CNS. Although data are not clear-cut on this issue THC has been shown to augment inhibitory effects of GABA [<xref rid="B194-brainsci-03-01483" ref-type="bibr">194</xref>,<xref rid="B195-brainsci-03-01483" ref-type="bibr">195</xref>,<xref rid="B196-brainsci-03-01483" ref-type="bibr">196</xref>,<xref rid="B197-brainsci-03-01483" ref-type="bibr">197</xref>]. Since we demonstrated various drugs which inhibited phantosmia [<xref rid="B166-brainsci-03-01483" ref-type="bibr">166</xref>,<xref rid="B167-brainsci-03-01483" ref-type="bibr">167</xref>] also increased CNS GABA function [<xref rid="B198-brainsci-03-01483" ref-type="bibr">198</xref>,<xref rid="B199-brainsci-03-01483" ref-type="bibr">199</xref>] it seems reasonable to speculate that these inhibitory effects may occur through increased GABAergic activity which might occur in the periphery as well as in CNS. On the other hand, it might seem reasonable to speculate that if initial effect of any of these maneuvers were to inhibit olfaction then subsequent effects would be deafferentation and functional cortical reorganization with GABA diminution rather than increased GABAergic function similar to induction of phantom limb syndrome. But in CUP we observed both hyposmia and phantosmia inhibition with these blocking maneuvers and we have suggested that this effect was due to increased CNS and presumably increased peripheral GABAergic activity. Mechanisms underlying these effects are complex and current data do not allow a definitive explanation.</p><p>Whereas these blocking maneuvers (nasal plugging, nasal cocaine installation) also induced hyposmia in normal subjects, cocaine [<xref rid="B200-brainsci-03-01483" ref-type="bibr">200</xref>,<xref rid="B201-brainsci-03-01483" ref-type="bibr">201</xref>,<xref rid="B202-brainsci-03-01483" ref-type="bibr">202</xref>] and THC [<xref rid="B203-brainsci-03-01483" ref-type="bibr">203</xref>,<xref rid="B204-brainsci-03-01483" ref-type="bibr">204</xref>] inhalation may initiate rather than inhibit hallucinations (obviously, normal subjects do not exhibit phantosmia prior to cocaine or THC use). These results suggest a plausible mechanism for these effects in normal subjects although it may be difficult again to separate peripheral from CNS effects. Hallucination induction in normals is consistent with data indicating nasal cocaine inhalation or THC smoking decreased CNS GABA or GABA function [<xref rid="B205-brainsci-03-01483" ref-type="bibr">205</xref>,<xref rid="B206-brainsci-03-01483" ref-type="bibr">206</xref>,<xref rid="B207-brainsci-03-01483" ref-type="bibr">207</xref>,<xref rid="B208-brainsci-03-01483" ref-type="bibr">208</xref>,<xref rid="B209-brainsci-03-01483" ref-type="bibr">209</xref>], perhaps also extending to peripheral structures, with subsequent changes in CNS GAD, other moieties, disinhibition of CNS and sensory function [<xref rid="B210-brainsci-03-01483" ref-type="bibr">210</xref>,<xref rid="B211-brainsci-03-01483" ref-type="bibr">211</xref>,<xref rid="B212-brainsci-03-01483" ref-type="bibr">212</xref>] and hallucination onset. It is this decreased GABA we previously hypothesized as consistent in both normals and CUP with onset of hallucinatory activity. However, this hallucinatory behavior in normals occurs after the local effect of cocaine occurs, <italic>i.e.</italic>, after cocaine-induced hyposmia. This loss of sensory input in normal subjects may induce a phenomenon similar to deafferentation hypersensitivity with subsequent CNS dysplasticity as in phantom limb syndrome, a change that may occur rapidly after hyposmia induction. This effect may be similar to rapid reductions in CNS GABA, which occur after deafferentation, as observed after reversible induction of forearm ischemia [<xref rid="B213-brainsci-03-01483" ref-type="bibr">213</xref>], unilateral labyrinthectomy in rat [<xref rid="B214-brainsci-03-01483" ref-type="bibr">214</xref>] and in other classic studies [<xref rid="B215-brainsci-03-01483" ref-type="bibr">215</xref>,<xref rid="B216-brainsci-03-01483" ref-type="bibr">216</xref>]. There are also slower CNS GABA reductions, long term changes reported in humans after limb amputation [<xref rid="B217-brainsci-03-01483" ref-type="bibr">217</xref>] after eye enucleation in animals [<xref rid="B218-brainsci-03-01483" ref-type="bibr">218</xref>,<xref rid="B219-brainsci-03-01483" ref-type="bibr">219</xref>,<xref rid="B220-brainsci-03-01483" ref-type="bibr">220</xref>] and after other sensory or activity dependent procedures [<xref rid="B221-brainsci-03-01483" ref-type="bibr">221</xref>,<xref rid="B222-brainsci-03-01483" ref-type="bibr">222</xref>] including changes in GAD [<xref rid="B222-brainsci-03-01483" ref-type="bibr">222</xref>]. </p><p>One possible attempt to understand this putative dichotomous effect of cocaine (and THC) in normals and in CUP may relate to reported biphasic effects of both cocaine and THC on GABAergic activity. Cocaine and THC have been shown to both increase or decrease GABAergic activity by direct CNS effects [<xref rid="B206-brainsci-03-01483" ref-type="bibr">206</xref>,<xref rid="B207-brainsci-03-01483" ref-type="bibr">207</xref>,<xref rid="B208-brainsci-03-01483" ref-type="bibr">208</xref>,<xref rid="B222-brainsci-03-01483" ref-type="bibr">222</xref>,<xref rid="B223-brainsci-03-01483" ref-type="bibr">223</xref>,<xref rid="B224-brainsci-03-01483" ref-type="bibr">224</xref>], through effects on G proteins [<xref rid="B220-brainsci-03-01483" ref-type="bibr">220</xref>], through effects on GABA receptor function, [<xref rid="B222-brainsci-03-01483" ref-type="bibr">222</xref>,<xref rid="B223-brainsci-03-01483" ref-type="bibr">223</xref>,<xref rid="B224-brainsci-03-01483" ref-type="bibr">224</xref>,<xref rid="B225-brainsci-03-01483" ref-type="bibr">225</xref>,<xref rid="B226-brainsci-03-01483" ref-type="bibr">226</xref>,<xref rid="B227-brainsci-03-01483" ref-type="bibr">227</xref>] through various GABA related metabolic enzymes [<xref rid="B205-brainsci-03-01483" ref-type="bibr">205</xref>,<xref rid="B228-brainsci-03-01483" ref-type="bibr">228</xref>,<xref rid="B229-brainsci-03-01483" ref-type="bibr">229</xref>] mediated by induction of dopamine uptake inhibition [<xref rid="B230-brainsci-03-01483" ref-type="bibr">230</xref>,<xref rid="B231-brainsci-03-01483" ref-type="bibr">231</xref>] or through complex chemical kindling mechanisms [<xref rid="B232-brainsci-03-01483" ref-type="bibr">232</xref>]. These effects for cocaine occur in addition to its well-known local nasal anesthetic effects. By analogy with dystonia, animal models of dystonia have shown that decreased CNS GABA levels resolved after disease disappearance [<xref rid="B190-brainsci-03-01483" ref-type="bibr">190</xref>,<xref rid="B233-brainsci-03-01483" ref-type="bibr">233</xref>,<xref rid="B234-brainsci-03-01483" ref-type="bibr">234</xref>] and treatment with GABAergic drugs restored normal peripheral motor function and CNS GABA levels [<xref rid="B232-brainsci-03-01483" ref-type="bibr">232</xref>]. Other drugs, which activate CNS GABA (e.g., baclofen, vigabatrin, gabapentin [<xref rid="B234-brainsci-03-01483" ref-type="bibr">234</xref>,<xref rid="B235-brainsci-03-01483" ref-type="bibr">235</xref>,<xref rid="B236-brainsci-03-01483" ref-type="bibr">236</xref>,<xref rid="B237-brainsci-03-01483" ref-type="bibr">237</xref>,<xref rid="B238-brainsci-03-01483" ref-type="bibr">238</xref>]) inhibited dystonic movements and we have shown that drugs with similar effects (haloperidol, thioridazine) inhibited phantosmia in CUP [<xref rid="B36-brainsci-03-01483" ref-type="bibr">36</xref>,<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>]. </p><p>These mechanisms are supported by our preliminary results with rTMS, which inhibited phantosmia in CUP (v.s.) consistent with induction of increased CNS GABA [<xref rid="B165-brainsci-03-01483" ref-type="bibr">165</xref>,<xref rid="B166-brainsci-03-01483" ref-type="bibr">166</xref>]. rTMS in normal humans [<xref rid="B239-brainsci-03-01483" ref-type="bibr">239</xref>,<xref rid="B240-brainsci-03-01483" ref-type="bibr">240</xref>], in patients [<xref rid="B241-brainsci-03-01483" ref-type="bibr">241</xref>] and in animals [<xref rid="B242-brainsci-03-01483" ref-type="bibr">242</xref>] applied in a similar manner was without any subsequent long term functional physiological effect albeit intracortical inhibitory circuitry was transiently suppressed [<xref rid="B243-brainsci-03-01483" ref-type="bibr">243</xref>]. Similar inhibitory results were also demonstrated in dystonia [<xref rid="B244-brainsci-03-01483" ref-type="bibr">244</xref>,<xref rid="B245-brainsci-03-01483" ref-type="bibr">245</xref>] since rTMS inhibited dystonic movements by inhibiting hypersensitivity with subsequent reorganization of the CNS and correction of maladaptive CNS plasticity. By analogy, these results suggest that phantosmia was created by disorganization of normal CNS pathways secondary to induction of CNS plasticity related to peripheral hypersensitivity and was corrected by rTMS through reorganization of the disorganized CNS. </p><sec><title>4.1.1. Valsalva Effects</title><p>Although mechanism(s) responsible for physiological termination of phantosmia in CUP may be complex, maneuvers, which inhibited phantosmia may offer clues as to CNS mechanism(s) of these effects and to the syndrome itself. A consistent method for phantosmia inhibition in CUP followed performance of a Valsalva maneuver. The normal Valsalva response involves an initial transient rise in systemic blood pressure, then a gradual decrease in pulse pressure and stroke volume, due to decreased venous return to the heart, then a transient decrease in systemic blood pressure followed by a characteristic overshoot of systemic blood pressure over baseline [<xref rid="B246-brainsci-03-01483" ref-type="bibr">246</xref>,<xref rid="B247-brainsci-03-01483" ref-type="bibr">247</xref>]. Changes in CSF pressure accompany these effects [<xref rid="B248-brainsci-03-01483" ref-type="bibr">248</xref>] as do changes in cerebral blood flow. It is therapeutically useful in terminating paroxysmal supraventricular tachycardias [<xref rid="B249-brainsci-03-01483" ref-type="bibr">249</xref>], ventricular tachycardias [<xref rid="B250-brainsci-03-01483" ref-type="bibr">250</xref>] and angina related to coronary artery disease [<xref rid="B251-brainsci-03-01483" ref-type="bibr">251</xref>,<xref rid="B252-brainsci-03-01483" ref-type="bibr">252</xref>]. This latter effect has been attributed to an abrupt decrease in determinants of myocardial oxygen demand. Other effects attributed to this maneuver are doubling of portal vein pressure in patients with cirrhosis [<xref rid="B253-brainsci-03-01483" ref-type="bibr">253</xref>] and an increase in factor VIII concentration attributed to an increase in circulating epinephrine [<xref rid="B254-brainsci-03-01483" ref-type="bibr">254</xref>]. Perhaps some aspect of changes in CSF pressure, cerebral blood flow or local catecholamine concentration may play roles in inhibiting phantosmia in patients with CUP. Studies using brain fMRI in patients with CUP demonstrated that Valsalva performance, which inhibited phantosmia in patients with their phantosmia initiated, increased brain fMRI activation over the already robust activation measured with the initiated phantosmia [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>]. This result is consistent with increased regional cerebral blood flow creating a transient state of oxyhemoglobin abundance such that use of pulse sequences that are sensitive to changes in oxyhemoglobin/deoxyhemoglobin disparities (<italic>i.e.</italic>, BOLD imaging [<xref rid="B255-brainsci-03-01483" ref-type="bibr">255</xref>,<xref rid="B256-brainsci-03-01483" ref-type="bibr">256</xref>]) allows visualization of these transient changes.</p><p>However, Valsalva may also inhibit phantosmia through direct CNS effects. In an investigation of hyperventilation, orthostasis and Valsalva in healthy normal volunteers, Lempert <italic>et al</italic>. induced syncope, generalized and multifocal myoclonic jerks, visual and auditory hallucinations and EEG changes of high-amplitude slowing and flattening [<xref rid="B257-brainsci-03-01483" ref-type="bibr">257</xref>], with hyperventilation, then Valsalva [<xref rid="B258-brainsci-03-01483" ref-type="bibr">258</xref>,<xref rid="B259-brainsci-03-01483" ref-type="bibr">259</xref>]. During Valsalva, brain fMRI activation in normal volunteers was observed in putamen, anterior hypothalamus, interpeduncular nuclei, basal and dorsal pons, deep cerebellar nuclei, ventral medullary surface and dorsal column nuclei [<xref rid="B260-brainsci-03-01483" ref-type="bibr">260</xref>] but not in regions of frontal cortex, a region in which we previously observed significant activation in brain fMRI studies of patients with both CUP [<xref rid="B105-brainsci-03-01483" ref-type="bibr">105</xref>] and BPAS [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>,<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>]. These studies suggest that while CNS changes in CUP may have a different locus from those in normal volunteers, Valsalva may alter the balance of CNS excitation/inhibition. While the multiple processes underlying this complex interaction were not addressed in any previous study it was hypothesized that frontal cortex would be a brain region that would be most sensitive to hypocapnia and changes in arterial pCO<sub>2</sub> [<xref rid="B261-brainsci-03-01483" ref-type="bibr">261</xref>].</p><p>If this latter hypothesis were correct then sensitivity of a focal brain region in frontal cortex to hypocapnia and changes in pCO<sub>2</sub> suggest another possible mechanism by which Valsalva could inhibit phantosmia and by which any physiological activity that would mimic hyperventilation could initiate it. It is well known that GABA activation or inhibition is very sensitive to focal changes in brain pH [<xref rid="B262-brainsci-03-01483" ref-type="bibr">262</xref>]. Thus, phantosmia inhibition by Valsalva may relate to partial breath holding associated with this maneuver with a subsequent transient focal brain CO<sub>2</sub> accumulation with focal acidification of enough magnitude to initiate GABAergic activation. On the other hand, forced ventilation, strenuous physical activity, coughing or sneezing may initiate transient focal brain CO<sub>2</sub> excretion of sufficient magnitude to initiate brain alkalization with subsequent diminution in GABAergic inhibitory function. Since CNS kindling has been considered to be a type of use or activity dependent CNS plasticity with inherent alterations at both single cells as well as CNS neuronal networks [<xref rid="B263-brainsci-03-01483" ref-type="bibr">263</xref>], this concept is consistent with our hypotheses related to pathogenesis of phantosmia induction and inhibition in CUP. Thus, we can speculate that there may be a specific focal brain area especially sensitive to CO<sub>2</sub> and changes in GABA [<xref rid="B264-brainsci-03-01483" ref-type="bibr">264</xref>] in these patients such that a type of chemical kindling [<xref rid="B265-brainsci-03-01483" ref-type="bibr">265</xref>,<xref rid="B266-brainsci-03-01483" ref-type="bibr">266</xref>,<xref rid="B267-brainsci-03-01483" ref-type="bibr">267</xref>] trigger effect might take place. Perhaps olfactory bulbs, anterior frontal cortex and rhinencephalic networks, anatomical regions known to be most sensitive to early and late stage kindling effects [<xref rid="B268-brainsci-03-01483" ref-type="bibr">268</xref>,<xref rid="B269-brainsci-03-01483" ref-type="bibr">269</xref>,<xref rid="B270-brainsci-03-01483" ref-type="bibr">270</xref>,<xref rid="B271-brainsci-03-01483" ref-type="bibr">271</xref>,<xref rid="B272-brainsci-03-01483" ref-type="bibr">272</xref>,<xref rid="B273-brainsci-03-01483" ref-type="bibr">273</xref>], might be logical regions for these effects to occur. Kindled seizures have been shown to be both hormonally [<xref rid="B274-brainsci-03-01483" ref-type="bibr">274</xref>,<xref rid="B275-brainsci-03-01483" ref-type="bibr">275</xref>,<xref rid="B276-brainsci-03-01483" ref-type="bibr">276</xref>] as well as possibly CO<sub>2</sub> [<xref rid="B277-brainsci-03-01483" ref-type="bibr">277</xref>,<xref rid="B278-brainsci-03-01483" ref-type="bibr">278</xref>,<xref rid="B279-brainsci-03-01483" ref-type="bibr">279</xref>,<xref rid="B280-brainsci-03-01483" ref-type="bibr">280</xref>,<xref rid="B281-brainsci-03-01483" ref-type="bibr">281</xref>] dependent and it is well known that there is a loss or reduction in GABAergic inhibition in epileptic tissue [<xref rid="B282-brainsci-03-01483" ref-type="bibr">282</xref>] associated with disinhibition leading to hyperexcitability and generation of epileptiform bursting. Chemical kindling describes a progressive and persistent change in focal brain sensitivity, which may be initially sub-threshold for evoking an electrical or epileptic discharge, but which we speculate may eventually evoke full-blown phantosmia. A decrease in CO<sub>2</sub> in this region could initiate a trigger related focal alkalization, decrease in GABAergic inhibitory activity and subsequent onset of phantosmia; a focal increase in CO<sub>2</sub> could initiate a focal acidification, activation of GABAergic inhibitory activity and subsequent inhibition of phantosmia. Thus, any maneuver that would increase CNS pCO<sub>2</sub> would be associated with phantosmia inhibition and any maneuver associated with decreased CNS pCO<sub>2</sub> would be associated with phantosmia activation. Indeed, raised tissue concentrations of CO<sub>2</sub> have been hypothesized to be protective in CNS whereas lowered concentrations have been considered injurious [<xref rid="B282-brainsci-03-01483" ref-type="bibr">282</xref>]. In this sense, the disease process in these patients could take the form of a focal brain abnormality in chemosensation such that a focal brain area exceedingly sensitive to changes in pCO<sub>2</sub> and pH could trigger either GABAergic inhibition or activation with subsequent onset or offset, respectively, of a chemically induced phantosmia and/or phantageusia. This hypothesis is supported by results of CO<sub>2</sub> inhalation studies in which seven of the 10 patients treated with CO<sub>2</sub> inhalation reported phantosmia inhibition with a subsequent inability to initiate phantosmia by those maneuvers, which prior to CO<sub>2</sub> inhalation uniformly initiated phantosmia. We suggest that this focal CNS area lies within the region of anterior frontal and/or temporal cortex [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>,<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>], the CNS region found activated during patient activation of phantosmia.</p></sec><sec><title>4.1.2. CO<sub>2</sub> Effects</title><p>Increased CO<sub>2</sub> concentrations (hypercarbia) initiate triphasic CNS effects [<xref rid="B283-brainsci-03-01483" ref-type="bibr">283</xref>,<xref rid="B284-brainsci-03-01483" ref-type="bibr">284</xref>]. Relatively low CO<sub>2</sub> levels (5%&#x02013;10%) induced depression in CNS excitability as measured by increased electroshock thresholds, protection against convulsions or seizures induced by electroshock or chemical agents [<xref rid="B284-brainsci-03-01483" ref-type="bibr">284</xref>] and fast, low voltage EEG waves [<xref rid="B284-brainsci-03-01483" ref-type="bibr">284</xref>]. As CO<sub>2</sub> concentrations increased to 30%&#x02013;35% of inspired air, increased CNS excitability was observed with experimental animals and humans exhibiting minimal type-missing seizures [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>] and slow, high voltage EEG activation [<xref rid="B284-brainsci-03-01483" ref-type="bibr">284</xref>,<xref rid="B286-brainsci-03-01483" ref-type="bibr">286</xref>,<xref rid="B287-brainsci-03-01483" ref-type="bibr">287</xref>]. If CO<sub>2</sub> concentrations were increased still further, to greater than 40% of inspired air, narcosis and anesthesia occurred [<xref rid="B288-brainsci-03-01483" ref-type="bibr">288</xref>,<xref rid="B289-brainsci-03-01483" ref-type="bibr">289</xref>,<xref rid="B290-brainsci-03-01483" ref-type="bibr">290</xref>], whereas if high concentrations of CO<sub>2</sub> were rapidly withdrawn, associated with a rapid decrease in blood CO<sub>2</sub>, clonic type seizures occurred [<xref rid="B291-brainsci-03-01483" ref-type="bibr">291</xref>,<xref rid="B292-brainsci-03-01483" ref-type="bibr">292</xref>]. CO<sub>2</sub> is rapidly transported into CNS and cerebral spinal fluid (CSF) with a time constant of 2.7 min [<xref rid="B293-brainsci-03-01483" ref-type="bibr">293</xref>] with an active transport of H<sup>+</sup> out of cells and consumption of organic acids [<xref rid="B294-brainsci-03-01483" ref-type="bibr">294</xref>]. Although acute CO<sub>2</sub> effects in CNS are difficult to measure, transmembrane fluxes of HCO3<sup>-</sup> and H<sup>+</sup> active transport were measureable in 45 min and return of cell pH to normal can take as long as 48 h [<xref rid="B295-brainsci-03-01483" ref-type="bibr">295</xref>]. Permissive hypercapnia in which CO<sub>2</sub> concentrations were increased was associated with protection from organ injury in patients with a variety of pulmonary disorders [<xref rid="B282-brainsci-03-01483" ref-type="bibr">282</xref>]. </p><p>Exposure to 35% CO<sub>2</sub> induced panic attacks [<xref rid="B296-brainsci-03-01483" ref-type="bibr">296</xref>] whereas CO<sub>2</sub> exposure inhibited phantosmia in CUP. Indeed, CO<sub>2</sub> challenge was considered the most informative challenge to induce panic disorder [<xref rid="B297-brainsci-03-01483" ref-type="bibr">297</xref>] because the prominent respiratory symptom in panic could be linked to a measureable abnormality (increased ventilatory responsiveness with a known physiological basis [<xref rid="B298-brainsci-03-01483" ref-type="bibr">298</xref>]). While glutamate release has not been generally observed during acute seizure induction in experimental animals, in chronic epilepsy models of several types, including those with spontaneous recurrent seizures after amygdala kindling [<xref rid="B299-brainsci-03-01483" ref-type="bibr">299</xref>], there has been a consistent marked increase in glutamate release during seizures [<xref rid="B295-brainsci-03-01483" ref-type="bibr">295</xref>]. While other maneuvers, which initiated phantosmia in CUP, may be less obviously related to hyperventilation they appear to activate similar mechanisms, which involve changes in blood and CNS pH with subsequent decreased CNS GABA and onset of an imbalance between excitation and inhibition such that excitation is emphasized, and phantosmia appears.</p><p>Breath holding, the opposite effect in terms of control of hyperventilation, resulted in increased end-tidal CO<sub>2</sub>, inhibited seizure frequency and severity in patients with severe chronic hyperventilation and seizures which were refractory to therapeutic levels of anticonvulsants [<xref rid="B300-brainsci-03-01483" ref-type="bibr">300</xref>]. After breath holding, signal intensity observed in human CNS during fMRI increased 3%&#x02013;10% [<xref rid="B301-brainsci-03-01483" ref-type="bibr">301</xref>,<xref rid="B302-brainsci-03-01483" ref-type="bibr">302</xref>,<xref rid="B303-brainsci-03-01483" ref-type="bibr">303</xref>,<xref rid="B304-brainsci-03-01483" ref-type="bibr">304</xref>]. It has also been suggested that evolutionary changes were developed to set a particular level of focal synaptic ratio of CNS excitation; inhibition based upon metabolic protection of hypoxia and hypoglycemia and dependent upon synthesis of GABA from glutamate (dependent upon input from acetyl CoA and citrate from the Krebs cycle (through GAD)) and degradation of GABA (by GABA transaminase to succinic semialdahyde to succinate and back into the Krebs cycle [<xref rid="B305-brainsci-03-01483" ref-type="bibr">305</xref>]). This so called &#x02018;GABA shunt&#x02019; is highly sensitive to changes in pCO<sub>2</sub> and pH with increased pCO<sub>2</sub> and decreased pH resulting in a shift in this reaction toward glutamate with increased brain excitability and with decreased pCO<sub>2</sub> and increased pH resulting in a shift in the reactivity toward increased GABA with decreased brain excitability.</p></sec><sec><title>4.1.3. Hyperventilation Effects</title><p>It has long been recognized that hyperventilation (hypocarbia) giving rise to hypocapnia precipitated seizures in epileptic patients [<xref rid="B295-brainsci-03-01483" ref-type="bibr">295</xref>,<xref rid="B299-brainsci-03-01483" ref-type="bibr">299</xref>,<xref rid="B306-brainsci-03-01483" ref-type="bibr">306</xref>,<xref rid="B307-brainsci-03-01483" ref-type="bibr">307</xref>,<xref rid="B308-brainsci-03-01483" ref-type="bibr">308</xref>], induced abnormal EEGs in both epileptic and some normal subjects (increased high voltage, slow waves [<xref rid="B308-brainsci-03-01483" ref-type="bibr">308</xref>,<xref rid="B309-brainsci-03-01483" ref-type="bibr">309</xref>,<xref rid="B310-brainsci-03-01483" ref-type="bibr">310</xref>]), independent of inspired O<sub>2</sub> concentration [<xref rid="B311-brainsci-03-01483" ref-type="bibr">311</xref>] due to cerebral hypoxia [<xref rid="B312-brainsci-03-01483" ref-type="bibr">312</xref>,<xref rid="B313-brainsci-03-01483" ref-type="bibr">313</xref>,<xref rid="B314-brainsci-03-01483" ref-type="bibr">314</xref>] and/or cerebral vasoconstriction [<xref rid="B312-brainsci-03-01483" ref-type="bibr">312</xref>], induced decreased blood CO<sub>2</sub> [<xref rid="B283-brainsci-03-01483" ref-type="bibr">283</xref>,<xref rid="B310-brainsci-03-01483" ref-type="bibr">310</xref>,<xref rid="B315-brainsci-03-01483" ref-type="bibr">315</xref>], cerebral arterial blood CO<sub>2</sub> tension ((PaCO<sub>2</sub>) [<xref rid="B316-brainsci-03-01483" ref-type="bibr">316</xref>]) and brain pCO<sub>2</sub> [<xref rid="B316-brainsci-03-01483" ref-type="bibr">316</xref>]. Indeed, hyperventilation is a well-known standard challenge in electroencephalography to induce CNS hyperactivity. Thus, there are intimate correlations among respiration, brain waves and seizure activity dependent upon changes in cerebral vascular tone, blood flow and cerebral arterial pCO<sub>2</sub>. Two deep breaths will reduce arterial CO<sub>2</sub> significantly [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>] and further hyperventilation will result in respiratory alkalosis [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>]. Doppler ultrasound indicated mean flow velocity in middle and posterior cerebral arteries decreased by up to 50% after four min of hyperventilation [<xref rid="B317-brainsci-03-01483" ref-type="bibr">317</xref>]; it also led to marked surface negative DC shift, perhaps due to depolarization of apical dendritic trees of cortical pyramidal cells [<xref rid="B318-brainsci-03-01483" ref-type="bibr">318</xref>,<xref rid="B319-brainsci-03-01483" ref-type="bibr">319</xref>] which increased excitability of cortical neuronal networks and may explain the resultant potential epileptogenicity [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>]. Hyperventilation eliminates CNS lactate rapidly [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>,<xref rid="B320-brainsci-03-01483" ref-type="bibr">320</xref>] which may be reflected in increased GAD concentration and decreased GABA. Hyperventilation strongly reduced global CNS magnetic resonance signal intensity [<xref rid="B321-brainsci-03-01483" ref-type="bibr">321</xref>,<xref rid="B322-brainsci-03-01483" ref-type="bibr">322</xref>] reflecting increased oxygen extraction due to cerebral vasoconstriction and decreased cerebral blood flow [<xref rid="B323-brainsci-03-01483" ref-type="bibr">323</xref>]. This maneuver is also consistent with induction of several neurotransmitters including glutamate, <italic>N</italic>-methyl-<sc>d</sc>-aspartate (NMDA), &#x003b1;-amino-3-hydroxy-5-methyl-isoxazole-4-propriovic acid (AMPA) which have been implicated in initiation of seizure or seizure-like activity [<xref rid="B315-brainsci-03-01483" ref-type="bibr">315</xref>]. The hypocapnia due to hyperventilation not only reduced cerebral blood flow and volume but also induced decreased signal response during functional imaging of the visual cortex with BOLD-contrast MRI [<xref rid="B323-brainsci-03-01483" ref-type="bibr">323</xref>]. By reducing cerebral blood flow the associated increased alkalosis shifts the oxyhemoglobin dissociation curve to the left further limiting oxygen delivery to the CNS [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>] and further impairing oxidative metabolism [<xref rid="B322-brainsci-03-01483" ref-type="bibr">322</xref>,<xref rid="B323-brainsci-03-01483" ref-type="bibr">323</xref>].</p><p>Cerebral hypoxia, linked to hyperventilation, has been considered etiologic in epilepsy [<xref rid="B324-brainsci-03-01483" ref-type="bibr">324</xref>,<xref rid="B325-brainsci-03-01483" ref-type="bibr">325</xref>] and seizure induction [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>], associated with shift in the oxygen dissociation curve (Bohr effect [<xref rid="B326-brainsci-03-01483" ref-type="bibr">326</xref>,<xref rid="B327-brainsci-03-01483" ref-type="bibr">327</xref>,<xref rid="B328-brainsci-03-01483" ref-type="bibr">328</xref>]). These results suggest that acid-base balance in epileptics is crucial to control of seizure thresholds and that successful strategies for seizure control need to consider physiological consequences of respiratory alkalosis [<xref rid="B329-brainsci-03-01483" ref-type="bibr">329</xref>] as manifested by activities such as hyperventilation. Indeed, patients with so-called &#x0201c;idiopathic seizures&#x0201d; have been considered different from normal subjects due to intolerance to deviation from critical limits of cerebral PaCO<sub>2</sub> [<xref rid="B329-brainsci-03-01483" ref-type="bibr">329</xref>]. This concept has led some investigators to believe that self-control of end-tidal CO<sub>2</sub> through respiratory training could control intractable &#x0201c;idiopathic seizures&#x0201d; [<xref rid="B329-brainsci-03-01483" ref-type="bibr">329</xref>].</p><p>However, there is confusion about relationships among hyperventilation, panic attacks and epilepsy [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>]. Indeed, confusion can also occur with respect to what has been called chronic hyperventilation syndrome [<xref rid="B330-brainsci-03-01483" ref-type="bibr">330</xref>], panic disorder [<xref rid="B331-brainsci-03-01483" ref-type="bibr">331</xref>,<xref rid="B332-brainsci-03-01483" ref-type="bibr">332</xref>], hyperventilation induced seizures [<xref rid="B333-brainsci-03-01483" ref-type="bibr">333</xref>], phobic anxiety depersonalization syndrome [<xref rid="B293-brainsci-03-01483" ref-type="bibr">293</xref>] and Rett&#x02019;s syndrome [<xref rid="B334-brainsci-03-01483" ref-type="bibr">334</xref>]. Hyperventilation induced seizures, albeit rarely tonic-clonic or partial [<xref rid="B333-brainsci-03-01483" ref-type="bibr">333</xref>], has been the subject of many case reports [<xref rid="B300-brainsci-03-01483" ref-type="bibr">300</xref>,<xref rid="B329-brainsci-03-01483" ref-type="bibr">329</xref>,<xref rid="B335-brainsci-03-01483" ref-type="bibr">335</xref>]. Many of these involved adults or children with mental retardation with what were commonly characterized as absence or atypical absence attacks. Physical exercise [<xref rid="B284-brainsci-03-01483" ref-type="bibr">284</xref>,<xref rid="B336-brainsci-03-01483" ref-type="bibr">336</xref>] but not hyperventilation [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>] has been shown to induce seizure activity in some patients. Mechanisms underlying these events are unclear but none had hallucinatory activity related to seizure induction [<xref rid="B285-brainsci-03-01483" ref-type="bibr">285</xref>].</p></sec><sec><title>4.1.4. O<sub>2</sub> Effects</title><p>For O<sub>2</sub>, seizures were induced at both abnormally high (hyperoxia) or abnormally low (hypoxia) levels. Hypoxia induced convulsions were first reported in birds, mice and cat, relatively sensitive species, by Boyle in 1660 [<xref rid="B337-brainsci-03-01483" ref-type="bibr">337</xref>], as have many more recent investigators [<xref rid="B338-brainsci-03-01483" ref-type="bibr">338</xref>,<xref rid="B339-brainsci-03-01483" ref-type="bibr">339</xref>,<xref rid="B340-brainsci-03-01483" ref-type="bibr">340</xref>] including studies in humans [<xref rid="B341-brainsci-03-01483" ref-type="bibr">341</xref>]. Recovery from an hypoxic episode in animals was associated with nervous system excitation [<xref rid="B338-brainsci-03-01483" ref-type="bibr">338</xref>,<xref rid="B339-brainsci-03-01483" ref-type="bibr">339</xref>,<xref rid="B342-brainsci-03-01483" ref-type="bibr">342</xref>]. While hypoxia can induce seizures under less dramatic conditions [<xref rid="B343-brainsci-03-01483" ref-type="bibr">343</xref>] hypoxia induced striking increases in brain GABA [<xref rid="B344-brainsci-03-01483" ref-type="bibr">344</xref>,<xref rid="B345-brainsci-03-01483" ref-type="bibr">345</xref>]. Bert first noted animals breathing oxygen at high pressure to initiate seizure activity in 1879 [<xref rid="B346-brainsci-03-01483" ref-type="bibr">346</xref>] and subsequently studied by many others [<xref rid="B347-brainsci-03-01483" ref-type="bibr">347</xref>,<xref rid="B348-brainsci-03-01483" ref-type="bibr">348</xref>]. These effects are dependent upon many factors including exposure to O<sub>2</sub> under increased pressure [<xref rid="B349-brainsci-03-01483" ref-type="bibr">349</xref>], decreased CO<sub>2</sub> [<xref rid="B350-brainsci-03-01483" ref-type="bibr">350</xref>], species susceptibility [<xref rid="B343-brainsci-03-01483" ref-type="bibr">343</xref>], male gender, since females are more sensitive than males [<xref rid="B351-brainsci-03-01483" ref-type="bibr">351</xref>] and nutritional status, since fasting induces decreased susceptibility [<xref rid="B343-brainsci-03-01483" ref-type="bibr">343</xref>]. Under these conditions of increased O<sub>2</sub> exposure, GAD is very readily oxidized and inhibited <italic>in vivo</italic> resulting in decreased CNS GABA [<xref rid="B343-brainsci-03-01483" ref-type="bibr">343</xref>]. The correlation between susceptibility to seizures and decreased CNS GABA is well known [<xref rid="B237-brainsci-03-01483" ref-type="bibr">237</xref>,<xref rid="B341-brainsci-03-01483" ref-type="bibr">341</xref>]; brain GABA levels increase in epileptics treated with GABAergic drugs [<xref rid="B352-brainsci-03-01483" ref-type="bibr">352</xref>,<xref rid="B353-brainsci-03-01483" ref-type="bibr">353</xref>].</p></sec><sec><title>4.1.5. Sleep Effects</title><p>Sleep usually inhibited phantosmia in CUP if &#x0201c;deep enough sleep&#x0201d; were obtained whereas no effect in BPAS was reported. This suggests the hypothesis that slow wave, REM sleep or both inhibited phantosmia in CUP. While clinical history does not allow a definitive answer the fact that &#x0201c;deep sleep&#x0201d; was required for this inhibition to occur and that its effectiveness was greatest if a nap were taken in the afternoon not in the morning suggests that slow wave not REM sleep was the mechanism through which this inhibition occurred, consistent with the well-known effect of latency to slow wave sleep longer in the morning than in the afternoon or early evening hours [<xref rid="B354-brainsci-03-01483" ref-type="bibr">354</xref>]. However, data in animals and in humans relate to roles that each of these sleep stages may play in this inhibitory process. REM sleep was initiated by administration of cholinergic agonists into pons [<xref rid="B355-brainsci-03-01483" ref-type="bibr">355</xref>,<xref rid="B356-brainsci-03-01483" ref-type="bibr">356</xref>]. Sleep related seizures in partial epilepsy occurred more than 20 times as frequently in non-REM (NREM) as opposed to REM sleep [<xref rid="B357-brainsci-03-01483" ref-type="bibr">357</xref>] and interictal epileptiform discharges in patients with epilepsy are more common in NREM than in REM sleep [<xref rid="B358-brainsci-03-01483" ref-type="bibr">358</xref>]. These results suggest that REM sleep may be considered neuroprotective and supports a role it may play in inhibiting phantosmia in these patients. On the other hand, sleep spindle activity has been associated with GABA release from thalamic reticular neurons and excitatory actions of thalamocortical (or relay) neurons which project to cerebral cortex and then project back to relay cells and inhibit them initiating a recurrent inhibitory circuit [<xref rid="B359-brainsci-03-01483" ref-type="bibr">359</xref>,<xref rid="B360-brainsci-03-01483" ref-type="bibr">360</xref>]. Thalamic perfusion of GABA in cats induced increased slow wave and paradoxical sleep as well as long lasting inhibition of somatosensory event-related potentials [<xref rid="B361-brainsci-03-01483" ref-type="bibr">361</xref>]. These results suggest slow wave sleep, through endogenous action of GABA release, may inhibit phantosmia in CUP. Clinically, as patients with CUP either aged or experienced phantosmia for a longer time period, sleep became less effective in inhibiting phantosmia consistent with the well-known phenomenon that time spent in slow wave sleep decreases with age [<xref rid="B362-brainsci-03-01483" ref-type="bibr">362</xref>]. </p></sec><sec><title>4.1.6. Hormonal Effects</title><p>Hormonal factors may influence CUP more than BPAS since significantly more women than men (3:1, women:men) had CUP than had BPAS (~1:1). Phantosmia was initiated in CUP in two women during pregnancy or immediately postpartum suggesting a role for estrogen, progesterone and/or prolactin. In at least 72% of women suffering from catamenial epilepsy, menses exacerbated seizures related, in part, to withdrawal of allopregnanolone, a progesterone metabolite, which acts as an endogenous anticonvulsant neurocorticosteroid that modulates GABA<sub>A</sub> receptors [<xref rid="B363-brainsci-03-01483" ref-type="bibr">363</xref>,<xref rid="B364-brainsci-03-01483" ref-type="bibr">364</xref>,<xref rid="B365-brainsci-03-01483" ref-type="bibr">365</xref>,<xref rid="B366-brainsci-03-01483" ref-type="bibr">366</xref>,<xref rid="B367-brainsci-03-01483" ref-type="bibr">367</xref>]. The putative effect of estrogen or lack thereof on phantosmia generation may also relate to the well-known interrelationship between this hormone and brain GABA and/or GABA<sub>A</sub> receptors. Estrogen specific effects on neuronal survival, differentiation and neurite extension suggested that this hormone modulates neurotransmitter and neuropeptide expression as well as tissue specific alterations in neural cell structure [<xref rid="B368-brainsci-03-01483" ref-type="bibr">368</xref>]. Estrogen has also been shown to bind specifically to preoptic GABAergic neurons [<xref rid="B369-brainsci-03-01483" ref-type="bibr">369</xref>] and to inhibit synthesis of GAD thereby decreasing local GABA concentration [<xref rid="B370-brainsci-03-01483" ref-type="bibr">370</xref>], Estrogen also acts to release neuronal epinephrine and nonepinepherine [<xref rid="B371-brainsci-03-01483" ref-type="bibr">371</xref>,<xref rid="B372-brainsci-03-01483" ref-type="bibr">372</xref>] although GABA may suppress CNS norepinephrine release [<xref rid="B371-brainsci-03-01483" ref-type="bibr">371</xref>]. Pregnenolone modulates GABA and GABA<sub>A</sub> receptor function thereby influencing GABA activity [<xref rid="B373-brainsci-03-01483" ref-type="bibr">373</xref>,<xref rid="B374-brainsci-03-01483" ref-type="bibr">374</xref>,<xref rid="B375-brainsci-03-01483" ref-type="bibr">375</xref>,<xref rid="B376-brainsci-03-01483" ref-type="bibr">376</xref>]. Conversely, there are powerful and complex feedback mechanisms whereby GABA acts as an inhibitory neurotransmitter restricting LHRH release [<xref rid="B377-brainsci-03-01483" ref-type="bibr">377</xref>] thereby inhibiting pituitary LH secretion and inhibiting gonadal estrogen [<xref rid="B378-brainsci-03-01483" ref-type="bibr">378</xref>]. Ovariectomized rats have been shown to exemplify this feedback mechanism [<xref rid="B379-brainsci-03-01483" ref-type="bibr">379</xref>] as have pubertal and prepubertal primates [<xref rid="B380-brainsci-03-01483" ref-type="bibr">380</xref>]. Estrogen is also known to play a role in neuronal plasticity [<xref rid="B381-brainsci-03-01483" ref-type="bibr">381</xref>,<xref rid="B382-brainsci-03-01483" ref-type="bibr">382</xref>,<xref rid="B383-brainsci-03-01483" ref-type="bibr">383</xref>] in part through neuronal sprouting [<xref rid="B384-brainsci-03-01483" ref-type="bibr">384</xref>,<xref rid="B385-brainsci-03-01483" ref-type="bibr">385</xref>]. </p><p>Women have a higher hemispheric cerebral blood flow than men [<xref rid="B386-brainsci-03-01483" ref-type="bibr">386</xref>,<xref rid="B387-brainsci-03-01483" ref-type="bibr">387</xref>] reflected in a 3%&#x02013;5% higher blood flow velocity in the middle cerebral artery [<xref rid="B388-brainsci-03-01483" ref-type="bibr">388</xref>]. Since blood flow velocity is dependent upon pCO<sub>2</sub>, gender differences in pCO<sub>2</sub> indicate differences in blood flow velocity as measured by transcranial Doppler sonography [<xref rid="B389-brainsci-03-01483" ref-type="bibr">389</xref>]. Studies by Kastrup <italic>et al</italic>. demonstrate not only that women have a significantly higher cerebrovascular CO<sub>2</sub> reactivity than men [<xref rid="B389-brainsci-03-01483" ref-type="bibr">389</xref>] but also that this difference disappears as women enter menopause and reappears upon treatment with hormone replacement therapy [<xref rid="B390-brainsci-03-01483" ref-type="bibr">390</xref>], presumably estrogenic compounds, and presumably based upon estrogenic effects, enhancing cerebrovascular reactivity.</p><p>These results suggest young women, who comprise the major subject group of CUP, may be particularly susceptible to these effects. However, studies in rat indicate GABAergic neuronal activity is greater in males than in females [<xref rid="B391-brainsci-03-01483" ref-type="bibr">391</xref>,<xref rid="B392-brainsci-03-01483" ref-type="bibr">392</xref>] although studies in sheep demonstrate that estrogen reactive cells colocalize with GABA [<xref rid="B393-brainsci-03-01483" ref-type="bibr">393</xref>]. Gender differences in CNS turnover of GABA have also been clearly demonstrated [<xref rid="B394-brainsci-03-01483" ref-type="bibr">394</xref>,<xref rid="B395-brainsci-03-01483" ref-type="bibr">395</xref>,<xref rid="B396-brainsci-03-01483" ref-type="bibr">396</xref>,<xref rid="B397-brainsci-03-01483" ref-type="bibr">397</xref>]. It is well known that estrogen administration to ovariectomized rats has proconvulsant effects [<xref rid="B398-brainsci-03-01483" ref-type="bibr">398</xref>], that increased seizure frequency occurs in follicular phase of menstrual cycle when estrogen concentration has peaked [<xref rid="B399-brainsci-03-01483" ref-type="bibr">399</xref>] and that seizures were exacerbated in women given estrogen premenstrually to treat catamenial epilepsy [<xref rid="B400-brainsci-03-01483" ref-type="bibr">400</xref>]. GABAergic neurons are present in olfactory bulbs and in hypothalamus in both embryonic [<xref rid="B401-brainsci-03-01483" ref-type="bibr">401</xref>] and adult [<xref rid="B402-brainsci-03-01483" ref-type="bibr">402</xref>] animals and appear to play a role in hormonal regulation [<xref rid="B403-brainsci-03-01483" ref-type="bibr">403</xref>]. GABA has been localized to interneurons in the granular cell layer of olfactory bulb and appears to play a role in olfactory transmission [<xref rid="B404-brainsci-03-01483" ref-type="bibr">404</xref>,<xref rid="B405-brainsci-03-01483" ref-type="bibr">405</xref>]. GABA<sub>A</sub> and GABA<sub>B</sub> receptors have also been shown to be present in olfactory bulb [<xref rid="B406-brainsci-03-01483" ref-type="bibr">406</xref>]. These findings suggest that women might be expected to have lower baseline brain GABA levels, which might make them more susceptible to focal pCO<sub>2</sub> changes than men. If they had relatively lower endogenous levels of brain GABA, coupled with focal brain pCO<sub>2</sub> changes associated with hyperventilation, cough, forced expiration, <italic>etc</italic>., might initiate a type of chemical kindling which might make them more susceptible to activation of phantosmia than men. Indeed, all women in CUP were premenopausal whereas the majority of women with BPAS were postmenopausal.</p></sec><sec><title>4.1.7. THC Effects</title><p>Recreational use of THC in one woman uniformly inhibiting phantosmia in CUP is consistent with the general hypothesis that GABA stimulation extinguishes phantosmia albeit there are several caveats to this effect. THC is mediated primarily through cannabinoid receptors which involve two types of G-protein-coupled cannabinoid receptors named CB<sub>1</sub> and CB<sub>2</sub> which have been identified and cloned [<xref rid="B407-brainsci-03-01483" ref-type="bibr">407</xref>]. Research data also suggest the presence of a third uncloned cannabinoid receptor [<xref rid="B407-brainsci-03-01483" ref-type="bibr">407</xref>]. Cannabinoids act at prejunctional CB<sub>1</sub> receptors to inhibit sympathetic neurotransmission [<xref rid="B408-brainsci-03-01483" ref-type="bibr">408</xref>]. THC acts through presynaptic CB<sub>1</sub> receptors which may reduce GABA<sub>A</sub> but not GABA<sub>B</sub> mediated inhibition of CA<sub>1</sub> pyramidal neurons by inhibiting voltage dependent calcium channels located in inhibitory nerve terminals [<xref rid="B409-brainsci-03-01483" ref-type="bibr">409</xref>] including hippocampal neurons [<xref rid="B410-brainsci-03-01483" ref-type="bibr">410</xref>,<xref rid="B411-brainsci-03-01483" ref-type="bibr">411</xref>]. THC also reduced glutamate release through the action of G-protein mediated inhibition of these calcium channels which are responsible for neurotransmitter release from hippocampal neurons [<xref rid="B410-brainsci-03-01483" ref-type="bibr">410</xref>]. While THC has a single saturable, reversible binding site [<xref rid="B412-brainsci-03-01483" ref-type="bibr">412</xref>] to a specifically identified CNS receptor of the GTP class [<xref rid="B413-brainsci-03-01483" ref-type="bibr">413</xref>,<xref rid="B414-brainsci-03-01483" ref-type="bibr">414</xref>] several neurotransmitters, including GABA, play roles in its neuropharmacology. Several cannabinoid-related agents exert anticonvulsant activity [<xref rid="B415-brainsci-03-01483" ref-type="bibr">415</xref>] and THC has been reported to inhibit acetylcholine turnover in hippocampus by increasing activity of septal GABAergic activity [<xref rid="B416-brainsci-03-01483" ref-type="bibr">416</xref>]. In animal studies THC-like agents protect mice against 3-mercaptopropriovic acid-induced convulsions, an action specific for GABAergic agents [<xref rid="B417-brainsci-03-01483" ref-type="bibr">417</xref>], stereospecifically blocked isoniasid-induced levels of cGMP [<xref rid="B417-brainsci-03-01483" ref-type="bibr">417</xref>] and similar to other GABAergic drugs, activated dopaminergic and benzodiazapine systems [<xref rid="B418-brainsci-03-01483" ref-type="bibr">418</xref>]. THC-like agents exhibit several pharmacological effects similar to GABA [<xref rid="B418-brainsci-03-01483" ref-type="bibr">418</xref>] including increasing attenuation of dopamine turnover after haloperidol [<xref rid="B419-brainsci-03-01483" ref-type="bibr">419</xref>] and stereospecifically increased <italic>in vivo</italic> 3H-flunitrazepan binding to benzodiazepine receptors from mouse brain [<xref rid="B417-brainsci-03-01483" ref-type="bibr">417</xref>]. Consistent with this latter observation levo-, but not dextro-mantradol enhanced potency and efficacy of diazepam blockade of pentylenetetrazol induced seizures [<xref rid="B417-brainsci-03-01483" ref-type="bibr">417</xref>]. Chronic injections of THC increase GABA content of rat brain [<xref rid="B420-brainsci-03-01483" ref-type="bibr">420</xref>] and THC itself has been reported to have unique anticonvulsant properties [<xref rid="B421-brainsci-03-01483" ref-type="bibr">421</xref>]. Cannabinoids, albeit variably, inhibit neurotransmission [<xref rid="B422-brainsci-03-01483" ref-type="bibr">422</xref>] and have been reported to augment GABA effects [<xref rid="B423-brainsci-03-01483" ref-type="bibr">423</xref>]. One mM &#x00394;<sup>9</sup> THC was reported to induce a consistent and significant increase in amplitude of grease-gap recordings of rat hippocampal slices in response to GABA [<xref rid="B196-brainsci-03-01483" ref-type="bibr">196</xref>] and other investigators suggested that THC interacts with GABA to mediate synaptic transmission [<xref rid="B424-brainsci-03-01483" ref-type="bibr">424</xref>]. Behavioral studies show that &#x00394;<sup>9</sup> THC and drugs which stimulate or facilitate GABAergic transmission exhibit a marked synergy in abolishing righting reflexes in mice [<xref rid="B425-brainsci-03-01483" ref-type="bibr">425</xref>] and in producing catalepsy in mice and rats [<xref rid="B425-brainsci-03-01483" ref-type="bibr">425</xref>,<xref rid="B426-brainsci-03-01483" ref-type="bibr">426</xref>]. Mechanism(s) underlying these various effects are unclear [<xref rid="B417-brainsci-03-01483" ref-type="bibr">417</xref>]. However, on the other hand, THC has been reported to have both convulsant as well as anticonvulsant properties [<xref rid="B421-brainsci-03-01483" ref-type="bibr">421</xref>]. It can diminish effects of GABA [<xref rid="B422-brainsci-03-01483" ref-type="bibr">422</xref>,<xref rid="B427-brainsci-03-01483" ref-type="bibr">427</xref>], enhance focal epileptic potentials and seizure activity [<xref rid="B428-brainsci-03-01483" ref-type="bibr">428</xref>] and can inhibit uptake of GABA in hippocampus [<xref rid="B196-brainsci-03-01483" ref-type="bibr">196</xref>]. These results suggest that THC exhibits multiple effects on CNS GABA that may act through some common mechanism (s) such as influencing CNS Ca<sup>2+</sup> uptake or reflex [<xref rid="B417-brainsci-03-01483" ref-type="bibr">417</xref>] alterations in activation of chloride channel proteins [<xref rid="B429-brainsci-03-01483" ref-type="bibr">429</xref>] or other mechanisms [<xref rid="B430-brainsci-03-01483" ref-type="bibr">430</xref>,<xref rid="B431-brainsci-03-01483" ref-type="bibr">431</xref>]. THC can also activate capsaicin-sensitive sensory nerves via the CB<sub>1</sub> and CB<sub>2</sub> receptor pathways suggesting other inhibitory pathways [<xref rid="B432-brainsci-03-01483" ref-type="bibr">432</xref>]. </p></sec></sec><sec><title>4.2. Pathophysiological, Peripheral and CNS Components of BPAS</title><p>In BPAS loss of sensory input (<italic>i.e.</italic>, hyposmia), as the initiating cause of phantosmia, is consistent with deafferentation hypersensitivity, similar to effects observed in phantom limb syndrome [<xref rid="B433-brainsci-03-01483" ref-type="bibr">433</xref>,<xref rid="B434-brainsci-03-01483" ref-type="bibr">434</xref>,<xref rid="B435-brainsci-03-01483" ref-type="bibr">435</xref>]. This effect may also be both rapid [<xref rid="B213-brainsci-03-01483" ref-type="bibr">213</xref>,<xref rid="B216-brainsci-03-01483" ref-type="bibr">216</xref>] or slow [<xref rid="B218-brainsci-03-01483" ref-type="bibr">218</xref>,<xref rid="B219-brainsci-03-01483" ref-type="bibr">219</xref>] associated with changes in GABAergic and GAD activity. These responses follow loss of a significant sensory input such that there are significant functional CNS changes including cortical enlargement, [<xref rid="B434-brainsci-03-01483" ref-type="bibr">434</xref>,<xref rid="B435-brainsci-03-01483" ref-type="bibr">435</xref>,<xref rid="B436-brainsci-03-01483" ref-type="bibr">436</xref>] rerouting and remapping of the usual cortical representation of the affected areas to specific brain areas [<xref rid="B435-brainsci-03-01483" ref-type="bibr">435</xref>,<xref rid="B437-brainsci-03-01483" ref-type="bibr">437</xref>,<xref rid="B438-brainsci-03-01483" ref-type="bibr">438</xref>] related to neuronal plasticity. These changes have been visualized by others studying deafferentation hypersensitivity related to various clinical syndromes using fMRI [<xref rid="B439-brainsci-03-01483" ref-type="bibr">439</xref>,<xref rid="B440-brainsci-03-01483" ref-type="bibr">440</xref>], magnetoencephalography [<xref rid="B441-brainsci-03-01483" ref-type="bibr">441</xref>] and PET [<xref rid="B434-brainsci-03-01483" ref-type="bibr">434</xref>] and in our own studies in BPAS using fMRI [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>]. </p></sec><sec><title>4.3. Common Clinical CNS Components in Both CUP and BPAS</title><p>Both CUP and BPAS exhibited EEG abnormalities although CUP exhibited significantly more frequent and specific EEG changes than did BPAS, despite the fact that 45% of patients with BPAS had symptoms secondary to a head injury. In CUP, EEG changes, if considered separately, could be and were considered clinically consistent with a temporal lobe seizure disorder. Indeed, 60% of CUP patients were initially considered to exhibit some form of epilepsy and were treated with anticonvulsants although none experienced phantosmia diminution with this therapy [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>]. In our initial description of this disorder [<xref rid="B155-brainsci-03-01483" ref-type="bibr">155</xref>] we also considered CUP a partial seizure disorder with simple psychosensory symptomatology since patients exhibited what were considered auras commonly associated with temporal lobe EEG abnormalities. However, the lack of clinical motor activity cast doubt about this diagnosis even at this initial stage of our studies. Our further investigations allowed a more definitive description of this disorder and its possible mechanism [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>].</p><p>In BPAS, while a peripheral component of phantosmia may be present, it may be less immediately apparent than in CUP. While binasal cocaine installation inhibited phantosmia in BPAS, as observed by others [<xref rid="B442-brainsci-03-01483" ref-type="bibr">442</xref>,<xref rid="B443-brainsci-03-01483" ref-type="bibr">443</xref>], this inhibition was only temporary. In CUP there was usually a post anesthesia inhibitory period along with the production of hyposmia. These results may relate to activation of GABAergic pathways after cocaine installation [<xref rid="B222-brainsci-03-01483" ref-type="bibr">222</xref>,<xref rid="B224-brainsci-03-01483" ref-type="bibr">224</xref>] but the issue of initial deafferentation hypersensitivity and decreased GABAergic activity prior to its use must be considered. rTMS was effective in inhibiting phantosmia in both CUP or BPAS consistent with inhibition of deafferentation hypersensitivity presumably by inducing increased CNS GABA [<xref rid="B165-brainsci-03-01483" ref-type="bibr">165</xref>,<xref rid="B166-brainsci-03-01483" ref-type="bibr">166</xref>].</p></sec><sec><title>4.4. Other Neurotransmitter Effects on CNS in CUP and BPAS</title><p>Several other neurotransmitters may also be involved in complex processes that initiate phantosmia in CUP (and also in BPAS) including relationships between both excitatory and inhibitory neurotransmitter systems related to various aspects of their synthesis, utilization or interaction with specific receptors. Hallucinations, usually visual or auditory, have been reported in Parkinson&#x02019;s disease [<xref rid="B444-brainsci-03-01483" ref-type="bibr">444</xref>] due in part to CNS deficits in cholinergic [<xref rid="B445-brainsci-03-01483" ref-type="bibr">445</xref>,<xref rid="B446-brainsci-03-01483" ref-type="bibr">446</xref>,<xref rid="B447-brainsci-03-01483" ref-type="bibr">447</xref>] or dopaminergic [<xref rid="B448-brainsci-03-01483" ref-type="bibr">448</xref>,<xref rid="B449-brainsci-03-01483" ref-type="bibr">449</xref>] function. Drugs have induced hallucinations due to increased glutaminergic activity [<xref rid="B450-brainsci-03-01483" ref-type="bibr">450</xref>] or decreased GABAergic function [<xref rid="B199-brainsci-03-01483" ref-type="bibr">199</xref>]. Phenobarbital, which increases CNS GABAergic activity [<xref rid="B451-brainsci-03-01483" ref-type="bibr">451</xref>,<xref rid="B452-brainsci-03-01483" ref-type="bibr">452</xref>,<xref rid="B453-brainsci-03-01483" ref-type="bibr">453</xref>], inhibited phantosmia in one patient with CUP. Indeed, both thioridazine and haloperidol, neuroleptics that enhance GABAergic CNS activity [<xref rid="B198-brainsci-03-01483" ref-type="bibr">198</xref>,<xref rid="B199-brainsci-03-01483" ref-type="bibr">199</xref>,<xref rid="B454-brainsci-03-01483" ref-type="bibr">454</xref>,<xref rid="B455-brainsci-03-01483" ref-type="bibr">455</xref>] inhibited phantosmia in both CUP [<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>] and BPAS [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>].</p></sec><sec><title>4.5. Behavioral and Sensory Effects in CUP and BPAS</title><p>Both seizure inhibition and activation by behavioral and sensory activities have been shown in patients with known seizure activity [<xref rid="B456-brainsci-03-01483" ref-type="bibr">456</xref>]. For seizure inhibition these activities have been classified as primary (direct seizure inhibition by an act of will) or secondary [by a behavior or mind action which interferes with seizure generation but was not intended to do so [<xref rid="B456-brainsci-03-01483" ref-type="bibr">456</xref>]]. Whereas 10% of patients with complex partial seizures were able to reduce their seizure frequency by behavioral means [<xref rid="B457-brainsci-03-01483" ref-type="bibr">457</xref>] patients with simple partial seizures were reportedly not able to do so [<xref rid="B456-brainsci-03-01483" ref-type="bibr">456</xref>]. Olfactory stimuli inhibited seizure activity [<xref rid="B458-brainsci-03-01483" ref-type="bibr">458</xref>] as has operant conditioning [<xref rid="B459-brainsci-03-01483" ref-type="bibr">459</xref>], behavior modification [<xref rid="B460-brainsci-03-01483" ref-type="bibr">460</xref>,<xref rid="B461-brainsci-03-01483" ref-type="bibr">461</xref>,<xref rid="B462-brainsci-03-01483" ref-type="bibr">462</xref>], relaxation programs [<xref rid="B463-brainsci-03-01483" ref-type="bibr">463</xref>] and other similar activities [<xref rid="B456-brainsci-03-01483" ref-type="bibr">456</xref>]. Historically, it is well known that focal epileptic seizures can be aborted by powerful sensory stimuli such as application of a tight ligature to a finger, vigorous massage of hand and foot muscles, forcibly resisting the first tonic seizure spasm, plunging a whole extremity into ice water or extremity pin pricking [<xref rid="B464-brainsci-03-01483" ref-type="bibr">464</xref>], related to activation of a widespread suppressor system of nociceptive impulses [<xref rid="B465-brainsci-03-01483" ref-type="bibr">465</xref>,<xref rid="B466-brainsci-03-01483" ref-type="bibr">466</xref>]. Gowers in 1885 wrote that seizures could be arrested by taste stimuli such as chewing ginger or swallowing table salt or olfactory stimuli such as smelling ammonia or amyl nitrite [<xref rid="B17-brainsci-03-01483" ref-type="bibr">17</xref>]. Efron&#x02019;s studies suggest that olfactory stimuli that inhibited uncinate seizures were independent of psychological suggestion and related to activation of a localized inhibitory system [<xref rid="B458-brainsci-03-01483" ref-type="bibr">458</xref>]. </p><p>On the other hand clinical experience suggests that there can be a close interrelationship between what may be considered &#x0201c;atypical behavior&#x0201d; and what some clinicians might consider seizure activity [<xref rid="B467-brainsci-03-01483" ref-type="bibr">467</xref>,<xref rid="B468-brainsci-03-01483" ref-type="bibr">468</xref>,<xref rid="B469-brainsci-03-01483" ref-type="bibr">469</xref>,<xref rid="B470-brainsci-03-01483" ref-type="bibr">470</xref>] such that sensory and other activities might activate seizure activity. Many adolescents reported auditory hallucinations without any psychotic ideation [<xref rid="B471-brainsci-03-01483" ref-type="bibr">471</xref>]. So-called psychogenic pseudoseizures have been reported in non-epileptic patients precipitated by suggestion or environmental stress but none had EEG changes either before or after these &#x0201c;attacks&#x0201d; [<xref rid="B472-brainsci-03-01483" ref-type="bibr">472</xref>]. As many as 20% of epileptics have been reported to have nonepileptic or &#x0201c;pseudoepileptic&#x0201d; episodes simulating status epilepticus [<xref rid="B473-brainsci-03-01483" ref-type="bibr">473</xref>]. Reflex seizures [<xref rid="B474-brainsci-03-01483" ref-type="bibr">474</xref>,<xref rid="B475-brainsci-03-01483" ref-type="bibr">475</xref>,<xref rid="B476-brainsci-03-01483" ref-type="bibr">476</xref>], sensory precipitation epilepsy [<xref rid="B476-brainsci-03-01483" ref-type="bibr">476</xref>] and stimulus-sensitive epilepsy precipitated by light [<xref rid="B477-brainsci-03-01483" ref-type="bibr">477</xref>,<xref rid="B478-brainsci-03-01483" ref-type="bibr">478</xref>], vestibular stimuli [<xref rid="B479-brainsci-03-01483" ref-type="bibr">479</xref>,<xref rid="B480-brainsci-03-01483" ref-type="bibr">480</xref>], music [<xref rid="B481-brainsci-03-01483" ref-type="bibr">481</xref>] tastes [<xref rid="B482-brainsci-03-01483" ref-type="bibr">482</xref>], propriociption [<xref rid="B483-brainsci-03-01483" ref-type="bibr">483</xref>], somatosensory stimulation [<xref rid="B484-brainsci-03-01483" ref-type="bibr">484</xref>], eating [<xref rid="B482-brainsci-03-01483" ref-type="bibr">482</xref>,<xref rid="B485-brainsci-03-01483" ref-type="bibr">485</xref>,<xref rid="B486-brainsci-03-01483" ref-type="bibr">486</xref>], startle and/or arousal [<xref rid="B459-brainsci-03-01483" ref-type="bibr">459</xref>,<xref rid="B487-brainsci-03-01483" ref-type="bibr">487</xref>], integration of higher cerebral functioning or thinking, reading and decision making [<xref rid="B488-brainsci-03-01483" ref-type="bibr">488</xref>,<xref rid="B489-brainsci-03-01483" ref-type="bibr">489</xref>] have been reported. Seizures of these various types have been related to an imbalance between GABAergic and dopaminergic neurotransmission [<xref rid="B476-brainsci-03-01483" ref-type="bibr">476</xref>] and initiated in animals following strychnization of sensory cortex, including olfactory cortex [<xref rid="B490-brainsci-03-01483" ref-type="bibr">490</xref>]. Seizures of this type have been reported evoked or self induced in as many as 30% of patients with so-called photoparoxysmal responses [<xref rid="B491-brainsci-03-01483" ref-type="bibr">491</xref>], have been estimated to occur in 5% of people with epilepsy [<xref rid="B461-brainsci-03-01483" ref-type="bibr">461</xref>], have been considered genetically determined [<xref rid="B492-brainsci-03-01483" ref-type="bibr">492</xref>] and occurred more commonly in young women than in men [<xref rid="B492-brainsci-03-01483" ref-type="bibr">492</xref>]. Psychogenic [<xref rid="B493-brainsci-03-01483" ref-type="bibr">493</xref>] or pseudoseizures [[<xref rid="B494-brainsci-03-01483" ref-type="bibr">494</xref>,<xref rid="B495-brainsci-03-01483" ref-type="bibr">495</xref>,<xref rid="B496-brainsci-03-01483" ref-type="bibr">496</xref>] (hysterical or nonepileptic seizures)] have been provoked by some psychic event [<xref rid="B469-brainsci-03-01483" ref-type="bibr">469</xref>,<xref rid="B493-brainsci-03-01483" ref-type="bibr">493</xref>], can be deliberately precipitated, have been estimated to occur in five to 40% of outpatients with epilepsy evaluated at epilepsy centers [<xref rid="B469-brainsci-03-01483" ref-type="bibr">469</xref>,<xref rid="B497-brainsci-03-01483" ref-type="bibr">497</xref>], again most commonly observed in young women [<xref rid="B493-brainsci-03-01483" ref-type="bibr">493</xref>] and have been related, particularly in animals, to activation in a single, focal brain area [<xref rid="B490-brainsci-03-01483" ref-type="bibr">490</xref>]. Some investigators considered epilepsy rare in patients with psychogenic seizures [<xref rid="B498-brainsci-03-01483" ref-type="bibr">498</xref>] whereas others found nonepileptic seizures and epilepsy, per se, to co-occur in 12%&#x02013;42% of patients [<xref rid="B499-brainsci-03-01483" ref-type="bibr">499</xref>] making these discriminations difficult. </p><p>Although seizure activity of the type described above is diffuse and difficult to specify none of these patients reported hallucinatory activity of the type observed in either CUP or BPAS. However, the symptomatology of these latter two syndromes may itself cause clinical confusion due to their protean character. At initial presentation it might be understandable that patients with CUP were considered to manifest a seizure disorder. However, while various types of seizures and mechanisms for their initiation and inhibition may be relatively common and difficult to classify, patients with epileptic seizures can be readily distinguishable from those with either CUP or BPAS by careful history. Thus, in both CUP and BPAS, there is a much longer duration of each sensory event which has a pattern of persistent intermittancy, a sudden onset of symptoms as opposed to the gradual onset of ictus, a lack of any overt autonomous activity as opposed to wild movements, intermittent jerking and myoclonic activity in the other disorders, a fixed, stereotypic phantosmia as opposed to non-fixed stimulus evoking and fluctuating clinical features in the other disorders, no type of post-ictal symptomatology which occur in each of these other disorders and in CUP, specific physiological not behavioral stimuli which initiate and/or inhibit phantosmia as opposed to the lack of these specific stimuli in either initiating or inhibiting activity in either BPAS or the other disorders.</p><p>Many of the patients with both CUP and BPAS expressed great personal distress associated with the presence of these hallucinations. Their presence, their intensity, their recurrent chronicity, the lack of understanding of the severity of their presence and the lack of effective treatment exacerbated their personal distress. Some patients likened their hallucinations to a recurrence or persistence of a chronic, recurrent nasal or oral pain without effective relief with which they had a great deal of difficulty in tolerating similar to the experience noted by others in relationship to the presence of chronic somatic pain [<xref rid="B500-brainsci-03-01483" ref-type="bibr">500</xref>]. </p></sec><sec><title>4.6. Epistemology of Sensory Hallucinations</title><p>Nomenclature related to sensory hallucinations has been historically diffuse and unclear (v.s.). Some investigators used the term &#x02018;pseudo-hallucination&#x02019; to differentiate onset of unprovoked odors from &#x0201c;true hallucinations&#x0201d; [<xref rid="B501-brainsci-03-01483" ref-type="bibr">501</xref>,<xref rid="B502-brainsci-03-01483" ref-type="bibr">502</xref>]. This terminology is vague and not only does it not accurately describe the sensory phenomena experienced in either CUP or BPAS but also does not account for demonstration of sensory specific brain fMRI activation associated and measured in each syndrome [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>,<xref rid="B104-brainsci-03-01483" ref-type="bibr">104</xref>]. A variety of other terms have been used to describe unusual, odd or peculiar &#x0201c;behavior&#x0201d; that may be and has been considered consistent with some type of seizure disorder. These terms include some associated with sensory behavior that could be considered an aura involving any number of sensory systems, including olfaction and taste [<xref rid="B8-brainsci-03-01483" ref-type="bibr">8</xref>,<xref rid="B93-brainsci-03-01483" ref-type="bibr">93</xref>,<xref rid="B137-brainsci-03-01483" ref-type="bibr">137</xref>,<xref rid="B503-brainsci-03-01483" ref-type="bibr">503</xref>,<xref rid="B504-brainsci-03-01483" ref-type="bibr">504</xref>]. We speculate that these behaviors may have a common origin. CUP and BPAS are manifestations of clinical and biochemical phenomena which at other times might have been considered odd or unusual behaviors but since they have specific neurological correlates they can be categorized specifically, whereas some of these other behaviors, without specific neurological correlates, were simply considered bizarre behaviors.</p><p>Attempts to systematize sensory hallucinations may assist to clarify mechanisms underlying phantosmia in CUP and BPAS. We have used the word phantosmia to refer to smell sensations induced in the absence of any known stimulus and the word phantageusia to refer to similar taste sensations. We classified phantosmia and phantageusia as primary or secondary [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>], similar to terminology used in dystonia [<xref rid="B505-brainsci-03-01483" ref-type="bibr">505</xref>] or Parkinsonism [<xref rid="B506-brainsci-03-01483" ref-type="bibr">506</xref>]. Primary phantosmia or phantageusia was defined as an odor or taste occurring in absence of any apparent stimulus in the absence of any apparent clinical or disease process; secondary phantosmia or phantageusia was defined as an odor or taste occurring in the absence of any apparent stimulus associated with a clinical disease process [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>]. Previously, the phantom, which we have classified as either primary or secondary phantosmia or phantageusia, was classified as an aura which may be considered a simple partial seizure [<xref rid="B507-brainsci-03-01483" ref-type="bibr">507</xref>,<xref rid="B508-brainsci-03-01483" ref-type="bibr">508</xref>]. We consider these symptoms to be pathophysiological processes involving a trigger mechanism (be it chemical kindling or some other similar mechanism) and a process in which CNS is altered due to what we consider an alteration in the complex balance between glutaminergic or similar neurotransmitter related CNS excitation and GABAergic or similar type inhibition in a type of maladaptive plasticity [<xref rid="B35-brainsci-03-01483" ref-type="bibr">35</xref>]; for CUP we hypothesize this effect initiated as a type of receptor hypersensitivity with subsequent CNS plasticity [as in dystonia [<xref rid="B181-brainsci-03-01483" ref-type="bibr">181</xref>,<xref rid="B184-brainsci-03-01483" ref-type="bibr">184</xref>]] and for BPAS we hypothesize this effect initiated as a type of deafferentiation hypersensitivity with subsequent CNS dysplasticity (as in phantom limb pain [<xref rid="B433-brainsci-03-01483" ref-type="bibr">433</xref>,<xref rid="B438-brainsci-03-01483" ref-type="bibr">438</xref>,<xref rid="B441-brainsci-03-01483" ref-type="bibr">441</xref>]). It is possible to consider the &#x0201c;secondary&#x0201d; phantosmia and phantageusia described by Jackson [<xref rid="B6-brainsci-03-01483" ref-type="bibr">6</xref>,<xref rid="B7-brainsci-03-01483" ref-type="bibr">7</xref>,<xref rid="B8-brainsci-03-01483" ref-type="bibr">8</xref>] and others [<xref rid="B92-brainsci-03-01483" ref-type="bibr">92</xref>] as another manifestation of chemical/electrical kindling set in motion by a tumor discharge or epileptic focus which can result in impaired consciousness, clonic movement or automotisms or which can itself, without a specific localizing epileptic focus, represent a manifestation of the seizure itself.</p><p>The observations we describe in both CUP and BPAS in which myoclonic activity does not occur relate to new, heretofore unrecognized applications of well-established and well known physiological principles dealing principally with changes in CNS plasticity and in CNS GABA.</p></sec></sec><sec><title>5. Conclusions</title><p>We describe two previously underrecognized syndromes, one with cyclic unirhinal phantosmia not directly associated with hyposmia labeled CUP and one with non-cyclic birhinal phantosmia directly associated with hyposmia labeled BPAS, but both without prior or subsequent myoclonic activity. Patients with CUP reflect an uncommon clinical syndrome whereas we suggest that patients with BPAS are relatively common although they are not recognized as such by the neurological or otorhinological communities. Studies of the mechanisms related to these disorders suggest that decreased CNS GABA activity in specific brain regions is associated with phantosmia in CUP whereas changes in CNS plasticity consistent with changes observed in phantom limb sensations are associated with phantosmia in BPAS. GABA agonists, increased either by pharmacological or neurophysiological means, have been useful in inhibiting phantosmia in each patient group and suggest the relevance of levels of CNS GABA in both initiation and inhibition of these two syndromes.</p></sec></body><back><ack><title>Acknowledgments</title><p>We wish to thank Dieter Schellinger for his assistance in interpreting the neuroimaging studies and Doctor E.T. Calderone for assistance in interpreting the EEG records of both patient groups.</p><p>We wish to dedicate this work to Desmond O&#x02019;Doherty, Emeritus Professor of Neurology and Chairman of the Department of Neurology, Georgetown University Medical Center, who supported us during the early stages of our development and whose hope and faith in performance of this work encouraged us to its completion.</p></ack><notes><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-brainsci-03-01483"><label>1.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Aretaeus</surname></name></person-group>
<source>The Extant Works of Aretaeus: The Cappadocian</source>
<person-group person-group-type="editor"><name><surname>Adams</surname><given-names>F.</given-names></name></person-group>
<publisher-name>Longwood Press</publisher-name>
<publisher-loc>Boston, MA, USA</publisher-loc>
<year>1978</year>
</element-citation></ref><ref id="B2-brainsci-03-01483"><label>2.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>K&#x000fc;hn</surname><given-names>C.G.</given-names></name></person-group>
<source>Claudii Galeni Opera Omnia</source>
<publisher-name>Georg Olms</publisher-name>
<publisher-loc>Hildesheim, Germany</publisher-loc>
<year>1964</year>
</element-citation></ref><ref id="B3-brainsci-03-01483"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manford</surname><given-names>M.</given-names></name><name><surname>Shorvon</surname><given-names>S.D.</given-names></name></person-group>
<article-title>Prolonged sensory or visceral symptoms: An under-diagnosed form of non-convulsive focal (simple partial) status epilepticus</article-title>
<source>J. Neurol. Neurosurg. Psychiatry</source>
<year>1992</year>
<volume>55</volume>
<fpage>714</fpage>
<lpage>716</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.55.8.714</pub-id>
<pub-id pub-id-type="pmid">1527544</pub-id></element-citation></ref><ref id="B4-brainsci-03-01483"><label>4.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gove</surname><given-names>P.B.</given-names></name></person-group>
<source>Webster&#x02019;s Seventh New Collegiate Dictionary</source>
<edition>3rd ed.</edition>
<publisher-name>G &#x00026; C Merriam</publisher-name>
<publisher-loc>Springfield, MA, USA</publisher-loc>
<year>1967</year>
</element-citation></ref><ref id="B5-brainsci-03-01483"><label>5.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Esquirol</surname><given-names>E.</given-names></name></person-group>
<source>Des Maladies Mentales Consid&#x000e9;r&#x000e9;es sous les Rapports M&#x000e9;dical, Hygi&#x000e9;nique et M&#x000e9;dico-L&#x000e9;gal, (1838)</source>
<publisher-name>Hafner</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<comment>Reprinted 1965</comment>
</element-citation></ref><ref id="B6-brainsci-03-01483"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Subjective sensations of smell with epileptiform attacks</article-title>
<source>R. Lond. Ophthalmic Hosp. Rep.</source>
<year>1866</year>
<volume>5</volume>
<fpage>304</fpage>
</element-citation></ref><ref id="B7-brainsci-03-01483"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Clinical remarks on the occasional occurrence of subjective sensations of smell in patients who are liable to epileptiform seizures or who have symptoms of mental derangement and in others</article-title>
<source>Lancet</source>
<year>1866</year>
<volume>1</volume>
<fpage>659</fpage>
<lpage>660</lpage>
</element-citation></ref><ref id="B8-brainsci-03-01483"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Subjective sensation of smell with epileptiform seizures</article-title>
<source>Lancet</source>
<year>1871</year>
<volume>1</volume>
<fpage>376</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="pmid">4109758</pub-id></element-citation></ref><ref id="B9-brainsci-03-01483"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lennox</surname><given-names>W.G.</given-names></name><name><surname>Cobb</surname><given-names>S.</given-names></name></person-group>
<article-title>Aura in epilepsy: A statistical review of 1,359 cases</article-title>
<source>Arch. Neurol. Psychiatry</source>
<year>1933</year>
<volume>30</volume>
<fpage>374</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="doi">10.1001/archneurpsyc.1933.02240140138007</pub-id>
</element-citation></ref><ref id="B10-brainsci-03-01483"><label>10.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Penfield</surname><given-names>W.</given-names></name><name><surname>Kristiansen</surname><given-names>K.</given-names></name></person-group>
<source>Epileptic Seizure Patterns</source>
<publisher-name>CC Thomas</publisher-name>
<publisher-loc>Springfield, IL, USA</publisher-loc>
<year>1951</year>
</element-citation></ref><ref id="B11-brainsci-03-01483"><label>11.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gastaut</surname><given-names>H.</given-names></name><name><surname>Broughton</surname><given-names>R.J.</given-names></name></person-group>
<source>Epileptic Seizures: Clinical and Electrographic Features, Diagnosis and Treatment</source>
<publisher-name>CC Thomas</publisher-name>
<publisher-loc>Springfield, IL, USA</publisher-loc>
<year>1972</year>
<fpage>124</fpage>
<lpage>134</lpage>
</element-citation></ref><ref id="B12-brainsci-03-01483"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daly</surname><given-names>D.D.</given-names></name></person-group>
<article-title>Ictal clinical manifestations of complex partial seizures</article-title>
<source>Adv. Neurol.</source>
<year>1975</year>
<volume>11</volume>
<fpage>57</fpage>
<lpage>83</lpage>
<?supplied-pmid 1217573?><pub-id pub-id-type="pmid">1217573</pub-id></element-citation></ref><ref id="B13-brainsci-03-01483"><label>13.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Weiser</surname><given-names>H.G.</given-names></name></person-group>
<source>Electroclinical Features of Psychomotor Seizure</source>
<publisher-name>Butterworths</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>1983</year>
</element-citation></ref><ref id="B14-brainsci-03-01483"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Currie</surname><given-names>S.</given-names></name><name><surname>Heathfield</surname><given-names>W.G.</given-names></name><name><surname>Henson</surname><given-names>R.A.</given-names></name><name><surname>Scott</surname><given-names>D.F.</given-names></name></person-group>
<article-title>Clinical course and prognosis of temporal lobe epilepsy. A survey of 666 patients</article-title>
<source>Brain</source>
<year>1971</year>
<volume>194</volume>
<fpage>173</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="pmid">5552161</pub-id></element-citation></ref><ref id="B15-brainsci-03-01483"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><collab>Commission on Classification and Terminology of the International League against Epilepsy</collab></person-group>
<article-title>Proposal for revised clinical and electroencephalographic classification of epileptic seizures</article-title>
<source>Epilepsia</source>
<year>1981</year>
<volume>22</volume>
<fpage>489</fpage>
<lpage>501</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1981.tb06159.x</pub-id>
<pub-id pub-id-type="pmid">6790275</pub-id></element-citation></ref><ref id="B16-brainsci-03-01483"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A.K.</given-names></name><name><surname>Jeavons</surname><given-names>P.M.</given-names></name><name><surname>Hughes</surname><given-names>R.C.</given-names></name><name><surname>Covanis</surname><given-names>A.</given-names></name></person-group>
<article-title>Aura in temporal lobe epilepsy: Clinical and electroencephalographic correlation</article-title>
<source>J. Neurol. Neurosurg. Psychiatry</source>
<year>1983</year>
<volume>46</volume>
<fpage>1079</fpage>
<lpage>1083</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.46.12.1079</pub-id>
<pub-id pub-id-type="pmid">6663306</pub-id></element-citation></ref><ref id="B17-brainsci-03-01483"><label>17.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gowers</surname><given-names>W.R.</given-names></name></person-group>
<source>Epilepsy and Other Chronic Convulsive Diseases: Their Causes, Symptoms and Treatment</source>
<publisher-name>William Wood</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>1885</year>
<volume>Volume 1</volume>
</element-citation></ref><ref id="B18-brainsci-03-01483"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jasper</surname><given-names>H.H.</given-names></name><name><surname>Rasmussen</surname><given-names>T.</given-names></name></person-group>
<article-title>Studies of clinical and electrical responses to deep temporal stimulation in man with some considerations of functional anatomy</article-title>
<source>Res. Publ. Assoc. Res. Nerv. Ment. Dis.</source>
<year>1958</year>
<volume>36</volume>
<fpage>316</fpage>
<lpage>334</lpage>
<?supplied-pmid 13527791?><pub-id pub-id-type="pmid">13527791</pub-id></element-citation></ref><ref id="B19-brainsci-03-01483"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Falconer</surname><given-names>M.A.</given-names></name><name><surname>Cavanagh</surname><given-names>J.B.</given-names></name></person-group>
<article-title>Clinico-pathological considerations of temporal lobe epilepsy due to small focal lesions</article-title>
<source>Brain</source>
<year>1959</year>
<volume>82</volume>
<fpage>483</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="doi">10.1093/brain/82.4.483</pub-id>
<pub-id pub-id-type="pmid">13821394</pub-id></element-citation></ref><ref id="B20-brainsci-03-01483"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Buren</surname><given-names>J.M.</given-names></name></person-group>
<article-title>The abdominal aura: A study of abdominal sensations occurring in epilepsy and produced by depth stimulation</article-title>
<source>Electroencephalogr. Clin. Neurophysiol.</source>
<year>1963</year>
<volume>15</volume>
<fpage>1</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1016/0013-4694(63)90035-X</pub-id>
<pub-id pub-id-type="pmid">13995971</pub-id></element-citation></ref><ref id="B21-brainsci-03-01483"><label>21.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Penfield</surname><given-names>W.</given-names></name><name><surname>Jasper</surname><given-names>H.H.</given-names></name></person-group>
<source>Epilepsy and the Functional Anatomy of the Human Brain</source>
<publisher-name>Little Brown</publisher-name>
<publisher-loc>Boston, MA, USA</publisher-loc>
<year>1954</year>
</element-citation></ref><ref id="B22-brainsci-03-01483"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mullan</surname><given-names>S.</given-names></name><name><surname>Penfield</surname><given-names>W.</given-names></name></person-group>
<article-title>Illusions of comparative interpretation and emotion; production by epileptic discharge and by electrical stimulation in the temporal cortex</article-title>
<source>Arch. Neurol. Psychiatry</source>
<year>1959</year>
<volume>81</volume>
<fpage>269</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="pmid">13626278</pub-id></element-citation></ref><ref id="B23-brainsci-03-01483"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Penfield</surname><given-names>W.</given-names></name><name><surname>Perot</surname><given-names>P.</given-names></name></person-group>
<article-title>The brain&#x02019;s record of auditory and visual experience. A final summary and discussion</article-title>
<source>Brain</source>
<year>1963</year>
<volume>86</volume>
<fpage>596</fpage>
<lpage>696</lpage>
</element-citation></ref><ref id="B24-brainsci-03-01483"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gloor</surname><given-names>P.</given-names></name><name><surname>Olivier</surname><given-names>A.</given-names></name><name><surname>Quesney</surname><given-names>L.</given-names></name><name><surname>Andermann</surname><given-names>F.</given-names></name><name><surname>Horowitz</surname><given-names>S.</given-names></name></person-group>
<article-title>The role of the limbic system in experiential phenomena of temporal lobe epilepsy</article-title>
<source>Ann. Neurol.</source>
<year>1982</year>
<volume>12</volume>
<fpage>129</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410120203</pub-id>
<pub-id pub-id-type="pmid">7125603</pub-id></element-citation></ref><ref id="B25-brainsci-03-01483"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sperling</surname><given-names>M.R.</given-names></name><name><surname>Lieb</surname><given-names>J.P.</given-names></name><name><surname>Engel</surname><given-names>J.</given-names></name><name><surname>Crandall</surname><given-names>P.H.</given-names></name></person-group>
<article-title>Prognostic significance of independent auras in temporal lobe seizures</article-title>
<source>Epilepsia</source>
<year>1989</year>
<volume>30</volume>
<fpage>322</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1989.tb05305.x</pub-id>
<pub-id pub-id-type="pmid">2721465</pub-id></element-citation></ref><ref id="B26-brainsci-03-01483"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palmini</surname><given-names>A.</given-names></name><name><surname>Gloor</surname><given-names>P.</given-names></name></person-group>
<article-title>The localizing value of auras in partial seizures: A prospective and retrospective study</article-title>
<source>Neurology</source>
<year>1992</year>
<volume>42</volume>
<fpage>801</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.42.4.801</pub-id>
<pub-id pub-id-type="pmid">1565234</pub-id></element-citation></ref><ref id="B27-brainsci-03-01483"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taylor</surname><given-names>D.C.</given-names></name><name><surname>Lochery</surname><given-names>M.</given-names></name></person-group>
<article-title>Temporal lobe epilepsy: Origin and significance of simple and complex auras</article-title>
<source>J. Neurol. Neurosurg. Psychiatry</source>
<year>1987</year>
<volume>50</volume>
<fpage>673</fpage>
<lpage>681</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.50.6.673</pub-id>
<pub-id pub-id-type="pmid">3612148</pub-id></element-citation></ref><ref id="B28-brainsci-03-01483"><label>28.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Williamson</surname><given-names>P.D.</given-names></name><name><surname>Wieser</surname><given-names>H.G.</given-names></name><name><surname>Delgado-Escueta</surname><given-names>A.V.</given-names></name></person-group>
<article-title>Clinical Characteristics of Partial Seizures</article-title>
<source>Surgical Treatment of the Epilepsies</source>
<person-group person-group-type="editor"><name><surname>Engel</surname><given-names>J.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1987</year>
<fpage>101</fpage>
<lpage>120</lpage>
</element-citation></ref><ref id="B29-brainsci-03-01483"><label>29.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ajmone-Marsan</surname><given-names>C.</given-names></name></person-group>
<article-title>Commentary: Clinical Characteristics of Partial Seizures</article-title>
<source>Surgical Treatment of the Epilepsies</source>
<person-group person-group-type="editor"><name><surname>Engel</surname><given-names>J.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1987</year>
<fpage>121</fpage>
<lpage>127</lpage>
</element-citation></ref><ref id="B30-brainsci-03-01483"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Janati</surname><given-names>A.</given-names></name><name><surname>Nowack</surname><given-names>W.J.</given-names></name><name><surname>Dorsey</surname><given-names>S.</given-names></name><name><surname>Chesser</surname><given-names>M.Z.</given-names></name></person-group>
<article-title>Correlative study of interictal electroencephalogram and aura in complex partial seizures</article-title>
<source>Epilepsia</source>
<year>1990</year>
<volume>31</volume>
<fpage>41</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1990.tb05358.x</pub-id>
<pub-id pub-id-type="pmid">2303011</pub-id></element-citation></ref><ref id="B31-brainsci-03-01483"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sperling</surname><given-names>M.R.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Auras and subclinical seizures: Characteristics and prognostic significance</article-title>
<source>Ann. Neurol.</source>
<year>1990</year>
<volume>28</volume>
<fpage>320</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410280304</pub-id>
<pub-id pub-id-type="pmid">2241115</pub-id></element-citation></ref><ref id="B32-brainsci-03-01483"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>King</surname><given-names>D.W.</given-names></name><name><surname>Marsan</surname><given-names>C.A.</given-names></name></person-group>
<article-title>Clinical features and ictal patterns in epileptic patients with EEG temporal lobe foci</article-title>
<source>Ann. Neurol.</source>
<year>1977</year>
<volume>2</volume>
<fpage>138</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410020209</pub-id></element-citation></ref><ref id="B33-brainsci-03-01483"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hausser-Hauw</surname><given-names>C.</given-names></name><name><surname>Bancaud</surname><given-names>J.</given-names></name></person-group>
<article-title>Gustatory hallucinations in epileptic seizures. Electrophysiological, clinical and anatomical correlates</article-title>
<source>Brain</source>
<year>1987</year>
<volume>110</volume>
<fpage>339</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1093/brain/110.2.339</pub-id>
<pub-id pub-id-type="pmid">3105808</pub-id></element-citation></ref><ref id="B34-brainsci-03-01483"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carter</surname><given-names>J.L.</given-names></name></person-group>
<article-title>Visual, somatosensory, olfactory and gustatory hallucinations</article-title>
<source>Psychiatr. Clin. N. Am.</source>
<year>1992</year>
<volume>15</volume>
<fpage>347</fpage>
<lpage>358</lpage>
</element-citation></ref><ref id="B35-brainsci-03-01483"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Lin</surname><given-names>C.S.</given-names></name></person-group>
<article-title>Taste and smell phantoms revealed by brain functional MRI (fMRI)</article-title>
<source>J. Comput. Assist. Tomogr.</source>
<year>2000</year>
<volume>24</volume>
<fpage>106</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="doi">10.1097/00004728-200001000-00022</pub-id>
<pub-id pub-id-type="pmid">10667670</pub-id></element-citation></ref><ref id="B36-brainsci-03-01483"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Brain gamma-aminobutyric acid levels are decreased in patients with phantageusia and phantosmia demonstrated by magnetic resonance spectroscopy</article-title>
<source>J. Comput. Assist. Tomogr.</source>
<year>2004</year>
<volume>28</volume>
<fpage>721</fpage>
<lpage>727</lpage>
<pub-id pub-id-type="doi">10.1097/00004728-200411000-00001</pub-id>
<pub-id pub-id-type="pmid">15538143</pub-id></element-citation></ref><ref id="B37-brainsci-03-01483"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J.H</given-names></name><name><surname>Beevor</surname><given-names>C.E.</given-names></name></person-group>
<article-title>Case of tumor of the right temporo-sphenoidal lobe, bearing on the localization of the sense of smell and on the interpretation of a particular variety of epilepsy</article-title>
<source>Brain</source>
<year>1890</year>
<volume>12</volume>
<fpage>346</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1093/brain/12.3.346</pub-id>
</element-citation></ref><ref id="B38-brainsci-03-01483"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J.H.</given-names></name><name><surname>Stewart</surname><given-names>P.</given-names></name></person-group>
<article-title>Epileptic attacks with a warning of a crude sensation of smell and the intellectual aura (Dreamy state) in a patient who had symptoms pointing to gross organic disease of the right temporo-sphenoidal lobe</article-title>
<source>Brain</source>
<year>1899</year>
<volume>22</volume>
<fpage>534</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="doi">10.1093/brain/22.4.534</pub-id>
</element-citation></ref><ref id="B39-brainsci-03-01483"><label>39.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Lectures on the Diagnosis of Epilepsy</article-title>
<source>On Epilepsy and Epileptiform Convulsions, Selected Writings of John Hughlings Jackson</source>
<person-group person-group-type="editor"><name><surname>Taylor</surname><given-names>J.</given-names></name></person-group>
<publisher-name>Hodder and Stoughton</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>1931&#x02013;1932</year>
<volume>Volume 1</volume>
<fpage>276</fpage>
<lpage>307</lpage>
</element-citation></ref><ref id="B40-brainsci-03-01483"><label>40.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gloor</surname><given-names>P.</given-names></name></person-group>
<article-title>Contributions of Electroencephalography and Electrocorticography to the Neurosurgical Treatment of the Epilepsies</article-title>
<source>Neurosurgical Management of the Epilepsies</source>
<person-group person-group-type="editor"><name><surname>Purpura</surname><given-names>D.P.</given-names></name><name><surname>Penry</surname><given-names>J.K.</given-names></name><name><surname>Walter</surname><given-names>R.D.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1975</year>
<volume>Volume 8</volume>
<fpage>59</fpage>
<lpage>105</lpage>
</element-citation></ref><ref id="B41-brainsci-03-01483"><label>41.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gloor</surname><given-names>P.</given-names></name></person-group>
<article-title>The EEG and Differential Diagnosis of Epilepsy</article-title>
<source>Current Concepts in Clinical Neurophysiology</source>
<person-group person-group-type="editor"><name><surname>van Duijn</surname><given-names>H.</given-names></name><name><surname>Donker</surname><given-names>D.N.</given-names></name><name><surname>van Huffelen</surname><given-names>A.C.</given-names></name></person-group>
<publisher-name>Trio</publisher-name>
<publisher-loc>The Hague, The Netherlands</publisher-loc>
<year>1977</year>
<fpage>9</fpage>
<lpage>21</lpage>
</element-citation></ref><ref id="B42-brainsci-03-01483"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Devinsky</surname><given-names>O.</given-names></name><name><surname>Kelley</surname><given-names>K.</given-names></name><name><surname>Porter</surname><given-names>R.J.</given-names></name><name><surname>Theodore</surname><given-names>W.H.</given-names></name></person-group>
<article-title>Clinical and electroencephalographic features of simple partial seizures</article-title>
<source>Neurology</source>
<year>1988</year>
<volume>38</volume>
<fpage>1347</fpage>
<lpage>1352</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.38.9.1347</pub-id><?supplied-pmid 3137487?><pub-id pub-id-type="pmid">3137487</pub-id></element-citation></ref><ref id="B43-brainsci-03-01483"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lieb</surname><given-names>J.P.</given-names></name><name><surname>Walsh</surname><given-names>G.O.</given-names></name><name><surname>Babb</surname><given-names>T.L.</given-names></name><name><surname>Walter</surname><given-names>R.D.</given-names></name><name><surname>Crandall</surname><given-names>P.H.</given-names></name></person-group>
<article-title>A comparison of EEG seizure patterns recorded with surface and depth electrodes in patients with temporal lobe epilepsy</article-title>
<source>Epilepsia</source>
<year>1976</year>
<volume>17</volume>
<fpage>137</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1976.tb03392.x</pub-id>
<pub-id pub-id-type="pmid">947745</pub-id></element-citation></ref><ref id="B44-brainsci-03-01483"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klass</surname><given-names>D.W.</given-names></name><name><surname>Espinosa</surname><given-names>R.E.</given-names></name><name><surname>Fischer-Williams</surname><given-names>M.</given-names></name></person-group>
<article-title>Analysis of concurrent electroencephalographic and clinical events occurring sequentially during partial seizures</article-title>
<source>Electroencephalogr. Clin. Neurophysiol.</source>
<year>1973</year>
<volume>34</volume>
<fpage>728</fpage>
</element-citation></ref><ref id="B45-brainsci-03-01483"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Theodore</surname><given-names>W.H.</given-names></name><name><surname>Porter</surname><given-names>R.J.</given-names></name><name><surname>Penry</surname><given-names>J.K.</given-names></name></person-group>
<article-title>Complex partial seizures: Clinical characteristics and differential diagnosis</article-title>
<source>Neurology</source>
<year>1983</year>
<volume>33</volume>
<fpage>1115</fpage>
<lpage>1121</lpage>
<?supplied-pmid 6684245?><pub-id pub-id-type="pmid">6684245</pub-id></element-citation></ref><ref id="B46-brainsci-03-01483"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Broglin</surname><given-names>D.</given-names></name><name><surname>Delgado-Escueta</surname><given-names>A.V.</given-names></name><name><surname>Walsh</surname><given-names>G.O.</given-names></name><name><surname>Bancaud</surname><given-names>J.</given-names></name><name><surname>Chauvel</surname><given-names>P.</given-names></name></person-group>
<article-title>Clinical approach to the patient with seizures and epilepsies of frontal origin</article-title>
<source>Adv. Neurol.</source>
<year>1992</year>
<volume>57</volume>
<fpage>59</fpage>
<lpage>88</lpage>
<?supplied-pmid 1543084?><pub-id pub-id-type="pmid">1543084</pub-id></element-citation></ref><ref id="B47-brainsci-03-01483"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fried</surname><given-names>I.</given-names></name><name><surname>Spencer</surname><given-names>D.D.</given-names></name><name><surname>Spenser</surname><given-names>S.S.</given-names></name></person-group>
<article-title>The anatomy of epileptic auras: Focal pathology and surgical outcome</article-title>
<source>J. Neurosurg.</source>
<year>1995</year>
<volume>83</volume>
<fpage>60</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.3171/jns.1995.83.1.0060</pub-id>
<pub-id pub-id-type="pmid">7782851</pub-id></element-citation></ref><ref id="B48-brainsci-03-01483"><label>48.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Rose</surname><given-names>F.C.</given-names></name></person-group>
<article-title>Migraine</article-title>
<source>Encyclopedia of Neuroscience</source>
<edition>2nd ed.</edition>
<person-group person-group-type="editor"><name><surname>Adelman</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>B.H.</given-names></name></person-group>
<publisher-name>Elsevier</publisher-name>
<publisher-loc>Amsterdam, The Netherlands</publisher-loc>
<year>1999</year>
<fpage>1181</fpage>
<lpage>1182</lpage>
</element-citation></ref><ref id="B49-brainsci-03-01483"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wolberg</surname><given-names>F.L.</given-names></name><name><surname>Ziegler</surname><given-names>D.K.</given-names></name></person-group>
<article-title>Olfactory hallucination in migraine</article-title>
<source>Arch. Neurol.</source>
<year>1982</year>
<volume>39</volume>
<fpage>382</fpage>
<pub-id pub-id-type="doi">10.1001/archneur.1982.00510180060017</pub-id>
<pub-id pub-id-type="pmid">7092619</pub-id></element-citation></ref><ref id="B50-brainsci-03-01483"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crosley</surname><given-names>C.J.</given-names></name><name><surname>Dhamoon</surname><given-names>S.</given-names></name></person-group>
<article-title>Migrainous olfactory aura in a family</article-title>
<source>Arch. Neurol.</source>
<year>1983</year>
<volume>40</volume>
<fpage>459</fpage>
<pub-id pub-id-type="doi">10.1001/archneur.1983.04050070089029</pub-id>
<pub-id pub-id-type="pmid">6860193</pub-id></element-citation></ref><ref id="B51-brainsci-03-01483"><label>51.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diamond</surname><given-names>S.</given-names></name><name><surname>Freitag</surname><given-names>F.G.</given-names></name><name><surname>Prager</surname><given-names>J.</given-names></name><name><surname>Gandi</surname><given-names>S.</given-names></name></person-group>
<article-title>Olfactory aura in migraine</article-title>
<source>N. Engl. J. Med.</source>
<year>1985</year>
<volume>312</volume>
<fpage>1390</fpage>
<lpage>1391</lpage>
<?supplied-pmid 3990743?><pub-id pub-id-type="pmid">3990743</pub-id></element-citation></ref><ref id="B52-brainsci-03-01483"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daniel</surname><given-names>C.</given-names></name><name><surname>Donnet</surname><given-names>A.</given-names></name></person-group>
<article-title>Migrainous complex hallucinations in a 17-year-old adolescent</article-title>
<source>Headache</source>
<year>2011</year>
<volume>51</volume>
<fpage>999</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="doi">10.1111/j.1526-4610.2010.01823.x</pub-id>
<pub-id pub-id-type="pmid">21631484</pub-id></element-citation></ref><ref id="B53-brainsci-03-01483"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coleman</surname><given-names>E.R.</given-names></name><name><surname>Grosberg</surname><given-names>B.M.</given-names></name><name><surname>Robbins</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Olfactory hallucinations in primary headache disorders: Case series and literature review</article-title>
<source>Cephalalgia</source>
<year>2011</year>
<volume>31</volume>
<fpage>1477</fpage>
<lpage>1489</lpage>
<pub-id pub-id-type="doi">10.1177/0333102411423315</pub-id>
<pub-id pub-id-type="pmid">21945891</pub-id></element-citation></ref><ref id="B54-brainsci-03-01483"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Demarquay</surname><given-names>G.</given-names></name><name><surname>Cr&#x000e9;ac&#x02019;h</surname><given-names>C.</given-names></name><name><surname>Peyron</surname><given-names>R.</given-names></name></person-group>
<article-title>Olfactory hallucinations in primary headache disorders: Case series and literature review. A comment</article-title>
<source>Cephalalgia</source>
<year>2012</year>
<volume>32</volume>
<fpage>583</fpage>
<lpage>584</lpage>
<pub-id pub-id-type="doi">10.1177/0333102411436125</pub-id>
<pub-id pub-id-type="pmid">22287566</pub-id></element-citation></ref><ref id="B55-brainsci-03-01483"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benemei</surname><given-names>S.</given-names></name><name><surname>Eleonora</surname><given-names>R.</given-names></name><name><surname>Geppetti</surname><given-names>P.</given-names></name></person-group>
<article-title>Trigeminal nerve and phantosmia in primary headaches</article-title>
<source>Cephalalgia</source>
<year>2012</year>
<volume>32</volume>
<fpage>85</fpage>
<pub-id pub-id-type="doi">10.1177/0333102411434169</pub-id>
<pub-id pub-id-type="pmid">22275405</pub-id></element-citation></ref><ref id="B56-brainsci-03-01483"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gardner</surname><given-names>K.</given-names></name></person-group>
<article-title>The genetic basis of migraine: How much do we know?</article-title>
<source>Can. J. Neurol. Sci.</source>
<year>1999</year>
<volume>26</volume>
<fpage>S37</fpage>
<lpage>S43</lpage>
<?supplied-pmid 10563232?><pub-id pub-id-type="pmid">10563232</pub-id></element-citation></ref><ref id="B57-brainsci-03-01483"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ducros</surname><given-names>A.</given-names></name></person-group>
<article-title>Genetics of migraine</article-title>
<source>Pathol. Biol. (Paris)</source>
<year>2000</year>
<volume>48</volume>
<fpage>658</fpage>
<lpage>662</lpage>
<comment>(in French)</comment>
<pub-id pub-id-type="pmid">11072644</pub-id></element-citation></ref><ref id="B58-brainsci-03-01483"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khalil</surname><given-names>N.M.</given-names></name><name><surname>Legg</surname><given-names>N.J.</given-names></name><name><surname>Anderson</surname><given-names>D.J.</given-names></name></person-group>
<article-title>Long term decline of P100 amplitude in migraine with aura</article-title>
<source>J. Neurol. Neurosurg. Psychiatry</source>
<year>2000</year>
<volume>69</volume>
<fpage>507</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.69.4.507</pub-id>
<pub-id pub-id-type="pmid">10990512</pub-id></element-citation></ref><ref id="B59-brainsci-03-01483"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baron</surname><given-names>J.C.</given-names></name></person-group>
<article-title>The pathophysiology of migraine: Insights from functional neuroimaging</article-title>
<source>Rev. Neurol. (Paris)</source>
<year>2000</year>
<volume>156</volume>
<issue>Suppl. 4</issue>
<fpage>S15</fpage>
<lpage>S23</lpage>
<comment>(in French)</comment>
</element-citation></ref><ref id="B60-brainsci-03-01483"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aurora</surname><given-names>S.K.</given-names></name><name><surname>Welch</surname><given-names>K.M.</given-names></name></person-group>
<article-title>Migraine: Imaging the aura</article-title>
<source>Curr. Opin. Neurol.</source>
<year>2000</year>
<volume>13</volume>
<fpage>273</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="doi">10.1097/00019052-200006000-00007</pub-id>
<pub-id pub-id-type="pmid">10871250</pub-id></element-citation></ref><ref id="B61-brainsci-03-01483"><label>61.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>James</surname><given-names>M.F.</given-names></name><name><surname>Smith</surname><given-names>J.M.</given-names></name><name><surname>Boniface</surname><given-names>S.J.</given-names></name><name><surname>Huang</surname><given-names>C.L.</given-names></name><name><surname>Leslie</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Cortical spreading depression and migraine: New insights from imaging?</article-title>
<source>Trends Neurosci.</source>
<year>2001</year>
<volume>24</volume>
<fpage>266</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1016/S0166-2236(00)01793-8</pub-id><?supplied-pmid 11311378?><pub-id pub-id-type="pmid">11311378</pub-id></element-citation></ref><ref id="B62-brainsci-03-01483"><label>62.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dreier</surname><given-names>J.P.</given-names></name><name><surname>Kleeberg</surname><given-names>J.</given-names></name><name><surname>Petzold</surname><given-names>G.</given-names></name><name><surname>Priller</surname><given-names>J.</given-names></name><name><surname>Windm&#x000fc;ller</surname><given-names>O.</given-names></name><name><surname>Orzechowski</surname><given-names>H.D.</given-names></name><name><surname> Lindauer</surname><given-names>U.</given-names></name><name><surname>Heinemann</surname><given-names>U.</given-names></name><name><surname>Einh&#x000e4;upl</surname><given-names>K.M.</given-names></name><name><surname>Dirnagl</surname><given-names>U.</given-names></name></person-group>
<article-title>Endothelin-1 potently induces Le&#x000e3;o&#x02019;s cortical spreading depression <italic>in vivo</italic> in the rat: A model for an endothelin trigger of migrainous aura?</article-title>
<source>Brain</source>
<year>2002</year>
<volume>125</volume>
<fpage>102</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awf007</pub-id><?supplied-pmid 11834596?><pub-id pub-id-type="pmid">11834596</pub-id></element-citation></ref><ref id="B63-brainsci-03-01483"><label>63.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vonderheid-Guth</surname><given-names>B.</given-names></name><name><surname>Todorova</surname><given-names>A.</given-names></name><name><surname>Wedekind</surname><given-names>W.</given-names></name><name><surname>Dimpfel</surname><given-names>W.</given-names></name></person-group>
<article-title>Evidence for neuronal dysfunction in migraine: Concurrence between specific EEG findings and clinical drug response-a retrospective analysis</article-title>
<source>Eur. J. Med. Res.</source>
<year>2000</year>
<volume>5</volume>
<fpage>473</fpage>
<lpage>483</lpage>
<?supplied-pmid 11121368?><pub-id pub-id-type="pmid">11121368</pub-id></element-citation></ref><ref id="B64-brainsci-03-01483"><label>64.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eggers</surname><given-names>A.E.</given-names></name></person-group>
<article-title>New neural theory of migraine</article-title>
<source>Med. Hypotheses</source>
<year>2001</year>
<volume>56</volume>
<fpage>360</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1054/mehy.2000.1214</pub-id>
<pub-id pub-id-type="pmid">11359360</pub-id></element-citation></ref><ref id="B65-brainsci-03-01483"><label>65.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gowers</surname><given-names>W.R.</given-names></name></person-group>
<source>A Manual of Diseases of the Nervous System</source>
<publisher-name>P. Blakiston</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>1892</year>
<volume>Volume 2</volume>
</element-citation></ref><ref id="B66-brainsci-03-01483"><label>66.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Migraine, aura and cortical spreading depression: Why are we still talking about it?</article-title>
<source>Ann. Neurol.</source>
<year>2001</year>
<volume>49</volume>
<fpage>4</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1002/1531-8249(200101)49:1&#x0003c;4::AID-ANA3&#x0003e;3.0.CO;2-W</pub-id>
<pub-id pub-id-type="pmid">11198295</pub-id></element-citation></ref><ref id="B67-brainsci-03-01483"><label>67.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olesen</surname><given-names>J.</given-names></name><name><surname>Larsen</surname><given-names>B.</given-names></name><name><surname>Lauritzen</surname><given-names>M.</given-names></name></person-group>
<article-title>Focal hyperemia followed by spreading oligema and impaired activation of rCBF in classic migraine</article-title>
<source>Ann. Neurol.</source>
<year>1981</year>
<volume>9</volume>
<fpage>344</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410090406</pub-id>
<pub-id pub-id-type="pmid">6784664</pub-id></element-citation></ref><ref id="B68-brainsci-03-01483"><label>68.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>P.J.</given-names></name><name><surname>Lipton</surname><given-names>R.B.</given-names></name><name><surname>Ferrari</surname><given-names>M.D.</given-names></name></person-group>
<article-title>Migraine-current understanding and treatment</article-title>
<source>N. Engl. J. Med.</source>
<year>2002</year>
<volume>346</volume>
<fpage>257</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra010917</pub-id>
<pub-id pub-id-type="pmid">11807151</pub-id></element-citation></ref><ref id="B69-brainsci-03-01483"><label>69.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woods</surname><given-names>R.P.</given-names></name><name><surname>Iacoboni</surname><given-names>M.</given-names></name><name><surname>Mazziota</surname><given-names>J.C.</given-names></name></person-group>
<article-title>Brief report: Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache</article-title>
<source>N. Engl. J. Med.</source>
<year>1994</year>
<volume>331</volume>
<fpage>1689</fpage>
<lpage>1692</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199412223312505</pub-id><?supplied-pmid 7969360?><pub-id pub-id-type="pmid">7969360</pub-id></element-citation></ref><ref id="B70-brainsci-03-01483"><label>70.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanchez del Rio</surname><given-names>M.</given-names></name><name><surname>Bakker</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>O.</given-names></name><name><surname>Agosti</surname><given-names>R.</given-names></name><name><surname>Mitsikostas</surname><given-names>D.D.</given-names></name><name><surname>Ostergaard</surname><given-names>L.</given-names></name><name><surname>Wells</surname><given-names>W.A.</given-names></name><name><surname>Rosen</surname><given-names>B.R.</given-names></name><name><surname>Sorensen</surname><given-names>G.</given-names></name><name><surname>Moskowitz</surname><given-names>M.A.</given-names></name><etal/></person-group>
<article-title>Perfusion weighted imaging during migraine: Spontaneous visual aura and headache</article-title>
<source>Cephalalgia</source>
<year>1999</year>
<volume>19</volume>
<fpage>701</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="doi">10.1046/j.1468-2982.1999.019008701.x</pub-id><?supplied-pmid 10570723?><pub-id pub-id-type="pmid">10570723</pub-id></element-citation></ref><ref id="B71-brainsci-03-01483"><label>71.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Le&#x000e3;o</surname><given-names>A.A.</given-names></name></person-group>
<article-title>Spreading depression of activity in the cerebral cortex</article-title>
<source>J. Neurophysiol.</source>
<year>1944</year>
<volume>7</volume>
<fpage>359</fpage>
<lpage>390</lpage>
</element-citation></ref><ref id="B72-brainsci-03-01483"><label>72.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Acharya</surname><given-names>V.</given-names></name><name><surname>Acharya</surname><given-names>J.</given-names></name><name><surname>L&#x000fc;ders</surname><given-names>H.</given-names></name></person-group>
<article-title>Olfactory epileptic auras</article-title>
<source>Neurology</source>
<year>1998</year>
<volume>51</volume>
<fpage>56</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.51.1.56</pub-id>
<pub-id pub-id-type="pmid">9674778</pub-id></element-citation></ref><ref id="B73-brainsci-03-01483"><label>73.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Halgren</surname><given-names>E.</given-names></name><name><surname>Walter</surname><given-names>R.D.</given-names></name><name><surname>Cherlow</surname><given-names>D.G.</given-names></name><name><surname>Crandall</surname><given-names>P.H.</given-names></name></person-group>
<article-title>Mental phenomena evoked by electrical stimulation of human hippocampal formation and amygdala</article-title>
<source>Brain</source>
<year>1978</year>
<volume>101</volume>
<fpage>93</fpage>
<lpage>117</lpage>
</element-citation></ref><ref id="B74-brainsci-03-01483"><label>74.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Herpin</surname><given-names>T.H.</given-names></name></person-group>
<source>Des Acc&#x000e8;s Incomplets d&#x02019;Epilepsie</source>
<publisher-name>Bailler</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1867</year>
</element-citation></ref><ref id="B75-brainsci-03-01483"><label>75.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Howe</surname><given-names>J.G.</given-names></name><name><surname>Gibson</surname><given-names>J.D.</given-names></name></person-group>
<article-title>Uncinate seizures and tumors, a myth reexamined</article-title>
<source>Ann. Neurol.</source>
<year>1982</year>
<volume>12</volume>
<fpage>227</fpage>
<pub-id pub-id-type="doi">10.1002/ana.410120238</pub-id>
<pub-id pub-id-type="pmid">7125609</pub-id></element-citation></ref><ref id="B76-brainsci-03-01483"><label>76.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kopala</surname><given-names>L.C.</given-names></name><name><surname>Good</surname><given-names>K.P.</given-names></name><name><surname>Honer</surname><given-names>W.G.</given-names></name></person-group>
<article-title>Olfactory hallucinations and olfactory identification ability in patients with schizophrenia and other psychiatric disorders</article-title>
<source>Schizophr. Res.</source>
<year>1994</year>
<volume>12</volume>
<fpage>205</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1016/0920-9964(94)90030-2</pub-id>
<pub-id pub-id-type="pmid">8054312</pub-id></element-citation></ref><ref id="B77-brainsci-03-01483"><label>77.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>R.J.</given-names></name><name><surname>Langdon</surname><given-names>R.</given-names></name><name><surname>McGuire</surname><given-names>J.</given-names></name></person-group>
<article-title>Olfactory hallucinations in schizophrenia and schizoaffective disorder: A phenomenological survey</article-title>
<source>Psychiatry Res.</source>
<year>2011</year>
<volume>185</volume>
<fpage>321</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2010.07.032</pub-id>
<pub-id pub-id-type="pmid">20727597</pub-id></element-citation></ref><ref id="B78-brainsci-03-01483"><label>78.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewandowski</surname><given-names>K.E.</given-names></name><name><surname>DePaola</surname><given-names>J.</given-names></name><name><surname>Camsari</surname><given-names>G.B.</given-names></name><name><surname>Cohen</surname><given-names>B.M.</given-names></name><name><surname>&#x000d6;ng&#x000fc;r</surname><given-names>D.</given-names></name></person-group>
<article-title>Tactile, olfactory, and gustatory hallucinations in psychotic disorders: A descriptive study</article-title>
<source>Ann. Acad. Med. Singapore</source>
<year>2009</year>
<volume>38</volume>
<fpage>383</fpage>
<lpage>385</lpage>
<?supplied-pmid 19521636?><pub-id pub-id-type="pmid">19521636</pub-id></element-citation></ref><ref id="B79-brainsci-03-01483"><label>79.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arguedas</surname><given-names>D.</given-names></name><name><surname>Langdon</surname><given-names>R.</given-names></name><name><surname>Stevenson</surname><given-names>R.</given-names></name></person-group>
<article-title>Neuropsychological characteristics associated with olfactory hallucinations in schizophrenia</article-title>
<source>J. Int. Neuropsychol. Soc.</source>
<year>2012</year>
<volume>18</volume>
<fpage>799</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="doi">10.1017/S1355617712000471</pub-id>
<pub-id pub-id-type="pmid">22613466</pub-id></element-citation></ref><ref id="B80-brainsci-03-01483"><label>80.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>St. John Bullen</surname><given-names>F.</given-names></name></person-group>
<article-title>Olfactory hallucinations in the insane</article-title>
<source>J. Ment. Sci.</source>
<year>1899</year>
<volume>45</volume>
<fpage>513</fpage>
<lpage>533</lpage>
</element-citation></ref><ref id="B81-brainsci-03-01483"><label>81.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Kraepelin</surname><given-names>E.</given-names></name></person-group>
<source>Dementia Praecox and Paraphrenia (1919)</source>
<publisher-name>Krieger Publishing</publisher-name>
<publisher-loc>Huntington, NY, USA</publisher-loc>
<comment>Reprinted 1971</comment>
</element-citation></ref><ref id="B82-brainsci-03-01483"><label>82.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bromberg</surname><given-names>W.</given-names></name><name><surname>Schilder</surname><given-names>P.</given-names></name></person-group>
<article-title>Olfactory imaginations and olfactory hallucinations</article-title>
<source>Arch. Neurol. Psychiatry</source>
<year>1934</year>
<volume>32</volume>
<fpage>467</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1001/archneurpsyc.1934.02250090002001</pub-id>
</element-citation></ref><ref id="B83-brainsci-03-01483"><label>83.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davidson</surname><given-names>G.M.</given-names></name></person-group>
<article-title>Concerning hallucinations of smell</article-title>
<source>Psychiatr. Q.</source>
<year>1938</year>
<volume>12</volume>
<fpage>253</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1007/BF01566189</pub-id>
</element-citation></ref><ref id="B84-brainsci-03-01483"><label>84.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mueser</surname><given-names>K.T.</given-names></name><name><surname>Bellack</surname><given-names>A.S.</given-names></name><name><surname>Brady</surname><given-names>E.U.</given-names></name></person-group>
<article-title>Hallucinations in schizophrenia</article-title>
<source>Acta Psychiatr. Scand.</source>
<year>1990</year>
<volume>82</volume>
<fpage>26</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0447.1990.tb01350.x</pub-id>
<pub-id pub-id-type="pmid">2399817</pub-id></element-citation></ref><ref id="B85-brainsci-03-01483"><label>85.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Assad</surname><given-names>G.</given-names></name></person-group>
<source>Hallucinations in Clinical Psychiatry: A Guide for Mental Health Professionals</source>
<publisher-name>Brunner/Mazel</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1990</year>
<fpage>70</fpage>
<lpage>85</lpage>
</element-citation></ref><ref id="B86-brainsci-03-01483"><label>86.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Croy</surname><given-names>I.</given-names></name><name><surname>Yarina</surname><given-names>S.</given-names></name><name><surname>Hummel</surname><given-names>T.</given-names></name></person-group>
<article-title>Research Letter: Enhanced parosmia and phantosmia in patients with severe depression</article-title>
<source>Psychol. Med.</source>
<year>2013</year>
<volume>24</volume>
<fpage>1</fpage>
<lpage>5</lpage>
</element-citation></ref><ref id="B87-brainsci-03-01483"><label>87.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pryse-Phillips</surname><given-names>W.</given-names></name></person-group>
<article-title>An olfactory reference syndrome</article-title>
<source>Acta Psychiatr. Scand.</source>
<year>1971</year>
<volume>47</volume>
<fpage>484</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0447.1971.tb03705.x</pub-id>
<pub-id pub-id-type="pmid">5146719</pub-id></element-citation></ref><ref id="B88-brainsci-03-01483"><label>88.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Munro</surname><given-names>A.</given-names></name><name><surname>Chmara</surname><given-names>J.</given-names></name></person-group>
<article-title>Monosymptomatic hypochondriacal psychosis: A diagnostic checklist based on 50 cases of the disorder</article-title>
<source>Can. J. Psychiatry</source>
<year>1982</year>
<volume>27</volume>
<fpage>374</fpage>
<lpage>376</lpage>
<?supplied-pmid 7116276?><pub-id pub-id-type="pmid">7116276</pub-id></element-citation></ref><ref id="B89-brainsci-03-01483"><label>89.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bishop</surname><given-names>E.R.</given-names><suffix>Jr.</suffix></name></person-group>
<article-title>An olfactory reference syndrome-monosymptomatic hypochondriasis</article-title>
<source>J. Clin. Psychiatry</source>
<year>1980</year>
<volume>41</volume>
<fpage>57</fpage>
<lpage>59</lpage>
<?supplied-pmid 7440526?><pub-id pub-id-type="pmid">7354010</pub-id></element-citation></ref><ref id="B90-brainsci-03-01483"><label>90.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Begum</surname><given-names>M.</given-names></name><name><surname>McKenna</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Olfactory reference syndrome: A systematic review of the world literature</article-title>
<source>Psychol. Med.</source>
<year>2011</year>
<volume>41</volume>
<fpage>453</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291710001091</pub-id>
<pub-id pub-id-type="pmid">20529415</pub-id></element-citation></ref><ref id="B91-brainsci-03-01483"><label>91.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muffatti</surname><given-names>R.</given-names></name><name><surname>Scarone</surname><given-names>S.</given-names></name><name><surname>Gambini</surname><given-names>O.</given-names></name></person-group>
<article-title>An olfactory reference syndrome successfully treated by aripiprazole augmentation of antidepressant therapy</article-title>
<source>Cogn. Behav. Neurol.</source>
<year>2008</year>
<volume>21</volume>
<fpage>258</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1097/WNN.0b013e318185e6bd</pub-id>
<pub-id pub-id-type="pmid">19057178</pub-id></element-citation></ref><ref id="B92-brainsci-03-01483"><label>92.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Furstenburg</surname><given-names>A.C.</given-names></name><name><surname>Crosby</surname><given-names>E.</given-names></name><name><surname>Farrior</surname><given-names>B.</given-names></name></person-group>
<article-title>Neurologic lesions which influence the sense of smell</article-title>
<source>Arch. Otolaryngol.</source>
<year>1943</year>
<volume>48</volume>
<fpage>529</fpage>
<lpage>530</lpage>
</element-citation></ref><ref id="B93-brainsci-03-01483"><label>93.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allen</surname><given-names>I.M.</given-names></name></person-group>
<article-title>Spontaneous olfactory and gustatory phenomena with and without organic lesions of the brain</article-title>
<source>N. Z. Med. J.</source>
<year>1944</year>
<volume>43</volume>
<fpage>165</fpage>
<lpage>168</lpage>
</element-citation></ref><ref id="B94-brainsci-03-01483"><label>94.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mulder</surname><given-names>D.W.</given-names></name><name><surname>Daly</surname><given-names>D.</given-names></name></person-group>
<article-title>Psychiatric symptoms associated with lesions of temporal lobe</article-title>
<source>J. Am. Med. Assoc.</source>
<year>1952</year>
<volume>150</volume>
<fpage>173</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1001/jama.1952.03680030005003</pub-id>
<pub-id pub-id-type="pmid">14955412</pub-id></element-citation></ref><ref id="B95-brainsci-03-01483"><label>95.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hollander</surname><given-names>E.</given-names></name><name><surname>Neville</surname><given-names>D.</given-names></name><name><surname>Frenkel</surname><given-names>M.</given-names></name><name><surname>Josephson</surname><given-names>S.</given-names></name><name><surname>Liebowitz</surname><given-names>M.R.</given-names></name></person-group>
<article-title>Body dysmorphic disorder. Diagnostic issues and related disorders</article-title>
<source>Psychosomatics</source>
<year>1992</year>
<volume>33</volume>
<fpage>156</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1016/S0033-3182(92)71991-4</pub-id><?supplied-pmid 1557480?><pub-id pub-id-type="pmid">1557480</pub-id></element-citation></ref><ref id="B96-brainsci-03-01483"><label>96.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harriman</surname><given-names>P.L.</given-names></name></person-group>
<article-title>A case of olfactory hallucinations in a hypochrondriacal prisoner</article-title>
<source>J. Abnorm. Soc. Psychol.</source>
<year>1934</year>
<volume>29</volume>
<fpage>457</fpage>
<lpage>458</lpage>
</element-citation></ref><ref id="B97-brainsci-03-01483"><label>97.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mizuo</surname><given-names>T.</given-names></name><name><surname>Ando</surname><given-names>M.</given-names></name></person-group>
<article-title>A case of olfactory hallucinations with adult enuresis</article-title>
<source>Hinyokika Kiyo</source>
<year>1988</year>
<volume>34</volume>
<fpage>178</fpage>
<lpage>180</lpage>
<comment>(in Japanese)</comment>
<?supplied-pmid 3376799?><pub-id pub-id-type="pmid">3376799</pub-id></element-citation></ref><ref id="B98-brainsci-03-01483"><label>98.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kellner</surname><given-names>C.H.</given-names></name><name><surname>Bachman</surname><given-names>D.L.</given-names></name></person-group>
<article-title>Olfactory hallucination after intravenous caffeine</article-title>
<source>Am. J. Psychiatry</source>
<year>1992</year>
<volume>149</volume>
<fpage>422</fpage>
<?supplied-pmid 1536300?><pub-id pub-id-type="pmid">1536300</pub-id></element-citation></ref><ref id="B99-brainsci-03-01483"><label>99.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koinigsburg</surname><given-names>H.W.</given-names></name><name><surname>Pollak</surname><given-names>C.P.</given-names></name><name><surname>Fine</surname><given-names>J.</given-names></name></person-group>
<article-title>Olfactory hallucinations after the infusion of caffeine during sleep</article-title>
<source>Am. J. Psychiatry</source>
<year>1993</year>
<volume>150</volume>
<fpage>1897</fpage>
<lpage>1898</lpage>
<?supplied-pmid 8238651?><pub-id pub-id-type="pmid">8238651</pub-id></element-citation></ref><ref id="B100-brainsci-03-01483"><label>100.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kroemer</surname><given-names>S.</given-names></name><name><surname>Kawohl</surname><given-names>W.</given-names></name></person-group>
<article-title>Gustatory and olfactory hallucinations under therapeutic dosing of bupropion</article-title>
<source>J. Neuropsychiatry Clin. Neurosci.</source>
<year>2011</year>
<volume>23</volume>
<fpage>E53</fpage>
<pub-id pub-id-type="doi">10.1176/appi.neuropsych.23.2.E53</pub-id>
<pub-id pub-id-type="pmid">21677231</pub-id></element-citation></ref><ref id="B101-brainsci-03-01483"><label>101.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schechter</surname><given-names>P.J.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Abnormalities of taste and smell after head trauma</article-title>
<source>J. Neurol. Neurosurg. Psychiatry</source>
<year>1974</year>
<volume>37</volume>
<fpage>802</fpage>
<lpage>810</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.37.7.802</pub-id>
<pub-id pub-id-type="pmid">4850368</pub-id></element-citation></ref><ref id="B102-brainsci-03-01483"><label>102.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Evaluation and Treatment of Human Olfactory Dysfunction</article-title>
<source>Otolaryngology</source>
<person-group person-group-type="editor"><name><surname>English</surname><given-names>G.M.</given-names></name></person-group>
<publisher-name>Lippincott</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>1993</year>
<volume>Volume 2</volume>
<fpage>1</fpage>
<lpage>86</lpage>
</element-citation></ref><ref id="B103-brainsci-03-01483"><label>103.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Drug induced taste and smell disorders: Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction</article-title>
<source>Drug Saf.</source>
<year>1994</year>
<volume>11</volume>
<fpage>318</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.2165/00002018-199411050-00004</pub-id>
<pub-id pub-id-type="pmid">7873092</pub-id></element-citation></ref><ref id="B104-brainsci-03-01483"><label>104.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Physiologically initiated and inhibited phantosmia: Cyclic unirhinal, episodic, recurrent phantosmia revealed by brain fMRI</article-title>
<source>J. Comput. Assist. Tomogr.</source>
<year>2000</year>
<volume>24</volume>
<fpage>501</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1097/00004728-200007000-00001</pub-id>
<pub-id pub-id-type="pmid">10966179</pub-id></element-citation></ref><ref id="B105-brainsci-03-01483"><label>105.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Fordyce</surname><given-names>A.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Fordyce</surname><given-names>A.</given-names></name></person-group>
<article-title>Taste and smell function in chronic disease: A review of clinical and biochemical evaluation of taste and smell dysfunction in over 5000 patients at The Taste and Smell Clinic in Washington, DC</article-title>
<source>Am. J. Otolaryngol.</source>
<year>2013</year>
<volume>34</volume>
<fpage>477</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjoto.2013.04.006</pub-id>
<pub-id pub-id-type="pmid">23731850</pub-id></element-citation></ref><ref id="B106-brainsci-03-01483"><label>106.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>S.H.</given-names></name><name><surname>Chu</surname><given-names>S.T.</given-names></name><name><surname>Yuan</surname><given-names>B.C.</given-names></name><name><surname>Shu</surname><given-names>C.H.</given-names></name></person-group>
<article-title>Survey of the frequency of olfactory dysfunction in Taiwan</article-title>
<source>J. Chin. Med. Assoc.</source>
<year>2009</year>
<volume>72</volume>
<fpage>68</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/S1726-4901(09)70025-5</pub-id>
<pub-id pub-id-type="pmid">19251533</pub-id></element-citation></ref><ref id="B107-brainsci-03-01483"><label>107.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hong</surname><given-names>S.C.</given-names></name><name><surname>Holbrook</surname><given-names>E.H.</given-names></name><name><surname>Leopold</surname><given-names>D.A.</given-names></name><name><surname>Hummel</surname><given-names>T.</given-names></name></person-group>
<article-title>Distorted olfactory perception: A systematic review</article-title>
<source>Acta Otolaryngol.</source>
<year>2012</year>
<volume>132</volume>
<fpage>S27</fpage>
<lpage>S31</lpage>
<pub-id pub-id-type="doi">10.3109/00016489.2012.659759</pub-id>
<pub-id pub-id-type="pmid">22582778</pub-id></element-citation></ref><ref id="B108-brainsci-03-01483"><label>108.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Shih</surname><given-names>Y.H.</given-names></name><name><surname>Yen</surname><given-names>D.J.</given-names></name><name><surname>Lirng</surname><given-names>J.F.</given-names></name><name><surname>Guo</surname><given-names>Y.C.</given-names></name><name><surname>Yu</surname><given-names>H.Y.</given-names></name><name><surname>Yiu</surname><given-names>C.H.</given-names></name></person-group>
<article-title>Olfactory auras in patients with temporal lobe epilepsy</article-title>
<source>Epilepsia</source>
<year>2003</year>
<volume>44</volume>
<fpage>257</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1046/j.1528-1157.2003.25902.x</pub-id>
<pub-id pub-id-type="pmid">12558584</pub-id></element-citation></ref><ref id="B109-brainsci-03-01483"><label>109.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mizobuchi</surname><given-names>M.</given-names></name><name><surname>Ito</surname><given-names>N.</given-names></name><name><surname>Tanaka</surname><given-names>C.</given-names></name><name><surname>Sako</surname><given-names>K.</given-names></name><name><surname>Sumi</surname><given-names>Y.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name></person-group>
<article-title>Unidirectional olfactory hallucination associated with ipsilateral unruptured intracranial aneurysm</article-title>
<source>Epilepsia</source>
<year>1999</year>
<volume>40</volume>
<fpage>516</fpage>
<lpage>519</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1999.tb00751.x</pub-id>
<pub-id pub-id-type="pmid">10219282</pub-id></element-citation></ref><ref id="B110-brainsci-03-01483"><label>110.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>ye</surname><given-names>E.</given-names></name><name><surname>Arendts</surname><given-names>G.</given-names></name></person-group>
<article-title>Intracerebral haemorrhage presenting as olfactory hallucinations</article-title>
<source>Emerg. Med. (Fremantle)</source>
<year>2002</year>
<volume>14</volume>
<fpage>447</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1046/j.1442-2026.2002.00385.x</pub-id><pub-id pub-id-type="pmid">12534490</pub-id></element-citation></ref><ref id="B111-brainsci-03-01483"><label>111.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Capampangan</surname><given-names>D.J.</given-names></name><name><surname>Hoerth</surname><given-names>M.T.</given-names></name><name><surname>Drazkowski</surname><given-names>J.F.</given-names></name><name><surname>Lipinski</surname><given-names>C.A.</given-names></name></person-group>
<article-title>Olfactory and gustatory hallucinations presenting as partial status epilepticus because of glioblastoma multiforme</article-title>
<source>Ann. Emerg. Med.</source>
<year>2010</year>
<volume>56</volume>
<fpage>374</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1016/j.annemergmed.2010.02.020</pub-id>
<pub-id pub-id-type="pmid">20303620</pub-id></element-citation></ref><ref id="B112-brainsci-03-01483"><label>112.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kumar</surname><given-names>G.</given-names></name><name><surname>Juh&#x000e1;sz</surname><given-names>C.</given-names></name><name><surname>Sood</surname><given-names>S.</given-names></name><name><surname>Asano</surname><given-names>E.</given-names></name></person-group>
<article-title>Olfactory hallucinations elicited by electrical stimulation via subdural electrodes: Effects of direct stimulation of olfactory bulb and tract</article-title>
<source>Epilepsy Behav.</source>
<year>2012</year>
<volume>24</volume>
<fpage>264</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1016/j.yebeh.2012.03.027</pub-id>
<pub-id pub-id-type="pmid">22554977</pub-id></element-citation></ref><ref id="B113-brainsci-03-01483"><label>113.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>DiFabio</surname><given-names>R.</given-names></name><name><surname>Casali</surname><given-names>C.</given-names></name><name><surname>Giugni</surname><given-names>E.</given-names></name><name><surname>Pierelli</surname><given-names>F.</given-names></name></person-group>
<article-title>Olfactory hallucinations as a manifestation of hidden rhinosinusitis</article-title>
<source>J. Clin. Neurosci.</source>
<year>2009</year>
<volume>16</volume>
<fpage>1353</fpage>
<lpage>1355</lpage>
<pub-id pub-id-type="doi">10.1016/j.jocn.2008.12.030</pub-id>
<pub-id pub-id-type="pmid">19564113</pub-id></element-citation></ref><ref id="B114-brainsci-03-01483"><label>114.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landis</surname><given-names>BN.</given-names></name><name><surname>Burkhard</surname><given-names>P.R.</given-names></name></person-group>
<article-title>Phantosmias and Parkinson disease</article-title>
<source>Arch. Neurol.</source>
<year>2008</year>
<volume>65</volume>
<fpage>1237</fpage>
<lpage>1239</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.65.9.1237</pub-id>
<pub-id pub-id-type="pmid">18779429</pub-id></element-citation></ref><ref id="B115-brainsci-03-01483"><label>115.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bannier</surname><given-names>S.</given-names></name><name><surname>Berdagu&#x000e9;</surname><given-names>J.L.</given-names></name><name><surname>Rieu</surname><given-names>I.</given-names></name><name><surname>de Chazeron</surname><given-names>I.</given-names></name><name><surname>Marques</surname><given-names>A.</given-names></name><name><surname>Derost</surname><given-names>P.</given-names></name><name><surname>Ulla</surname><given-names>M.</given-names></name><name><surname>Llorca</surname><given-names>P.M.</given-names></name><name><surname>Durif</surname><given-names>F.</given-names></name></person-group>
<article-title>Prevalence and phenomenology of olfactory hallucinations in Parkinson&#x02019;s disease</article-title>
<source>J. Neurol. Neurosurg. Psychiatry</source>
<year>2012</year>
<volume>83</volume>
<fpage>1019</fpage>
<lpage>1021</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp-2012-302414</pub-id>
<pub-id pub-id-type="pmid">22752694</pub-id></element-citation></ref><ref id="B116-brainsci-03-01483"><label>116.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tousi</surname><given-names>B.</given-names></name><name><surname>Frankel</surname><given-names>M.</given-names></name></person-group>
<article-title>Olfactory and visual hallucinations in Parksinson&#x02019;s disease</article-title>
<source>Parkinsonism Relat. Disord.</source>
<year>2004</year>
<volume>10</volume>
<fpage>253</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/j.parkreldis.2004.01.003</pub-id>
<pub-id pub-id-type="pmid">15120101</pub-id></element-citation></ref><ref id="B117-brainsci-03-01483"><label>117.</label><element-citation publication-type="patent">
<person-group person-group-type="author"><name><surname>Brundin</surname><given-names>P.</given-names></name><name><surname>Petit</surname><given-names>G.</given-names></name></person-group>
<article-title>Use of Rasagiline for the Treatment of Olfactory Dysfunction</article-title>
<source>U.S. Patent</source>
<patent>Application PCT/US2011/045574</patent>
<day>27</day>
<month>7</month>
<year>2011</year>
</element-citation></ref><ref id="B118-brainsci-03-01483"><label>118.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.C.</given-names></name><name><surname>Khakoo</surname><given-names>Y.</given-names></name><name><surname>Lightner</surname><given-names>D.D.</given-names></name><name><surname>Wolden</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Phantosmia during radiation therapy: A report of 2 cases</article-title>
<source>J. Child Neurol.</source>
<year>2013</year>
<volume>28</volume>
<fpage>791</fpage>
<lpage>794</lpage>
<pub-id pub-id-type="doi">10.1177/0883073812450616</pub-id>
<pub-id pub-id-type="pmid">22805250</pub-id></element-citation></ref><ref id="B119-brainsci-03-01483"><label>119.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leopold</surname><given-names>D.A.</given-names></name><name><surname>Loehrl</surname><given-names>T.A.</given-names></name><name><surname>Schwob</surname><given-names>J.E.</given-names></name></person-group>
<article-title>Long-term follow-up of surgically treated phantosmia</article-title>
<source>Arch. Otolaryngol. Head Neck Surg.</source>
<year>2002</year>
<volume>128</volume>
<fpage>642</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="doi">10.1001/archotol.128.6.642</pub-id>
<pub-id pub-id-type="pmid">12049557</pub-id></element-citation></ref><ref id="B120-brainsci-03-01483"><label>120.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Markert</surname><given-names>J.M.</given-names></name><name><surname>Hartshorn</surname><given-names>D.O.</given-names></name><name><surname>Farhat</surname><given-names>S.M.</given-names></name></person-group>
<article-title>Paroxysmal bilateral dysosmia treated by resection of the olfactory bulbs</article-title>
<source>Surg. Neurol.</source>
<year>1993</year>
<volume>40</volume>
<fpage>160</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1016/0090-3019(93)90129-O</pub-id>
<pub-id pub-id-type="pmid">8362355</pub-id></element-citation></ref><ref id="B121-brainsci-03-01483"><label>121.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landis</surname><given-names>B.N.</given-names></name><name><surname>Croy</surname><given-names>I.</given-names></name><name><surname>Haehner</surname><given-names>A.</given-names></name></person-group>
<article-title>Long lasting phantosmia treated with venlafaxine</article-title>
<source>Neurocase</source>
<year>2012</year>
<volume>18</volume>
<fpage>112</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1080/13554794.2011.568497</pub-id>
<pub-id pub-id-type="pmid">21942993</pub-id></element-citation></ref><ref id="B122-brainsci-03-01483"><label>122.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>J.</given-names></name><name><surname>Bourgeois</surname><given-names>J.A.</given-names></name><name><surname>Quanbeck</surname><given-names>C.</given-names></name></person-group>
<article-title>Treatment of olfactory hallucinations with topiramate</article-title>
<source>J. Clin. Psychopharmacol.</source>
<year>2006</year>
<volume>26</volume>
<fpage>340</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1097/01.jcp.0000218406.10362.27</pub-id>
<pub-id pub-id-type="pmid">16702906</pub-id></element-citation></ref><ref id="B123-brainsci-03-01483"><label>123.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landis</surname><given-names>B.N.</given-names></name><name><surname>Reden</surname><given-names>J.</given-names></name><name><surname>Haehner</surname><given-names>A.</given-names></name></person-group>
<article-title>Idiopathic phantosmia: Outcome and clinical significance</article-title>
<source>ORL J. Otorhinolaryngol. Relat. Spec.</source>
<year>2010</year>
<volume>72</volume>
<fpage>252</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1159/000317024</pub-id>
<pub-id pub-id-type="pmid">20714205</pub-id></element-citation></ref><ref id="B124-brainsci-03-01483"><label>124.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>R.J.</given-names></name><name><surname>Bouska</surname><given-names>J.F.</given-names></name><name><surname>Frow</surname><given-names>A.</given-names></name><name><surname>Kirkby</surname><given-names>A.</given-names></name><name><surname>Baker</surname><given-names>G.A.</given-names></name><name><surname>Kemp</surname><given-names>S.</given-names></name><name><surname>Burness</surname><given-names>C.</given-names></name><name><surname>Reuber</surname><given-names>M.</given-names></name></person-group>
<article-title>Emotional dysregulation, alexithymia, and attachment in psychogenic nonepileptic seizures</article-title>
<source>Epilepsy Behav.</source>
<year>2013</year>
<volume>29</volume>
<fpage>178</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1016/j.yebeh.2013.07.019</pub-id>
<pub-id pub-id-type="pmid">23973643</pub-id></element-citation></ref><ref id="B125-brainsci-03-01483"><label>125.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xue</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Z.Y.</given-names></name><name><surname>Xiong</surname><given-names>X.C.</given-names></name><name><surname>Tian</surname><given-names>C.Y.</given-names></name><name><surname>Wang</surname><given-names>Y.P.</given-names></name><name><surname>Xu</surname><given-names>P.</given-names></name></person-group>
<article-title>Altered brain connectivity in patients with psychogenic non-epileptic seizures: A scalp electroencephalography study</article-title>
<source>J. Int. Med. Res.</source>
<year>2013</year>
<volume>41</volume>
<fpage>1682</fpage>
<lpage>1690</lpage>
<pub-id pub-id-type="doi">10.1177/0300060513496170</pub-id>
<pub-id pub-id-type="pmid">24026773</pub-id></element-citation></ref><ref id="B126-brainsci-03-01483"><label>126.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Report on a survey on smell in the US</article-title>
<source>Olfactory Rev.</source>
<year>1987</year>
<volume>1</volume>
<fpage>1</fpage>
<lpage>8</lpage>
</element-citation></ref><ref id="B127-brainsci-03-01483"><label>127.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ikui</surname><given-names>A.</given-names></name><name><surname>Ikeda</surname><given-names>M.</given-names></name><name><surname>Tahara</surname><given-names>I.</given-names></name><name><surname>Ito</surname><given-names>I.</given-names></name><name><surname>Endo</surname><given-names>S.</given-names></name></person-group>
<article-title>Clinical Aspects of Phantogeusia</article-title>
<source>Olfaction and Taste XI</source>
<person-group person-group-type="editor"><name><surname>Kurihara</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Ogawa</surname><given-names>H.</given-names></name></person-group>
<publisher-name>Springer-Verlag</publisher-name>
<publisher-loc>Tokyo, Japan</publisher-loc>
<year>1994</year>
<fpage>580</fpage>
</element-citation></ref><ref id="B128-brainsci-03-01483"><label>128.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Disorders of taste and smell</article-title>
<source>JAMA</source>
<year>1971</year>
<volume>218</volume>
<fpage>1946</fpage>
<pub-id pub-id-type="doi">10.1001/jama.1971.03190260060028</pub-id>
<pub-id pub-id-type="pmid">5171076</pub-id></element-citation></ref><ref id="B129-brainsci-03-01483"><label>129.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anderson</surname><given-names>J. </given-names></name></person-group>
<article-title>On sensory epilepsy. A case of basal cerebral tumour affecting the left tempero-sphenoidal lobe, and giving rise to a paroxysmal taste-sensation and dreamy state</article-title>
<source>Brain</source>
<year>1886</year>
<volume>9</volume>
<fpage>385</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="doi">10.1093/brain/9.3.385</pub-id></element-citation></ref><ref id="B130-brainsci-03-01483"><label>130.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Concepts of Therapy in Taste and Smell Dysfunction: Repair of Sensory Receptor Function as Primary Treatment</article-title>
<source>Olfaction and Taste XI</source>
<person-group person-group-type="editor"><name><surname>Kurihara</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Ogawa</surname><given-names>H.</given-names></name></person-group>
<publisher-name>Springer-Verlag</publisher-name>
<publisher-loc>Tokyo, Japan</publisher-loc>
<year>1994</year>
<fpage>568</fpage>
<lpage>573</lpage>
</element-citation></ref><ref id="B131-brainsci-03-01483"><label>131.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beeman</surname><given-names>C.E.</given-names></name></person-group>
<article-title>A case of epilepsy with olfactory aura from a tumour in the tempero-sphenoidal lobe</article-title>
<source>Br. Med. J.</source>
<year>1889</year>
<volume>1</volume>
<fpage>414</fpage>
<lpage>416</lpage>
</element-citation></ref><ref id="B132-brainsci-03-01483"><label>132.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Clarke</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Epileptic attacks preceded by subjective auditory and taste sensations, probably due to tumour of the left tempero-sphenoidal lobe</article-title>
<source>Lancet</source>
<year>1900</year>
<volume>1</volume>
<fpage>1119</fpage>
<lpage>1120</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(01)96642-5</pub-id>
</element-citation></ref><ref id="B133-brainsci-03-01483"><label>133.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friedman</surname><given-names>H.</given-names></name></person-group>
<article-title>Taste hallucinations in cerebral tumor</article-title>
<source>Wien Klin Rundsch.</source>
<year>1909</year>
<volume>47</volume>
<fpage>787</fpage>
<lpage>790</lpage>
</element-citation></ref><ref id="B134-brainsci-03-01483"><label>134.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fer&#x000e9;</surname><given-names>C.</given-names></name></person-group>
<article-title>Note sur les sensations subjectives de l&#x02019;odorat chez un &#x000e9;pileptique</article-title>
<source>Compt. Rendus Soc. Biol.</source>
<year>1896</year>
<volume>48</volume>
<fpage>1036</fpage>
<lpage>1038</lpage>
</element-citation></ref><ref id="B135-brainsci-03-01483"><label>135.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Phantageusia</article-title>
<source>Difficult Diagnosis II</source>
<person-group person-group-type="editor"><name><surname>Taylor</surname><given-names>R.B.</given-names></name></person-group>
<publisher-name>W.B. Saunders</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>1992</year>
<fpage>348</fpage>
<lpage>356</lpage>
</element-citation></ref><ref id="B136-brainsci-03-01483"><label>136.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toulouse</surname><given-names>E.</given-names></name><name><surname>Vaschide</surname><given-names>N.</given-names></name></person-group>
<article-title>Influence des crises &#x000e9;pileptiques sur l&#x02019;olfaction</article-title>
<source>Compt. Rendus Soc.Biol.</source>
<year>1899</year>
<volume>51</volume>
<fpage>742</fpage>
<lpage>744</lpage>
</element-citation></ref><ref id="B137-brainsci-03-01483"><label>137.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gastaut</surname><given-names>H.</given-names></name><name><surname>Roger</surname><given-names>J.</given-names></name><name><surname>Giove</surname><given-names>C.</given-names></name></person-group>
<article-title>Troubles de l&#x02019;olfaction, de la gustation et de l&#x02019;appetit chez les &#x000e9;pileptiques psychomoteurs</article-title>
<source>Ann. Med. Psychol.</source>
<year>1955</year>
<volume>46</volume>
<fpage>177</fpage>
<lpage>182</lpage>
</element-citation></ref><ref id="B138-brainsci-03-01483"><label>138.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartlet</surname><given-names>J.E.</given-names></name></person-group>
<article-title>A case of organized visual hallucinations in an old man with cataract and their relation to the phenomena of the phantom limb</article-title>
<source>Brain</source>
<year>1951</year>
<volume>74</volume>
<fpage>363</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1093/brain/74.3.363</pub-id>
<pub-id pub-id-type="pmid">14869541</pub-id></element-citation></ref><ref id="B139-brainsci-03-01483"><label>139.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Podoll</surname><given-names>K.</given-names></name><name><surname>Osterheider</surname><given-names>M.</given-names></name><name><surname>Noth</surname><given-names>J.</given-names></name></person-group>
<article-title>The Charles Bonnet syndrome</article-title>
<source>Fortschr. Neurol. Psychiatr.</source>
<year>1989</year>
<volume>57</volume>
<fpage>43</fpage>
<lpage>60</lpage>
<comment>(in German)</comment>
<pub-id pub-id-type="doi">10.1055/s-2007-1000744</pub-id><?supplied-pmid 2651256?><pub-id pub-id-type="pmid">2651256</pub-id></element-citation></ref><ref id="B140-brainsci-03-01483"><label>140.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pliskin</surname><given-names>N.H.</given-names></name><name><surname>Kiolbasa</surname><given-names>T.A.</given-names></name><name><surname>Towle</surname><given-names>V.L.</given-names></name><name><surname>Pankow</surname><given-names>L.</given-names></name><name><surname>Ernest</surname><given-names>J.</given-names></name><name><surname>Noronha</surname><given-names>A</given-names></name><name><surname>Luchins</surname><given-names>D.J.</given-names></name></person-group>
<article-title>Charles Bonnet syndrome: An early marker for dementia?</article-title>
<source>J. Am. Geriatr. Soc.</source>
<year>1996</year>
<volume>44</volume>
<fpage>1055</fpage>
<lpage>1061</lpage>
<?supplied-pmid 8790230?><pub-id pub-id-type="pmid">8790230</pub-id></element-citation></ref><ref id="B141-brainsci-03-01483"><label>141.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teunisse</surname><given-names>R.J.</given-names></name><name><surname>Cruysberg</surname><given-names>J.R.</given-names></name><name><surname>Verbeek</surname><given-names>A.</given-names></name><name><surname>Zitman</surname><given-names>F.G.</given-names></name></person-group>
<article-title>The Charles Bonnet syndrome: A large prospective study in the Netherlands</article-title>
<source>Br. J. Psychiatry</source>
<year>1995</year>
<volume>166</volume>
<fpage>254</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.166.2.254</pub-id>
<pub-id pub-id-type="pmid">7728372</pub-id></element-citation></ref><ref id="B142-brainsci-03-01483"><label>142.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teunisse</surname><given-names>R.J.</given-names></name><name><surname>Cruysberg</surname><given-names>J.R.</given-names></name><name><surname>Hoefnagels</surname><given-names>W.H.</given-names></name><name><surname>Verbeek</surname><given-names>A.L.</given-names></name><name><surname>Zitman</surname><given-names>F.G.</given-names></name></person-group>
<article-title>Visual hallucinations in psychologically normal people: Charles Bonnet&#x02019;s syndrome</article-title>
<source>Lancet</source>
<year>1996</year>
<volume>347</volume>
<fpage>794</fpage>
<lpage>797</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(96)90869-7</pub-id>
<pub-id pub-id-type="pmid">8622335</pub-id></element-citation></ref><ref id="B143-brainsci-03-01483"><label>143.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teunisse</surname><given-names>R.J.</given-names></name><name><surname>Cruysberg</surname><given-names>J.R.</given-names></name><name><surname>Hoefnagels</surname><given-names>W.H.</given-names></name><name><surname>van&#x02019;t Hof</surname><given-names>M.A.</given-names></name><name><surname>Verbeek</surname><given-names>A.L.</given-names></name><name><surname>Zitman</surname><given-names>F.G.</given-names></name></person-group>
<article-title>Risk indicators for the Charles Bonnet Syndrome</article-title>
<source>J. Nerv. Ment. Dis.</source>
<year>1998</year>
<volume>186</volume>
<fpage>190</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1097/00005053-199803000-00009</pub-id>
<pub-id pub-id-type="pmid">9521356</pub-id></element-citation></ref><ref id="B144-brainsci-03-01483"><label>144.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Ajuriaguerra</surname><given-names>J.</given-names></name><name><surname>LeGenne</surname><given-names>J.</given-names></name></person-group>
<article-title>Unilateral auditory and visual hallucinations in a hard of hearing blind man with deafness in the right ear</article-title>
<source>Ann. Med. Psychol. (Paris)</source>
<year>1946</year>
<volume>104</volume>
<fpage>246</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="pmid">20986466</pub-id></element-citation></ref><ref id="B145-brainsci-03-01483"><label>145.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>H&#x000e9;caen</surname><given-names>H.</given-names></name><name><surname>Ropert</surname><given-names>R.</given-names></name></person-group>
<article-title>Auditory hallucinations in the course of neurologic syndromes</article-title>
<source>Ann. Med. Psychol. (Paris)</source>
<year>1959</year>
<volume>117</volume>
<fpage>257</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="pmid">13627611</pub-id></element-citation></ref><ref id="B146-brainsci-03-01483"><label>146.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lennox</surname><given-names>G.</given-names></name></person-group>
<article-title>Auditory hallucinations due to ear disease</article-title>
<source>Br. J. Psychiatry</source>
<year>1988</year>
<volume>153</volume>
<fpage>713</fpage>
<lpage>714</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.153.5.713b</pub-id>
<pub-id pub-id-type="pmid">3255469</pub-id></element-citation></ref><ref id="B147-brainsci-03-01483"><label>147.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toulouse</surname><given-names>E.</given-names></name></person-group>
<article-title>Unilateral hallucinations</article-title>
<source>Gazette H&#x000f4;pitaux</source>
<year>1892</year>
<volume>65</volume>
<fpage>609</fpage>
<lpage>618</lpage>
</element-citation></ref><ref id="B148-brainsci-03-01483"><label>148.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chamorro</surname><given-names>A.</given-names></name><name><surname>Sacco</surname><given-names>R.L.</given-names></name><name><surname>Ciecierski</surname><given-names>K.</given-names></name><name><surname>Binder</surname><given-names>J.R.</given-names></name><name><surname>Tatemichi</surname><given-names>T.K.</given-names></name><name><surname>Mohr</surname><given-names>J.P.</given-names></name></person-group>
<article-title>Visual hemineglect and hemihallucinations in a patient with a subcortical infarction</article-title>
<source>Neurology</source>
<year>1990</year>
<volume>40</volume>
<fpage>1463</fpage>
<lpage>1464</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.40.9.1463</pub-id>
<pub-id pub-id-type="pmid">2392237</pub-id></element-citation></ref><ref id="B149-brainsci-03-01483"><label>149.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bergman</surname><given-names>P.S.</given-names></name></person-group>
<article-title>Unilateral auditory hallucinations</article-title>
<source>Trans. Am. Neurol. Assoc.</source>
<year>1965</year>
<volume>90</volume>
<fpage>226</fpage>
<lpage>227</lpage>
<?supplied-pmid 5857747?><pub-id pub-id-type="pmid">5857747</pub-id></element-citation></ref><ref id="B150-brainsci-03-01483"><label>150.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hauptman</surname><given-names>B.</given-names></name><name><surname>Glick</surname><given-names>I.D.</given-names></name></person-group>
<article-title>Auditory hallucinations with imipramine</article-title>
<source>J. Hillside Hosp.</source>
<year>1968</year>
<volume>17</volume>
<fpage>32</fpage>
<lpage>34</lpage>
</element-citation></ref><ref id="B151-brainsci-03-01483"><label>151.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gordon</surname><given-names>A.G.</given-names></name></person-group>
<article-title>Unilateral auditory hallucinations</article-title>
<source>Br. J. Psychiatry</source>
<year>1988</year>
<volume>153</volume>
<fpage>263</fpage>
<lpage>264</lpage>
<?supplied-pmid 3255449?><pub-id pub-id-type="pmid">3255449</pub-id></element-citation></ref><ref id="B152-brainsci-03-01483"><label>152.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Almeida</surname><given-names>O.P.</given-names></name><name><surname>Forstl</surname><given-names>H.</given-names></name><name><surname>Howard</surname><given-names>R.</given-names></name><name><surname>David</surname><given-names>A.S.</given-names></name></person-group>
<article-title>Unilateral auditory hallucinations</article-title>
<source>Br. J. Psychiatry</source>
<year>1993</year>
<volume>162</volume>
<fpage>262</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.162.2.262</pub-id>
<pub-id pub-id-type="pmid">8435701</pub-id></element-citation></ref><ref id="B153-brainsci-03-01483"><label>153.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bremer</surname><given-names>J.</given-names></name></person-group>
<article-title>New onset auditory hallucinations after right temporal lobectomy</article-title>
<source>Am. J. Psychiatry</source>
<year>1996</year>
<volume>153</volume>
<fpage>442</fpage>
<lpage>443</lpage>
<?supplied-pmid 8610841?><pub-id pub-id-type="pmid">8610841</pub-id></element-citation></ref><ref id="B154-brainsci-03-01483"><label>154.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gordon</surname><given-names>A.G.</given-names></name></person-group>
<article-title>Unilateral auditory hallucinations: Ear or brain?</article-title>
<source>J. Neurol. Neurosurg. Psychiatry</source>
<year>1997</year>
<volume>63</volume>
<fpage>814</fpage>
<lpage>815</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.63.6.814</pub-id>
<pub-id pub-id-type="pmid">9416830</pub-id></element-citation></ref><ref id="B155-brainsci-03-01483"><label>155.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Potolicchio</surname><given-names>S.J.</given-names></name><name><surname>Lossing</surname><given-names>J.H.</given-names></name><name><surname>O&#x02019;Doherty</surname><given-names>D.S.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Partial seizures with simple psychosensory symptomatology (cyclic phantosmia): A new and distinct seizure disorder</article-title>
<source>Clin. Res.</source>
<year>1986</year>
<volume>34</volume>
<fpage>635A</fpage>
</element-citation></ref><ref id="B156-brainsci-03-01483"><label>156.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Hutter</surname><given-names>A.</given-names></name><name><surname>Schroder</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Schellinger</surname><given-names>D.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Brain localization of cyclic unilateral olfactory phantoms by functional magnetic resonance imaging (fMRI) by treatment with valproic acid and thioridazine</article-title>
<source>J. Invest. Med.</source>
<year>1997</year>
<volume>45</volume>
<fpage>238A</fpage>
</element-citation></ref><ref id="B157-brainsci-03-01483"><label>157.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Larson</surname><given-names>A.L.</given-names></name><name><surname>Powell</surname><given-names>R.D.</given-names></name></person-group>
<article-title>Hypogeusia, dysgeusia, hyposmia and dysosmia following influenza-like infection</article-title>
<source>Ann. Otol. Rhinol. Laryngol.</source>
<year>1975</year>
<volume>84</volume>
<fpage>672</fpage>
<lpage>682</lpage>
<?supplied-pmid 1190677?><pub-id pub-id-type="pmid">1190677</pub-id></element-citation></ref><ref id="B158-brainsci-03-01483"><label>158.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Church</surname><given-names>J.A.</given-names></name><name><surname>Bauer</surname><given-names>H.</given-names></name><name><surname>Bellanti</surname><given-names>J.A.</given-names></name><name><surname>Satterly</surname><given-names>R.A.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Hyposmia associated with atopy</article-title>
<source>Ann. Allergy</source>
<year>1978</year>
<volume>40</volume>
<fpage>105</fpage>
<lpage>109</lpage>
<?supplied-pmid 629425?><pub-id pub-id-type="pmid">629425</pub-id></element-citation></ref><ref id="B159-brainsci-03-01483"><label>159.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Hyposmia and hypogeusia due to nonallergic rhinitis</article-title>
<source>J. Am. Med. Assoc.</source>
<year>1973</year>
<volume>225</volume>
<fpage>1256</fpage>
</element-citation></ref><ref id="B160-brainsci-03-01483"><label>160.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Velicu</surname><given-names>I.</given-names></name><name><surname>Schmidt</surname><given-names>L.</given-names></name></person-group>
<article-title>An open-label controlled trial of theophylline for treatment of patients with hyposmia</article-title>
<source>Am. J. Med. Sci.</source>
<year>2009</year>
<volume>337</volume>
<fpage>396</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.1097/MAJ.0b013e3181914a97</pub-id><?supplied-pmid 19359985?><pub-id pub-id-type="pmid">19359985</pub-id></element-citation></ref><ref id="B161-brainsci-03-01483"><label>161.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Schultz</surname><given-names>M.</given-names></name><name><surname>Minnick-Poppe</surname><given-names>L.</given-names></name></person-group>
<article-title>Intranasal theophylline treatment of patients with hyposmia and hypogeusia: A pilot study</article-title>
<source>Arch. Otolaryngol. Head Neck Surg.</source>
<year>2012</year>
<volume>138</volume>
<fpage>1064</fpage>
<lpage>1070</lpage>
<pub-id pub-id-type="doi">10.1001/2013.jamaoto.342</pub-id>
<pub-id pub-id-type="pmid">23165381</pub-id></element-citation></ref><ref id="B162-brainsci-03-01483"><label>162.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Hutter</surname><given-names>A.</given-names></name><name><surname>Schellinger</surname><given-names>D.</given-names></name></person-group>
<article-title>Odor memory induces brain activation as measured by functional MRI</article-title>
<source>J. Comput. Assist. Tomogr.</source>
<year>1999</year>
<volume>23</volume>
<fpage>487</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="doi">10.1097/00004728-199907000-00001</pub-id><?supplied-pmid 10433273?><pub-id pub-id-type="pmid">10433273</pub-id></element-citation></ref><ref id="B163-brainsci-03-01483"><label>163.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Finley</surname><given-names>A.</given-names></name><name><surname>Schellinger</surname><given-names>D.</given-names></name></person-group>
<article-title>Taste memory induces brain activation as revealed by functional MRI</article-title>
<source>J. Comput. Assist. Tomogr.</source>
<year>1999</year>
<volume>23</volume>
<fpage>499</fpage>
<lpage>505</lpage>
<pub-id pub-id-type="doi">10.1097/00004728-199907000-00002</pub-id>
<pub-id pub-id-type="pmid">10433274</pub-id></element-citation></ref><ref id="B164-brainsci-03-01483"><label>164.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Hallett</surname><given-names>M.</given-names></name></person-group>
<article-title>Impaired brain GABA in focal dystonia</article-title>
<source>Ann. Neurol.</source>
<year>2002</year>
<volume>51</volume>
<fpage>93</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10073</pub-id>
<pub-id pub-id-type="pmid">11782988</pub-id></element-citation></ref><ref id="B165-brainsci-03-01483"><label>165.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Potolicchio</surname><given-names>S.J.</given-names></name><name><surname>Levy</surname><given-names>L.M.</given-names></name></person-group>
<article-title>Improvement in smell and taste dysfunction after repetitive transcranial magnetic stimulation</article-title>
<source>Am. J. Otolaryngol.</source>
<year>2011</year>
<volume>32</volume>
<fpage>38</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjoto.2009.10.001</pub-id>
<pub-id pub-id-type="pmid">20022663</pub-id></element-citation></ref><ref id="B166-brainsci-03-01483"><label>166.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Potolicchio</surname><given-names>S.J.</given-names></name><name><surname>Levy</surname><given-names>L.M.</given-names></name></person-group>
<article-title>Rapid changes in taste and smell function following transcranial magnetic stimulation (TCMS) in humans: Relationships to CNS plasticity</article-title>
<source>FASEB J.</source>
<year>2002</year>
<volume>16</volume>
<fpage>A875</fpage>
</element-citation></ref><ref id="B167-brainsci-03-01483"><label>167.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Potolicchio</surname><given-names>S.J.</given-names></name><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Moharram</surname><given-names>R.</given-names></name><name><surname>Velicu</surname><given-names>I.</given-names></name><name><surname>Martin</surname><given-names>B.M.</given-names></name></person-group>
<article-title>Carbonic anhydrase (CA) I, II and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation</article-title>
<source>Am. J. Med. Sci.</source>
<year>2010</year>
<volume>339</volume>
<fpage>249</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1097/MAJ.0b013e3181cda0e3</pub-id>
<pub-id pub-id-type="pmid">20090508</pub-id></element-citation></ref><ref id="B168-brainsci-03-01483"><label>168.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Herron</surname><given-names>J.</given-names></name></person-group>
<source>Neuropsychology of Left-Handedness</source>
<publisher-name>Academic Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1980</year>
</element-citation></ref><ref id="B169-brainsci-03-01483"><label>169.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>McManus</surname><given-names>I.C.</given-names></name><name><surname>Bryden</surname><given-names>M.C.</given-names></name></person-group>
<article-title>The Genetics of Handedness, Cerebral Dominance and Lateralization</article-title>
<source>Handbook of Neuropsychology</source>
<person-group person-group-type="editor"><name><surname>Rapin</surname><given-names>I.</given-names></name><name><surname>Segalowitz</surname><given-names>S.J.</given-names></name></person-group>
<publisher-name>Elsevier</publisher-name>
<publisher-loc>Amsterdam, The Netherlands</publisher-loc>
<year>1992</year>
<volume>Volume 6</volume>
<fpage>115</fpage>
<lpage>144</lpage>
</element-citation></ref><ref id="B170-brainsci-03-01483"><label>170.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Katzman</surname><given-names>G.L.</given-names></name><name><surname>Dagher</surname><given-names>A.P.</given-names></name><name><surname>Patronas</surname><given-names>N.J.</given-names></name></person-group>
<article-title>Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers</article-title>
<source>JAMA</source>
<year>1999</year>
<volume>282</volume>
<fpage>36</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1001/jama.282.1.36</pub-id>
<pub-id pub-id-type="pmid">10404909</pub-id></element-citation></ref><ref id="B171-brainsci-03-01483"><label>171.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maly</surname><given-names>P.V.</given-names></name><name><surname>Sundgren</surname><given-names>P.C.</given-names></name></person-group>
<article-title>Changes in paranasal sinus abnormalities found incidentally on MR</article-title>
<source>Neuroradiology</source>
<year>1995</year>
<volume>37</volume>
<fpage>471</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.1007/BF00600097</pub-id>
<pub-id pub-id-type="pmid">7477862</pub-id></element-citation></ref><ref id="B172-brainsci-03-01483"><label>172.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patel</surname><given-names>K.</given-names></name><name><surname>Chvada</surname><given-names>S.V.</given-names></name><name><surname>Violaris</surname><given-names>N.</given-names></name><name><surname>Pahor</surname><given-names>A.L.</given-names></name></person-group>
<article-title>Incidental paranasal sinus inflammatory changes in a British population</article-title>
<source>J. Laryngol. Otol.</source>
<year>1996</year>
<volume>110</volume>
<fpage>649</fpage>
<lpage>651</lpage>
<?supplied-pmid 8759538?><pub-id pub-id-type="pmid">8759538</pub-id></element-citation></ref><ref id="B173-brainsci-03-01483"><label>173.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iwabuchi</surname><given-names>Y.</given-names></name><name><surname>Hanamure</surname><given-names>Y.</given-names></name><name><surname>Hirota</surname><given-names>J.</given-names></name><name><surname>Ohyama</surname><given-names>M.</given-names></name></person-group>
<article-title>Clinical significance of asymptomatic sinus abnormalities on magnetic resonance imaging</article-title>
<source>Arch. Otolaryngol. Head Neck Surg.</source>
<year>1997</year>
<volume>123</volume>
<fpage>602</fpage>
<lpage>604</lpage>
<pub-id pub-id-type="doi">10.1001/archotol.1997.01900060044007</pub-id>
<pub-id pub-id-type="pmid">9193220</pub-id></element-citation></ref><ref id="B174-brainsci-03-01483"><label>174.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kurz</surname><given-names>A.</given-names></name><name><surname>Sessler</surname><given-names>D.I.</given-names></name><name><surname>Lenhardt</surname><given-names>R.</given-names></name></person-group>
<article-title>Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group</article-title>
<source>N. Engl. J. Med.</source>
<year>1996</year>
<volume>334</volume>
<fpage>1209</fpage>
<lpage>1215</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199605093341901</pub-id>
<pub-id pub-id-type="pmid">8606715</pub-id></element-citation></ref><ref id="B175-brainsci-03-01483"><label>175.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Levy</surname><given-names>L.M.</given-names></name></person-group>
<article-title>Lateralization of brain activation to imagination and smell of odors using functional magnetic resonance imaging (fMRI): Left hemispheric localization of pleasant and right hemispheric localization of unpleasant odors</article-title>
<source>J. Comput. Assist. Tomogr.</source>
<year>2001</year>
<volume>25</volume>
<fpage>493</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1097/00004728-200107000-00001</pub-id>
<pub-id pub-id-type="pmid">11473178</pub-id></element-citation></ref><ref id="B176-brainsci-03-01483"><label>176.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greif</surname><given-names>R.</given-names></name><name><surname>Ak&#x000e7;a</surname><given-names>O.</given-names></name><name><surname>Horn</surname><given-names>E.P.</given-names></name><name><surname>Kurz</surname><given-names>A.</given-names></name><name><surname>Sessler</surname><given-names>D.I.</given-names></name><collab>Outcomes Research Group</collab></person-group>
<article-title>Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection</article-title>
<source>N. Engl. J. Med,</source>
<year>2000</year>
<volume>342</volume>
<fpage>161</fpage>
<lpage>167</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM200001203420303</pub-id>
<pub-id pub-id-type="pmid">10639541</pub-id></element-citation></ref><ref id="B177-brainsci-03-01483"><label>177.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gottrup</surname><given-names>F.</given-names></name><name><surname>Firmin</surname><given-names>R.</given-names></name><name><surname>Rabkin</surname><given-names>J.</given-names></name><name><surname>Halliday</surname><given-names>B.J.</given-names></name><name><surname>Hunt</surname><given-names>T.K.</given-names></name></person-group>
<article-title>Directly measured tissue oxygen tension and arterial oxygen tension assess tissue perfusion</article-title>
<source>Crit. Care Med.</source>
<year>1987</year>
<volume>15</volume>
<fpage>1030</fpage>
<lpage>1036</lpage>
<pub-id pub-id-type="doi">10.1097/00003246-198711000-00008</pub-id><?supplied-pmid 3677745?><pub-id pub-id-type="pmid">3677745</pub-id></element-citation></ref><ref id="B178-brainsci-03-01483"><label>178.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gottrup</surname><given-names>F.</given-names></name></person-group>
<article-title>Prevention of surgical-wound infections</article-title>
<source>N. Engl. J. Med.</source>
<year>2000</year>
<volume>342</volume>
<fpage>202</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM200001203420310</pub-id>
<pub-id pub-id-type="pmid">10639548</pub-id></element-citation></ref><ref id="B179-brainsci-03-01483"><label>179.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levy</surname><given-names>L.M.</given-names></name><name><surname>Henkin</surname><given-names>R.I.</given-names></name><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Hutter</surname><given-names>A.</given-names></name><name><surname>Schellinger</surname><given-names>D.</given-names></name></person-group>
<article-title>Increased brain activation in response to odors in patients with hyposmia after theophylline treatment demonstrated by fMRI</article-title>
<source>J. Comput. Assist. Tomogr.</source>
<year>1998</year>
<volume>22</volume>
<fpage>760</fpage>
<lpage>770</lpage>
<pub-id pub-id-type="doi">10.1097/00004728-199809000-00019</pub-id>
<pub-id pub-id-type="pmid">9754114</pub-id></element-citation></ref><ref id="B180-brainsci-03-01483"><label>180.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sheehy</surname><given-names>M.P.</given-names></name><name><surname>Marsden</surname><given-names>C.D.</given-names></name></person-group>
<article-title>Writers&#x02019; cramp-a focal dystonia</article-title>
<source>Brain</source>
<year>1982</year>
<volume>105</volume>
<fpage>461</fpage>
<lpage>480</lpage>
<pub-id pub-id-type="doi">10.1093/brain/105.3.461</pub-id>
<pub-id pub-id-type="pmid">7104663</pub-id></element-citation></ref><ref id="B181-brainsci-03-01483"><label>181.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berardelli</surname><given-names>A.</given-names></name><name><surname>Rothwell</surname><given-names>J.C.</given-names></name><name><surname>Hallett</surname><given-names>M.</given-names></name><name><surname>Thompson</surname><given-names>P.D.</given-names></name><name><surname>Manfredi</surname><given-names>M.</given-names></name><name><surname>Marsden</surname><given-names>C.D.</given-names></name></person-group>
<article-title>The pathophysiology of primary dystonia</article-title>
<source>Brain</source>
<year>1998</year>
<volume>121</volume>
<fpage>1195</fpage>
<lpage>1212</lpage>
<pub-id pub-id-type="doi">10.1093/brain/121.7.1195</pub-id>
<pub-id pub-id-type="pmid">9679773</pub-id></element-citation></ref><ref id="B182-brainsci-03-01483"><label>182.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Byl</surname><given-names>N.N.</given-names></name><name><surname>McKenzie</surname><given-names>A.</given-names></name><name><surname>Nagarajan</surname><given-names>S.S.</given-names></name></person-group>
<article-title>Differences in somatosensory hand organization in a healthy flutist and a flutist with focal hand dystonia: A case report</article-title>
<source>J. Hand Ther.</source>
<year>2000</year>
<volume>13</volume>
<fpage>302</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="doi">10.1016/S0894-1130(00)80022-8</pub-id>
<pub-id pub-id-type="pmid">11129255</pub-id></element-citation></ref><ref id="B183-brainsci-03-01483"><label>183.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tinazzi</surname><given-names>M.</given-names></name><name><surname>Priori</surname><given-names>A.</given-names></name><name><surname>Bertolasi</surname><given-names>L.</given-names></name><name><surname>Frasson</surname><given-names>E.</given-names></name><name><surname>Maugui&#x000e8;re</surname><given-names>F.</given-names></name><name><surname>Fiasche</surname><given-names>A.</given-names></name></person-group>
<article-title>Abnormal central integration of a dual somatosensory input in dystonia. Evidence for sensory overflow</article-title>
<source>Brain</source>
<year>2000</year>
<volume>123</volume>
<fpage>42</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1093/brain/123.1.42</pub-id>
<pub-id pub-id-type="pmid">10611119</pub-id></element-citation></ref><ref id="B184-brainsci-03-01483"><label>184.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Priori</surname><given-names>A.</given-names></name><name><surname>Pesenti</surname><given-names>A.</given-names></name><name><surname>Cappellari</surname><given-names>A.</given-names></name><name><surname>Scarlato</surname><given-names>G.</given-names></name><name><surname>Barbieri</surname><given-names>S.</given-names></name></person-group>
<article-title>Limb immobilization for the treatment of focal occupational dystonia</article-title>
<source>Neurology</source>
<year>2001</year>
<volume>57</volume>
<fpage>405</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.57.3.405</pub-id><?supplied-pmid 11502904?><pub-id pub-id-type="pmid">11502904</pub-id></element-citation></ref><ref id="B185-brainsci-03-01483"><label>185.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pascual-Leone</surname><given-names>A.</given-names></name></person-group>
<article-title>The brain that plays music and is changed by it</article-title>
<source>Ann. N. Y. Acad. Sci.</source>
<year>2001</year>
<volume>930</volume>
<fpage>315</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2001.tb05741.x</pub-id>
<pub-id pub-id-type="pmid">11458838</pub-id></element-citation></ref><ref id="B186-brainsci-03-01483"><label>186.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumura</surname><given-names>M.</given-names></name><name><surname>Sawaguchi</surname><given-names>T.</given-names></name><name><surname>Oishi</surname><given-names>T.</given-names></name><name><surname>Ueki</surname><given-names>K.</given-names></name><name><surname>Kubota</surname><given-names>K.</given-names></name></person-group>
<article-title>Behavioral deficits induced by local injection of bicuculline and muscimol into the primate motor and premotor cortex</article-title>
<source>J. Neurophysiol.</source>
<year>1991</year>
<volume>65</volume>
<fpage>1542</fpage>
<lpage>1553</lpage>
<?supplied-pmid 1875261?><pub-id pub-id-type="pmid">1875261</pub-id></element-citation></ref><ref id="B187-brainsci-03-01483"><label>187.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>L&#x000f6;scher</surname><given-names>W.</given-names></name><name><surname>H&#x000f6;rstermann</surname><given-names>D.</given-names></name></person-group>
<article-title>Abnormalities in amino acid neurotransmitters in discrete brain regions of genetically dystonic hamsters</article-title>
<source>J. Neurochem.</source>
<year>1992</year>
<volume>59</volume>
<fpage>689</fpage>
<lpage>694</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1992.tb09423.x</pub-id><?supplied-pmid 1352802?><pub-id pub-id-type="pmid">1352802</pub-id></element-citation></ref><ref id="B188-brainsci-03-01483"><label>188.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Yebenes</surname><given-names>J.G.</given-names></name><name><surname>Vazquez</surname><given-names>A.</given-names></name><name><surname>Martinez</surname><given-names>A.</given-names></name><name><surname>Mena</surname><given-names>M.A.</given-names></name><name><surname>del Rio</surname><given-names>R.M.</given-names></name><name><surname>de Felipe</surname><given-names>C.</given-names></name><name><surname>del Rio</surname><given-names>J.</given-names></name></person-group>
<article-title>Biochemical findings in symptomatic dystonias</article-title>
<source>Adv. Neurol.</source>
<year>1988</year>
<volume>50</volume>
<fpage>167</fpage>
<lpage>175</lpage>
<?supplied-pmid 3400491?><pub-id pub-id-type="pmid">3400491</pub-id></element-citation></ref><ref id="B189-brainsci-03-01483"><label>189.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richter</surname><given-names>A.</given-names></name><name><surname>L&#x000f6;schmann</surname><given-names>P.A.</given-names></name><name><surname>L&#x000f6;scher</surname><given-names>W.</given-names></name></person-group>
<article-title>The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalized dystonia</article-title>
<source>Eur. J. Pharmacol.</source>
<year>1994</year>
<volume>264</volume>
<fpage>345</fpage>
<lpage>351</lpage>
<pub-id pub-id-type="doi">10.1016/0014-2999(94)00493-5</pub-id><?supplied-pmid 7698175?><pub-id pub-id-type="pmid">7698175</pub-id></element-citation></ref><ref id="B190-brainsci-03-01483"><label>190.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Messer</surname><given-names>A.</given-names></name></person-group>
<article-title>Amino acid changes in the mouse mutant dystonia musculorum similar to those in Friedreich&#x02019;s ataxia</article-title>
<source>Can. J. Neurol. Sci.</source>
<year>1982</year>
<volume>9</volume>
<fpage>185</fpage>
<lpage>188</lpage>
<?supplied-pmid 6125255?><pub-id pub-id-type="pmid">6125255</pub-id></element-citation></ref><ref id="B191-brainsci-03-01483"><label>191.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leopold</surname><given-names>D.A.</given-names></name><name><surname>Schwob</surname><given-names>J.E.</given-names></name><name><surname>Youngentob</surname><given-names>S.L.</given-names></name><name><surname>Hornung</surname><given-names>D.E.</given-names></name><name><surname>Wright</surname><given-names>H.N.</given-names></name><name><surname>Mozell</surname><given-names>M.M.</given-names></name></person-group>
<article-title>Successful treatment of phantosmia with preservation of olfaction</article-title>
<source>Arch. Otolarngol. Head Neck Surg.</source>
<year>1991</year>
<volume>117</volume>
<fpage>1402</fpage>
<lpage>1406</lpage>
<pub-id pub-id-type="doi">10.1001/archotol.1991.01870240094016</pub-id>
</element-citation></ref><ref id="B192-brainsci-03-01483"><label>192.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pujol</surname><given-names>J.</given-names></name><name><surname>Roset-Llobet</surname><given-names>J.</given-names></name><name><surname>Rosin&#x000e9;s-Cubells</surname><given-names>D.</given-names></name><name><surname>Deus</surname><given-names>J.</given-names></name><name><surname>Narberhaus</surname><given-names>B.</given-names></name><name><surname>Valls-Sol&#x000e9;</surname><given-names>J.</given-names></name><name><surname>Capdevila</surname><given-names>A.</given-names></name><name><surname>Pascual-Leone</surname><given-names>A.</given-names></name></person-group>
<article-title>Brain cortical activation during guitar-induced hand dystonia studied by functional MRI</article-title>
<source>Neuroimage</source>
<year>2000</year>
<volume>12</volume>
<fpage>257</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1006/nimg.2000.0615</pub-id>
<pub-id pub-id-type="pmid">10944408</pub-id></element-citation></ref><ref id="B193-brainsci-03-01483"><label>193.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>C.</given-names></name></person-group>
<article-title>Gamma-aminobutyric acid in peripheral tissues</article-title>
<source>Life Sci.</source>
<year>1985</year>
<volume>37</volume>
<fpage>2221</fpage>
<lpage>2235</lpage>
<pub-id pub-id-type="doi">10.1016/0024-3205(85)90013-X</pub-id>
<pub-id pub-id-type="pmid">2999544</pub-id></element-citation></ref><ref id="B194-brainsci-03-01483"><label>194.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pertwee</surname><given-names>R.G.</given-names></name><name><surname>Wickens</surname><given-names>A.P.</given-names></name></person-group>
<article-title>Enhancement by chloridiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids</article-title>
<source>Neuropharmacology</source>
<year>1991</year>
<volume>30</volume>
<fpage>237</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1016/0028-3908(91)90150-A</pub-id>
<pub-id pub-id-type="pmid">1649415</pub-id></element-citation></ref><ref id="B195-brainsci-03-01483"><label>195.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Romero</surname><given-names>J.</given-names></name><name><surname>Garcia-Palomero</surname><given-names>E.</given-names></name><name><surname>Fern&#x000e1;ndez-Ruiz</surname><given-names>J.J.</given-names></name><name><surname>Ramos</surname><given-names>J.A.</given-names></name></person-group>
<article-title>Involvement of GABA(B) receptors in the motor inhibition produced by agonists of brain cannabinoid receptors</article-title>
<source>Behav. Pharmacol.</source>
<year>1996</year>
<volume>7</volume>
<fpage>299</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1097/00008877-199605000-00011</pub-id>
<pub-id pub-id-type="pmid">11224422</pub-id></element-citation></ref><ref id="B196-brainsci-03-01483"><label>196.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coull</surname><given-names>M.A.</given-names></name><name><surname>Johnston</surname><given-names>A.T.</given-names></name><name><surname>Pertree</surname><given-names>R.G.</given-names></name><name><surname>Davies</surname><given-names>S.N.</given-names></name></person-group>
<article-title>Action of delta-9-tetrahydrocannabinal on GABA(A) receptor mediated responses in a grease-gap recording preparation of the rat hippocampal slice</article-title>
<source>Neuropharmacology</source>
<year>1997</year>
<volume>36</volume>
<fpage>1387</fpage>
<lpage>1392</lpage>
<pub-id pub-id-type="doi">10.1016/S0028-3908(97)00110-X</pub-id>
<pub-id pub-id-type="pmid">9423926</pub-id></element-citation></ref><ref id="B197-brainsci-03-01483"><label>197.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garcia-Gil</surname><given-names>L.</given-names></name><name><surname>de Miguel</surname><given-names>R.</given-names></name><name><surname>Romero</surname><given-names>J.</given-names></name><name><surname>Perez</surname><given-names>A.</given-names></name><name><surname>Ramos</surname><given-names>J.A.</given-names></name><name><surname>Fern&#x000e1;ndez-Ruiz</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Perinatal delta-9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats</article-title>
<source>Neurotoxicol. Teratol.</source>
<year>1999</year>
<volume>21</volume>
<fpage>277</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1016/S0892-0362(98)00058-0</pub-id>
<pub-id pub-id-type="pmid">10386831</pub-id></element-citation></ref><ref id="B198-brainsci-03-01483"><label>198.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gale</surname><given-names>K.</given-names></name></person-group>
<article-title>Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra</article-title>
<source>Nature</source>
<year>1980</year>
<volume>283</volume>
<fpage>569</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1038/283569a0</pub-id>
<pub-id pub-id-type="pmid">7354838</pub-id></element-citation></ref><ref id="B199-brainsci-03-01483"><label>199.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>L.J.</given-names></name><name><surname>Geen</surname><given-names>K.W.</given-names></name><name><surname>Yamamura</surname><given-names>H.I.</given-names></name></person-group>
<article-title>GABA Involvement in Benzodiazepine Receptor Modulation of the Chloride Ionophore</article-title>
<source>Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties</source>
<person-group person-group-type="editor"><name><surname>Olsen</surname><given-names>R.W.</given-names></name><name><surname>Venter</surname><given-names>C.J.</given-names></name></person-group>
<publisher-name>A.R. Liss</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1986</year>
<volume>Volume 5</volume>
<fpage>225</fpage>
<lpage>445</lpage>
<page-range>225&#x02013;240, 445</page-range>
</element-citation></ref><ref id="B200-brainsci-03-01483"><label>200.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ey</surname><given-names>H.</given-names></name></person-group>
<source>Trait&#x000e9; des Hallucinations</source>
<publisher-name>Masson</publisher-name>
<publisher-loc>Paris, France</publisher-loc>
<year>1973</year>
<volume>Volume 1</volume>
<fpage>157</fpage>
<lpage>158</lpage>
</element-citation></ref><ref id="B201-brainsci-03-01483"><label>201.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Mantegazza</surname><given-names>P.</given-names></name></person-group>
<article-title>On the Hygienic and Medicinal Virtues of Coca</article-title>
<source>The Coca Leaf and Cocaine Papers</source>
<person-group person-group-type="editor"><name><surname>Andrews</surname><given-names>G.</given-names></name><name><surname>Solomon</surname><given-names>D.</given-names></name></person-group>
<publisher-name>Harcourt Brace Jovanovich</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1975</year>
<fpage>38</fpage>
<lpage>42</lpage>
</element-citation></ref><ref id="B202-brainsci-03-01483"><label>202.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R.K.</given-names></name></person-group>
<article-title>Cocaine hallucinations</article-title>
<source>Am. J. Psychiatry</source>
<year>1978</year>
<volume>135</volume>
<fpage>309</fpage>
<lpage>314</lpage>
<?supplied-pmid 626219?><pub-id pub-id-type="pmid">626219</pub-id></element-citation></ref><ref id="B203-brainsci-03-01483"><label>203.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dittrich</surname><given-names>A.</given-names></name><name><surname>Bickel</surname><given-names>P.</given-names></name><name><surname>Sch&#x000f6;pf</surname><given-names>J.</given-names></name><name><surname>Zimmer</surname><given-names>D.</given-names></name></person-group>
<article-title>Comparison of altered states of consciousness induced by the hallucinogens (&#x02212;)-delta9-<italic>trans</italic>-tetrahydrocannabinol (delta9-THC) and <italic>N</italic>,<italic>N</italic>-dimethyltryptamine (DMT) (author&#x02019;s transl)</article-title>
<source>Arch. Psychiatr. Nervenkr.</source>
<year>1976</year>
<volume>223</volume>
<fpage>77</fpage>
<lpage>87</lpage>
<comment>(in German)</comment>
<pub-id pub-id-type="doi">10.1007/BF00367455</pub-id><?supplied-pmid 1070948?><pub-id pub-id-type="pmid">1070948</pub-id></element-citation></ref><ref id="B204-brainsci-03-01483"><label>204.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koukkou</surname><given-names>M.</given-names></name><name><surname>Lehmann</surname><given-names>D.</given-names></name></person-group>
<article-title>Human EEG spectra before and during cannibis hallucinations</article-title>
<source>Biol. Psychiatry</source>
<year>1976</year>
<volume>11</volume>
<fpage>663</fpage>
<lpage>677</lpage>
<?supplied-pmid 999986?><pub-id pub-id-type="pmid">999986</pub-id></element-citation></ref><ref id="B205-brainsci-03-01483"><label>205.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sorg</surname><given-names>B.A.</given-names></name><name><surname>Guminski</surname><given-names>B.J.</given-names></name><name><surname>Hooks</surname><given-names>M.S.</given-names></name><name><surname>Kalivas</surname><given-names>P.W.</given-names></name></person-group>
<article-title>Cocaine alters glutamic acid decarboxylase differentially in the nucleus accumbens core and shell</article-title>
<source>Brain Res. Mol. Brain Res.</source>
<year>1995</year>
<volume>29</volume>
<fpage>381</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1016/0169-328X(94)00281-I</pub-id><?supplied-pmid 7609627?><pub-id pub-id-type="pmid">7609627</pub-id></element-citation></ref><ref id="B206-brainsci-03-01483"><label>206.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peris</surname><given-names>J.</given-names></name><name><surname>Jung</surname><given-names>B.J.</given-names></name><name><surname>Resnick</surname><given-names>A.</given-names></name><name><surname>Walker</surname><given-names>P.</given-names></name><name><surname>Malakhova</surname><given-names>O.</given-names></name><name><surname>Bokrand</surname><given-names>Y.</given-names></name><name><surname>Wielbo</surname><given-names>D.</given-names></name></person-group>
<article-title>Antisense inhibition of striatal GABA<sub>A</sub> receptor proteins decreases GABA-stimulated chloride uptake and increases cocaine sensitivity in rats</article-title>
<source>Brain Res. Mol. Brain Res.</source>
<year>1998</year>
<volume>57</volume>
<fpage>310</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1016/S0169-328X(98)00102-8</pub-id><?supplied-pmid 9675429?><pub-id pub-id-type="pmid">9675429</pub-id></element-citation></ref><ref id="B207-brainsci-03-01483"><label>207.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peris</surname><given-names>J.</given-names></name></person-group>
<article-title>Repeated cocaine injections decrease the function of striatal gamma-aminobutyric acid (A) receptors</article-title>
<source>J. Pharmacol. Exp. Ther.</source>
<year>1996</year>
<volume>276</volume>
<fpage>1002</fpage>
<lpage>1008</lpage>
<?supplied-pmid 8786528?><pub-id pub-id-type="pmid">8786528</pub-id></element-citation></ref><ref id="B208-brainsci-03-01483"><label>208.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ye</surname><given-names>J.H.</given-names></name><name><surname>Liu</surname><given-names>P.L.</given-names></name><name><surname>Wu</surname><given-names>W.H.</given-names></name><name><surname>McArdle</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Cocaine depresses GABA<sub>A</sub> current of hippocampal neurons</article-title>
<source>Brain Res.</source>
<year>1997</year>
<volume>770</volume>
<fpage>169</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(97)00782-8</pub-id><?supplied-pmid 9372216?><pub-id pub-id-type="pmid">9372216</pub-id></element-citation></ref><ref id="B209-brainsci-03-01483"><label>209.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giorgetti</surname><given-names>M.</given-names></name><name><surname>Javaid</surname><given-names>J.I.</given-names></name><name><surname>Davis</surname><given-names>J.M.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Appel</surname><given-names>S.B.</given-names></name><name><surname>Brodie</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Imidazenil, a positive allosteric GABA<sub>A</sub> receptor modulator, inhibits the effects of cocaine on locomotor activity and extracellular dopamine in the nucleus accumbens shell without tolerance liability</article-title>
<source>J. Pharmacol. Exp. Ther.</source>
<year>1998</year>
<volume>287</volume>
<fpage>58</fpage>
<lpage>66</lpage>
<?supplied-pmid 9765322?><pub-id pub-id-type="pmid">9765322</pub-id></element-citation></ref><ref id="B210-brainsci-03-01483"><label>210.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Isbell</surname><given-names>H.</given-names></name><name><surname>Gorodetzsky</surname><given-names>C.W.</given-names></name><name><surname>Jasinski</surname><given-names>D.</given-names></name><name><surname>Claussen</surname><given-names>U.</given-names></name><name><surname>von Spulak</surname><given-names>F.</given-names></name><name><surname>Korte</surname><given-names>F.</given-names></name></person-group>
<article-title>Effects of (&#x02212;)-delta-9-<italic>trans</italic>-tetrahydrocannabinol in man</article-title>
<source>Psychopharmacologia</source>
<year>1967</year>
<volume>11</volume>
<fpage>184</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1007/BF00401256</pub-id><?supplied-pmid 4871478?><pub-id pub-id-type="pmid">4871478</pub-id></element-citation></ref><ref id="B211-brainsci-03-01483"><label>211.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berrios</surname><given-names>G.E.</given-names></name></person-group>
<article-title>Tactile hallucinations: Conceptual and historical aspects</article-title>
<source>J. Neurol. Neurosurg. Psychiatry</source>
<year>1982</year>
<volume>45</volume>
<fpage>285</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.45.4.285</pub-id><?supplied-pmid 7042917?><pub-id pub-id-type="pmid">7042917</pub-id></element-citation></ref><ref id="B212-brainsci-03-01483"><label>212.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bekavac</surname><given-names>I.</given-names></name><name><surname>Waterhouse</surname><given-names>B.D.</given-names></name></person-group>
<article-title>Systemically administered cocaine selectively enhances long-latency responses of rat barrel field cortical neurons to vibrissae stimulation</article-title>
<source>J. Pharmacol. Exp. Ther.</source>
<year>1995</year>
<volume>272</volume>
<fpage>333</fpage>
<lpage>342</lpage>
<?supplied-pmid 7815349?><pub-id pub-id-type="pmid">7815349</pub-id></element-citation></ref><ref id="B213-brainsci-03-01483"><label>213.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ziemann</surname><given-names>U.</given-names></name><name><surname>Hallett</surname><given-names>M.</given-names></name><name><surname>Cohen</surname><given-names>L.G.</given-names></name></person-group>
<article-title>Mechanisms of deafferentation-induced plasticity in human motor cortex</article-title>
<source>J. Neurosci.</source>
<year>1998</year>
<volume>18</volume>
<fpage>7000</fpage>
<lpage>7007</lpage>
<?supplied-pmid 9712668?><pub-id pub-id-type="pmid">9712668</pub-id></element-citation></ref><ref id="B214-brainsci-03-01483"><label>214.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>T.</given-names></name><name><surname>Him</surname><given-names>A.</given-names></name><name><surname>Cameron</surname><given-names>S.A.</given-names></name><name><surname>Dutia</surname><given-names>M.B.</given-names></name></person-group>
<article-title>Rapid compensatory changes in GABA receptor efficacy in rat vestibular neurons after unilateral labyrinthectomy</article-title>
<source>J. Physiol.</source>
<year>2000</year>
<volume>523</volume>
<fpage>413</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.t01-1-00413.x</pub-id><?supplied-pmid 10699085?><pub-id pub-id-type="pmid">10699085</pub-id></element-citation></ref><ref id="B215-brainsci-03-01483"><label>215.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Donaghue</surname><given-names>J.P.</given-names></name><name><surname>Hess</surname><given-names>G.</given-names></name><name><surname>Sanes</surname><given-names>J.N.</given-names></name></person-group>
<article-title>Substrates and Mechanisms for Learning in Motor Cortex</article-title>
<source>The Acquisition of Motor Behavior in Vertebrates</source>
<person-group person-group-type="editor"><name><surname>Bloedel</surname><given-names>J.R.</given-names></name><name><surname>Ebner</surname><given-names>T.J.</given-names></name><name><surname>Wise</surname><given-names>S.P.</given-names></name></person-group>
<publisher-name>MIT Press</publisher-name>
<publisher-loc>Cambridge, MA, USA</publisher-loc>
<year>1996</year>
<fpage>363</fpage>
<lpage>386</lpage>
</element-citation></ref><ref id="B216-brainsci-03-01483"><label>216.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huntley</surname><given-names>G.W.</given-names></name></person-group>
<article-title>Correlation between patterns of horizontal connectivity and the extent of short-term representational plasticity in rat motor cortex</article-title>
<source>Cereb. Cortex</source>
<year>1997</year>
<volume>7</volume>
<fpage>143</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/7.2.143</pub-id><?supplied-pmid 9087822?><pub-id pub-id-type="pmid">9087822</pub-id></element-citation></ref><ref id="B217-brainsci-03-01483"><label>217.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Capaday</surname><given-names>C.</given-names></name><name><surname>Richardson</surname><given-names>M.P.</given-names></name><name><surname>Rothwell</surname><given-names>J.C.</given-names></name><name><surname>Brooks</surname><given-names>D.J.</given-names></name></person-group>
<article-title>Long-term changes of GABAergic function in the sensorimotor cortex of amputees. A combined magnetic stimulation and 11C-flumazenil PET study</article-title>
<source>Exp. Brain Res.</source>
<year>2000</year>
<volume>133</volume>
<fpage>552</fpage>
<lpage>556</lpage>
<pub-id pub-id-type="doi">10.1007/s002210000477</pub-id><?supplied-pmid 10985690?><pub-id pub-id-type="pmid">10985690</pub-id></element-citation></ref><ref id="B218-brainsci-03-01483"><label>218.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hendry</surname><given-names>S.H.</given-names></name><name><surname>Jones</surname><given-names>E.G.</given-names></name></person-group>
<article-title>Reduction in number of immunostained GABAergic neurons in deprived-eye dominance columns of monkey area 17</article-title>
<source>Nature</source>
<year>1986</year>
<volume>320</volume>
<fpage>750</fpage>
<lpage>753</lpage>
<pub-id pub-id-type="doi">10.1038/320750a0</pub-id><?supplied-pmid 3703001?><pub-id pub-id-type="pmid">3703001</pub-id></element-citation></ref><ref id="B219-brainsci-03-01483"><label>219.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hendry</surname><given-names>S.H.</given-names></name><name><surname>Jones</surname><given-names>E.G.</given-names></name></person-group>
<article-title>Activity-dependent regulation of GABA expression in the visual cortex of adult monkeys</article-title>
<source>Neuron</source>
<year>1988</year>
<volume>1</volume>
<fpage>701</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1016/0896-6273(88)90169-9</pub-id><?supplied-pmid 3272185?><pub-id pub-id-type="pmid">3272185</pub-id></element-citation></ref><ref id="B220-brainsci-03-01483"><label>220.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosier</surname><given-names>A.M.</given-names></name><name><surname>Arckens</surname><given-names>L.</given-names></name><name><surname>Demeulemeester</surname><given-names>H.</given-names></name><name><surname>Orban</surname><given-names>G.A.</given-names></name><name><surname>Eysel</surname><given-names>U.T.</given-names></name><name><surname>Wu</surname><given-names>Y.J.</given-names></name><name><surname>Vandesande</surname><given-names>F.</given-names></name></person-group>
<article-title>Effect of sensory deafferentation on immunoreactivity of GABAergic cells and on GABA receptors in the adult cat visual cortex</article-title>
<source>J. Comp. Neurol.</source>
<year>1995</year>
<volume>359</volume>
<fpage>476</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="doi">10.1002/cne.903590309</pub-id><?supplied-pmid 7499542?><pub-id pub-id-type="pmid">7499542</pub-id></element-citation></ref><ref id="B221-brainsci-03-01483"><label>221.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Welker</surname><given-names>E.</given-names></name><name><surname>Soriano</surname><given-names>E.</given-names></name><name><surname>van der Loss</surname><given-names>H.</given-names></name></person-group>
<article-title>Plasticity in the barrel cortex of the adult mouse: Effects of peripheral deprivation on GAD-immunoreactivity</article-title>
<source>Exp. Brain Res.</source>
<year>1989</year>
<volume>74</volume>
<fpage>441</fpage>
<lpage>452</lpage>
<?supplied-pmid 2707320?><pub-id pub-id-type="pmid">2707320</pub-id></element-citation></ref><ref id="B222-brainsci-03-01483"><label>222.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cameron</surname><given-names>D.L.</given-names></name><name><surname>Williams</surname><given-names>J.T.</given-names></name></person-group>
<article-title>Cocaine inhibits GABA release in the VTA through endogenous 5-HT</article-title>
<source>J. Neurosci.</source>
<year>1994</year>
<volume>14</volume>
<fpage>6763</fpage>
<lpage>6767</lpage>
<?supplied-pmid 7965077?><pub-id pub-id-type="pmid">7965077</pub-id></element-citation></ref><ref id="B223-brainsci-03-01483"><label>223.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dewey</surname><given-names>S.L.</given-names></name><name><surname>Chaurasia</surname><given-names>C.S.</given-names></name><name><surname>Chen</surname><given-names>C.E.</given-names></name><name><surname>Volkow</surname><given-names>N.D.</given-names></name><name><surname>Clarkson</surname><given-names>F.A.</given-names></name><name><surname>Porter</surname><given-names>S.P.</given-names></name><name><surname>Straughter-Moore</surname><given-names>R.M.</given-names></name><name><surname>Alexoff</surname><given-names>D.L.</given-names></name><name><surname>Tedeschi</surname><given-names>D.</given-names></name><name><surname>Russo</surname><given-names>N.B.</given-names></name><etal/></person-group>
<article-title>ABAergic attenuation of cocaine-induced dopamine release and locomotor activity</article-title>
<source>Synapse</source>
<year>1997</year>
<volume>25</volume>
<fpage>393</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1098-2396(199704)25:4&#x0003c;393::AID-SYN11&#x0003e;3.0.CO;2-W</pub-id><?supplied-pmid 9097399?><pub-id pub-id-type="pmid">9097399</pub-id></element-citation></ref><ref id="B224-brainsci-03-01483"><label>224.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morgan</surname><given-names>A.E.</given-names></name><name><surname>Dewey</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine</article-title>
<source>Synapse</source>
<year>1998</year>
<volume>28</volume>
<fpage>60</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1098-2396(199801)28:1&#x0003c;60::AID-SYN7&#x0003e;3.0.CO;2-A</pub-id><?supplied-pmid 9414018?><pub-id pub-id-type="pmid">9414018</pub-id></element-citation></ref><ref id="B225-brainsci-03-01483"><label>225.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shoaib</surname><given-names>M.</given-names></name><name><surname>Swanner</surname><given-names>L.S.</given-names></name><name><surname>Beyer</surname><given-names>C.E.</given-names></name><name><surname>Goldberg</surname><given-names>S.R.</given-names></name><name><surname>Schindler</surname><given-names>C.W.</given-names></name></person-group>
<article-title>The GABAB agonist baclofen modifies cocaine self-administration in rats</article-title>
<source>Behav. Pharmacol.</source>
<year>1998</year>
<volume>9</volume>
<fpage>195</fpage>
<lpage>206</lpage>
<?supplied-pmid 9832934?><pub-id pub-id-type="pmid">9832934</pub-id></element-citation></ref><ref id="B226-brainsci-03-01483"><label>226.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Abe</surname><given-names>S.</given-names></name><name><surname>Yamaguchi</surname><given-names>M.</given-names></name><name><surname>Baba</surname><given-names>A.</given-names></name><name><surname>Hori</surname><given-names>T.</given-names></name><name><surname>Shiraishi</surname><given-names>H.</given-names></name><name><surname>Ito</surname><given-names>T.</given-names></name></person-group>
<article-title>Effects of cocaine administration on receptor binding and subunits mRNA of GABA(A)-benzodiazepine receptor complexes</article-title>
<source>Synapse</source>
<year>2000</year>
<volume>38</volume>
<fpage>198</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1002/1098-2396(200011)38:2&#x0003c;198::AID-SYN11&#x0003e;3.0.CO;2-K</pub-id><?supplied-pmid 11018794?><pub-id pub-id-type="pmid">11018794</pub-id></element-citation></ref><ref id="B227-brainsci-03-01483"><label>227.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lilly</surname><given-names>S.M.</given-names></name><name><surname>Tietz</surname><given-names>E.I.</given-names></name></person-group>
<article-title>Chronic cocaine differentially affects diazepam&#x02019;s anxiolytic and anticonvulsant actions. Relationship to GABA(A) receptor subunit expression</article-title>
<source>Brain Res.</source>
<year>2000</year>
<volume>882</volume>
<fpage>139</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(00)02858-4</pub-id><?supplied-pmid 11056193?><pub-id pub-id-type="pmid">11056193</pub-id></element-citation></ref><ref id="B228-brainsci-03-01483"><label>228.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abel</surname><given-names>M.S.</given-names></name><name><surname>Kohli</surname><given-names>N.</given-names></name></person-group>
<article-title>GABA-transaminase antisense oligodeoxynucleotide modulates cocaine- and pentylenetetrazol-induced seizures in mice</article-title>
<source>Metab. Brain Dis.</source>
<year>1999</year>
<volume>14</volume>
<fpage>253</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1023/A:1020737125843</pub-id><?supplied-pmid 10850552?><pub-id pub-id-type="pmid">10850552</pub-id></element-citation></ref><ref id="B229-brainsci-03-01483"><label>229.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Leon</surname><given-names>K.R.</given-names></name><name><surname>Todtenkopf</surname><given-names>M.S.</given-names></name><name><surname>Stellar</surname><given-names>J.R.</given-names></name></person-group>
<article-title>An examination of glutamate decarboxylase (65) immunoreactive puncta with respect to rat ventral pallidum neurons after repeated cocaine administration</article-title>
<source>Neurosci. Lett.</source>
<year>2000</year>
<volume>284</volume>
<fpage>69</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-3940(00)00973-3</pub-id><?supplied-pmid 10771164?><pub-id pub-id-type="pmid">10771164</pub-id></element-citation></ref><ref id="B230-brainsci-03-01483"><label>230.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ali</surname><given-names>S.F.</given-names></name><name><surname>Newport</surname><given-names>G.D.</given-names></name><name><surname>Scallet</surname><given-names>A.C.</given-names></name><name><surname>Gee</surname><given-names>K.W.</given-names></name><name><surname>Paule</surname><given-names>M.G.</given-names></name><name><surname>Brown</surname><given-names>R.M.</given-names></name><name><surname>Slikker</surname><given-names>W.</given-names></name></person-group>
<article-title>Effects of chronic delta-9-tetrahydrocannabinol (THC) administration on neurotransmitter concentrations and receptor binding in the rat brain</article-title>
<source>Neurotoxicology</source>
<year>1989</year>
<volume>10</volume>
<fpage>491</fpage>
<lpage>500</lpage>
<?supplied-pmid 2576303?><pub-id pub-id-type="pmid">2576303</pub-id></element-citation></ref><ref id="B231-brainsci-03-01483"><label>231.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bonci</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>J.T.</given-names></name></person-group>
<article-title>A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine</article-title>
<source>Neuron</source>
<year>1996</year>
<volume>16</volume>
<fpage>631</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80082-3</pub-id><?supplied-pmid 8785060?><pub-id pub-id-type="pmid">8785060</pub-id></element-citation></ref><ref id="B232-brainsci-03-01483"><label>232.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neugebauer</surname><given-names>V.</given-names></name><name><surname>Zinebi</surname><given-names>F.</given-names></name><name><surname>Russell</surname><given-names>R.</given-names></name><name><surname>Gallagher</surname><given-names>J.P.</given-names></name><name><surname>Shinnick-Gallagher</surname><given-names>P.</given-names></name></person-group>
<article-title>Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala</article-title>
<source>J. Neurophysiol.</source>
<year>2000</year>
<volume>84</volume>
<fpage>759</fpage>
<lpage>770</lpage>
<?supplied-pmid 10938303?><pub-id pub-id-type="pmid">10938303</pub-id></element-citation></ref><ref id="B233-brainsci-03-01483"><label>233.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Messer</surname><given-names>A.</given-names></name><name><surname>Gordon</surname><given-names>D.</given-names></name></person-group>
<article-title>Changes in whole tissue biosynthesis of gamma-amino butyric acid (GABA) in basal ganglia of the dystonia (dtAlb) mouse</article-title>
<source>Life Sci.</source>
<year>1979</year>
<volume>25</volume>
<fpage>2217</fpage>
<lpage>2221</lpage>
<pub-id pub-id-type="doi">10.1016/0024-3205(79)90095-X</pub-id><?supplied-pmid 542100?><pub-id pub-id-type="pmid">542100</pub-id></element-citation></ref><ref id="B234-brainsci-03-01483"><label>234.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richter</surname><given-names>A.</given-names></name><name><surname>L&#x000f6;scher</surname><given-names>W.</given-names></name></person-group>
<article-title>Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis</article-title>
<source>Eur. J. Pharmacol.</source>
<year>1999</year>
<volume>369</volume>
<fpage>335</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-2999(99)00104-1</pub-id><?supplied-pmid 10225372?><pub-id pub-id-type="pmid">10225372</pub-id></element-citation></ref><ref id="B235-brainsci-03-01483"><label>235.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weber</surname><given-names>O.M.</given-names></name><name><surname>Verhagen</surname><given-names>A.</given-names></name><name><surname>Duc</surname><given-names>D.O.</given-names></name><name><surname>Meier</surname><given-names>D.</given-names></name><name><surname>Leenders</surname><given-names>K.L.</given-names></name><name><surname>Boesiger</surname><given-names>P.</given-names></name></person-group>
<article-title>Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography</article-title>
<source>Magn. Reson. Imaging</source>
<year>1999</year>
<volume>17</volume>
<fpage>417</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="doi">10.1016/S0730-725X(98)00184-2</pub-id><?supplied-pmid 10195585?><pub-id pub-id-type="pmid">10195585</pub-id></element-citation></ref><ref id="B236-brainsci-03-01483"><label>236.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greene</surname><given-names>P.</given-names></name></person-group>
<article-title>Baclofen in the treatment of dystonia</article-title>
<source>Clin. Neuropharmacol.</source>
<year>1992</year>
<volume>15</volume>
<fpage>276</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1097/00002826-199208000-00002</pub-id><?supplied-pmid 1516073?><pub-id pub-id-type="pmid">1516073</pub-id></element-citation></ref><ref id="B237-brainsci-03-01483"><label>237.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petroff</surname><given-names>O.A.</given-names></name><name><surname>Rothman</surname><given-names>D.L.</given-names></name><name><surname>Behar</surname><given-names>K.L.</given-names></name><name><surname>Mattson</surname><given-names>R.H.</given-names></name></person-group>
<article-title>Low brain GABA level is associated with poor seizure control</article-title>
<source>Ann. Neurol.</source>
<year>1996</year>
<volume>40</volume>
<fpage>908</fpage>
<lpage>911</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410400613</pub-id><?supplied-pmid 9007096?><pub-id pub-id-type="pmid">9007096</pub-id></element-citation></ref><ref id="B238-brainsci-03-01483"><label>238.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Siebner</surname><given-names>H.R.</given-names></name><name><surname>Tormos</surname><given-names>J.M.</given-names></name><name><surname>Ceballos-Baumann</surname><given-names>A.O.</given-names></name><name><surname>Auer</surname><given-names>C.</given-names></name><name><surname>Catala</surname><given-names>M.D.</given-names></name><name><surname>Conrad</surname><given-names>B.</given-names></name><name><surname>Pascual-Leone</surname><given-names>A.</given-names></name></person-group>
<article-title>Low frequency repetitive transcranial magnetic stimulation of the motor cortex in writer&#x02019;s cramp</article-title>
<source>Neurology</source>
<year>1999</year>
<volume>52</volume>
<fpage>529</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.52.3.529</pub-id><?supplied-pmid 10025782?><pub-id pub-id-type="pmid">10025782</pub-id></element-citation></ref><ref id="B239-brainsci-03-01483"><label>239.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pascual-Leone</surname><given-names>A.</given-names></name><name><surname>Valls-Sole</surname><given-names>J.</given-names></name><name><surname>Wassermann</surname><given-names>E.M.</given-names></name><name><surname>Hallett</surname><given-names>M.</given-names></name></person-group>
<article-title>Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex</article-title>
<source>Brain</source>
<year>1994</year>
<volume>117</volume>
<fpage>847</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="doi">10.1093/brain/117.4.847</pub-id><?supplied-pmid 7922470?><pub-id pub-id-type="pmid">7922470</pub-id></element-citation></ref><ref id="B240-brainsci-03-01483"><label>240.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoshiyama</surname><given-names>M.</given-names></name><name><surname>Kakige</surname><given-names>R.</given-names></name></person-group>
<article-title>Shortening of the cortical silent period following transcranial magnetic brain stimulation during an experimental paradign for generating contingent negative variation (CNV)</article-title>
<source>Clin. Neurophysiol.</source>
<year>1999</year>
<volume>110</volume>
<fpage>1394</fpage>
<lpage>1398</lpage>
<pub-id pub-id-type="doi">10.1016/S1388-2457(99)00110-8</pub-id><?supplied-pmid 10454275?><pub-id pub-id-type="pmid">10454275</pub-id></element-citation></ref><ref id="B241-brainsci-03-01483"><label>241.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sommer</surname><given-names>M.</given-names></name><name><surname>Tergau</surname><given-names>F.</given-names></name><name><surname>Wischer</surname><given-names>S.</given-names></name><name><surname>Reimers</surname><given-names>C.D.</given-names></name><name><surname>Beuche</surname><given-names>W.</given-names></name><name><surname>Paulus</surname><given-names>W.</given-names></name></person-group>
<article-title>Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis</article-title>
<source>J. Neurol.</source>
<year>1999</year>
<volume>246</volume>
<fpage>22</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1007/BF03161086</pub-id></element-citation></ref><ref id="B242-brainsci-03-01483"><label>242.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ben-Shacher</surname><given-names>D.</given-names></name><name><surname>Gazawi</surname><given-names>H.</given-names></name><name><surname>Riboyad-Levin</surname><given-names>J.</given-names></name><name><surname>Klein</surname><given-names>E.</given-names></name></person-group>
<article-title>Chronic repetitive transcranial magnetic stimulation alters beta adrenergic and 5-HT2 receptor characteristics in rat brain</article-title>
<source>Brain Res.</source>
<year>1999</year>
<volume>816</volume>
<fpage>78</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(98)01119-6</pub-id><?supplied-pmid 9878693?><pub-id pub-id-type="pmid">9878693</pub-id></element-citation></ref><ref id="B243-brainsci-03-01483"><label>243.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Sommer</surname><given-names>M.</given-names></name><name><surname>Tergau</surname><given-names>F.</given-names></name><name><surname>Paulus</surname><given-names>W.</given-names></name></person-group>
<article-title>Lasting influence of repetitive transcranial magnetic stimulation on intracortical excitability in human subjects</article-title>
<source>Neurosci. Lett.</source>
<year>2000</year>
<volume>287</volume>
<fpage>37</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-3940(00)01132-0</pub-id><?supplied-pmid 10841985?><pub-id pub-id-type="pmid">10841985</pub-id></element-citation></ref><ref id="B244-brainsci-03-01483"><label>244.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Terao</surname><given-names>Y.</given-names></name><name><surname>Hayashi</surname><given-names>H.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name><name><surname>Tanabe</surname><given-names>H.</given-names></name><name><surname>Hanajima</surname><given-names>R.</given-names></name><name><surname>Ugawa</surname><given-names>Y.</given-names></name></person-group>
<article-title>Altered motor cortical excitability to magnetic stimulation in a patient with a lesion in the globus pallidus</article-title>
<source>J. Neurol. Sci.</source>
<year>1995</year>
<volume>129</volume>
<fpage>175</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1016/0022-510X(94)00273-Q</pub-id><?supplied-pmid 7608733?><pub-id pub-id-type="pmid">7608733</pub-id></element-citation></ref><ref id="B245-brainsci-03-01483"><label>245.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Siebner</surname><given-names>H.R.</given-names></name><name><surname>Dressmandt</surname><given-names>J.</given-names></name><name><surname>Auer</surname><given-names>C.</given-names></name><name><surname>Conrad</surname><given-names>B.</given-names></name></person-group>
<article-title>Continuous tracheal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia</article-title>
<source>Muscle Nerve</source>
<year>1998</year>
<volume>21</volume>
<fpage>1209</fpage>
<lpage>1212</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1097-4598(199809)21:9&#x0003c;1209::AID-MUS15&#x0003e;3.0.CO;2-M</pub-id><?supplied-pmid 9703450?><pub-id pub-id-type="pmid">9703450</pub-id></element-citation></ref><ref id="B246-brainsci-03-01483"><label>246.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>W.F.</given-names></name><name><surname>Woodbury</surname><given-names>R.A.</given-names></name><name><surname>Harper</surname><given-names>H.T.</given-names><suffix>Jr.</suffix></name></person-group>
<article-title>Physiologic relationships between intrathoracic, intraspinal and arterial pressure</article-title>
<source>JAMA</source>
<year>1936</year>
<volume>107</volume>
<fpage>853</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="doi">10.1001/jama.1936.02770370017005</pub-id></element-citation></ref><ref id="B247-brainsci-03-01483"><label>247.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>R.A.</given-names></name><name><surname>Tajik</surname><given-names>A.J.</given-names></name></person-group>
<article-title>The valsalva maneuver and response revisited</article-title>
<source>Mayo Clin. Prac.</source>
<year>1986</year>
<volume>61</volume>
<fpage>211</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1016/S0025-6196(12)61852-7</pub-id></element-citation></ref><ref id="B248-brainsci-03-01483"><label>248.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>W.F.</given-names></name><name><surname>Woodbury</surname><given-names>R.A.</given-names></name><name><surname>Harper</surname><given-names>H.T.</given-names><suffix>Jr.</suffix></name></person-group>
<article-title>Arterial, cerebrospinal and venous pressures in man during cough and strain</article-title>
<source>Am. J. Physiol.</source>
<year>1944</year>
<volume>141</volume>
<fpage>42</fpage>
<lpage>50</lpage>
</element-citation></ref><ref id="B249-brainsci-03-01483"><label>249.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bellet</surname><given-names>S.</given-names></name></person-group>
<source>Essentials of Cardiac Arrhythmias: Diagnosis and Management</source>
<publisher-name>Saunders</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>1972</year>
<fpage>102</fpage>
<lpage>114</lpage>
</element-citation></ref><ref id="B250-brainsci-03-01483"><label>250.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Waxman</surname><given-names>M.B.</given-names></name><name><surname>Wald</surname><given-names>R.W.</given-names></name><name><surname>Finley</surname><given-names>J.P.</given-names></name><name><surname>Bonet</surname><given-names>J.F.</given-names></name><name><surname>Downar</surname><given-names>E.</given-names></name><name><surname>Sharma</surname><given-names>A.D.</given-names></name></person-group>
<article-title>Valsalva termination of ventricular tachycardia</article-title>
<source>Circulation</source>
<year>1980</year>
<volume>62</volume>
<fpage>843</fpage>
<lpage>851</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.62.4.843</pub-id><?supplied-pmid 6773699?><pub-id pub-id-type="pmid">6773699</pub-id></element-citation></ref><ref id="B251-brainsci-03-01483"><label>251.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levine</surname><given-names>H.J.</given-names></name><name><surname>McIntyre</surname><given-names>K.M.</given-names></name><name><surname>Glovsky</surname><given-names>M.M.</given-names></name></person-group>
<article-title>Relief of angina pectoris by Valsalva maneuver</article-title>
<source>N. Engl. J. Med.</source>
<year>1966</year>
<volume>275</volume>
<fpage>487</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM196609012750907</pub-id><?supplied-pmid 5917943?><pub-id pub-id-type="pmid">5917943</pub-id></element-citation></ref><ref id="B252-brainsci-03-01483"><label>252.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pepine</surname><given-names>C.J.</given-names></name><name><surname>Wiener</surname><given-names>L.</given-names></name></person-group>
<article-title>Clinical and hemodynamic responses to the Valsalva maneuver during angina pectoris (abstract)</article-title>
<source>Circulation</source>
<year>1971</year>
<volume>44</volume>
<fpage>50</fpage>
</element-citation></ref><ref id="B253-brainsci-03-01483"><label>253.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burcharth</surname><given-names>F.</given-names></name><name><surname>Bertheussen</surname><given-names>K.</given-names></name></person-group>
<article-title>The influence of posture, Valsalva maneuver and coughing on portal hypertension in cirrhosis</article-title>
<source>Scand. J. Clin. Lab. Invest.</source>
<year>1979</year>
<volume>39</volume>
<fpage>665</fpage>
<lpage>669</lpage>
<pub-id pub-id-type="doi">10.3109/00365517909108872</pub-id><?supplied-pmid 556537?><pub-id pub-id-type="pmid">556537</pub-id></element-citation></ref><ref id="B254-brainsci-03-01483"><label>254.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jankovic</surname><given-names>G.M.</given-names></name></person-group>
<article-title>Factor VIII response to a Valsalva manoeuvre</article-title>
<source>Br. J. Haematol.</source>
<year>1980</year>
<volume>46</volume>
<fpage>137</fpage>
<lpage>139</lpage>
<?supplied-pmid 6775676?><pub-id pub-id-type="pmid">6775676</pub-id></element-citation></ref><ref id="B255-brainsci-03-01483"><label>255.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>T.M.</given-names></name><name><surname>Nayak</surname><given-names>A.S.</given-names></name><name><surname>Glynn</surname><given-names>P.</given-names></name></person-group>
<article-title>Oxygenation-sensitive sensory contrast in magnetic resonance image of rodent brain at high magnetic fields</article-title>
<source>Mag. Reson. Med.</source>
<year>1990</year>
<volume>14</volume>
<fpage>68</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1002/mrm.1910140108</pub-id></element-citation></ref><ref id="B256-brainsci-03-01483"><label>256.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwong</surname><given-names>K.K.</given-names></name><name><surname>Belliveau</surname><given-names>J.W.</given-names></name><name><surname>Chesler</surname><given-names>D.A.</given-names></name><name><surname>Goldberg</surname><given-names>I.E.</given-names></name><name><surname>Weiskoff</surname><given-names>R.M.</given-names></name><name><surname>Poncelet</surname><given-names>B.P.</given-names></name><name><surname>Kennedy</surname><given-names>D.N.</given-names></name><name><surname>Hoppel</surname><given-names>B.E.</given-names></name><name><surname>Cohen</surname><given-names>M.S.</given-names></name><name><surname>Turner</surname><given-names>R.</given-names></name><etal/></person-group>
<article-title>Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>1992</year>
<volume>89</volume>
<fpage>5675</fpage>
<lpage>5679</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.89.12.5675</pub-id><?supplied-pmid 1608978?><pub-id pub-id-type="pmid">1608978</pub-id></element-citation></ref><ref id="B257-brainsci-03-01483"><label>257.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lempert</surname><given-names>T.</given-names></name><name><surname>Bauer</surname><given-names>M.</given-names></name><name><surname>Schmidt</surname><given-names>D.</given-names></name></person-group>
<article-title>Syncope: A videometric analysis of 56 episodes of transient cerebral hypoxia</article-title>
<source>Ann. Neurol.</source>
<year>1994</year>
<volume>36</volume>
<fpage>233</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410360217</pub-id><?supplied-pmid 8053660?><pub-id pub-id-type="pmid">8053660</pub-id></element-citation></ref><ref id="B258-brainsci-03-01483"><label>258.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duvoisin</surname><given-names>R.C.</given-names></name></person-group>
<article-title>Convulsive syncope induced by the Weber maneuver</article-title>
<source>Arch. Neurol.</source>
<year>1962</year>
<volume>7</volume>
<fpage>219</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.1962.04210030057008</pub-id><?supplied-pmid 13888762?><pub-id pub-id-type="pmid">13888762</pub-id></element-citation></ref><ref id="B259-brainsci-03-01483"><label>259.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Whinnery</surname><given-names>J.E.</given-names></name><name><surname>Whinnery</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Acceleration-induced loss of consciousness. A review of 500 episodes</article-title>
<source>Arch. Neurol.</source>
<year>1990</year>
<volume>47</volume>
<fpage>764</fpage>
<lpage>776</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.1990.00530070058012</pub-id><?supplied-pmid 2357157?><pub-id pub-id-type="pmid">2357157</pub-id></element-citation></ref><ref id="B260-brainsci-03-01483"><label>260.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harper</surname><given-names>R.M.</given-names></name><name><surname>Gozal</surname><given-names>D.</given-names></name><name><surname>Bandler</surname><given-names>R.</given-names></name><name><surname>Spriggs</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Alger</surname><given-names>J.</given-names></name></person-group>
<article-title>Regional brain activation in humans during respiratory and blood pressure challenges</article-title>
<source>Clin. Exp. Pharmacol. Physiol.</source>
<year>1998</year>
<volume>25</volume>
<fpage>483</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1681.1998.tb02240.x</pub-id><?supplied-pmid 9673830?><pub-id pub-id-type="pmid">9673830</pub-id></element-citation></ref><ref id="B261-brainsci-03-01483"><label>261.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Posse</surname><given-names>S.</given-names></name><name><surname>Olthoff</surname><given-names>U.</given-names></name><name><surname>Weckesser</surname><given-names>M.</given-names></name><name><surname>J&#x000e4;ncke-M&#x000fc;ller-G&#x000e4;rtner</surname><given-names>H.W.</given-names></name><name><surname>Dager</surname><given-names>S.R.</given-names></name></person-group>
<article-title>Regional dynamic signal changes during controlled hyperventilation assessed with blood oxygen level-dependent functional MR imaging</article-title>
<source>Am. J. Neuroradiol.</source>
<year>1997</year>
<volume>18</volume>
<fpage>1763</fpage>
<lpage>1770</lpage>
<?supplied-pmid 9367329?><pub-id pub-id-type="pmid">9367329</pub-id></element-citation></ref><ref id="B262-brainsci-03-01483"><label>262.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Roberts</surname><given-names>E.</given-names></name></person-group>
<article-title>Gamma-Aminobutyric Acid (GABA)</article-title>
<source>Encyclopedia of Neuroscience</source>
<person-group person-group-type="editor"><name><surname>Adelman</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>B.H.</given-names></name></person-group>
<publisher-name>Elsevier</publisher-name>
<publisher-loc>Amsterdam, The Netherlands</publisher-loc>
<year>1999</year>
<fpage>745</fpage>
<lpage>749</lpage>
</element-citation></ref><ref id="B263-brainsci-03-01483"><label>263.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>K.</given-names></name><name><surname>Goddard</surname><given-names>G.V.</given-names></name></person-group>
<article-title>Kindling induced changes in EEG recorded during stimulation from the site of stimulation: Collapse of GABA-mediated inhibition and onset of rhythymic synchronous burst</article-title>
<source>Exp. Neurol.</source>
<year>1986</year>
<volume>94</volume>
<fpage>551</fpage>
<lpage>584</lpage>
</element-citation></ref><ref id="B264-brainsci-03-01483"><label>264.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Harris</surname><given-names>J.K.</given-names></name><name><surname>DeLorenzo</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Epilepsy-A Molecular and Cellular Views</article-title>
<source>Epilepsy: Current Approaches to Diagnosis and Treatment</source>
<person-group person-group-type="editor"><name><surname>Smith</surname><given-names>D.B.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1990</year>
<fpage>227</fpage>
<lpage>237</lpage>
</element-citation></ref><ref id="B265-brainsci-03-01483"><label>265.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McNamara</surname><given-names>J.O.</given-names></name><name><surname>Bonhaus</surname><given-names>D.W.</given-names></name><name><surname>Shin</surname><given-names>C.</given-names></name><name><surname>Crain</surname><given-names>B.J.</given-names></name><name><surname>Gellman</surname><given-names>R.L.</given-names></name><name><surname>Giacchino</surname><given-names>J.L.</given-names></name></person-group>
<article-title>The kindling model of epilepsy, a critical review</article-title>
<source>CRC Crit. Rev. Clin. Neurobiol.</source>
<year>1985</year>
<volume>1</volume>
<fpage>341</fpage>
<lpage>391</lpage>
<?supplied-pmid 3915977?><pub-id pub-id-type="pmid">3915977</pub-id></element-citation></ref><ref id="B266-brainsci-03-01483"><label>266.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsura</surname><given-names>N.</given-names></name></person-group>
<article-title>Neuronal firing pattern following amygdaloid kindling in unrestrained rats</article-title>
<source>Epilepsia</source>
<year>1985</year>
<volume>26</volume>
<fpage>488</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1985.tb05685.x</pub-id><?supplied-pmid 4043019?><pub-id pub-id-type="pmid">4043019</pub-id></element-citation></ref><ref id="B267-brainsci-03-01483"><label>267.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Wasterlain</surname><given-names>C.G.</given-names></name><name><surname>Morin</surname><given-names>A.M.</given-names></name><name><surname>Fujikawa</surname><given-names>D.G.</given-names></name><name><surname>Bronstein</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Chemical Kindling</article-title>
<source>The Clinical Relevance of Kindling</source>
<person-group person-group-type="editor"><name><surname>Bolwig</surname><given-names>T.G.</given-names></name><name><surname>Trimble</surname><given-names>M.R.</given-names></name></person-group>
<publisher-name>J. Wiley &#x00026; Sons</publisher-name>
<publisher-loc>Chichester, UK</publisher-loc>
<year>1989</year>
<fpage>35</fpage>
<lpage>53</lpage>
</element-citation></ref><ref id="B268-brainsci-03-01483"><label>268.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goddard</surname><given-names>G.</given-names></name><name><surname>McIntyre</surname><given-names>D.</given-names></name><name><surname>Leech</surname><given-names>C.K.</given-names></name></person-group>
<article-title>A permanent change in brain function resulting from daily electrical stimulation</article-title>
<source>Exp. Neurol.</source>
<year>1969</year>
<volume>25</volume>
<fpage>295</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1016/0014-4886(69)90128-9</pub-id><?supplied-pmid 4981856?><pub-id pub-id-type="pmid">4981856</pub-id></element-citation></ref><ref id="B269-brainsci-03-01483"><label>269.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goddard</surname><given-names>G.V.</given-names></name></person-group>
<article-title>The kindling model of epilepsy</article-title>
<source>Trends Neurosci.</source>
<year>1983</year>
<volume>6</volume>
<fpage>275</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="doi">10.1016/0166-2236(83)90118-2</pub-id></element-citation></ref><ref id="B270-brainsci-03-01483"><label>270.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Morrell</surname><given-names>F.</given-names></name></person-group>
<source>Kindling and Synaptic Plasticity: The Legacy of Graham Goddard</source>
<publisher-name>Birkhauser</publisher-name>
<publisher-loc>Boston, MA, USA</publisher-loc>
<year>1991</year>
</element-citation></ref><ref id="B271-brainsci-03-01483"><label>271.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Burchfiel</surname><given-names>J.L.</given-names></name><name><surname>Appelgate</surname><given-names>C.D.</given-names></name><name><surname>Samoriski</surname><given-names>G.M.</given-names></name><name><surname>Nierenberg</surname><given-names>J.</given-names></name></person-group>
<article-title>The Role of Rhinencephalic Networks in Early Stage Kindling</article-title>
<source>Kindling 5 Advances in Behavioral Biology</source>
<person-group person-group-type="editor"><name><surname>Corcoran</surname><given-names>M.E.</given-names></name><name><surname>Moshe</surname><given-names>S.L.</given-names></name></person-group>
<publisher-name>Springer</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1998</year>
<fpage>133</fpage>
<lpage>149</lpage>
</element-citation></ref><ref id="B272-brainsci-03-01483"><label>272.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Appelgate</surname><given-names>C.D.</given-names></name><name><surname>Burchfiel</surname><given-names>J.L.</given-names></name><name><surname>Ferland</surname><given-names>R.J.</given-names></name><name><surname>Nierenberg</surname><given-names>J.</given-names></name></person-group>
<article-title>The Role of Rhinencephalic Networks in the Late Stages of Kindling</article-title>
<source>Kindling 5 Advances in Behavioral Biology</source>
<person-group person-group-type="editor"><name><surname>Corcoran</surname><given-names>M.E.</given-names></name><name><surname>Moshe</surname><given-names>S.L.</given-names></name></person-group>
<publisher-name>Springer</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1998</year>
<fpage>151</fpage>
<lpage>165</lpage>
</element-citation></ref><ref id="B273-brainsci-03-01483"><label>273.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>McIntyre</surname><given-names>D.C.</given-names></name><name><surname>Kelly</surname><given-names>M.E.</given-names></name></person-group>
<article-title>The Perirhinal Cortex and Kindled Motor Seizures. The Role of Rhinencephalic Networks in Early Stage Kindling</article-title>
<source>Kindling 5 Advances in Behavioral Biology</source>
<person-group person-group-type="editor"><name><surname>Corcoran</surname><given-names>M.E.</given-names></name><name><surname>Moshe</surname><given-names>S.L.</given-names></name></person-group>
<publisher-name>Springer</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1998</year>
<fpage>167</fpage>
<lpage>177</lpage>
</element-citation></ref><ref id="B274-brainsci-03-01483"><label>274.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Corcoran</surname><given-names>M.E.</given-names></name></person-group>
<article-title>Catecholamines and Kindling</article-title>
<source>Kindling 2</source>
<person-group person-group-type="editor"><name><surname>Wada</surname><given-names>J.A.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1981</year>
<fpage>87</fpage>
<lpage>104</lpage>
</element-citation></ref><ref id="B275-brainsci-03-01483"><label>275.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Piwko</surname><given-names>C.</given-names></name><name><surname>Gobbi</surname><given-names>M.</given-names></name><name><surname>Schwarzer</surname><given-names>C.</given-names></name><name><surname>Sperk</surname><given-names>G.</given-names></name><name><surname>Hoyer</surname><given-names>D.</given-names></name></person-group>
<article-title>Somatostatin-and Neuropeptide y-Mediated Neurotransmission in Kindling Epileptogenesis</article-title>
<source>Kindling 5 Advances in Behavioral Biology</source>
<person-group person-group-type="editor"><name><surname>Corcoran</surname><given-names>M.E.</given-names></name><name><surname>Moshe</surname><given-names>S.L.</given-names></name></person-group>
<publisher-name>Springer</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1998</year>
<fpage>313</fpage>
<lpage>325</lpage>
</element-citation></ref><ref id="B276-brainsci-03-01483"><label>276.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nillni</surname><given-names>E.A.</given-names></name><name><surname>Sevarino</surname><given-names>K.A.</given-names></name></person-group>
<article-title>The biology of prothyrotropin-releasing hormone-derived peptides</article-title>
<source>Endocr. Rev.</source>
<year>1999</year>
<volume>20</volume>
<fpage>599</fpage>
<lpage>648</lpage>
<pub-id pub-id-type="doi">10.1210/er.20.5.599</pub-id><?supplied-pmid 10529897?><pub-id pub-id-type="pmid">10529897</pub-id></element-citation></ref><ref id="B277-brainsci-03-01483"><label>277.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holmes</surname><given-names>G.L.</given-names></name><name><surname>Weber</surname><given-names>D.A.</given-names></name></person-group>
<article-title>Effects of hypoxic-ischemic encephalopathies on kindling in the immature brain</article-title>
<source>Exp. Neurol.</source>
<year>1985</year>
<volume>90</volume>
<fpage>194</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1016/0014-4886(85)90052-4</pub-id><?supplied-pmid 4043292?><pub-id pub-id-type="pmid">4043292</pub-id></element-citation></ref><ref id="B278-brainsci-03-01483"><label>278.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moshe</surname><given-names>S.L.</given-names></name><name><surname>Albala</surname><given-names>B.J.</given-names></name></person-group>
<article-title>Perinatal hypoxia and subsequent development of seizures</article-title>
<source>Physiol. Behav.</source>
<year>1985</year>
<volume>35</volume>
<fpage>819</fpage>
<lpage>823</lpage>
<pub-id pub-id-type="doi">10.1016/0031-9384(85)90418-4</pub-id><?supplied-pmid 3936075?><pub-id pub-id-type="pmid">3936075</pub-id></element-citation></ref><ref id="B279-brainsci-03-01483"><label>279.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vion-Dury</surname><given-names>J.</given-names></name><name><surname>Rougier</surname><given-names>I.</given-names></name><name><surname>LeGal LaSalle</surname><given-names>G.</given-names></name><name><surname>Bras</surname><given-names>J.</given-names></name><name><surname>Papy</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Epileptogenesis caused by the kindling effect in diving at 3 ATA of air</article-title>
<source>J. Physiol. (Paris)</source>
<year>1985</year>
<volume>80</volume>
<fpage>32</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="pmid">4020711</pub-id></element-citation></ref><ref id="B280-brainsci-03-01483"><label>280.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vion-Dury</surname><given-names>J.</given-names></name><name><surname>LeGal LaSalle</surname><given-names>G.</given-names></name><name><surname>Rougier</surname><given-names>I.</given-names></name><name><surname>Papy</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Effects of hyperbaric and hyperoxic conditions on amygdala kindled seizures in rat</article-title>
<source>Exp. Neurol.</source>
<year>1986</year>
<volume>92</volume>
<fpage>513</fpage>
<lpage>521</lpage>
<pub-id pub-id-type="doi">10.1016/0014-4886(86)90293-1</pub-id><?supplied-pmid 3709731?><pub-id pub-id-type="pmid">3709731</pub-id></element-citation></ref><ref id="B281-brainsci-03-01483"><label>281.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frantseva</surname><given-names>M.V.</given-names></name><name><surname>Perez Velazquez</surname><given-names>J.L.</given-names></name><name><surname>Tsoraklidis</surname><given-names>G.</given-names></name><name><surname>Mendonca</surname><given-names>A.J.</given-names></name><name><surname>Adamchik</surname><given-names>Y.</given-names></name><name><surname>Mills</surname><given-names>L.R.</given-names></name><name><surname>Carlen</surname><given-names>P.L.</given-names></name><name><surname>Burnham</surname><given-names>M.W.</given-names></name></person-group>
<article-title>Oxidative stress is involved in seizure induced neurodegeneration in the kindling model of epilepsy</article-title>
<source>Neuroscience</source>
<year>2000</year>
<volume>97</volume>
<fpage>431</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(00)00041-5</pub-id><?supplied-pmid 10828526?><pub-id pub-id-type="pmid">10828526</pub-id></element-citation></ref><ref id="B282-brainsci-03-01483"><label>282.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laffey</surname><given-names>J.G.</given-names></name><name><surname>Kavanaugh</surname><given-names>B.P.</given-names></name></person-group>
<article-title>Carbon dioxide and the critically ill&#x02014;Too little of a good thing?</article-title>
<source>Lancet</source>
<year>1999</year>
<volume>354</volume>
<fpage>1283</fpage>
<lpage>1286</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(99)02388-0</pub-id><?supplied-pmid 10520649?><pub-id pub-id-type="pmid">10520649</pub-id></element-citation></ref><ref id="B283-brainsci-03-01483"><label>283.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lennox</surname><given-names>W.G.</given-names></name><name><surname>Gibbs</surname><given-names>F.A.</given-names></name><name><surname>Gibbs</surname><given-names>E.L.</given-names></name></person-group>
<article-title>The relationship in man of cerebral activity to blood flow and to blood constituents</article-title>
<source>J. Neurol. Psychiatry</source>
<year>1938</year>
<volume>1</volume>
<fpage>221</fpage>
<lpage>225</lpage>
</element-citation></ref><ref id="B284-brainsci-03-01483"><label>284.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woodbury</surname><given-names>D.M.</given-names></name><name><surname>Rollins</surname><given-names>L.T.</given-names></name><name><surname>Cardner</surname><given-names>M.O.</given-names></name><name><surname>Hirschi</surname><given-names>W.L.</given-names></name><name><surname>Hogan</surname><given-names>J.R.</given-names></name><name><surname>Rallison</surname><given-names>M.L.</given-names></name><name><surname>Tanner</surname><given-names>G.S.</given-names></name><name><surname>Brodie</surname><given-names>D.A.</given-names></name></person-group>
<article-title>Effects of carbon dioxide on brain excitability and electrolytes</article-title>
<source>Am. J. Physiol.</source>
<year>1957</year>
<volume>192</volume>
<fpage>79</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">13498155</pub-id></element-citation></ref><ref id="B285-brainsci-03-01483"><label>285.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bird</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Hyperventilation and Panic Attacks</article-title>
<source>Epilepsy: A Comprehensive Textbook</source>
<person-group person-group-type="editor"><name><surname>Engel</surname><given-names>J.</given-names><suffix>Jr.</suffix></name><name><surname>Padley</surname><given-names>T.A.</given-names></name></person-group>
<publisher-name>Lippincott-Raven</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>1997</year>
<volume>Volume 3</volume>
<fpage>2785</fpage>
<lpage>2790</lpage>
</element-citation></ref><ref id="B286-brainsci-03-01483"><label>286.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meduna</surname><given-names>L.J.</given-names></name><name><surname>Gyarfas</surname><given-names>K.</given-names></name></person-group>
<article-title>Motor and sensory phenomena during CO<sub>2</sub> inhalations</article-title>
<source>Dis. Nerv. Syst.</source>
<year>1949</year>
<volume>10</volume>
<fpage>3</fpage>
<lpage>7</lpage>
<?supplied-pmid 18105429?><pub-id pub-id-type="pmid">18105429</pub-id></element-citation></ref><ref id="B287-brainsci-03-01483"><label>287.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gyarfas</surname><given-names>K.</given-names></name><name><surname>Pollack</surname><given-names>G.H.</given-names></name><name><surname>Stein</surname><given-names>S.N.</given-names></name></person-group>
<article-title>Central inhibitory effects of carbon dioxide, IV. Convulsive phenomena</article-title>
<source>Exp. Biol. Med.</source>
<year>1949</year>
<volume>70</volume>
<fpage>292</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.3181/00379727-70-16903</pub-id></element-citation></ref><ref id="B288-brainsci-03-01483"><label>288.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leake</surname><given-names>C.D.</given-names></name><name><surname>Waters</surname><given-names>R.M.</given-names></name></person-group>
<article-title>The anesthetic properties of carbon dioxide</article-title>
<source>Anesth. Analg.</source>
<year>1929</year>
<volume>8</volume>
<fpage>17</fpage>
<lpage>19</lpage>
</element-citation></ref><ref id="B289-brainsci-03-01483"><label>289.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seevers</surname><given-names>M.H.</given-names></name></person-group>
<article-title>The narcotic properties of carbon dioxide</article-title>
<source>N. Y. State J. Med.</source>
<year>1944</year>
<volume>44</volume>
<fpage>597</fpage>
<lpage>602</lpage>
</element-citation></ref><ref id="B290-brainsci-03-01483"><label>290.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poulsen</surname><given-names>T.</given-names></name></person-group>
<article-title>Investigations into the anesthetic properties of carbon dioxide</article-title>
<source>Acta Pharmacol. Toxicol.</source>
<year>1952</year>
<volume>8</volume>
<fpage>30</fpage>
<lpage>46</lpage>
</element-citation></ref><ref id="B291-brainsci-03-01483"><label>291.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>F.A.</given-names></name><name><surname>Gibbs</surname><given-names>E.L.</given-names></name><name><surname>Lennox</surname><given-names>W.G.</given-names></name></person-group>
<article-title>Cerebral dysrhythmias of epilepsy</article-title>
<source>Arch. Neurol. Psychiatry</source>
<year>1938</year>
<volume>39</volume>
<fpage>298</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="doi">10.1001/archneurpsyc.1938.02270020088007</pub-id></element-citation></ref><ref id="B292-brainsci-03-01483"><label>292.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Clowes</surname><given-names>G.H.A.</given-names><suffix>Jr.</suffix></name><name><surname>Hopkins</surname><given-names>A.L.</given-names></name><name><surname>Simeone</surname><given-names>F.A.</given-names></name></person-group>
<article-title>A comparison of the physiological effects of hypercapnia and hypoxia in the production of cardiac arrest</article-title>
<source>Ann. Surg.</source>
<year>1955</year>
<volume>142</volume>
<fpage>446</fpage>
<lpage>460</lpage>
<pub-id pub-id-type="doi">10.1097/00000658-195509000-00011</pub-id><?supplied-pmid 13249341?><pub-id pub-id-type="pmid">13249341</pub-id></element-citation></ref><ref id="B293-brainsci-03-01483"><label>293.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roth</surname><given-names>M.</given-names></name><name><surname>Harper</surname><given-names>M.</given-names></name></person-group>
<article-title>Temporal lobe epilepsy and the phobic anxiety-depersonalization syndrome. II. Practical and theoretical considerations</article-title>
<source>Compr. Psychiatry</source>
<year>1962</year>
<volume>3</volume>
<fpage>215</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="doi">10.1016/S0010-440X(62)80022-4</pub-id><?supplied-pmid 14494394?><pub-id pub-id-type="pmid">14494394</pub-id></element-citation></ref><ref id="B294-brainsci-03-01483"><label>294.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holmberg</surname><given-names>G.</given-names></name></person-group>
<article-title>The electroencephalogram during hypoxia and hyperventilation</article-title>
<source>Electroencephalogr. Clin. Neurophysiol.</source>
<year>1953</year>
<volume>5</volume>
<fpage>371</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="doi">10.1016/0013-4694(53)90078-9</pub-id><?supplied-pmid 13068301?><pub-id pub-id-type="pmid">13068301</pub-id></element-citation></ref><ref id="B295-brainsci-03-01483"><label>295.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Wyke</surname><given-names>B.</given-names></name></person-group>
<source>Brain Function and Metabolic Disorders: The Neurological Effects of Changes in Hydrogen ion Concentration</source>
<publisher-name>Butterworths</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>1963</year>
</element-citation></ref><ref id="B296-brainsci-03-01483"><label>296.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bellodi</surname><given-names>L.</given-names></name><name><surname>Perna</surname><given-names>G.</given-names></name><name><surname>Caldirola</surname><given-names>D.</given-names></name><name><surname>Arancio</surname><given-names>C.</given-names></name><name><surname>Bertani</surname><given-names>A.</given-names></name><name><surname>Di Bella</surname><given-names>D.</given-names></name></person-group>
<article-title>CO<sub>2</sub> induced panic attacks: A twin study</article-title>
<source>Am. J. Psychiatry</source>
<year>1998</year>
<volume>155</volume>
<fpage>1184</fpage>
<lpage>1188</lpage>
<?supplied-pmid 9734540?><pub-id pub-id-type="pmid">9734540</pub-id></element-citation></ref><ref id="B297-brainsci-03-01483"><label>297.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Papp</surname><given-names>L.A.</given-names></name><name><surname>Marinez</surname><given-names>J.M.</given-names></name><name><surname>Kelin</surname><given-names>D.F.</given-names></name><name><surname>Coplan</surname><given-names>J.D.</given-names></name><name><surname>Norman</surname><given-names>R.G.</given-names></name><name><surname>Cole</surname><given-names>R.</given-names></name><name><surname>de Jesus</surname><given-names>M.J.</given-names></name><name><surname>Ross</surname><given-names>D.</given-names></name><name><surname>Goetz</surname><given-names>R.</given-names></name><name><surname>Gorman</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Respiratory psychopathology of panic disorder: Three respiratory challenges in 98 subjects</article-title>
<source>Am. J. Psychiatry</source>
<year>1997</year>
<volume>154</volume>
<fpage>1557</fpage>
<lpage>1565</lpage>
<?supplied-pmid 9356564?><pub-id pub-id-type="pmid">9356564</pub-id></element-citation></ref><ref id="B298-brainsci-03-01483"><label>298.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roy-Byrne</surname><given-names>P.P.</given-names></name><name><surname>Cowley</surname><given-names>D.S.</given-names></name></person-group>
<article-title>Search for pathophysiology of panic disorder</article-title>
<source>Lancet</source>
<year>1998</year>
<volume>352</volume>
<fpage>1646</fpage>
<lpage>1647</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(05)61445-6</pub-id><?supplied-pmid 9853434?><pub-id pub-id-type="pmid">9853434</pub-id></element-citation></ref><ref id="B299-brainsci-03-01483"><label>299.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>E.B.</given-names><suffix>Jr.</suffix></name></person-group>
<article-title>Physiological effects of hyperventilation</article-title>
<source>Physiol. Rev.</source>
<year>1953</year>
<volume>33</volume>
<fpage>445</fpage>
<lpage>471</lpage>
<?supplied-pmid 13100065?><pub-id pub-id-type="pmid">13100065</pub-id></element-citation></ref><ref id="B300-brainsci-03-01483"><label>300.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Magarian</surname><given-names>G.J.</given-names></name><name><surname>Olney</surname><given-names>R.K.</given-names></name></person-group>
<article-title>Absence spells. Hyperventilation syndrome as a previously unrecognized cause</article-title>
<source>Am. J. Med.</source>
<year>1984</year>
<volume>76</volume>
<fpage>905</fpage>
<lpage>909</lpage>
<pub-id pub-id-type="doi">10.1016/0002-9343(84)91007-6</pub-id><?supplied-pmid 6426301?><pub-id pub-id-type="pmid">6426301</pub-id></element-citation></ref><ref id="B301-brainsci-03-01483"><label>301.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stillman</surname><given-names>A.E.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Jerosch-Herold</surname><given-names>M.</given-names></name></person-group>
<article-title>Functional MRI of brain during breath holding at 4T</article-title>
<source>Magn. Reson. Imaging</source>
<year>1995</year>
<volume>13</volume>
<fpage>893</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="doi">10.1016/0730-725X(95)00037-H</pub-id><?supplied-pmid 8544661?><pub-id pub-id-type="pmid">8544661</pub-id></element-citation></ref><ref id="B302-brainsci-03-01483"><label>302.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwong</surname><given-names>K.K.</given-names></name><name><surname>Wanke</surname><given-names>I.</given-names></name><name><surname>Donahue</surname><given-names>K.M.</given-names></name><name><surname>Dass</surname><given-names>T.L.</given-names></name><name><surname>Rosen</surname><given-names>B.R.</given-names></name></person-group>
<article-title>EPI imaging of global increase in brain MR signal with breath-hold preceded by breathing O<sub>2</sub></article-title>
<source>Magn. Reson. Med.</source>
<year>1995</year>
<volume>33</volume>
<fpage>448</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1002/mrm.1910330322</pub-id><?supplied-pmid 7760716?><pub-id pub-id-type="pmid">7760716</pub-id></element-citation></ref><ref id="B303-brainsci-03-01483"><label>303.</label><element-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Moritz</surname><given-names>C.H.</given-names></name><name><surname>Meyerand</surname><given-names>M.E.</given-names></name><name><surname>Saykin</surname><given-names>A.J.</given-names></name></person-group>
<article-title>BOLD Contrast Response in Human Brain during Simple Breathhold Measured at 1.5 Tesla</article-title>
<source>Proceedings of the ISMRM 6th Annual Meeting</source>
<conf-loc>Sydney, Australia</conf-loc>
<conf-date>18&#x02013;24 April 1998</conf-date>
<fpage>1405</fpage>
</element-citation></ref><ref id="B304-brainsci-03-01483"><label>304.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>T.-Q.</given-names></name><name><surname>Kastrup</surname><given-names>A.</given-names></name><name><surname>Takakashi</surname><given-names>A.M.</given-names></name><name><surname>Moseley</surname><given-names>M.E.</given-names></name></person-group>
<article-title>Functional MRI of human brain during breath holding by BOLD and FAIR techniques</article-title>
<source>Neuroimage</source>
<year>1999</year>
<volume>9</volume>
<fpage>243</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1006/nimg.1998.0399</pub-id><?supplied-pmid 9927553?><pub-id pub-id-type="pmid">9927553</pub-id></element-citation></ref><ref id="B305-brainsci-03-01483"><label>305.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tillakaratne</surname><given-names>N.J.</given-names></name><name><surname>Medina-Kaaawe</surname><given-names>L.</given-names></name><name><surname>Gibson</surname><given-names>K.M.</given-names></name></person-group>
<article-title>Gamma-aminobutyric acid (GABA) metabolism in mammalian neural and non-neural tissues</article-title>
<source>Comp. Biochem. Physiol. A Physiol.</source>
<year>1995</year>
<volume>112</volume>
<fpage>247</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1016/0300-9629(95)00099-2</pub-id><?supplied-pmid 7584821?><pub-id pub-id-type="pmid">7584821</pub-id></element-citation></ref><ref id="B306-brainsci-03-01483"><label>306.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lennox</surname><given-names>W.G.</given-names></name></person-group>
<article-title>Certain chemical and physiological conditions which may influence seizures</article-title>
<source>Assoc. Res. Nerv. Ment. Dis. Proc.</source>
<year>1931</year>
<volume>7</volume>
<fpage>475</fpage>
<lpage>490</lpage>
</element-citation></ref><ref id="B307-brainsci-03-01483"><label>307.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lennox</surname><given-names>W.G.</given-names></name><name><surname>Behnke</surname><given-names>A.R.</given-names></name></person-group>
<article-title>Effect of increased oxygen pressure on the seizures of epilepsy</article-title>
<source>Arch. Neurol. Psychiatry</source>
<year>1936</year>
<volume>35</volume>
<fpage>782</fpage>
<lpage>788</lpage>
<pub-id pub-id-type="doi">10.1001/archneurpsyc.1936.02260040090006</pub-id></element-citation></ref><ref id="B308-brainsci-03-01483"><label>308.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toman</surname><given-names>J.E.P.</given-names></name><name><surname>Davis</surname><given-names>J.P.</given-names></name></person-group>
<article-title>The effects of drugs upon the electrical activity of the brain</article-title>
<source>Pharm. Rev.</source>
<year>1949</year>
<volume>1</volume>
<fpage>425</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="pmid">24536987</pub-id></element-citation></ref><ref id="B309-brainsci-03-01483"><label>309.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Swanson</surname><given-names>A.G.</given-names></name><name><surname>Stavney</surname><given-names>L.S.</given-names></name><name><surname>Stavney</surname><given-names>F.</given-names></name></person-group>
<article-title>Effects of blood pH and carbon dioxide on cerebral electrical activity</article-title>
<source>Neurology</source>
<year>1958</year>
<volume>8</volume>
<fpage>787</fpage>
<lpage>792</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.8.10.787</pub-id><?supplied-pmid 13590387?><pub-id pub-id-type="pmid">13590387</pub-id></element-citation></ref><ref id="B310-brainsci-03-01483"><label>310.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Withrow</surname><given-names>C.D.</given-names></name></person-group>
<article-title>Systemic Carbon Dioxide Derangements</article-title>
<source>Experimental Models of Epilepsy</source>
<person-group person-group-type="editor"><name><surname>Purpara</surname><given-names>D.P.</given-names></name><name><surname>Penry</surname><given-names>J.K.</given-names></name><name><surname>Woodburg</surname><given-names>D.M.</given-names></name><name><surname>Tower</surname><given-names>D.B.</given-names></name><name><surname>Water</surname><given-names>R.D.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1972</year>
<fpage>478</fpage>
<lpage>494</lpage>
</element-citation></ref><ref id="B311-brainsci-03-01483"><label>311.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kennealy</surname><given-names>J.A.</given-names></name><name><surname>Penovich</surname><given-names>P.E.</given-names></name><name><surname>Moore-Nease</surname><given-names>S.E.</given-names></name></person-group>
<article-title>EEG and spectral analysis in acute hyperventilation</article-title>
<source>Electroencephalogr. Clin. Neurophysiol.</source>
<year>1986</year>
<volume>63</volume>
<fpage>98</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1016/0013-4694(86)90002-7</pub-id><?supplied-pmid 2417822?><pub-id pub-id-type="pmid">2417822</pub-id></element-citation></ref><ref id="B312-brainsci-03-01483"><label>312.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>F.A.</given-names></name><name><surname>Davis</surname><given-names>H.</given-names></name><name><surname>Lennox</surname><given-names>W.G.</given-names></name></person-group>
<article-title>The electroencephalogram in epilepsy and in condition of impaired consciousness</article-title>
<source>Arch. Neurol. Psychiatry</source>
<year>1935</year>
<volume>34</volume>
<fpage>1133</fpage>
<lpage>1148</lpage>
<pub-id pub-id-type="doi">10.1001/archneurpsyc.1935.02250240002001</pub-id></element-citation></ref><ref id="B313-brainsci-03-01483"><label>313.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>J.S.</given-names></name><name><surname>Waltz</surname><given-names>A.G.</given-names></name></person-group>
<article-title>Arterial oxygen saturation and alveolar carbon dioxide during electroencephalography. I. Comparison of hyperventilation and induced hypoxia in subjects without brain disease</article-title>
<source>Arch. Neurol.</source>
<year>1960</year>
<volume>2</volume>
<fpage>631</fpage>
<lpage>643</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.1960.03840120037005</pub-id></element-citation></ref><ref id="B314-brainsci-03-01483"><label>314.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>J.S.</given-names></name><name><surname>Waltz</surname><given-names>A.G.</given-names></name></person-group>
<article-title>Arterial oxygen saturation and alveolar carbon dioxide during electroencephalography. II. Comparison of hyperventilation and induced hypoxia in subjects with epilepsy</article-title>
<source>Arch. Neurol.</source>
<year>1960</year>
<volume>2</volume>
<fpage>644</fpage>
<lpage>656</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.1960.03840120050006</pub-id></element-citation></ref><ref id="B315-brainsci-03-01483"><label>315.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sokoloff</surname><given-names>L.</given-names></name></person-group>
<article-title>The effects of carbon dioxide on the cerebral circulation</article-title>
<source>Anesthesiology</source>
<year>1960</year>
<volume>21</volume>
<fpage>664</fpage>
<lpage>673</lpage>
<pub-id pub-id-type="doi">10.1097/00000542-196011000-00010</pub-id></element-citation></ref><ref id="B316-brainsci-03-01483"><label>316.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Siesjo</surname><given-names>B.K.</given-names></name><name><surname>Messeter</surname><given-names>K.</given-names></name></person-group>
<article-title>Factors Determining Intracellular pH</article-title>
<source>Ion Homeostasis of the Brain</source>
<person-group person-group-type="editor"><name><surname>Siesjo</surname><given-names>B.K.</given-names></name><name><surname>Sprensen</surname><given-names>S.C.</given-names></name></person-group>
<publisher-name>Munks Yaard</publisher-name>
<publisher-loc>Copenhagen, The Netherlands</publisher-loc>
<year>1971</year>
<fpage>244</fpage>
<lpage>262</lpage>
</element-citation></ref><ref id="B317-brainsci-03-01483"><label>317.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bode</surname><given-names>H.</given-names></name><name><surname>Puglia</surname><given-names>E.</given-names></name></person-group>
<article-title>Intra-individual variability of cerebral blood flow velocities in children while awake and asleep</article-title>
<source>Ultraschall Med.</source>
<year>1992</year>
<volume>13</volume>
<fpage>204</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1055/s-2007-1005311</pub-id><?supplied-pmid 1439715?><pub-id pub-id-type="pmid">1439715</pub-id></element-citation></ref><ref id="B318-brainsci-03-01483"><label>318.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>VonBulow</surname><given-names>I.</given-names></name><name><surname>Ebert</surname><given-names>T.</given-names></name><name><surname>Rockstroh</surname><given-names>B.</given-names></name><name><surname>Lutzenberger</surname><given-names>W.</given-names></name><name><surname>Canavan</surname><given-names>A.</given-names></name><name><surname>Birnbaumer</surname><given-names>N.</given-names></name></person-group>
<article-title>Effects of hyperventilation on EEG frequency and slow wave potentials in relation to an anticonvulsant and epilepsy</article-title>
<source>J. Neuropsychophysiol.</source>
<year>1989</year>
<volume>3</volume>
<fpage>147</fpage>
<lpage>154</lpage>
</element-citation></ref><ref id="B319-brainsci-03-01483"><label>319.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rockstroh</surname><given-names>B.</given-names></name></person-group>
<article-title>Hyperventilation-induced EEG changes in humans and their modulation by anticonvulsant drug</article-title>
<source>Epilepsy Res.</source>
<year>1990</year>
<volume>7</volume>
<fpage>146</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1016/0920-1211(90)90100-A</pub-id><?supplied-pmid 2289472?><pub-id pub-id-type="pmid">2289472</pub-id></element-citation></ref><ref id="B320-brainsci-03-01483"><label>320.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Plum</surname><given-names>F.</given-names></name><name><surname>Pasner</surname><given-names>J.B.</given-names></name><name><surname>Smith</surname><given-names>W.W.</given-names></name></person-group>
<article-title>Effect of hyperbaric-hyperoxic hyperventilation on blood, brain, and CSF lactate</article-title>
<source>Am. J. Physiol.</source>
<year>1968</year>
<volume>215</volume>
<fpage>1240</fpage>
<lpage>1244</lpage>
<?supplied-pmid 5687518?><pub-id pub-id-type="pmid">5687518</pub-id></element-citation></ref><ref id="B321-brainsci-03-01483"><label>321.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stehling</surname><given-names>M.K.</given-names></name><name><surname>Schmitt</surname><given-names>F.</given-names></name><name><surname>Ladebeck</surname><given-names>R.</given-names></name></person-group>
<article-title>Echo-planar MR imaging of human brain oxygenation changes</article-title>
<source>J. Magn. Reson. Imaging</source>
<year>1993</year>
<volume>3</volume>
<fpage>471</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.1002/jmri.1880030307</pub-id><?supplied-pmid 8324305?><pub-id pub-id-type="pmid">8324305</pub-id></element-citation></ref><ref id="B322-brainsci-03-01483"><label>322.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prisman</surname><given-names>E.</given-names></name><name><surname>Slessarev</surname><given-names>M.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Poublanc</surname><given-names>J.</given-names></name><name><surname>Mardimae</surname><given-names>A.</given-names></name><name><surname>Crawley</surname><given-names>A.</given-names></name><name><surname>Fisher</surname><given-names>J.</given-names></name><name><surname>Mikulis</surname><given-names>D.</given-names></name></person-group>
<article-title>Comparison of the effects of independently-controlled end-tidal PCO<sub>2</sub> and PO<sub>2</sub> on blood oxygen level-dependent (BOLD) MRI</article-title>
<source>J. Magn. Reson. Imaging.</source>
<year>2008</year>
<volume>27</volume>
<fpage>185</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1002/jmri.21102</pub-id><?supplied-pmid 18050321?><pub-id pub-id-type="pmid">18050321</pub-id></element-citation></ref><ref id="B323-brainsci-03-01483"><label>323.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weckesser</surname><given-names>M.</given-names></name><name><surname>Posse</surname><given-names>S.</given-names></name><name><surname>Olthoff</surname><given-names>U.</given-names></name><name><surname>Kemna</surname><given-names>L.</given-names></name><name><surname>Drager</surname><given-names>S.</given-names></name><name><surname>Muller-Gartner</surname><given-names>H.W.</given-names></name></person-group>
<article-title>Functional imaging of the visual cortex with bold-contrast MRI: Hyperventilation decreases signal response</article-title>
<source>Magn. Res. Med.</source>
<year>1999</year>
<volume>41</volume>
<fpage>213</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1522-2594(199901)41:1&#x0003c;213::AID-MRM31&#x0003e;3.0.CO;2-S</pub-id></element-citation></ref><ref id="B324-brainsci-03-01483"><label>324.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Riley</surname><given-names>T.I.</given-names></name></person-group>
<article-title>Epilepsy-or merely hyperventilation?</article-title>
<source>Emerg. Med.</source>
<year>1982</year>
<volume>14</volume>
<fpage>162</fpage>
<lpage>167</lpage>
</element-citation></ref><ref id="B325-brainsci-03-01483"><label>325.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Chapman</surname><given-names>A.G.</given-names></name></person-group>
<article-title>Excitatory Neurotransmission and Antiepileptic Drug Development in Status Report</article-title>
<source>Recent Advances Epilepsy</source>
<person-group person-group-type="editor"><name><surname>Pedley</surname><given-names>T.A.</given-names></name><name><surname>Meldrum</surname><given-names>B.S.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1995</year>
<volume>Volume 6</volume>
<fpage>1</fpage>
<lpage>21</lpage>
</element-citation></ref><ref id="B326-brainsci-03-01483"><label>326.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chanutin</surname><given-names>A.</given-names></name><name><surname>Curnish</surname><given-names>R.R.</given-names></name></person-group>
<article-title>Effect of organic and inorganic phosphates on the oxygen equilibrium of human erythrocytes</article-title>
<source>Arch. Biochem. Biophys.</source>
<year>1967</year>
<volume>121</volume>
<fpage>96</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1016/0003-9861(67)90013-6</pub-id><?supplied-pmid 6035074?><pub-id pub-id-type="pmid">6035074</pub-id></element-citation></ref><ref id="B327-brainsci-03-01483"><label>327.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brewer</surname><given-names>G.J.</given-names></name><name><surname>Eaton</surname><given-names>J.W.</given-names></name></person-group>
<article-title>Erythrocyte metabolism: Interaction with oxygen transport</article-title>
<source>Science</source>
<year>1971</year>
<volume>171</volume>
<fpage>1205</fpage>
<lpage>1211</lpage>
<pub-id pub-id-type="doi">10.1126/science.171.3977.1205</pub-id><?supplied-pmid 5545197?><pub-id pub-id-type="pmid">5545197</pub-id></element-citation></ref><ref id="B328-brainsci-03-01483"><label>328.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woodson</surname><given-names>R.D.</given-names></name></person-group>
<article-title>Physiological significance of oxygen dissociation curve shift</article-title>
<source>Crit. Care Med.</source>
<year>1979</year>
<volume>7</volume>
<fpage>368</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1097/00003246-197909000-00004</pub-id><?supplied-pmid 467087?><pub-id pub-id-type="pmid">467087</pub-id></element-citation></ref><ref id="B329-brainsci-03-01483"><label>329.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fried</surname><given-names>R.</given-names></name><name><surname>Rubin</surname><given-names>S.R.</given-names></name><name><surname>Carlton</surname><given-names>R.M.</given-names></name><name><surname>Fox</surname><given-names>M.C.</given-names></name></person-group>
<article-title>Behavioral control of intractable idiopathic seizures: 1. Self-regulation of end-tidal carbon dioxide</article-title>
<source>Psychosom. Med.</source>
<year>1984</year>
<volume>46</volume>
<fpage>315</fpage>
<lpage>331</lpage>
<?supplied-pmid 6435147?><pub-id pub-id-type="pmid">6435147</pub-id></element-citation></ref><ref id="B330-brainsci-03-01483"><label>330.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Pincus</surname><given-names>J.H.</given-names></name><name><surname>Tucker</surname><given-names>G.J.</given-names></name></person-group>
<source>Behavioral Neurology</source>
<edition>3rd ed.</edition>
<publisher-name>Oxford University Press</publisher-name>
<publisher-loc>Oxford, UK</publisher-loc>
<year>1985</year>
<fpage>287</fpage>
<lpage>292</lpage>
</element-citation></ref><ref id="B331-brainsci-03-01483"><label>331.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Klein</surname><given-names>D.F.</given-names></name></person-group>
<article-title>Anxiety Reconceptualized</article-title>
<source>Anxiety: New Research and Changing Concepts</source>
<person-group person-group-type="editor"><name><surname>Klein</surname><given-names>D.F.</given-names></name><name><surname>Rakin</surname><given-names>J.G.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1981</year>
<fpage>235</fpage>
<lpage>263</lpage>
</element-citation></ref><ref id="B332-brainsci-03-01483"><label>332.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gorman</surname><given-names>J.M.</given-names></name><name><surname>Laebowitz</surname><given-names>M.R.</given-names></name><name><surname>Fryer</surname><given-names>A.J.</given-names></name><name><surname>Stein</surname><given-names>J.A.</given-names></name></person-group>
<article-title>A neuroanatomical hypothesis for panic disorder</article-title>
<source>Am. J. Psychiatry</source>
<year>1989</year>
<volume>146</volume>
<fpage>148</fpage>
<lpage>161</lpage>
<?supplied-pmid 2643361?><pub-id pub-id-type="pmid">2643361</pub-id></element-citation></ref><ref id="B333-brainsci-03-01483"><label>333.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Engel</surname><given-names>G.L.</given-names></name><name><surname>Ferriss</surname><given-names>E.B.</given-names></name><name><surname>Logan</surname><given-names>M.</given-names></name></person-group>
<article-title>Hyperventilation: Analysis of clinical symptomatology</article-title>
<source>Ann. Int. Med.</source>
<year>1947</year>
<volume>27</volume>
<fpage>683</fpage>
<lpage>704</lpage>
<pub-id pub-id-type="doi">10.7326/0003-4819-27-5-683</pub-id><?supplied-pmid 20271031?><pub-id pub-id-type="pmid">20271031</pub-id></element-citation></ref><ref id="B334-brainsci-03-01483"><label>334.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>B.</given-names></name><name><surname>Aicardi</surname><given-names>J.</given-names></name><name><surname>Dias</surname><given-names>K.</given-names></name><name><surname>Ramos</surname><given-names>O.</given-names></name></person-group>
<article-title>A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls: Rett&#x02019;s syndrome, a report of 35 cases</article-title>
<source>Am. Neurol.</source>
<year>1983</year>
<volume>14</volume>
<fpage>471</fpage>
<lpage>479</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410140412</pub-id></element-citation></ref><ref id="B335-brainsci-03-01483"><label>335.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bruno-Golden</surname><given-names>P.</given-names></name><name><surname>Holmes</surname><given-names>G.L.</given-names></name></person-group>
<article-title>Hyperventilation-induced seizures in mentally impaired children</article-title>
<source>Seizure</source>
<year>1993</year>
<volume>2</volume>
<fpage>229</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1016/S1059-1311(05)80132-3</pub-id><?supplied-pmid 8162387?><pub-id pub-id-type="pmid">8162387</pub-id></element-citation></ref><ref id="B336-brainsci-03-01483"><label>336.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogunyemi</surname><given-names>A.O.</given-names></name><name><surname>Gomez</surname><given-names>M.R.</given-names></name><name><surname>Klass</surname><given-names>D.W.</given-names></name></person-group>
<article-title>Seizures induced by exercise</article-title>
<source>Neurology</source>
<year>1988</year>
<volume>38</volume>
<fpage>633</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.38.4.633</pub-id><?supplied-pmid 3352923?><pub-id pub-id-type="pmid">3352923</pub-id></element-citation></ref><ref id="B337-brainsci-03-01483"><label>337.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Boyle</surname><given-names>R.</given-names></name></person-group>
<source>New Experiments Physico-Mechanical, Touching the Spring of Air and Its Effects</source>
<edition>2nd ed.</edition>
<publisher-name>H. Hall</publisher-name>
<publisher-loc>Oxford, UK</publisher-loc>
<year>1660</year>
</element-citation></ref><ref id="B338-brainsci-03-01483"><label>338.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poussouant</surname><given-names>P.</given-names></name><name><surname>Cadilhoc</surname><given-names>J.</given-names></name><name><surname>Pternitis</surname><given-names>C.</given-names></name><name><surname>Baldy-Moulinier</surname><given-names>M.</given-names></name></person-group>
<article-title>&#x000c9;pilepsie-temporale et decharges ammoniques provoque&#x000e9;s per l&#x02019;anoxie exprive</article-title>
<source>Rev. Neurol.</source>
<year>1967</year>
<volume>117</volume>
<fpage>65</fpage>
<lpage>70</lpage>
<?supplied-pmid 6063881?><pub-id pub-id-type="pmid">6063881</pub-id></element-citation></ref><ref id="B339-brainsci-03-01483"><label>339.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poussouant</surname><given-names>P.</given-names></name><name><surname>Cadilhoc</surname><given-names>J.</given-names></name><name><surname>Pternitis</surname><given-names>C.</given-names></name><name><surname>Baldy-Moulinier</surname><given-names>M.</given-names></name></person-group>
<article-title>Temporal epilepsy and hippocampal discharges induced by oxyprivic anoxia</article-title>
<source>Electroencephalogr. Clin. Neurophysiol.</source>
<year>1967</year>
<volume>23</volume>
<fpage>379</fpage>
<pub-id pub-id-type="doi">10.1016/0013-4694(67)90052-1</pub-id><?supplied-pmid 4167773?><pub-id pub-id-type="pmid">4167773</pub-id></element-citation></ref><ref id="B340-brainsci-03-01483"><label>340.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nelson</surname><given-names>S.R.</given-names></name><name><surname>Mantz</surname><given-names>M.L.</given-names></name></person-group>
<article-title>Brain energy reserve levels at the onset of convulsions in hypoxic mice</article-title>
<source>Life Sci. I</source>
<year>1971</year>
<volume>10</volume>
<fpage>901</fpage>
<lpage>907</lpage>
<?supplied-pmid 5570822?><pub-id pub-id-type="pmid">5570822</pub-id></element-citation></ref><ref id="B341-brainsci-03-01483"><label>341.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Tower</surname><given-names>D.B.</given-names></name></person-group>
<article-title>The Administration of Gamma-Aminobutyric Acid to Man: Systemic Effects and Anticonvulsant Actions</article-title>
<source>Inhibition in the Nervous System and Gamma-Aminobutyric Acid</source>
<person-group person-group-type="editor"><name><surname>Roberts</surname><given-names>E.</given-names></name></person-group>
<publisher-name>Pergamon Press</publisher-name>
<publisher-loc>Oxford, UK</publisher-loc>
<year>1960</year>
<fpage>562</fpage>
<lpage>578</lpage>
</element-citation></ref><ref id="B342-brainsci-03-01483"><label>342.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gellhorn</surname><given-names>E.</given-names></name><name><surname>Heymans</surname><given-names>C.</given-names></name></person-group>
<article-title>Differential action of anoxia, asphyxia and carbon dioxide on normal and convulsive potentials</article-title>
<source>J. Neurophysiol.</source>
<year>1948</year>
<volume>11</volume>
<fpage>261</fpage>
<lpage>273</lpage>
<?supplied-pmid 18865015?><pub-id pub-id-type="pmid">18865015</pub-id></element-citation></ref><ref id="B343-brainsci-03-01483"><label>343.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Wood</surname><given-names>J.D.</given-names></name></person-group>
<article-title>Systemic Oxygen Derangements</article-title>
<source>Experimental Models of Epilepsy</source>
<person-group person-group-type="editor"><name><surname>Purpura</surname><given-names>D.P.</given-names></name><name><surname>Penry</surname><given-names>J.K.</given-names></name><name><surname>Woodbury</surname><given-names>D.M.</given-names></name><name><surname>Tower</surname><given-names>D.B.</given-names></name><name><surname>Walter</surname><given-names>R.D.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1972</year>
<fpage>461</fpage>
<lpage>476</lpage>
</element-citation></ref><ref id="B344-brainsci-03-01483"><label>344.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lovell</surname><given-names>R.A.</given-names></name><name><surname>Elliott</surname><given-names>S.J.</given-names></name><name><surname>Elliott</surname><given-names>K.A.</given-names></name></person-group>
<article-title>The gamma-aminobutyric acid and Factor I content of brain</article-title>
<source>J. Neurochem.</source>
<year>1963</year>
<volume>10</volume>
<fpage>479</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1963.tb09850.x</pub-id><?supplied-pmid 14045539?><pub-id pub-id-type="pmid">14045539</pub-id></element-citation></ref><ref id="B345-brainsci-03-01483"><label>345.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wood</surname><given-names>J.D.</given-names></name><name><surname>Watson</surname><given-names>W.J.</given-names></name><name><surname>Ducker</surname><given-names>A.J.</given-names></name></person-group>
<article-title>Gamma-aminobutyric acid and oxygen poisoning</article-title>
<source>J. Neurochem.</source>
<year>1963</year>
<volume>10</volume>
<fpage>625</fpage>
<lpage>633</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1963.tb08934.x</pub-id><?supplied-pmid 14066624?><pub-id pub-id-type="pmid">14066624</pub-id></element-citation></ref><ref id="B346-brainsci-03-01483"><label>346.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bert</surname><given-names>P.</given-names></name></person-group>
<source>La Pression Barom&#x000e9;trique</source>
<person-group person-group-type="editor"><name><surname>Hitchcock</surname><given-names>M.A.</given-names></name><name><surname>Hitchcock</surname><given-names>F.A.</given-names></name></person-group>
<publisher-name>College Book Co</publisher-name>
<publisher-loc>Columbus, OH, USA</publisher-loc>
<year>1943</year>
</element-citation></ref><ref id="B347-brainsci-03-01483"><label>347.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stadie</surname><given-names>W.C.</given-names></name><name><surname>Riggs</surname><given-names>B.C.</given-names></name><name><surname>Haugaard</surname><given-names>N.</given-names></name></person-group>
<article-title>Oxygen poisoning</article-title>
<source>Am. J. Med. Sci.</source>
<year>1944</year>
<volume>207</volume>
<fpage>84</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1097/00000441-194401000-00009</pub-id></element-citation></ref><ref id="B348-brainsci-03-01483"><label>348.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bean</surname><given-names>J.W.</given-names></name></person-group>
<article-title>Effects of oxygen at increased pressure</article-title>
<source>Physiol. Rev.</source>
<year>1945</year>
<volume>25</volume>
<fpage>1</fpage>
<lpage>147</lpage>
</element-citation></ref><ref id="B349-brainsci-03-01483"><label>349.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Lambertson</surname><given-names>C.J.</given-names></name></person-group>
<article-title>Effects of Oxygen at High Partial Pressure</article-title>
<source>Handbook of Physiology</source>
<person-group person-group-type="editor"><name><surname>Fenn</surname><given-names>W.O.</given-names></name><name><surname>Rahn</surname><given-names>H.</given-names></name></person-group>
<publisher-name>American Physiology Society</publisher-name>
<publisher-loc>Washington, DC, USA</publisher-loc>
<year>1965</year>
<volume>Volume 2</volume>
<fpage>1027</fpage>
<lpage>1046</lpage>
</element-citation></ref><ref id="B350-brainsci-03-01483"><label>350.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lambertson</surname><given-names>C.J.</given-names></name><name><surname>Ewing</surname><given-names>J.H.</given-names></name><name><surname>Kough</surname><given-names>R.H.</given-names></name><name><surname>Gould</surname><given-names>R.</given-names></name><name><surname>Stroud</surname><given-names>M.W.</given-names></name></person-group>
<article-title>Oxygen toxicity</article-title>
<source>J. Appl. Physiol.</source>
<year>1955&#x02013;1956</year>
<volume>8</volume>
<fpage>255</fpage>
<lpage>263</lpage>
</element-citation></ref><ref id="B351-brainsci-03-01483"><label>351.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wood</surname><given-names>J.D.</given-names></name></person-group>
<article-title>Development of a strain of rats with greater than normal susceptibility to oxygen poisoning</article-title>
<source>Can. J. Physiol. Pharmacol.</source>
<year>1966</year>
<volume>44</volume>
<fpage>259</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1139/y66-030</pub-id><?supplied-pmid 5946562?><pub-id pub-id-type="pmid">5946562</pub-id></element-citation></ref><ref id="B352-brainsci-03-01483"><label>352.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Novotny</surname><given-names>E.J.</given-names><suffix>Jr.</suffix></name><name><surname>Hyder</surname><given-names>F.</given-names></name><name><surname>Shevell</surname><given-names>M.</given-names></name><name><surname>Rothman</surname><given-names>D.L.</given-names></name></person-group>
<article-title>GABA changes with vigabatrin in the developing human brain</article-title>
<source>Epilepsia</source>
<year>1999</year>
<volume>40</volume>
<fpage>462</fpage>
<lpage>466</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1999.tb00741.x</pub-id><?supplied-pmid 10219272?><pub-id pub-id-type="pmid">10219272</pub-id></element-citation></ref><ref id="B353-brainsci-03-01483"><label>353.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petroff</surname><given-names>O.A.</given-names></name><name><surname>Rothman</surname><given-names>D.L.</given-names></name><name><surname>Behar</surname><given-names>K.L.</given-names></name><name><surname>Collins</surname><given-names>T.L.</given-names></name><name><surname>Mattson</surname><given-names>R.H.</given-names></name></person-group>
<article-title>Human brain GABA levels rise rapidly after initiation of vigabatrin therapy</article-title>
<source>Neurology</source>
<year>1996</year>
<volume>47</volume>
<fpage>1567</fpage>
<lpage>1571</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.47.6.1567</pub-id><?supplied-pmid 8960747?><pub-id pub-id-type="pmid">8960747</pub-id></element-citation></ref><ref id="B354-brainsci-03-01483"><label>354.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Webb</surname><given-names>W.B.</given-names></name></person-group>
<article-title>Slow Wave Sleep and Prior Wakefulness, Sleep Time, and Stability across Time</article-title>
<source>Slow Wave Sleep: Physiological, Pathophysiological and Functional Aspects</source>
<person-group person-group-type="editor"><name><surname>Wauquier</surname><given-names>A.</given-names></name><name><surname>Dugovic</surname><given-names>C.</given-names></name><name><surname>Radulovacki</surname><given-names>M.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1989</year>
<fpage>119</fpage>
<lpage>129</lpage>
</element-citation></ref><ref id="B355-brainsci-03-01483"><label>355.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Hobson</surname><given-names>J.A.</given-names></name></person-group>
<article-title>Sleep: Behavior and Cellular Mechanism</article-title>
<source>Encyclopedia of Neuroscience</source>
<publisher-name>Elsevier</publisher-name>
<publisher-loc>Amsterdam, The Netherlands</publisher-loc>
<year>1989</year>
<volume>Volume 2</volume>
<fpage>1872</fpage>
<lpage>1875</lpage>
</element-citation></ref><ref id="B356-brainsci-03-01483"><label>356.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Datta</surname><given-names>S.</given-names></name><name><surname>Calvo</surname><given-names>J.</given-names></name><name><surname>Quatrochi</surname><given-names>J.</given-names></name><name><surname>Hobson</surname><given-names>J.A.</given-names></name></person-group>
<article-title>Long-term enhancement of REM sleep following cholinergic stimulation</article-title>
<source>Neuroreport</source>
<year>1991</year>
<volume>2</volume>
<fpage>619</fpage>
<lpage>622</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-199110000-00017</pub-id><?supplied-pmid 1756243?><pub-id pub-id-type="pmid">1756243</pub-id></element-citation></ref><ref id="B357-brainsci-03-01483"><label>357.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steriade</surname><given-names>M.</given-names></name><name><surname>Contreras</surname><given-names>D.</given-names></name><name><surname>Amzica</surname><given-names>F.</given-names></name></person-group>
<article-title>Synchronized sleep oscillations and their paroxysmal developments</article-title>
<source>Trends Neurosci.</source>
<year>1994</year>
<volume>17</volume>
<fpage>199</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1016/0166-2236(94)90104-X</pub-id><?supplied-pmid 7520202?><pub-id pub-id-type="pmid">7520202</pub-id></element-citation></ref><ref id="B358-brainsci-03-01483"><label>358.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steriade</surname><given-names>M.</given-names></name><name><surname>Nunez</surname><given-names>A.</given-names></name><name><surname>Amzica</surname><given-names>F.</given-names></name></person-group>
<article-title>Intracellular analysis of relations between the slow (&#x0003c;1 Hz) neocortical oscillation and other sleep rhythms of the electroencephalogram</article-title>
<source>J. Neurosci.</source>
<year>1993</year>
<volume>13</volume>
<fpage>3266</fpage>
<lpage>3283</lpage>
<?supplied-pmid 8340807?><pub-id pub-id-type="pmid">8340807</pub-id></element-citation></ref><ref id="B359-brainsci-03-01483"><label>359.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Montplaiser</surname><given-names>J.</given-names></name><name><surname>Laverdi&#x000e8;re</surname><given-names>M.</given-names></name><name><surname>Saint-Hilaire</surname><given-names>J.M.</given-names></name><name><surname>Rouleau</surname><given-names>I.</given-names></name></person-group>
<article-title>Noctural sleep recording in partial epilepsy: A study with depth electrodes</article-title>
<source>J. Clin. Neurophys.</source>
<year>1987</year>
<volume>4</volume>
<fpage>383</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1097/00004691-198710000-00003</pub-id></element-citation></ref><ref id="B360-brainsci-03-01483"><label>360.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Chokroverty</surname><given-names>S.</given-names></name></person-group>
<article-title>Sleep and Epilepsy</article-title>
<source>Sleep Disorders Medicine</source>
<person-group person-group-type="editor"><name><surname>Chokroverty</surname><given-names>S.</given-names></name></person-group>
<publisher-name>Butterworth-Heinemann</publisher-name>
<publisher-loc>Boston, MA, USA</publisher-loc>
<year>1994</year>
<fpage>429</fpage>
</element-citation></ref><ref id="B361-brainsci-03-01483"><label>361.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Juhasz</surname><given-names>G.</given-names></name><name><surname>Emri</surname><given-names>Z.</given-names></name><name><surname>Kekesi</surname><given-names>K.</given-names></name><name><surname>Pungor</surname><given-names>K.</given-names></name></person-group>
<article-title>Local perfusion of the thalamus with GABA increases sleep and induces long-lasting inhibition of somatosensory event-related potentials in cats</article-title>
<source>Neurosci. Lett.</source>
<year>1989</year>
<volume>103</volume>
<fpage>229</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1016/0304-3940(89)90581-8</pub-id><?supplied-pmid 2771185?><pub-id pub-id-type="pmid">2771185</pub-id></element-citation></ref><ref id="B362-brainsci-03-01483"><label>362.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Feinberg</surname><given-names>I.</given-names></name></person-group>
<article-title>Effects of Maturation and Aging on Slow-Wave Sleep in Man: Implications for Neurobiology</article-title>
<source>Slow Wave Sleep: Physiological, Pathophysiological and Functional Aspects</source>
<person-group person-group-type="editor"><name><surname>Wauquier</surname><given-names>A.</given-names></name><name><surname>Dugovic</surname><given-names>C.</given-names></name><name><surname>Radulovacki</surname><given-names>M.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1989</year>
<fpage>31</fpage>
<lpage>48</lpage>
</element-citation></ref><ref id="B363-brainsci-03-01483"><label>363.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reddy</surname><given-names>D.S.</given-names></name></person-group>
<article-title>Enhanced anticonvulsant activity of ganoxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy</article-title>
<source>J. Pharmacol. Exp. Ther.</source>
<year>2000</year>
<volume>294</volume>
<fpage>909</fpage>
<lpage>915</lpage>
<?supplied-pmid 10945840?><pub-id pub-id-type="pmid">10945840</pub-id></element-citation></ref><ref id="B364-brainsci-03-01483"><label>364.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reddy</surname><given-names>D.S.</given-names></name><name><surname>Rogawski</surname><given-names>M.A.</given-names></name></person-group>
<article-title>Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy</article-title>
<source>Epilepsia</source>
<year>2001</year>
<volume>42</volume>
<fpage>337</fpage>
<lpage>344</lpage>
<?supplied-pmid 11442150?><pub-id pub-id-type="pmid">11442150</pub-id></element-citation></ref><ref id="B365-brainsci-03-01483"><label>365.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sim</surname><given-names>J.A.</given-names></name><name><surname>Skynner</surname><given-names>M.J.</given-names></name><name><surname>Herbison</surname><given-names>A.E.</given-names></name></person-group>
<article-title>Direct regulation of postnatal GnRH neurons by the progesterone derivative allopregnanolone in the mouse</article-title>
<source>Endocrinology</source>
<year>2001</year>
<volume>142</volume>
<fpage>4448</fpage>
<lpage>4453</lpage>
<pub-id pub-id-type="doi">10.1210/en.142.10.4448</pub-id><?supplied-pmid 11564709?><pub-id pub-id-type="pmid">11564709</pub-id></element-citation></ref><ref id="B366-brainsci-03-01483"><label>366.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mennerick</surname><given-names>S.</given-names></name><name><surname>Zeng</surname><given-names>C.M.</given-names></name><name><surname>Benz</surname><given-names>A.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Izumi</surname><given-names>Y.</given-names></name><name><surname>Evers</surname><given-names>A.S.</given-names></name><name><surname>Covey</surname><given-names>D.F.</given-names></name><name><surname>Zorumski</surname><given-names>C.F.</given-names></name></person-group>
<article-title>Effects on gamma aminobutyric acid (GABA) (A) receptors of a neuroactive steroid that negatively modulates glutamate neurotransmission and augments GABA neurotransmission</article-title>
<source>Mol. Pharmacol.</source>
<year>2001</year>
<volume>60</volume>
<fpage>732</fpage>
<lpage>741</lpage>
<?supplied-pmid 11562435?><pub-id pub-id-type="pmid">11562435</pub-id></element-citation></ref><ref id="B367-brainsci-03-01483"><label>367.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Puia</surname><given-names>G.</given-names></name><name><surname>Belelli</surname><given-names>D.</given-names></name></person-group>
<article-title>Neurosteroids on our minds</article-title>
<source>Trends Pharmacol. Sci.</source>
<year>2001</year>
<volume>22</volume>
<fpage>266</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-6147(00)01706-5</pub-id><?supplied-pmid 11436852?><pub-id pub-id-type="pmid">11436852</pub-id></element-citation></ref><ref id="B368-brainsci-03-01483"><label>368.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawata</surname><given-names>M.</given-names></name><name><surname>Yuri</surname><given-names>K.</given-names></name><name><surname>Morimoto</surname><given-names>M.</given-names></name></person-group>
<article-title>Steroid hormone effects on gene expression, neuronal structure and differentiation</article-title>
<source>Horm. Behav.</source>
<year>1994</year>
<volume>28</volume>
<fpage>477</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="doi">10.1006/hbeh.1994.1045</pub-id><?supplied-pmid 7729816?><pub-id pub-id-type="pmid">7729816</pub-id></element-citation></ref><ref id="B369-brainsci-03-01483"><label>369.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sar</surname><given-names>M.</given-names></name><name><surname>Stumpf</surname><given-names>W.E.</given-names></name><name><surname>Tappaz</surname><given-names>M.L.</given-names></name></person-group>
<article-title>Localization of <sup>3</sup>H-estradiol in preoptic GABAergic neurons</article-title>
<source>Fed. Proc.</source>
<year>1983</year>
<volume>42</volume>
<fpage>495</fpage>
</element-citation></ref><ref id="B370-brainsci-03-01483"><label>370.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wallis</surname><given-names>C.J.</given-names></name><name><surname>Luttge</surname><given-names>W.G.</given-names></name></person-group>
<article-title>Influence of estrogen and progesterone on glutamic acid decarboxylase activity in discrete regions of rat Brain</article-title>
<source>J. Neurochem.</source>
<year>1980</year>
<volume>34</volume>
<fpage>609</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1980.tb11187.x</pub-id><?supplied-pmid 7354335?><pub-id pub-id-type="pmid">7354335</pub-id></element-citation></ref><ref id="B371-brainsci-03-01483"><label>371.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mansky</surname><given-names>T.</given-names></name><name><surname>Mestres-Ventura</surname><given-names>P.</given-names></name><name><surname>Wuttke</surname><given-names>W.</given-names></name></person-group>
<article-title>Involvement of GABA in the feedback action of estradiol on gonadotropin and prolactin release: Hypothalamic GABA and catecholamine turnover rates</article-title>
<source>Brain Res.</source>
<year>1982</year>
<volume>231</volume>
<fpage>353</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(82)90372-9</pub-id><?supplied-pmid 7198927?><pub-id pub-id-type="pmid">7198927</pub-id></element-citation></ref><ref id="B372-brainsci-03-01483"><label>372.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>V.D.</given-names></name><name><surname>Feder</surname><given-names>H.H.</given-names></name><name><surname>Sawyer</surname><given-names>C.H.</given-names></name></person-group>
<article-title>The Role of Brain Catecholamines in the Regulation of LH Secretion: A Critical Inquiry</article-title>
<source>Frontiers in Neuroendocrinology</source>
<person-group person-group-type="editor"><name><surname>Martini</surname><given-names>L.</given-names></name><name><surname>Ganong</surname><given-names>W.F.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1984</year>
<fpage>27</fpage>
<lpage>84</lpage>
</element-citation></ref><ref id="B373-brainsci-03-01483"><label>373.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Majewska</surname><given-names>M.D.</given-names></name><name><surname>Mienville</surname><given-names>J.M.</given-names></name><name><surname>Vicini</surname><given-names>S.</given-names></name></person-group>
<article-title>Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons</article-title>
<source>Neurosci. Lett.</source>
<year>1988</year>
<volume>90</volume>
<fpage>279</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="doi">10.1016/0304-3940(88)90202-9</pub-id><?supplied-pmid 3138576?><pub-id pub-id-type="pmid">3138576</pub-id></element-citation></ref><ref id="B374-brainsci-03-01483"><label>374.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mienville</surname><given-names>J.M.</given-names></name><name><surname>Vicini</surname><given-names>S.</given-names></name></person-group>
<article-title>Pregnenolone sulfate antagonizes GABA<sub>A</sub> receptor-mediated currents via a reduction of channel opening frequency</article-title>
<source>Brain Res.</source>
<year>1989</year>
<volume>489</volume>
<fpage>190</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(89)90024-3</pub-id><?supplied-pmid 2472854?><pub-id pub-id-type="pmid">2472854</pub-id></element-citation></ref><ref id="B375-brainsci-03-01483"><label>375.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kis</surname><given-names>Z.</given-names></name><name><surname>Budai</surname><given-names>D.</given-names></name><name><surname>Imre</surname><given-names>G.</given-names></name><name><surname>Farkas</surname><given-names>T.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name><name><surname>Toldi</surname><given-names>J.</given-names></name></person-group>
<article-title>The modulatory effect of estrogen on the neuronal activity in the barrel cortex of the rat. An electrophysiological study</article-title>
<source>Neuroreport</source>
<year>2001</year>
<volume>12</volume>
<fpage>2509</fpage>
<lpage>2512</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-200108080-00044</pub-id><?supplied-pmid 11496139?><pub-id pub-id-type="pmid">11496139</pub-id></element-citation></ref><ref id="B376-brainsci-03-01483"><label>376.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saleh</surname><given-names>T.M.</given-names></name><name><surname>Saleh</surname><given-names>M.C.</given-names></name></person-group>
<article-title>Inhibitory effect of 17 beta-estradiol in the parabrachial nucleus is mediated by GABA</article-title>
<source>Brain Res.</source>
<year>2001</year>
<volume>911</volume>
<fpage>116</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(01)02699-3</pub-id><?supplied-pmid 11511378?><pub-id pub-id-type="pmid">11511378</pub-id></element-citation></ref><ref id="B377-brainsci-03-01483"><label>377.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mitsushima</surname><given-names>D.</given-names></name><name><surname>Hei</surname><given-names>D.L.</given-names></name><name><surname>Terasawa</surname><given-names>E.</given-names></name></person-group>
<article-title>gamma-aminobutyric acid is an inhibitory neurotransmitter restricting the release of luteinizing hormone-releasing hormone before the onset of puberty</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>1994</year>
<volume>91</volume>
<fpage>395</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.91.1.395</pub-id><?supplied-pmid 8278400?><pub-id pub-id-type="pmid">8278400</pub-id></element-citation></ref><ref id="B378-brainsci-03-01483"><label>378.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adler</surname><given-names>B.A.</given-names></name><name><surname>Crowley</surname><given-names>W.R.</given-names></name></person-group>
<article-title>Evidence for gamma-aminobutyric acid modulation of ovarian hormone effects on luteinizing hormone secretion and hypothalamic catecholamine activity in the female rat</article-title>
<source>J. Endocrinol.</source>
<year>1986</year>
<volume>118</volume>
<fpage>91</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1210/endo-118-1-91</pub-id></element-citation></ref><ref id="B379-brainsci-03-01483"><label>379.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Celotti</surname><given-names>F.</given-names></name><name><surname>Apud</surname><given-names>J.A.</given-names></name><name><surname>Melcangi</surname><given-names>R.C.</given-names></name><name><surname>Masotto</surname><given-names>C.</given-names></name><name><surname>Tappaz</surname><given-names>M.</given-names></name><name><surname>Racagni</surname><given-names>G.</given-names></name></person-group>
<article-title>Endocrine modulation of gamma-aminobutyric acidergic innervation in the rat fallopian tube</article-title>
<source>Endocrinology</source>
<year>1986</year>
<volume>118</volume>
<fpage>334</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.1210/endo-118-1-334</pub-id><?supplied-pmid 3510120?><pub-id pub-id-type="pmid">3510120</pub-id></element-citation></ref><ref id="B380-brainsci-03-01483"><label>380.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Terasawa</surname><given-names>E.</given-names></name></person-group>
<article-title>Mechanisms Controlling the Onset of Puberty in Primates: The Role of GABAergic Neurons</article-title>
<source>The Neurobiology of Puberty</source>
<person-group person-group-type="editor"><name><surname>Plant</surname><given-names>T.M.</given-names></name><name><surname>Lee</surname><given-names>P.A.</given-names></name></person-group>
<publisher-name>J. Endocrinol. Limited</publisher-name>
<publisher-loc>Bristol, UK</publisher-loc>
<year>1995</year>
<fpage>139</fpage>
<lpage>151</lpage>
</element-citation></ref><ref id="B381-brainsci-03-01483"><label>381.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mayo</surname><given-names>W.</given-names></name><name><surname>Dellu</surname><given-names>F.</given-names></name><name><surname>Robel</surname><given-names>P.</given-names></name><name><surname>Cherkaoui</surname><given-names>J.</given-names></name><name><surname>le Moal</surname><given-names>M.</given-names></name><name><surname>Baulieu</surname><given-names>E.E.</given-names></name><name><surname>Simon</surname><given-names>H.</given-names></name></person-group>
<article-title>Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat</article-title>
<source>Brain Res.</source>
<year>1993</year>
<volume>607</volume>
<fpage>324</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(93)91524-V</pub-id><?supplied-pmid 8386975?><pub-id pub-id-type="pmid">8386975</pub-id></element-citation></ref><ref id="B382-brainsci-03-01483"><label>382.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garcia-Segura</surname><given-names>L.M.</given-names></name><name><surname>Chowen</surname><given-names>J.A.</given-names></name><name><surname>Due&#x000f1;as</surname><given-names>M.</given-names></name><name><surname>Torres-Aleman</surname><given-names>I.</given-names></name><name><surname>Naftolin</surname><given-names>F.</given-names></name></person-group>
<article-title>Gonadal steroids as promoters of neuro-glial plasticity</article-title>
<source>Psychoneuroendocrinology</source>
<year>1994</year>
<volume>19</volume>
<fpage>445</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4530(94)90031-0</pub-id><?supplied-pmid 7938345?><pub-id pub-id-type="pmid">7938345</pub-id></element-citation></ref><ref id="B383-brainsci-03-01483"><label>383.</label><element-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Matsumoto</surname><given-names>A.</given-names></name></person-group>
<source>Sexual Differentiation of the Brain</source>
<publisher-name>CRC Press</publisher-name>
<publisher-loc>Boca Raton, FL, USA</publisher-loc>
<year>2000</year>
</element-citation></ref><ref id="B384-brainsci-03-01483"><label>384.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gould</surname><given-names>E.</given-names></name><name><surname>Woolley</surname><given-names>C.S.</given-names></name><name><surname>Frankfurt</surname><given-names>M.</given-names></name><name><surname>McEwen</surname><given-names>B.S.</given-names></name></person-group>
<article-title>Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood</article-title>
<source>J. Neurosci.</source>
<year>1990</year>
<volume>10</volume>
<fpage>1286</fpage>
<lpage>1291</lpage>
<?supplied-pmid 2329377?><pub-id pub-id-type="pmid">2329377</pub-id></element-citation></ref><ref id="B385-brainsci-03-01483"><label>385.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frankfurt</surname><given-names>M.</given-names></name><name><surname>McEwen</surname><given-names>B.S.</given-names></name></person-group>
<article-title>Estrogen increases axodendritic synapses in the VMN of rats after ovariectomy</article-title>
<source>Neuroreport</source>
<year>1991</year>
<volume>2</volume>
<fpage>380</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-199107000-00006</pub-id><?supplied-pmid 1912470?><pub-id pub-id-type="pmid">1912470</pub-id></element-citation></ref><ref id="B386-brainsci-03-01483"><label>386.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gur</surname><given-names>R.C.</given-names></name><name><surname>Gur</surname><given-names>R.E.</given-names></name><name><surname>Obrist</surname><given-names>W.D.</given-names></name><name><surname>Skolnick</surname><given-names>B.E.</given-names></name><name><surname>Reivich</surname><given-names>M.</given-names></name></person-group>
<article-title>Age and regional cerebral blood flow at rest and during cognitive activity</article-title>
<source>Arch. Gen. Psychiatry</source>
<year>1987</year>
<volume>44</volume>
<fpage>617</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.1987.01800190037006</pub-id><?supplied-pmid 3606327?><pub-id pub-id-type="pmid">3606327</pub-id></element-citation></ref><ref id="B387-brainsci-03-01483"><label>387.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thomas</surname><given-names>D.J.</given-names></name><name><surname>Marshall</surname><given-names>J.</given-names></name><name><surname>Ross Russell</surname><given-names>R.W.</given-names></name><name><surname>Wetherly-Mein</surname><given-names>G.</given-names></name><name><surname>Du Boulay</surname><given-names>G.H.</given-names></name><name><surname>Pearson</surname><given-names>T.C.</given-names></name><name><surname>Syman</surname><given-names>L.</given-names></name><name><surname>Zilkha</surname><given-names>E.</given-names></name></person-group>
<article-title>Effects of haematocrit on cerebral blood-flow in man</article-title>
<source>Lancet</source>
<year>1977</year>
<volume>2</volume>
<fpage>941</fpage>
<lpage>943</lpage>
<?supplied-pmid 72286?><pub-id pub-id-type="pmid">72286</pub-id></element-citation></ref><ref id="B388-brainsci-03-01483"><label>388.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vriens</surname><given-names>E.M.</given-names></name><name><surname>Kraaier</surname><given-names>V.</given-names></name><name><surname>Musbach</surname><given-names>M.</given-names></name><name><surname>Wiencke</surname><given-names>G.H.</given-names></name><name><surname>van Huffelen</surname><given-names>A.C.</given-names></name></person-group>
<article-title>Transcranial pulse Doppler measurements of blood velocity in the middle cerebral artery: Reference values at rest and during hyperventilation in healthy volunteers in relation to age and sex</article-title>
<source>Ultrasound Med. Biol.</source>
<year>1989</year>
<volume>15</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<?supplied-pmid 2672503?><pub-id pub-id-type="pmid">2646803</pub-id></element-citation></ref><ref id="B389-brainsci-03-01483"><label>389.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kastrup</surname><given-names>A.</given-names></name><name><surname>Thomas</surname><given-names>C.</given-names></name><name><surname>Hartmann</surname><given-names>C.</given-names></name><name><surname>Schabet</surname><given-names>M.</given-names></name></person-group>
<article-title>Sex dependency of cerebrovascular CO<sub>2</sub> reactivity in normal subjects</article-title>
<source>Stroke</source>
<year>1997</year>
<volume>28</volume>
<fpage>2353</fpage>
<lpage>2356</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.28.12.2353</pub-id><?supplied-pmid 9412613?><pub-id pub-id-type="pmid">9412613</pub-id></element-citation></ref><ref id="B390-brainsci-03-01483"><label>390.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kastrup</surname><given-names>A.</given-names></name><name><surname>Dichgans</surname><given-names>J.</given-names></name><name><surname>Niemeier</surname><given-names>M.</given-names></name><name><surname>Schabet</surname><given-names>M.</given-names></name></person-group>
<article-title>Changes of cerebrovascular CO<sub>2</sub> reactivity during normal aging</article-title>
<source>Stroke</source>
<year>1998</year>
<volume>29</volume>
<fpage>1311</fpage>
<lpage>1314</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.29.7.1311</pub-id><?supplied-pmid 9660378?><pub-id pub-id-type="pmid">9660378</pub-id></element-citation></ref><ref id="B391-brainsci-03-01483"><label>391.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frankfurt</surname><given-names>M.</given-names></name><name><surname>Fuchs</surname><given-names>E.</given-names></name><name><surname>Wuttke</surname><given-names>W.</given-names></name></person-group>
<article-title>Sex differences in gamma-aminobutyric acid and glutamate concentrations in discrete rat brain nuclei</article-title>
<source>Neurosci. Lett.</source>
<year>1984</year>
<volume>50</volume>
<fpage>245</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1016/0304-3940(84)90493-2</pub-id><?supplied-pmid 6149503?><pub-id pub-id-type="pmid">6149503</pub-id></element-citation></ref><ref id="B392-brainsci-03-01483"><label>392.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grattan</surname><given-names>D.R.</given-names></name><name><surname>Selmanoff</surname><given-names>M.</given-names></name></person-group>
<article-title>Sex differences in the activity of gamma-aminobutyric acidergic neurons in the rat hypothalamus</article-title>
<source>Brain Res.</source>
<year>1997</year>
<volume>775</volume>
<fpage>244</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(97)01069-X</pub-id><?supplied-pmid 9439853?><pub-id pub-id-type="pmid">9439853</pub-id></element-citation></ref><ref id="B393-brainsci-03-01483"><label>393.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Herbison</surname><given-names>A.E.</given-names></name><name><surname>Robinson</surname><given-names>J.E.</given-names></name><name><surname>Skinner</surname><given-names>D.C.</given-names></name></person-group>
<article-title>Distribution of estrogen receptor- immunoreactive cells in the preoptic area of the ewe: Co-localization with glutamic acid decarboxylase but not luteinizing hormone-releasing hormone</article-title>
<source>Neuroendocrinology</source>
<year>1993</year>
<volume>57</volume>
<fpage>751</fpage>
<lpage>759</lpage>
<pub-id pub-id-type="doi">10.1159/000126433</pub-id><?supplied-pmid 8367037?><pub-id pub-id-type="pmid">8367037</pub-id></element-citation></ref><ref id="B394-brainsci-03-01483"><label>394.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vijayan</surname><given-names>E.</given-names></name><name><surname>McCann</surname><given-names>S.M.</given-names></name></person-group>
<article-title>The effects of intraventricular injection of gamma-aminobutyric acid (GABA) on prolactin and gonadotropin release in conscious female rats</article-title>
<source>Brain Res.</source>
<year>1978</year>
<volume>155</volume>
<fpage>35</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(78)90303-7</pub-id><?supplied-pmid 688015?><pub-id pub-id-type="pmid">688015</pub-id></element-citation></ref><ref id="B395-brainsci-03-01483"><label>395.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manev</surname><given-names>H.</given-names></name><name><surname>Perici&#x00107;</surname><given-names>D.</given-names></name></person-group>
<article-title>Sex difference in the turnover of GABA in the rat substantia nigra</article-title>
<source>J. Neural. Transm.</source>
<year>1987</year>
<volume>70</volume>
<fpage>321</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1007/BF01253606</pub-id><?supplied-pmid 3681288?><pub-id pub-id-type="pmid">3681288</pub-id></element-citation></ref><ref id="B396-brainsci-03-01483"><label>396.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McEwen</surname><given-names>B.S.</given-names></name></person-group>
<article-title>Non-genomic and genomic effects of steroids on neural activity</article-title>
<source>Trends Pharmacol. Sci.</source>
<year>1991</year>
<volume>12</volume>
<fpage>141</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1016/0165-6147(91)90531-V</pub-id><?supplied-pmid 2063480?><pub-id pub-id-type="pmid">2063480</pub-id></element-citation></ref><ref id="B397-brainsci-03-01483"><label>397.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sagrillo</surname><given-names>C.A.</given-names></name><name><surname>Selmanoff</surname><given-names>M.</given-names></name></person-group>
<article-title>Castration decreased mRNA levels encoding glutamic acid decarboxylase within that region of the medial preoptic area which coincides with the sexually dimorphic nucleus (SDN-mPOA)</article-title>
<source>Soc. Neurosci. Abst.</source>
<year>1994</year>
<volume>20</volume>
<fpage>994</fpage>
</element-citation></ref><ref id="B398-brainsci-03-01483"><label>398.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woolley</surname><given-names>D.</given-names></name><name><surname>Timiras</surname><given-names>P.S.</given-names></name></person-group>
<article-title>The gonad-brain relationship: Effects of female sex hormones on electroshock convulsions in the rat</article-title>
<source>Endocrinology</source>
<year>1962</year>
<volume>70</volume>
<fpage>196</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.1210/endo-70-2-196</pub-id><?supplied-pmid 14008291?><pub-id pub-id-type="pmid">14008291</pub-id></element-citation></ref><ref id="B399-brainsci-03-01483"><label>399.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>B&#x000e4;ckstr&#x000f6;m</surname><given-names>T.</given-names></name></person-group>
<article-title>Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle</article-title>
<source>Acta Neurol. Scand.</source>
<year>1976</year>
<volume>54</volume>
<fpage>321</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0404.1976.tb04363.x</pub-id><?supplied-pmid 973554?><pub-id pub-id-type="pmid">973554</pub-id></element-citation></ref><ref id="B400-brainsci-03-01483"><label>400.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Logothetis</surname><given-names>J.</given-names></name><name><surname>Harner</surname><given-names>R.</given-names></name><name><surname>Morrell</surname><given-names>F.</given-names></name><name><surname>Torres</surname><given-names>F.</given-names></name></person-group>
<article-title>The role of estrogens in catamenial exacerbation of epilepsy</article-title>
<source>Neurology</source>
<year>1959</year>
<volume>9</volume>
<fpage>352</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.9.5.352</pub-id><?supplied-pmid 13657294?><pub-id pub-id-type="pmid">13657294</pub-id></element-citation></ref><ref id="B401-brainsci-03-01483"><label>401.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wray</surname><given-names>S.</given-names></name><name><surname>Fueshko</surname><given-names>S.M.</given-names></name><name><surname>Kusano</surname><given-names>K.</given-names></name><name><surname>Gainer</surname><given-names>H.</given-names></name></person-group>
<article-title>GABAergic neurons in the embryonic olfactory pit/vomeronasal organ: Maintenance of functional GABAergic synapses in olfactory explants</article-title>
<source>Dev. Biol.</source>
<year>1996</year>
<volume>180</volume>
<fpage>631</fpage>
<lpage>645</lpage>
<pub-id pub-id-type="doi">10.1006/dbio.1996.0334</pub-id><?supplied-pmid 8954733?><pub-id pub-id-type="pmid">8954733</pub-id></element-citation></ref><ref id="B402-brainsci-03-01483"><label>402.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tobet</surname><given-names>S.A.</given-names></name><name><surname>Chickering</surname><given-names>T.W.</given-names></name><name><surname>King</surname><given-names>J.C.</given-names></name><name><surname>Stopa</surname><given-names>E.G.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Kuo-Leblank</surname><given-names>V.</given-names></name><name><surname>Schwarting</surname><given-names>G.A.</given-names></name></person-group>
<article-title>Expression of gamma-aminobutyric acid and gonadotropin-releasing hormone during neuronal migration through the olfactory system</article-title>
<source>Endocrinology</source>
<year>1996</year>
<volume>137</volume>
<fpage>5415</fpage>
<lpage>5420</lpage>
<pub-id pub-id-type="doi">10.1210/en.137.12.5415</pub-id><?supplied-pmid 8940365?><pub-id pub-id-type="pmid">8940365</pub-id></element-citation></ref><ref id="B403-brainsci-03-01483"><label>403.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fueshko</surname><given-names>S.M.</given-names></name><name><surname>Key</surname><given-names>S.</given-names></name><name><surname>Wray</surname><given-names>S.</given-names></name></person-group>
<article-title>GABA inhibits migration of luteinizing hormone-releasing hormone neurons in embryonic olfactory explants</article-title>
<source>J. Neurosci.</source>
<year>1998</year>
<volume>18</volume>
<fpage>2560</fpage>
<lpage>2569</lpage>
<?supplied-pmid 9502815?><pub-id pub-id-type="pmid">9502815</pub-id></element-citation></ref><ref id="B404-brainsci-03-01483"><label>404.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Shepherd</surname><given-names>G.</given-names></name><name><surname>Greer</surname><given-names>C.</given-names></name></person-group>
<article-title>Olfactory Bulb</article-title>
<source>The Synaptic Organization of the Brain</source>
<person-group person-group-type="editor"><name><surname>Shepherd</surname><given-names>G.</given-names></name></person-group>
<publisher-name>Oxford Univ. Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1990</year>
<fpage>133</fpage>
<lpage>169</lpage>
</element-citation></ref><ref id="B405-brainsci-03-01483"><label>405.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trombley</surname><given-names>P.Q.</given-names></name><name><surname>Shepherd</surname><given-names>G.M.</given-names></name></person-group>
<article-title>Synaptic transmission and modulation in the olfactory bulb</article-title>
<source>Curr. Opin. Neurobiol.</source>
<year>1993</year>
<volume>3</volume>
<fpage>540</fpage>
<lpage>547</lpage>
<pub-id pub-id-type="doi">10.1016/0959-4388(93)90053-2</pub-id><?supplied-pmid 8219719?><pub-id pub-id-type="pmid">8219719</pub-id></element-citation></ref><ref id="B406-brainsci-03-01483"><label>406.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>S.</given-names></name></person-group>
<article-title>Metabotropic glutamate receptors: Synaptic transmission, modulation and plasticity</article-title>
<source>Neuron</source>
<year>1994</year>
<volume>13</volume>
<fpage>1031</fpage>
<lpage>1037</lpage>
<pub-id pub-id-type="doi">10.1016/0896-6273(94)90043-4</pub-id><?supplied-pmid 7946343?><pub-id pub-id-type="pmid">7946343</pub-id></element-citation></ref><ref id="B407-brainsci-03-01483"><label>407.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Esfandyari</surname><given-names>T.</given-names></name><name><surname>Camilleri</surname><given-names>M.</given-names></name><name><surname>Busciglio</surname><given-names>I.</given-names></name><name><surname>Burton</surname><given-names>D.</given-names></name><name><surname>Baxter</surname><given-names>K.</given-names></name><name><surname>Zinsmeister</surname><given-names>A.R.</given-names></name></person-group>
<article-title>Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: A randomized, placebo-controlled study</article-title>
<source>Am. J. Physiol. Gastrointest. Liver Physiol.</source>
<year>2007</year>
<volume>294</volume>
<fpage>G137</fpage>
<lpage>G145</lpage>
<pub-id pub-id-type="pmid">17395895</pub-id></element-citation></ref><ref id="B408-brainsci-03-01483"><label>408.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ralevic</surname><given-names>V.</given-names></name><name><surname>Kendall</surname><given-names>D.A.</given-names></name></person-group>
<article-title>Cannabinoid modulation of perivascular sympathetic and sensory neurotransmission</article-title>
<source>Curr. Vasc. Pharmacol.</source>
<year>2009</year>
<volume>7</volume>
<fpage>15</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.2174/157016109787354114</pub-id><?supplied-pmid 19149636?><pub-id pub-id-type="pmid">19149636</pub-id></element-citation></ref><ref id="B409-brainsci-03-01483"><label>409.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>A.F.</given-names></name><name><surname>Lupica</surname><given-names>C.R.</given-names></name></person-group>
<article-title>Mechanisms of cannabinoid inhibition of GABA<sub>A</sub> synaptic transmission in the hippocampus</article-title>
<source>J. Neurosci.</source>
<year>2000</year>
<volume>20</volume>
<fpage>2470</fpage>
<lpage>2479</lpage>
<?supplied-pmid 10729327?><pub-id pub-id-type="pmid">10729327</pub-id></element-citation></ref><ref id="B410-brainsci-03-01483"><label>410.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids</article-title>
<source>Learn. Mem.</source>
<year>2000</year>
<volume>7</volume>
<fpage>132</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1101/lm.7.3.132</pub-id><?supplied-pmid 10837502?><pub-id pub-id-type="pmid">10837502</pub-id></element-citation></ref><ref id="B411-brainsci-03-01483"><label>411.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Egerton</surname><given-names>A.</given-names></name><name><surname>Allison</surname><given-names>C.</given-names></name><name><surname>Brett</surname><given-names>R.R.</given-names></name><name><surname>Pratt</surname><given-names>J.A.</given-names></name></person-group>
<article-title>Cannabinoids and prefrontal cortical function: Insights from preclinical studies</article-title>
<source>Neurosci. Biobehav. Rev.</source>
<year>2006</year>
<volume>30</volume>
<fpage>680</fpage>
<lpage>695</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2005.12.002</pub-id><?supplied-pmid 16574226?><pub-id pub-id-type="pmid">16574226</pub-id></element-citation></ref><ref id="B412-brainsci-03-01483"><label>412.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>L.A.</given-names></name><name><surname>Lolait</surname><given-names>S.J.</given-names></name><name><surname>Brownstein</surname><given-names>M.J.</given-names></name><name><surname>Young</surname><given-names>A.C.</given-names></name><name><surname>Bonner</surname><given-names>T.I.</given-names></name></person-group>
<article-title>Structure of a cannabinoid receptor and functional expression of the cloned cDNA</article-title>
<source>Nature</source>
<year>1990</year>
<volume>346</volume>
<fpage>561</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1038/346561a0</pub-id><?supplied-pmid 2165569?><pub-id pub-id-type="pmid">2165569</pub-id></element-citation></ref><ref id="B413-brainsci-03-01483"><label>413.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>B.R.</given-names></name><name><surname>Welch</surname><given-names>S.P.</given-names></name><name><surname>Abood</surname><given-names>M.E.</given-names></name></person-group>
<article-title>Progress toward understanding the cannabinoid receptor and its second messenger systems</article-title>
<source>Adv. Pharmacol.</source>
<year>1994</year>
<volume>25</volume>
<fpage>341</fpage>
<lpage>397</lpage>
<?supplied-pmid 8204506?><pub-id pub-id-type="pmid">8204506</pub-id></element-citation></ref><ref id="B414-brainsci-03-01483"><label>414.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>B.R.</given-names></name></person-group>
<article-title>Marijuana</article-title>
<source>Encyclopedia of Neuroscience</source>
<person-group person-group-type="editor"><name><surname>Adelman</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>B.H.</given-names></name></person-group>
<publisher-name>Elsevier</publisher-name>
<publisher-loc>Amsterdam, The Netherlands</publisher-loc>
<year>1999</year>
<fpage>1101</fpage>
<lpage>1105</lpage>
</element-citation></ref><ref id="B415-brainsci-03-01483"><label>415.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>L&#x000f6;scher</surname><given-names>W.</given-names></name></person-group>
<article-title>3-Mercaptopropionic acid: Convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine</article-title>
<source>Biochem. Pharmacol.</source>
<year>1979</year>
<volume>28</volume>
<fpage>1397</fpage>
<lpage>1407</lpage>
<pub-id pub-id-type="doi">10.1016/0006-2952(79)90443-X</pub-id><?supplied-pmid 444305?><pub-id pub-id-type="pmid">444305</pub-id></element-citation></ref><ref id="B416-brainsci-03-01483"><label>416.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Revuelta</surname><given-names>A.V.</given-names></name><name><surname>Cheney</surname><given-names>D.L.</given-names></name><name><surname>Wood</surname><given-names>P.L.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name></person-group>
<article-title>GABAergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by delta 9-tetrahydrocannabinol</article-title>
<source>Neuropharmacology</source>
<year>1979</year>
<volume>18</volume>
<fpage>525</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="doi">10.1016/0028-3908(79)90095-9</pub-id><?supplied-pmid 481705?><pub-id pub-id-type="pmid">481705</pub-id></element-citation></ref><ref id="B417-brainsci-03-01483"><label>417.</label><element-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Mechoulam</surname><given-names>R.</given-names></name></person-group>
<source>Cannabinoids as Therapeutic Agents</source>
<publisher-name>CRC Press</publisher-name>
<publisher-loc>Boca Raton, FL, USA</publisher-loc>
<year>1986</year>
<fpage>137</fpage>
<lpage>138</lpage>
</element-citation></ref><ref id="B418-brainsci-03-01483"><label>418.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leader</surname><given-names>J.P.</given-names></name><name><surname>Koe</surname><given-names>B.K.</given-names></name><name><surname>Weissman</surname><given-names>A.</given-names></name></person-group>
<article-title>GABA-like actions of levonantradol</article-title>
<source>J. Clin. Pharmacol.</source>
<year>1981</year>
<volume>21</volume>
<fpage>262S</fpage>
<lpage>270S</lpage>
<pub-id pub-id-type="doi">10.1002/j.1552-4604.1981.tb02604.x</pub-id><?supplied-pmid 6271832?><pub-id pub-id-type="pmid">6271832</pub-id></element-citation></ref><ref id="B419-brainsci-03-01483"><label>419.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Cheney</surname><given-names>D.L.</given-names></name><name><surname>Murray</surname><given-names>T.F.</given-names></name></person-group>
<article-title>Levonantradol-induced inhibition of acetylcholine turnover in rat hippocampus and striatum</article-title>
<source>J. Clin. Pharmacol.</source>
<year>1981</year>
<volume>21</volume>
<fpage>256S</fpage>
<lpage>261S</lpage>
<pub-id pub-id-type="doi">10.1002/j.1552-4604.1981.tb02603.x</pub-id><?supplied-pmid 6271831?><pub-id pub-id-type="pmid">6271831</pub-id></element-citation></ref><ref id="B420-brainsci-03-01483"><label>420.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Edery</surname><given-names>H.</given-names></name><name><surname>Gottesfeld</surname><given-names>Z.</given-names></name></person-group>
<article-title>The gamma-aminobutyric acid system in rat cerebellum during cannabinoid-induced cataleptoid state</article-title>
<source>Br. J. Pharmacol.</source>
<year>1975</year>
<volume>54</volume>
<fpage>406</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1111/j.1476-5381.1975.tb07584.x</pub-id><?supplied-pmid 1172451?><pub-id pub-id-type="pmid">1172451</pub-id></element-citation></ref><ref id="B421-brainsci-03-01483"><label>421.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feeney</surname><given-names>D.M.</given-names></name></person-group>
<article-title>Marihuana and epilepsy: Paradoxical anticonvulsant and convulsant effects</article-title>
<source>Adv. Biosci.</source>
<year>1978</year>
<volume>23</volume>
<fpage>643</fpage>
<lpage>657</lpage>
<pub-id pub-id-type="pmid">756849</pub-id></element-citation></ref><ref id="B422-brainsci-03-01483"><label>422.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>M.A.</given-names></name><name><surname>Ward</surname><given-names>S.J.</given-names></name><name><surname>Childers</surname><given-names>S.R.</given-names></name></person-group>
<article-title>Identification of cannabinoid receptors in cultures of rat cerebellar granule cells</article-title>
<source>Brain Res.</source>
<year>1993</year>
<volume>603</volume>
<fpage>102</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(93)91304-B</pub-id><?supplied-pmid 8384043?><pub-id pub-id-type="pmid">8384043</pub-id></element-citation></ref><ref id="B423-brainsci-03-01483"><label>423.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Pertwee</surname><given-names>R.G.</given-names></name></person-group>
<article-title>The Central Neuropharmocology of Psychotropic Cannabinoids</article-title>
<source>Psychotropic Drugs of Abuse</source>
<person-group person-group-type="editor"><name><surname>Balfour</surname><given-names>D.J.K.</given-names></name></person-group>
<publisher-name>Pergamon Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1990</year>
<fpage>355</fpage>
<lpage>429</lpage>
</element-citation></ref><ref id="B424-brainsci-03-01483"><label>424.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wickens</surname><given-names>A.P.</given-names></name><name><surname>Pertree</surname><given-names>R.G.</given-names></name></person-group>
<article-title>Effect of delta-9-tetrahydrocannabinol on circling in rats induced by intranigral muscimol administration</article-title>
<source>Eur. J. Pharmocol.</source>
<year>1995</year>
<volume>282</volume>
<fpage>251</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/0014-2999(95)00346-M</pub-id></element-citation></ref><ref id="B425-brainsci-03-01483"><label>425.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pertwee</surname><given-names>R.G.</given-names></name><name><surname>Greentree</surname><given-names>S.G.</given-names></name><name><surname>Swift</surname><given-names>P.A.</given-names></name></person-group>
<article-title>Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice</article-title>
<source>Neuropharmacology</source>
<year>1988</year>
<volume>27</volume>
<fpage>1265</fpage>
<lpage>1270</lpage>
<pub-id pub-id-type="doi">10.1016/0028-3908(88)90029-9</pub-id><?supplied-pmid 2854226?><pub-id pub-id-type="pmid">2854226</pub-id></element-citation></ref><ref id="B426-brainsci-03-01483"><label>426.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>M.</given-names></name><name><surname>Piser</surname><given-names>T.M.</given-names></name><name><surname>Seybold</surname><given-names>V.S.</given-names></name><name><surname>Thayer</surname><given-names>S.A.</given-names></name></person-group>
<article-title>Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures</article-title>
<source>J. Neurosci.</source>
<year>1996</year>
<volume>16</volume>
<fpage>4322</fpage>
<lpage>4334</lpage>
<?supplied-pmid 8699243?><pub-id pub-id-type="pmid">8699243</pub-id></element-citation></ref><ref id="B427-brainsci-03-01483"><label>427.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Joy</surname><given-names>J.E.</given-names></name><name><surname>Watson</surname><given-names>S.J.</given-names><suffix>Jr.</suffix></name><name><surname>Benson</surname><given-names>J.A.</given-names><suffix>Jr.</suffix></name></person-group>
<source>Marijuana and Medicine</source>
<publisher-name>National Academies Press</publisher-name>
<publisher-loc>Washington, DC, USA</publisher-loc>
<year>2000</year>
<fpage>50</fpage>
</element-citation></ref><ref id="B428-brainsci-03-01483"><label>428.</label><element-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Agurell</surname><given-names>S.</given-names></name><name><surname>Dewey</surname><given-names>W.L.</given-names></name><name><surname>Willtette</surname><given-names>R.D.</given-names></name></person-group>
<source>The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects</source>
<publisher-name>Academic Press</publisher-name>
<publisher-loc>Orlando, FL, USA</publisher-loc>
<year>1984</year>
<fpage>691</fpage>
</element-citation></ref><ref id="B429-brainsci-03-01483"><label>429.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pertwee</surname><given-names>R.G.</given-names></name><name><surname>Browne</surname><given-names>S.E.</given-names></name><name><surname>Ross</surname><given-names>T.M.</given-names></name><name><surname>Stretton</surname><given-names>C.D.</given-names></name></person-group>
<article-title>An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol</article-title>
<source>Pharmacol. Biochem. Behav.</source>
<year>1991</year>
<volume>40</volume>
<fpage>581</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="doi">10.1016/0091-3057(91)90366-A</pub-id><?supplied-pmid 1666920?><pub-id pub-id-type="pmid">1666920</pub-id></element-citation></ref><ref id="B430-brainsci-03-01483"><label>430.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>B.R.</given-names></name></person-group>
<article-title>Cellular effects of cannabinoids</article-title>
<source>Pharmacol. Rev.</source>
<year>1986</year>
<volume>38</volume>
<fpage>45</fpage>
<lpage>74</lpage>
<?supplied-pmid 2872689?><pub-id pub-id-type="pmid">2872689</pub-id></element-citation></ref><ref id="B431-brainsci-03-01483"><label>431.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Consroe</surname><given-names>P.</given-names></name><name><surname>Mechoulam</surname><given-names>R.</given-names></name></person-group>
<article-title>Anticonvulsant and neurotoxic effects of tetrahydrocannabinol stereoisomers</article-title>
<source>NIDA Res. Monogr.</source>
<year>1987</year>
<volume>79</volume>
<fpage>59</fpage>
<lpage>66</lpage>
<?supplied-pmid 2830538?><pub-id pub-id-type="pmid">2830538</pub-id></element-citation></ref><ref id="B432-brainsci-03-01483"><label>432.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zygmunt</surname><given-names>P.M.</given-names></name><name><surname>Andersson</surname><given-names>D.A.</given-names></name><name><surname>Hogestatt</surname><given-names>E.D.</given-names></name></person-group>
<article-title>Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB<sub>1</sub> and CB<sub>2</sub> cannabinoid receptor-independent mechanism</article-title>
<source>J. Neurosci.</source>
<year>2002</year>
<volume>22</volume>
<fpage>4720</fpage>
<lpage>4727</lpage>
<?supplied-pmid 12040079?><pub-id pub-id-type="pmid">12040079</pub-id></element-citation></ref><ref id="B433-brainsci-03-01483"><label>433.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cronholm</surname><given-names>B.</given-names></name></person-group>
<article-title>Phantom limb in amputees; a study of changes in the integration of centripetal impulses with special reference to referred sensations</article-title>
<source>Acta Psychiatr. Neurol. Scand. Suppl.</source>
<year>1951</year>
<volume>72</volume>
<fpage>1</fpage>
<lpage>310</lpage>
<?supplied-pmid 14837770?><pub-id pub-id-type="pmid">14837770</pub-id></element-citation></ref><ref id="B434-brainsci-03-01483"><label>434.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kew</surname><given-names>J.J.</given-names></name><name><surname>Halligan</surname><given-names>P.W.</given-names></name><name><surname>Marshall</surname><given-names>J.C.</given-names></name><name><surname>Passingham</surname><given-names>R.E.</given-names></name><name><surname>Rothwell</surname><given-names>J.C.</given-names></name><name><surname>Ridding</surname><given-names>M.C.</given-names></name><name><surname>Marsden</surname><given-names>C.D.</given-names></name><name><surname>Brooks</surname><given-names>D.J.</given-names></name></person-group>
<article-title>Abnormal access of axial vibrotactile input to deafferented somatosensory cortex in human upper limb amputees</article-title>
<source>J. Neurophysiol.</source>
<year>1997</year>
<volume>77</volume>
<fpage>2753</fpage>
<lpage>2764</lpage>
<?supplied-pmid 9163390?><pub-id pub-id-type="pmid">9163390</pub-id></element-citation></ref><ref id="B435-brainsci-03-01483"><label>435.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knecht</surname><given-names>S.</given-names></name><name><surname>Henningsen</surname><given-names>H.</given-names></name><name><surname>H&#x000f6;hling</surname><given-names>C.</given-names></name><name><surname>Elbert</surname><given-names>T.</given-names></name><name><surname>Flor</surname><given-names>H.</given-names></name><name><surname>Pantev</surname><given-names>C.</given-names></name><name><surname>Taub</surname><given-names>E.</given-names></name></person-group>
<article-title>Plasticity of plasticity? Changes in the pattern of perceptual correlates of reorganization after amputation</article-title>
<source>Brain</source>
<year>1998</year>
<volume>121</volume>
<fpage>717</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="doi">10.1093/brain/121.4.717</pub-id><?supplied-pmid 9577396?><pub-id pub-id-type="pmid">9577396</pub-id></element-citation></ref><ref id="B436-brainsci-03-01483"><label>436.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>M.</given-names></name><name><surname>B&#x000f6;hler</surname><given-names>P.</given-names></name><name><surname>Weisbrod</surname><given-names>M.</given-names></name><name><surname>Kischka</surname><given-names>U.</given-names></name></person-group>
<article-title>A neural network model of phantom limbs</article-title>
<source>Biol. Cybern.</source>
<year>1995</year>
<volume>72</volume>
<fpage>197</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1007/BF00201484</pub-id><?supplied-pmid 7703296?><pub-id pub-id-type="pmid">7703296</pub-id></element-citation></ref><ref id="B437-brainsci-03-01483"><label>437.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ojemann</surname><given-names>J.G.</given-names></name><name><surname>Silbergeld</surname><given-names>D.L.</given-names></name></person-group>
<article-title>Cortical stimulation mapping of phantom limb rolandic cortex. Case Report</article-title>
<source>J. Neurosurg.</source>
<year>1995</year>
<volume>82</volume>
<fpage>641</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="doi">10.3171/jns.1995.82.4.0641</pub-id><?supplied-pmid 7897528?><pub-id pub-id-type="pmid">7897528</pub-id></element-citation></ref><ref id="B438-brainsci-03-01483"><label>438.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>E.G.</given-names></name><name><surname>Pons</surname><given-names>T.P.</given-names></name></person-group>
<article-title>Thalamic and brain stem contributions to large-scale plasticity of primate somatosensory cortex</article-title>
<source>Science</source>
<year>1998</year>
<volume>282</volume>
<fpage>1121</fpage>
<lpage>1125</lpage>
<pub-id pub-id-type="doi">10.1126/science.282.5391.1121</pub-id><?supplied-pmid 9804550?><pub-id pub-id-type="pmid">9804550</pub-id></element-citation></ref><ref id="B439-brainsci-03-01483"><label>439.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Craig</surname><given-names>A.D.</given-names></name><name><surname>Reiman</surname><given-names>E.M.</given-names></name><name><surname>Evans</surname><given-names>A.</given-names></name><name><surname>Bushnell</surname><given-names>M.C.</given-names></name></person-group>
<article-title>Functional imaging of an illusion of pain</article-title>
<source>Nature</source>
<year>1996</year>
<volume>384</volume>
<fpage>258</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1038/384258a0</pub-id><?supplied-pmid 8918874?><pub-id pub-id-type="pmid">8918874</pub-id></element-citation></ref><ref id="B440-brainsci-03-01483"><label>440.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borsook</surname><given-names>D.</given-names></name><name><surname>Becerra</surname><given-names>L.</given-names></name><name><surname>Fishman</surname><given-names>S.</given-names></name><name><surname>Edwards</surname><given-names>A.</given-names></name><name><surname>Jennings</surname><given-names>C.L.</given-names></name><name><surname>Stojanovic</surname><given-names>M.</given-names></name><name><surname>Papinicolas</surname><given-names>L.</given-names></name><name><surname>Ramachandran</surname><given-names>V.S.</given-names></name><name><surname>Gonzales</surname><given-names>R.G.</given-names></name><name><surname>Breiter</surname><given-names>H.</given-names></name></person-group>
<article-title>Acute plasticity in the human somatosensory cortex following amputation</article-title>
<source>Neuroreport</source>
<year>1998</year>
<volume>9</volume>
<fpage>1013</fpage>
<lpage>1017</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-199804200-00011</pub-id><?supplied-pmid 9601659?><pub-id pub-id-type="pmid">9601659</pub-id></element-citation></ref><ref id="B441-brainsci-03-01483"><label>441.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Flor</surname><given-names>H.</given-names></name><name><surname>Elbert</surname><given-names>T.</given-names></name><name><surname>Knecht</surname><given-names>S.</given-names></name><name><surname>Wienbruch</surname><given-names>C.</given-names></name><name><surname>Pantev</surname><given-names>C.</given-names></name><name><surname>Birbaumers</surname><given-names>N.</given-names></name><name><surname>Larbig</surname><given-names>W.</given-names></name><name><surname>Taub</surname><given-names>E.</given-names></name></person-group>
<article-title>Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation</article-title>
<source>Nature</source>
<year>1995</year>
<volume>375</volume>
<fpage>482</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="doi">10.1038/375482a0</pub-id><?supplied-pmid 7777055?><pub-id pub-id-type="pmid">7777055</pub-id></element-citation></ref><ref id="B442-brainsci-03-01483"><label>442.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zilstorff</surname><given-names>K.</given-names></name></person-group>
<article-title>Parosmia</article-title>
<source>J. Laryngol. Otol.</source>
<year>1966</year>
<volume>80</volume>
<fpage>1102</fpage>
<lpage>1104</lpage>
<pub-id pub-id-type="doi">10.1017/S0022215100066457</pub-id><?supplied-pmid 5927746?><pub-id pub-id-type="pmid">5927746</pub-id></element-citation></ref><ref id="B443-brainsci-03-01483"><label>443.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zilstorff</surname><given-names>K.</given-names></name><name><surname>Herbild</surname><given-names>O.</given-names></name></person-group>
<article-title>Parosmia</article-title>
<source>Acta Otolaryngol. Suppl.</source>
<year>1979</year>
<volume>360</volume>
<fpage>40</fpage>
<lpage>41</lpage>
<?supplied-pmid 287347?><pub-id pub-id-type="pmid">287347</pub-id></element-citation></ref><ref id="B444-brainsci-03-01483"><label>444.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Korczyn</surname><given-names>A.D.</given-names></name></person-group>
<article-title>Hallucination in Parkinson&#x02019;s disease</article-title>
<source>Lancet</source>
<year>2001</year>
<volume>358</volume>
<fpage>1031</fpage>
<lpage>1032</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(01)06230-4</pub-id><?supplied-pmid 11589931?><pub-id pub-id-type="pmid">11589931</pub-id></element-citation></ref><ref id="B445-brainsci-03-01483"><label>445.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gsell</surname><given-names>W.</given-names></name><name><surname>Strein</surname><given-names>I.</given-names></name><name><surname>Krause</surname><given-names>U.</given-names></name><name><surname>Riederer</surname><given-names>P.</given-names></name></person-group>
<article-title>Neurochemical abnormalities in Alzheimer&#x02019;s disease and Parkinson&#x02019;s disease: A comparative review</article-title>
<source>J. Neural. Transm.</source>
<year>1997</year>
<volume>51</volume>
<fpage>145</fpage>
<lpage>159</lpage>
</element-citation></ref><ref id="B446-brainsci-03-01483"><label>446.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cummings</surname><given-names>J.L.</given-names></name></person-group>
<article-title>Cholinesterase inhibitors: Expanding applications</article-title>
<source>Lancet</source>
<year>2000</year>
<volume>356</volume>
<fpage>2024</fpage>
<lpage>2025</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(00)03393-6</pub-id><?supplied-pmid 11145482?><pub-id pub-id-type="pmid">11145482</pub-id></element-citation></ref><ref id="B447-brainsci-03-01483"><label>447.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haussermann</surname><given-names>P.</given-names></name><name><surname>Ceballos-Baumann</surname><given-names>A.</given-names></name><name><surname>Reinbold</surname><given-names>H.</given-names></name><name><surname>Goecker</surname><given-names>P.</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>S.</given-names></name></person-group>
<article-title>Applications of cholinesterase inhibitors</article-title>
<source>Lancet</source>
<year>2001</year>
<volume>357</volume>
<fpage>1039</fpage>
<?supplied-pmid 11293614?><pub-id pub-id-type="pmid">11293614</pub-id></element-citation></ref><ref id="B448-brainsci-03-01483"><label>448.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Creese</surname><given-names>I.</given-names></name><name><surname>Burt</surname><given-names>D.</given-names></name><name><surname>Snyder</surname><given-names>S.H.</given-names></name></person-group>
<article-title>Biochemical Actions of Neuroleptic Drugs: Focus on Dopamine Receptor</article-title>
<source>Handbook of Psycho-Pharmacology</source>
<person-group person-group-type="editor"><name><surname>Iverson</surname><given-names>L.L.</given-names></name><name><surname>Iverson</surname><given-names>S.D.</given-names></name><name><surname>Snyder</surname><given-names>S.H.</given-names></name></person-group>
<publisher-name>Plenum Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1978</year>
<volume>Volume 10</volume>
<fpage>37</fpage>
<lpage>89</lpage>
</element-citation></ref><ref id="B449-brainsci-03-01483"><label>449.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goetz</surname><given-names>C.G.</given-names></name><name><surname>Vogel</surname><given-names>C.</given-names></name><name><surname>Tanner</surname><given-names>C.M.</given-names></name><name><surname>Stebbins</surname><given-names>G.T.</given-names></name></person-group>
<article-title>Early dopaminergic drug-induced hallucinations in parkinsonian patients</article-title>
<source>Neurology</source>
<year>1998</year>
<volume>51</volume>
<fpage>811</fpage>
<lpage>814</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.51.3.811</pub-id><?supplied-pmid 9748031?><pub-id pub-id-type="pmid">9748031</pub-id></element-citation></ref><ref id="B450-brainsci-03-01483"><label>450.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feinberg</surname><given-names>A.P.</given-names></name><name><surname>Snyder</surname><given-names>S.H.</given-names></name></person-group>
<article-title>Phenothiazine drugs: Structure-activity relationships explained by a conformation that mimics dopamine</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>1975</year>
<volume>72</volume>
<fpage>1899</fpage>
<lpage>1903</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.72.5.1899</pub-id><?supplied-pmid 239403?><pub-id pub-id-type="pmid">239403</pub-id></element-citation></ref><ref id="B451-brainsci-03-01483"><label>451.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>Y.</given-names></name><name><surname>Andoh</surname><given-names>T.</given-names></name><name><surname>Furuya</surname><given-names>R.</given-names></name><name><surname>Hattori</surname><given-names>S.</given-names></name><name><surname>Watanabe</surname><given-names>I.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>H.</given-names></name><name><surname>Okumura</surname><given-names>F.</given-names></name></person-group>
<article-title>Comparison of the effects of convulsant and depressant barbiturate stereoisomers on AMPA-type glutamate receptors</article-title>
<source>Anesthesiology</source>
<year>1999</year>
<volume>90</volume>
<fpage>1704</fpage>
<lpage>1713</lpage>
<pub-id pub-id-type="doi">10.1097/00000542-199906000-00028</pub-id><?supplied-pmid 10360870?><pub-id pub-id-type="pmid">10360870</pub-id></element-citation></ref><ref id="B452-brainsci-03-01483"><label>452.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yokoro</surname><given-names>C.M.</given-names></name><name><surname>Pesquero</surname><given-names>S.M.</given-names></name><name><surname>Turchetti-Maia</surname><given-names>R.M.</given-names></name><name><surname>Francischi</surname><given-names>J.N.</given-names></name><name><surname>Tatsuo</surname><given-names>M.A.</given-names></name></person-group>
<article-title>Acute phenobarbital administration induces hyperalgesia: Pharmacological evidence for the involvement of supraspinal GABA-A receptors</article-title>
<source>Braz. J. Med. Biol. Res.</source>
<year>2001</year>
<volume>34</volume>
<fpage>397</fpage>
<lpage>405</lpage>
<?supplied-pmid 11262592?><pub-id pub-id-type="pmid">11262592</pub-id></element-citation></ref><ref id="B453-brainsci-03-01483"><label>453.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Akk</surname><given-names>G.</given-names></name><name><surname>Steinbach</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Activation and block of recombinant GABA(A) receptors by pentobarbitone: A single channel study</article-title>
<source>Br. J. Pharmacol.</source>
<year>2000</year>
<volume>130</volume>
<fpage>249</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjp.0703335</pub-id><?supplied-pmid 10807661?><pub-id pub-id-type="pmid">10807661</pub-id></element-citation></ref><ref id="B454-brainsci-03-01483"><label>454.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ortho-McNeil</surname><given-names>H.</given-names></name></person-group>
<article-title>Thioridazine</article-title>
<source>Physicians Desk Reference</source>
<publisher-name>Medical Economics</publisher-name>
<publisher-loc>Montvale, NJ, USA</publisher-loc>
<year>2002</year>
<fpage>2533</fpage>
<lpage>2534</lpage>
</element-citation></ref><ref id="B455-brainsci-03-01483"><label>455.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Mylan</surname><given-names>T.</given-names></name></person-group>
<article-title>Haloperidol</article-title>
<source>Physicians Desk Reference</source>
<publisher-name>Medical Economics</publisher-name>
<publisher-loc>Montvale, NJ, USA</publisher-loc>
<year>2002</year>
<fpage>2289</fpage>
<lpage>2290</lpage>
</element-citation></ref><ref id="B456-brainsci-03-01483"><label>456.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fenwick</surname><given-names>P.</given-names></name></person-group>
<article-title>The behavioral treatment of epilepsy generation and inhibition of seizures</article-title>
<source>Neurol. Clin.</source>
<year>1994</year>
<volume>12</volume>
<fpage>175</fpage>
<lpage>202</lpage>
<?supplied-pmid 8183209?><pub-id pub-id-type="pmid">8183209</pub-id></element-citation></ref><ref id="B457-brainsci-03-01483"><label>457.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pritchard</surname><given-names>P.</given-names></name><name><surname>Holmstrom</surname><given-names>V.</given-names></name><name><surname>Giacinto</surname><given-names>J.</given-names></name></person-group>
<article-title>Self-abatement of complex partial seizures</article-title>
<source>Ann. Neurol.</source>
<year>1985</year>
<volume>18</volume>
<fpage>265</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410180217</pub-id><?supplied-pmid 4037767?><pub-id pub-id-type="pmid">4037767</pub-id></element-citation></ref><ref id="B458-brainsci-03-01483"><label>458.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Efron</surname><given-names>R.</given-names></name></person-group>
<article-title>The effect of olfactory stimuli in arresting uncinate fits</article-title>
<source>Brain</source>
<year>1956</year>
<volume>79</volume>
<fpage>267</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="doi">10.1093/brain/79.2.267</pub-id><?supplied-pmid 13364083?><pub-id pub-id-type="pmid">13364083</pub-id></element-citation></ref><ref id="B459-brainsci-03-01483"><label>459.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iwata</surname><given-names>B.A.</given-names></name><name><surname>Lorentzson</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Operant control of seizure-like behavior in an institutionalized retarded adult</article-title>
<source>Behav. Ther.</source>
<year>1976</year>
<volume>7</volume>
<fpage>247</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/S0005-7894(76)80283-3</pub-id></element-citation></ref><ref id="B460-brainsci-03-01483"><label>460.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gardner</surname><given-names>J.E.</given-names></name></person-group>
<article-title>Behavior therapy treatment approach to a psychogenic seizure case</article-title>
<source>J. Consult. Psychol.</source>
<year>1967</year>
<volume>31</volume>
<fpage>209</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1037/h0024446</pub-id><?supplied-pmid 6042058?><pub-id pub-id-type="pmid">6042058</pub-id></element-citation></ref><ref id="B461-brainsci-03-01483"><label>461.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Sterman</surname><given-names>M.B.</given-names></name></person-group>
<article-title>Neurophysiological and Clinical Studies of Sensori-Motor EEG Biofeedback Training: Some Effects of Epilepsy</article-title>
<source>Biofeedback: Behavior Medicine</source>
<person-group person-group-type="editor"><name><surname>Birk</surname><given-names>L.</given-names></name></person-group>
<publisher-name>Grune &#x00026; Stratton</publisher-name>
<publisher-loc>Boston, MA, USA</publisher-loc>
<year>1973</year>
<fpage>507</fpage>
<lpage>526</lpage>
</element-citation></ref><ref id="B462-brainsci-03-01483"><label>462.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dahl</surname><given-names>J.</given-names></name><name><surname>Melin</surname><given-names>L.</given-names></name><name><surname>Brorson</surname><given-names>L.O.</given-names></name><name><surname>Schollin</surname><given-names>J.</given-names></name></person-group>
<article-title>Effects of a broad-spectrum behavior modification treatment program on children with refractory epileptic seizures</article-title>
<source>Epilepsia</source>
<year>1985</year>
<volume>26</volume>
<fpage>303</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1985.tb05654.x</pub-id><?supplied-pmid 4006888?><pub-id pub-id-type="pmid">4006888</pub-id></element-citation></ref><ref id="B463-brainsci-03-01483"><label>463.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dahl</surname><given-names>J.</given-names></name><name><surname>Melin</surname><given-names>L.</given-names></name><name><surname>Lund</surname><given-names>L.</given-names></name></person-group>
<article-title>Effects of a contingent relaxation treatment program on adults with refractory epileptic seizures</article-title>
<source>Epilepsia</source>
<year>1987</year>
<volume>28</volume>
<fpage>125</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1987.tb03637.x</pub-id><?supplied-pmid 3545797?><pub-id pub-id-type="pmid">3545797</pub-id></element-citation></ref><ref id="B464-brainsci-03-01483"><label>464.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tassinari</surname><given-names>C.A.</given-names></name></person-group>
<article-title>Suppression of focal spikes by somatosensory stimuli</article-title>
<source>Electroencephalogr. Clin. Neurophysiol.</source>
<year>1968</year>
<volume>25</volume>
<fpage>574</fpage>
<lpage>578</lpage>
<pub-id pub-id-type="doi">10.1016/0013-4694(68)90237-X</pub-id><?supplied-pmid 4178752?><pub-id pub-id-type="pmid">4178752</pub-id></element-citation></ref><ref id="B465-brainsci-03-01483"><label>465.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gellhorn</surname><given-names>E.</given-names></name></person-group>
<article-title>Effect of afferent impulses on cortical suppressor areas</article-title>
<source>J. Neurophysiol.</source>
<year>1947</year>
<volume>10</volume>
<fpage>125</fpage>
<lpage>132</lpage>
<?supplied-pmid 20291839?><pub-id pub-id-type="pmid">20291839</pub-id></element-citation></ref><ref id="B466-brainsci-03-01483"><label>466.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barker</surname><given-names>S.H.</given-names></name><name><surname>Gellhorn</surname><given-names>E.</given-names></name></person-group>
<article-title>Influence of suppressor areas on afferent impulses</article-title>
<source>J. Neurophysiol.</source>
<year>1947</year>
<volume>10</volume>
<fpage>133</fpage>
<lpage>138</lpage>
<?supplied-pmid 20291840?><pub-id pub-id-type="pmid">20291840</pub-id></element-citation></ref><ref id="B467-brainsci-03-01483"><label>467.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mostofsky</surname><given-names>D.I.</given-names></name><name><surname>Balaschak</surname><given-names>B.A.</given-names></name></person-group>
<article-title>Psychobiological control of seizures</article-title>
<source>Psychol. Bull.</source>
<year>1977</year>
<volume>84</volume>
<fpage>723</fpage>
<lpage>750</lpage>
<pub-id pub-id-type="doi">10.1037/0033-2909.84.4.723</pub-id><?supplied-pmid 19800?><pub-id pub-id-type="pmid">19800</pub-id></element-citation></ref><ref id="B468-brainsci-03-01483"><label>468.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morrell</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Differential diagnosis of seizures</article-title>
<source>Neurol. Clin.</source>
<year>1993</year>
<volume>11</volume>
<fpage>737</fpage>
<lpage>754</lpage>
<?supplied-pmid 8272029?><pub-id pub-id-type="pmid">8272029</pub-id></element-citation></ref><ref id="B469-brainsci-03-01483"><label>469.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alper</surname><given-names>K.</given-names></name></person-group>
<article-title>Nonepileptic seizures</article-title>
<source>Neurol. Clin.</source>
<year>1994</year>
<volume>12</volume>
<fpage>153</fpage>
<lpage>173</lpage>
<?supplied-pmid 8183208?><pub-id pub-id-type="pmid">8183208</pub-id></element-citation></ref><ref id="B470-brainsci-03-01483"><label>470.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alper</surname><given-names>K.R.</given-names></name><name><surname>Devinsky</surname><given-names>O.</given-names></name><name><surname>Perrine</surname><given-names>K.</given-names></name><name><surname>Vasquez</surname><given-names>B.</given-names></name><name><surname>Luciano</surname><given-names>D.</given-names></name></person-group>
<article-title>Psychiatric classification of nonconversion nonepileptic seizures</article-title>
<source>Arch. Neurol.</source>
<year>1995</year>
<volume>52</volume>
<fpage>199</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.1995.00540260105025</pub-id><?supplied-pmid 7848132?><pub-id pub-id-type="pmid">7848132</pub-id></element-citation></ref><ref id="B471-brainsci-03-01483"><label>471.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Altman</surname><given-names>H.</given-names></name><name><surname>Collins</surname><given-names>M.</given-names></name><name><surname>Mundy</surname><given-names>P.</given-names></name></person-group>
<article-title>Subclinical hallucinations and delusions in nonpsychotic adolescents</article-title>
<source>J. Child Psychol. Psychiatry</source>
<year>1997</year>
<volume>38</volume>
<fpage>413</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7610.1997.tb01526.x</pub-id><?supplied-pmid 9232486?><pub-id pub-id-type="pmid">9232486</pub-id></element-citation></ref><ref id="B472-brainsci-03-01483"><label>472.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guberman</surname><given-names>A.</given-names></name></person-group>
<article-title>Psychogenic pseudoseizures in non-epileptic patients</article-title>
<source>Can. J. Psychiatry</source>
<year>1982</year>
<volume>27</volume>
<fpage>401</fpage>
<lpage>404</lpage>
<?supplied-pmid 7116280?><pub-id pub-id-type="pmid">7116280</pub-id></element-citation></ref><ref id="B473-brainsci-03-01483"><label>473.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pakalnis</surname><given-names>A.</given-names></name><name><surname>Drake</surname><given-names>M.E.</given-names></name><name><surname>Phillips</surname><given-names>B.</given-names></name></person-group>
<article-title>Neuropsychiatric aspects of psychogenic status epilepticus</article-title>
<source>Neurology</source>
<year>1991</year>
<volume>41</volume>
<fpage>1104</fpage>
<lpage>1106</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.41.7.1104</pub-id><?supplied-pmid 2067641?><pub-id pub-id-type="pmid">2067641</pub-id></element-citation></ref><ref id="B474-brainsci-03-01483"><label>474.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Merlis</surname><given-names>J.K.</given-names></name></person-group>
<article-title>Reflex Epilepsy</article-title>
<source>Handbook of Clinical Neurology: The Epilepsies</source>
<person-group person-group-type="editor"><name><surname>Vinken</surname><given-names>J.P.</given-names></name><name><surname>Bruyn</surname><given-names>G.W.</given-names></name></person-group>
<publisher-name>Elsevier</publisher-name>
<publisher-loc>Amsterdam, The Netherlands</publisher-loc>
<year>1974</year>
<volume>Volume 15</volume>
<fpage>450</fpage>
<lpage>456</lpage>
</element-citation></ref><ref id="B475-brainsci-03-01483"><label>475.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Forster</surname><given-names>F.M.</given-names></name></person-group>
<article-title>Behavioral Therapy of Reflex Epilepsy: Maintenance or Reinforcement of Therapy</article-title>
<source>Reflex Epilepsy, Behavior Therapy and Conditional Reflexes</source>
<person-group person-group-type="editor"><name><surname>Forster</surname><given-names>F.M.</given-names></name></person-group>
<publisher-name>C.C. Thomas</publisher-name>
<publisher-loc>Springfield, IL, USA</publisher-loc>
<year>1977</year>
<fpage>73</fpage>
<lpage>86</lpage>
</element-citation></ref><ref id="B476-brainsci-03-01483"><label>476.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rotaccio</surname><given-names>A.L.</given-names></name></person-group>
<article-title>Reflex seizures</article-title>
<source>Neurol. Clin.</source>
<year>1994</year>
<volume>12</volume>
<fpage>57</fpage>
<lpage>83</lpage>
<?supplied-pmid 8183213?><pub-id pub-id-type="pmid">8183213</pub-id></element-citation></ref><ref id="B477-brainsci-03-01483"><label>477.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Jeavons</surname><given-names>P.M.</given-names></name><name><surname>Harding</surname><given-names>G.F.</given-names></name></person-group>
<source>Photosensitive Epilepsy: A Review of the Literature and a Study of 460 Patients</source>
<publisher-name>Heineman</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>1975</year>
</element-citation></ref><ref id="B478-brainsci-03-01483"><label>478.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Jeavons</surname><given-names>P.M.</given-names></name></person-group>
<article-title>Photosensitive Epilepsy</article-title>
<source>A Textbook of Epilepsy</source>
<edition>2nd ed.</edition>
<person-group person-group-type="editor"><name><surname>Laidlaw</surname><given-names>J.</given-names></name><name><surname>Richens</surname><given-names>A.</given-names></name></person-group>
<publisher-name>Churchill Livingstone</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1982</year>
<fpage>195</fpage>
<lpage>210</lpage>
</element-citation></ref><ref id="B479-brainsci-03-01483"><label>479.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Behrman</surname><given-names>S.</given-names></name><name><surname>Wyke</surname><given-names>B.D.</given-names></name></person-group>
<article-title>Vestibulogenic seizures</article-title>
<source>Brain</source>
<year>1958</year>
<volume>81</volume>
<fpage>529</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="doi">10.1093/brain/81.4.529</pub-id><?supplied-pmid 13618450?><pub-id pub-id-type="pmid">13618450</pub-id></element-citation></ref><ref id="B480-brainsci-03-01483"><label>480.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cantor</surname><given-names>F.K.</given-names></name></person-group>
<article-title>Vestibular-temporal lobe connections demonstrated by induced seizures</article-title>
<source>Neurology</source>
<year>1971</year>
<volume>21</volume>
<fpage>507</fpage>
<lpage>516</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.21.5.507</pub-id><?supplied-pmid 5314329?><pub-id pub-id-type="pmid">5314329</pub-id></element-citation></ref><ref id="B481-brainsci-03-01483"><label>481.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Critchley</surname><given-names>M.</given-names></name></person-group>
<article-title>Musicogenic epilepsy</article-title>
<source>Brain</source>
<year>1937</year>
<volume>60</volume>
<fpage>13</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1093/brain/60.1.13</pub-id></element-citation></ref><ref id="B482-brainsci-03-01483"><label>482.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abenson</surname><given-names>M.H.</given-names></name></person-group>
<article-title>Epileptic fits provoked by taste</article-title>
<source>Br. J. Psychiatry</source>
<year>1969</year>
<volume>115</volume>
<fpage>123</fpage>
<?supplied-pmid 5781956?><pub-id pub-id-type="pmid">5781955</pub-id></element-citation></ref><ref id="B483-brainsci-03-01483"><label>483.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tedrus</surname><given-names>G.M.</given-names></name><name><surname>Albertin</surname><given-names>M.C.</given-names></name><name><surname>Odashima</surname><given-names>N.S.</given-names></name><name><surname>Fonseca</surname><given-names>C.</given-names></name></person-group>
<article-title>Partial motor seizures induced by movement in diabetic patients</article-title>
<source>Arq. Neuropsiquiatr.</source>
<year>1991</year>
<volume>49</volume>
<fpage>442</fpage>
<lpage>446</lpage>
<comment>(in Portuguese)</comment>
<pub-id pub-id-type="pmid">1842194</pub-id></element-citation></ref><ref id="B484-brainsci-03-01483"><label>484.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Penfield</surname><given-names>W.</given-names></name><name><surname>Erickson</surname><given-names>T.C.</given-names></name></person-group>
<source>Epilepsy and Cerebral Localization: A Study of the Mechanism, Treatment and Prevention of Epileptic Seizures</source>
<publisher-name>C.C. Thomas</publisher-name>
<publisher-loc>Springfield, IL, USA</publisher-loc>
<year>1941</year>
</element-citation></ref><ref id="B485-brainsci-03-01483"><label>485.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cirignotta</surname><given-names>F.</given-names></name><name><surname>Marcacci</surname><given-names>G.</given-names></name><name><surname>Lugaresi</surname><given-names>E.</given-names></name></person-group>
<article-title>Epileptic seizures precipitated by eating</article-title>
<source>Epilepsia</source>
<year>1977</year>
<volume>18</volume>
<fpage>445</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1977.tb04990.x</pub-id><?supplied-pmid 412665?><pub-id pub-id-type="pmid">412665</pub-id></element-citation></ref><ref id="B486-brainsci-03-01483"><label>486.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fiol</surname><given-names>M.E.</given-names></name><name><surname>Leppik</surname><given-names>I.E.</given-names></name><name><surname>Pretzel</surname><given-names>K.</given-names></name></person-group>
<article-title>Eating epilepsy. EEG and clinical study</article-title>
<source>Epilepsia</source>
<year>1986</year>
<volume>27</volume>
<fpage>441</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1986.tb03565.x</pub-id><?supplied-pmid 3720704?><pub-id pub-id-type="pmid">3720704</pub-id></element-citation></ref><ref id="B487-brainsci-03-01483"><label>487.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alajouahine</surname><given-names>T.</given-names></name><name><surname>Gastaut</surname><given-names>H.</given-names></name></person-group>
<article-title>Synkinesis-startle and epilepsy startle triggered by unexpected sensory and sensitive factors. I. Anatomical and clinical data on 15 cases</article-title>
<source>Rev. Neurol. (Paris)</source>
<year>1995</year>
<volume>93</volume>
<fpage>29</fpage>
<lpage>41</lpage>
<comment>(in French)</comment>
</element-citation></ref><ref id="B488-brainsci-03-01483"><label>488.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bickford</surname><given-names>R.G.</given-names></name><name><surname>Whelan</surname><given-names>J.L.</given-names></name><name><surname>Klass</surname><given-names>D.W.</given-names></name><name><surname>Corbin</surname><given-names>K.B.</given-names></name></person-group>
<article-title>Reading epilepsy: Clinical and electroencephalographic studies of a new syndrome</article-title>
<source>Trans. Am. Neurol. Assoc.</source>
<year>1956</year>
<volume>81</volume>
<fpage>100</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="pmid">13409480</pub-id></element-citation></ref><ref id="B489-brainsci-03-01483"><label>489.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ingvar</surname><given-names>D.H.</given-names></name><name><surname>Nyman</surname><given-names>G.E.</given-names></name></person-group>
<article-title>Epilepsia arithmetices. A new psychological trigger mechanism in a case of epilepsy</article-title>
<source>Neurology</source>
<year>1962</year>
<volume>12</volume>
<fpage>282</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.12.4.282</pub-id></element-citation></ref><ref id="B490-brainsci-03-01483"><label>490.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Clementi</surname><given-names>A.</given-names></name></person-group>
<article-title>Storicizzazione circoscritta del lobo piriforme del cervello ed epilessia sperimentale da stimoli odoriferi</article-title>
<source>Arch. Fisiol.</source>
<year>1931</year>
<volume>30</volume>
<fpage>12</fpage>
</element-citation></ref><ref id="B491-brainsci-03-01483"><label>491.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kasteleijn-Nolst Trenit&#x000e9;</surname><given-names>D.G.</given-names></name></person-group>
<article-title>Photosensitivity in epilepsy. Electrophysiological and clinical correlates</article-title>
<source>Acta Neurol. Scand. Suppl.</source>
<year>1989</year>
<volume>125</volume>
<fpage>3</fpage>
<lpage>149</lpage>
<?supplied-pmid 2618589?><pub-id pub-id-type="pmid">2618589</pub-id></element-citation></ref><ref id="B492-brainsci-03-01483"><label>492.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doose</surname><given-names>H.</given-names></name><name><surname>Gerken</surname><given-names>H.</given-names></name><name><surname>Hien-V&#x000f6;lpel</surname><given-names>K.F.</given-names></name></person-group>
<article-title>Genetics of photosensitive epilepsy</article-title>
<source>Neuropediatrie</source>
<year>1969</year>
<volume>1</volume>
<fpage>56</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1055/s-0028-1091864</pub-id></element-citation></ref><ref id="B493-brainsci-03-01483"><label>493.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Lesser</surname><given-names>R.P.</given-names></name></person-group>
<article-title>Psychogenic Seizures</article-title>
<source>Recent Advances in Epilepsy 2</source>
<person-group person-group-type="editor"><name><surname>Pedley</surname><given-names>T.A.</given-names></name><name><surname>Meldrum</surname><given-names>B.J.</given-names></name></person-group>
<publisher-name>Churchill, Livingston</publisher-name>
<publisher-loc>Edinburgh, UK</publisher-loc>
<year>1985</year>
<fpage>273</fpage>
<lpage>296</lpage>
</element-citation></ref><ref id="B494-brainsci-03-01483"><label>494.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trimble</surname><given-names>M.</given-names></name></person-group>
<article-title>Pseudo problems pseudoseizures</article-title>
<source>Br. J. Hosp. Med.</source>
<year>1983</year>
<volume>29</volume>
<fpage>326</fpage>
<lpage>333</lpage>
<?supplied-pmid 6871521?><pub-id pub-id-type="pmid">6871521</pub-id></element-citation></ref><ref id="B495-brainsci-03-01483"><label>495.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ramani</surname><given-names>V.</given-names></name></person-group>
<article-title>Intensive Monitoring of Psychogenic Seizures, Aggression and Dyscontrol Syndromes</article-title>
<source>Advances in Neurology</source>
<person-group person-group-type="editor"><name><surname>Gumnit</surname><given-names>R.</given-names></name></person-group>
<publisher-name>Raven Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1986</year>
<volume>Volume 46</volume>
<fpage>203</fpage>
<lpage>217</lpage>
</element-citation></ref><ref id="B496-brainsci-03-01483"><label>496.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Betts</surname><given-names>T.</given-names></name></person-group>
<article-title>Pseudoseizures: Seizures that are not epilepsy</article-title>
<source>Lancet</source>
<year>1990</year>
<volume>336</volume>
<fpage>163</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1016/0140-6736(90)91673-X</pub-id><?supplied-pmid 1973484?><pub-id pub-id-type="pmid">1973484</pub-id></element-citation></ref><ref id="B497-brainsci-03-01483"><label>497.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gates</surname><given-names>J.R.</given-names></name><name><surname>Luciano</surname><given-names>D.</given-names></name><name><surname>Devinsky</surname><given-names>O.</given-names></name></person-group>
<article-title>The Classification and Treatment of Nonepileptic Events</article-title>
<source>Epilepsy and Behavior</source>
<person-group person-group-type="editor"><name><surname>Devinsky</surname><given-names>O.</given-names></name><name><surname>Theodore</surname><given-names>W.H.</given-names></name></person-group>
<publisher-name>Wiley-Liss</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1991</year>
<volume>Volume 12</volume>
<fpage>251</fpage>
<lpage>263</lpage>
</element-citation></ref><ref id="B498-brainsci-03-01483"><label>498.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lesser</surname><given-names>R.P.</given-names></name><name><surname>Lueders</surname><given-names>H.</given-names></name><name><surname>Dinner</surname><given-names>D.S.</given-names></name></person-group>
<article-title>Evidence for epilepsy is rare in patients with psychogenic seizures</article-title>
<source>Neurology</source>
<year>1983</year>
<volume>33</volume>
<fpage>502</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.33.4.502</pub-id><?supplied-pmid 6682199?><pub-id pub-id-type="pmid">6682199</pub-id></element-citation></ref><ref id="B499-brainsci-03-01483"><label>499.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lelliott</surname><given-names>P.T.</given-names></name><name><surname>Fenwick</surname><given-names>P.</given-names></name></person-group>
<article-title>Cerebral pathology in pseudoseizures</article-title>
<source>Acta Neurol. Scand.</source>
<year>1991</year>
<volume>83</volume>
<fpage>129</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0404.1991.tb04661.x</pub-id><?supplied-pmid 1902011?><pub-id pub-id-type="pmid">1902011</pub-id></element-citation></ref><ref id="B500-brainsci-03-01483"><label>500.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pizzo</surname><given-names>P.A.</given-names></name></person-group>
<article-title>Lessons in pain relief &#x02013; a personal postgraduate experience</article-title>
<source>N. Engl. J. Med.</source>
<year>2013</year>
<volume>369</volume>
<fpage>1092</fpage>
<lpage>1093</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMp1306467</pub-id><?supplied-pmid 24047058?><pub-id pub-id-type="pmid">24047058</pub-id></element-citation></ref><ref id="B501-brainsci-03-01483"><label>501.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Jaspers</surname><given-names>K.</given-names></name></person-group>
<source>General Psychopathology</source>
<edition>7th ed.</edition>
<publisher-name>Manchester University Press</publisher-name>
<publisher-loc>Manchester, UK</publisher-loc>
<year>1963</year>
</element-citation></ref><ref id="B502-brainsci-03-01483"><label>502.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Olfactory Hallucinations</article-title>
<source>Science of Olfaction</source>
<person-group person-group-type="editor"><name><surname>Serby</surname><given-names>M.J.</given-names></name><name><surname>Chobor</surname><given-names>K.L.</given-names></name></person-group>
<publisher-name>Springer</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1992</year>
<fpage>467</fpage>
<lpage>499</lpage>
</element-citation></ref><ref id="B503-brainsci-03-01483"><label>503.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tilley</surname><given-names>H.</given-names></name></person-group>
<article-title>hree cases of parosmia; causes, treatment, <italic>etc.</italic></article-title>
<source>Lancet</source>
<year>1895</year>
<volume>146</volume>
<fpage>907</fpage>
<lpage>908</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(01)47039-5</pub-id></element-citation></ref><ref id="B504-brainsci-03-01483"><label>504.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allaez</surname><given-names>J.</given-names></name><name><surname>Dongiers</surname><given-names>S.</given-names></name></person-group>
<article-title>EEG correlations of olfactory hallucinations</article-title>
<source>Am. Med. Psychol.</source>
<year>1955</year>
<volume>110</volume>
<fpage>665</fpage>
<lpage>667</lpage>
</element-citation></ref><ref id="B505-brainsci-03-01483"><label>505.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fahn</surname><given-names>S.</given-names></name><name><surname>Bressman</surname><given-names>S.B.</given-names></name><name><surname>Marsden</surname><given-names>C.D.</given-names></name></person-group>
<article-title>Classification of dystonia</article-title>
<source>Adv. Neurol.</source>
<year>1998</year>
<volume>78</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<?supplied-pmid 9841474?><pub-id pub-id-type="pmid">9750897</pub-id></element-citation></ref><ref id="B506-brainsci-03-01483"><label>506.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Fahn</surname><given-names>S.</given-names></name></person-group>
<article-title>Atypical Tremors, Rare Tremors and Unclassified Tremors</article-title>
<source>Movement Disorders: Tremor</source>
<person-group person-group-type="editor"><name><surname>Findley</surname><given-names>L.J.</given-names></name><name><surname>Capildeo</surname><given-names>R.</given-names></name></person-group>
<publisher-name>Oxford University Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>1984</year>
<fpage>431</fpage>
<lpage>433</lpage>
</element-citation></ref><ref id="B507-brainsci-03-01483"><label>507.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Epileptiform convulsions from cerebral disease</article-title>
<source>Trans. Int. Med. Congr.</source>
<year>1881</year>
<volume>2</volume>
<fpage>6</fpage>
<lpage>19</lpage>
</element-citation></ref><ref id="B508-brainsci-03-01483"><label>508.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Florence</surname><given-names>S.L.</given-names></name><name><surname>Taub</surname><given-names>H.B.</given-names></name><name><surname>Kaas</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Large-scale sprouting of cortical connections after peripheral injury in adult macaque monkeys</article-title>
<source>Science</source>
<year>1998</year>
<volume>282</volume>
<fpage>1117</fpage>
<lpage>1121</lpage>
<pub-id pub-id-type="doi">10.1126/science.282.5391.1117</pub-id><?supplied-pmid 9804549?><pub-id pub-id-type="pmid">9804549</pub-id></element-citation></ref></ref-list></back></article>